0000950170-21-003800.txt : 20211109 0000950170-21-003800.hdr.sgml : 20211109 20211109171049 ACCESSION NUMBER: 0000950170-21-003800 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211109 DATE AS OF CHANGE: 20211109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kodiak Sciences Inc. CENTRAL INDEX KEY: 0001468748 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270476525 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38682 FILM NUMBER: 211393203 BUSINESS ADDRESS: STREET 1: 1200 PAGE MILL RD CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-281-0850 MAIL ADDRESS: STREET 1: 1200 PAGE MILL RD CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: Oligasis, LLC DATE OF NAME CHANGE: 20090721 10-Q 1 kod-20210930.htm 10-Q 10-Q
--12-31Q30001468748false0001468748us-gaap:RetainedEarningsMember2020-12-310001468748us-gaap:CommonStockMember2021-06-3000014687482021-10-132021-10-130001468748us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001468748us-gaap:ResearchAndDevelopmentExpenseMember2021-07-012021-09-300001468748kod:TwoThousandEighteenEquityIncentivePlanMember2021-01-012021-01-310001468748srt:MaximumMember2020-12-310001468748us-gaap:CorporateNoteSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-3100014687482020-03-3100014687482021-01-012021-09-300001468748kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember2020-12-310001468748kod:PerformanceBasedRestrictedStockUnitsMember2021-01-012021-09-3000014687482020-06-300001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001468748kod:PerformanceBasedStockOptionsMemberus-gaap:SubsequentEventMemberkod:TwoThousandEighteenEquityIncentivePlanMember2021-10-132021-10-130001468748kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember2020-01-012020-12-310001468748us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-09-3000014687482021-01-012021-03-3100014687482020-09-300001468748us-gaap:RetainedEarningsMember2020-04-012020-06-300001468748us-gaap:RetainedEarningsMember2021-04-012021-06-300001468748us-gaap:ResearchAndDevelopmentExpenseMember2020-07-012020-09-300001468748kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember2021-01-012021-09-300001468748us-gaap:RestrictedStockMember2021-01-012021-09-3000014687482020-04-012020-06-300001468748us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-09-300001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001468748srt:MinimumMemberus-gaap:SubsequentEventMemberkod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember2021-10-130001468748kod:ClinicalAndCommercialSupplyMemberkod:LonzaMembersrt:MaximumMemberkod:ManufacturingAgreementMember2020-08-012020-08-310001468748us-gaap:AdditionalPaidInCapitalMember2021-03-310001468748us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001468748us-gaap:CommonStockMember2021-07-012021-09-300001468748us-gaap:OtherAssetsMemberkod:ManufacturingAgreementMember2021-01-012021-09-300001468748kod:PerformanceBasedEquityAwardsMember2020-07-012020-09-300001468748srt:MaximumMemberus-gaap:SubsequentEventMemberkod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember2021-10-130001468748kod:LonzaMemberkod:ClinicalAndCommercialSupplyMemberkod:ManufacturingAgreementMember2021-04-3000014687482021-06-300001468748us-gaap:AdditionalPaidInCapitalMember2020-12-310001468748kod:ClinicalAndCommercialSupplyMemberkod:LonzaMemberkod:ManufacturingAgreementMember2020-08-012020-08-3100014687482020-07-012020-09-3000014687482021-07-012021-09-300001468748us-gaap:RestrictedStockMember2020-01-012020-09-3000014687482021-10-290001468748us-gaap:GeneralAndAdministrativeExpenseMember2021-07-012021-09-300001468748us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001468748us-gaap:EmployeeStockOptionMember2020-01-012020-09-300001468748us-gaap:RetainedEarningsMember2021-03-310001468748us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-09-300001468748us-gaap:AdditionalPaidInCapitalMember2019-12-310001468748us-gaap:RestrictedStockMember2021-01-012021-09-300001468748us-gaap:CommonStockMember2021-03-310001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001468748us-gaap:RetainedEarningsMember2020-09-300001468748us-gaap:FairValueMeasurementsRecurringMember2021-09-300001468748us-gaap:GeneralAndAdministrativeExpenseMember2020-07-012020-09-3000014687482019-12-3100014687482020-01-012020-09-300001468748kod:PerformanceBasedRestrictedStockUnitsMember2019-01-012019-12-310001468748us-gaap:CommonStockMember2020-01-012020-03-310001468748us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001468748srt:MaximumMember2021-09-300001468748kod:TwoThousandEighteenEmployeeSharePurchasePlanMember2021-09-300001468748us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001468748kod:PerformanceBasedEquityAwardsMember2020-01-012020-09-300001468748us-gaap:CommonStockMember2021-09-300001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001468748us-gaap:CommonStockMember2020-12-310001468748kod:PerformanceBasedStockOptionsMember2019-01-012019-12-310001468748kod:PerformanceBasedStockOptionsMember2021-01-012021-09-300001468748kod:TwoThousandEighteenEquityIncentivePlanMember2020-01-012020-01-310001468748us-gaap:RestrictedStockMember2021-09-300001468748us-gaap:RetainedEarningsMember2021-07-012021-09-300001468748us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-09-300001468748us-gaap:USTreasurySecuritiesMember2020-12-310001468748us-gaap:CommonStockMember2020-07-012020-09-300001468748us-gaap:RetainedEarningsMember2021-09-300001468748us-gaap:RestrictedStockMember2020-12-310001468748kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember2021-09-300001468748us-gaap:RetainedEarningsMember2020-07-012020-09-300001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001468748us-gaap:AdditionalPaidInCapitalMember2020-03-310001468748us-gaap:RetainedEarningsMember2019-12-310001468748us-gaap:RetainedEarningsMember2020-01-012020-03-310001468748us-gaap:RetainedEarningsMember2021-06-300001468748us-gaap:CommonStockMember2021-01-012021-03-310001468748us-gaap:AdditionalPaidInCapitalMember2021-06-300001468748us-gaap:SubsequentEventMember2021-10-132021-10-130001468748us-gaap:RetainedEarningsMember2020-03-310001468748us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001468748us-gaap:CorporateNoteSecuritiesMember2020-12-310001468748us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300001468748us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-3100014687482021-03-310001468748us-gaap:FairValueMeasurementsRecurringMember2020-12-310001468748kod:PerformanceBasedStockOptionsMember2020-01-012020-09-300001468748us-gaap:CommonStockMember2020-04-012020-06-300001468748us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001468748us-gaap:RetainedEarningsMember2020-06-300001468748us-gaap:AdditionalPaidInCapitalMember2021-09-300001468748us-gaap:LeaseAgreementsMember2021-09-300001468748us-gaap:CommonStockMember2020-03-310001468748kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember2021-01-012021-09-300001468748us-gaap:CommonStockMember2020-06-300001468748kod:TwoThousandEighteenEmployeeSharePurchasePlanMember2021-07-012021-09-3000014687482020-12-310001468748us-gaap:SubsequentEventMemberkod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember2021-10-130001468748us-gaap:CommonStockMember2020-09-300001468748us-gaap:RetainedEarningsMember2021-01-012021-03-3100014687482021-09-300001468748kod:PerformanceBasedEquityAwardsMember2021-07-012021-09-300001468748us-gaap:AdditionalPaidInCapitalMember2020-09-300001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001468748us-gaap:EmployeeStockOptionMember2021-01-012021-09-300001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001468748us-gaap:CommonStockMember2019-12-3100014687482021-04-012021-06-300001468748kod:TwoThousandEighteenEmployeeSharePurchasePlanMember2021-01-012021-09-300001468748us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001468748kod:PerformanceBasedEquityAwardsMember2021-01-012021-09-3000014687482020-01-012020-03-310001468748us-gaap:AdditionalPaidInCapitalMember2020-06-300001468748us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateNoteSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001468748us-gaap:CommonStockMember2021-04-012021-06-300001468748us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001468748us-gaap:SubsequentEventMemberkod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember2021-10-132021-10-130001468748us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001468748us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001468748us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001468748us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001468748us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-30xbrli:pureiso4217:USDxbrli:sharesxbrli:shareskod:Daysiso4217:CHFkod:PurchasePeriodiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to _________

Commission File Number: 001-38682

 

KODIAK SCIENCES INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

27-0476525

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1200 Page Mill Road

Palo Alto, CA

94304

(Address of principal executive offices)

(Zip Code)

 

Registrant’s telephone number, including area code: (650) 281-0850

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.0001

KOD

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

Accelerated filer

 

 

 

Non-accelerated filer

 

 

Smaller reporting company

 

 

 

 

 

 

 

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☒

As of October 29, 2021, the registrant had 51,717,286 shares of common stock, $0.0001 par value per share, outstanding.

 

 

 


 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, or Exchange Act. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith beliefs as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.

Forward-looking statements include all statements that are not historical facts. In some cases, you can identify forward-looking statements by terms such as “may,” “might,” “will,” “objective,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “anticipate,” “project,” “target,” “design,” “estimate,” “predict,” “potential,” “plan”, “hope” or the negative of these terms, or similar expressions and comparable terminology intended to identify forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties, including those set forth under the section of this Quarterly Report on Form 10-Q titled “Part II, Item 1A — Risk Factors” and elsewhere in this report. Forward-looking statements include, but are not limited to, statements about:

the success, cost and timing of our development activities, preclinical studies, clinical trials and regulatory filings;
the translation of our preclinical results and data and early clinical trial results in particular relating to safety, efficacy and durability into future clinical trials in humans;
the continued durability, efficacy and safety of our product candidates;
the portfolio of clinical trials planned for submission in our Biologics License Application, or BLA, of KSI-301;
our ability to present clinical data across our pivotal trials beginning in early 2022;
our and Lonza’s ability to successfully execute on our manufacturing development plan;
the number, size and design of clinical trials that regulatory authorities may require to obtain marketing approval, including the order and number of clinical studies required to support a BLA in wet age-related macular degeneration, or wet AMD, diabetic macular edema, or DME, retinal vein occlusion, or RVO, and diabetic retinopathy, or DR;
our expectations regarding chemistry manufacturing and controls, or CMC, requirements of the United States Food and Drug Administration, or FDA, and other regulatory bodies to support our BLA submission and potential commercial launch;
the timing or likelihood of regulatory filings and approvals, including the potential to achieve FDA approval of KSI-301 in wet AMD, DME, RVO and DR;
our ability to obtain and maintain regulatory approval of our product candidates, and any related restrictions, limitations and/or warnings in the label of any approved product candidate;
our ability to obtain funding for our operations, including funding necessary to develop, manufacture and commercialize our product candidates;
the rate and degree of market acceptance of our product candidates;
the success of competing products or platform technologies that are or may become available;
our plans and ability to establish sales, marketing and distribution infrastructure to commercialize any product candidates for which we obtain approval;
our expectation as to the concentration of retinal specialists in the United States and its impact on our sales and marketing plans;
our expectations regarding our ability to enter into manufacturing-related commitments, and the timing thereof;
future agreements with third parties in connection with the commercialization of our product candidates;
the size and growth potential of the markets for our product candidates, if approved for commercial use, and our ability to serve those markets;
existing regulations and regulatory developments in the United States and foreign countries;

i


 

the expected potential benefits of strategic collaboration agreements and our ability to attract collaborators with development, regulatory and commercialization expertise;
the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology;
potential claims relating to our intellectual property and third-party intellectual property;
our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately;
the pricing and reimbursement of our product candidates, if approved;
our estimates regarding the impact of the novel coronavirus, or COVID-19, pandemic on our business and operations, the business and operations of our collaborators, and on the global economy;
our aspirational goals and objectives related to our human capital resources and workforce objectives;
our ability to attract and retain key managerial, scientific and medical personnel;
the accuracy of our estimates regarding the sufficiency of our cash resources, expenses, future revenue, capital requirements and needs for additional financing; and
our financial performance.

All forward-looking statements are based on information available to us on the date of this Quarterly Report on Form 10-Q and we will not update any of the forward-looking statements after the date of this Quarterly Report on Form 10-Q, except as required by law. Our actual results could differ materially from those discussed in this Quarterly Report on Form 10-Q. The forward-looking statements contained in this Quarterly Report on Form 10-Q, and other written and oral forward-looking statements made by us from time to time, are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements, and you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Factors that might cause such a difference include, but are not limited to, those discussed in the following discussion and within the section of this Quarterly Report on Form 10-Q titled “Part II, Item 1A — Risk Factors”.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

All brand names or trademarks appearing in this report are the property of their respective holders. Unless the context requires otherwise, references in this report to “Kodiak” the “Company,” “we,” “us,” and “our” refer to Kodiak Sciences Inc. and its subsidiaries.

ii


 

SELECTED RISKS AFFECTING OUR BUSINESS

Investing in our common stock involves numerous risks, including the risks described in “Part II—Other Information, Item 1A. Risk Factors” of this Quarterly Report on Form 10-Q, any one of which could materially adversely affect our business, financial condition, results of operations, and prospects. These risks include, among others, the following:

We are in the clinical stage of drug development and have a very limited operating history and no products approved for commercial sale, which may make it difficult to evaluate our current business and predict our future success and viability.
We have incurred significant net losses in each period since our inception and anticipate that we will continue to incur significant and increasing net losses for the foreseeable future.
Drug development is a highly uncertain undertaking and involves a substantial degree of risk. We have never generated any revenue from product sales, and we may never generate revenue or be profitable.
Our prospects are heavily dependent on our KSI-301 product candidate, which is currently in clinical development for multiple indications.
A failure of KSI-301 in clinical development may require us to discontinue development of other product candidates based on our ABC Platform.
Research and development of biopharmaceutical products is inherently risky. We cannot give any assurance that any of our product candidates will receive regulatory, including marketing, approval, which is necessary before they can be commercialized.
We may encounter substantial delays in our clinical trials, or may not be able to conduct or complete our clinical trials on the timelines we expect, if at all.
We may encounter difficulties enrolling patients in our clinical trials, and our clinical development activities could thereby be delayed or otherwise adversely affected.
Our clinical trials may fail to demonstrate substantial evidence of the durability, efficacy and safety of our product candidates, which would prevent, delay or limit the scope of regulatory approval and commercialization.
We face significant competition in an environment of rapid technological and scientific change, and there is a possibility that our competitors may retain their market share with existing drugs or achieve regulatory approval before us or develop therapies that are safer, more advanced or more effective than ours, which may negatively impact our ability to successfully market or commercialize any product candidates we may develop and ultimately harm our financial condition.
The manufacture of our product candidates is highly complex and requires substantial lead time to produce.
We have no experience manufacturing any of our product candidates at a commercial scale. If we or any of our third-party manufacturers encounter difficulties in production or fail to meet rigorously enforced regulatory standards, our ability to provide supply of our product candidates for clinical trials or our ability to provide the information needed in the regulatory dossiers for our BLA filing, or our ability to supply our products for patients, if approved, could be delayed or stopped, or we may be unable to establish a commercially viable cost structure.
The regulatory approval processes of the FDA, EMA, NMPA and comparable foreign regulatory authorities are lengthy, time consuming, and inherently unpredictable. If we are ultimately unable to obtain regulatory approval for our product candidates, we will be unable to generate product revenue and our business will be substantially harmed.
We plan to conduct clinical trials for our product candidates outside the United States, and the FDA, EMA, NMPA and applicable foreign regulatory authorities may not accept data from such trials.
Our business is subject to complex and evolving U.S. and foreign laws and regulations relating to privacy and data protection. These laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, or monetary penalties, and otherwise may harm our business.
If we or any contract manufacturers and suppliers we engage fail to comply with environmental, health, and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.
We expect to rely on third parties to conduct many aspects of our clinical trials and some aspects of our research and preclinical testing, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research or testing.

iii


 

If we are unable to obtain and maintain patent protection for any product candidates we develop or for our ABC Platform, our competitors could develop and commercialize products or technology similar or identical to ours, and our ability to successfully commercialize any product candidates we may develop, and our technology may be adversely affected.
If the scope of any patent protection we obtain is not sufficiently broad, or if we lose any of our patent protection, our ability to prevent our competitors from commercializing similar or identical technology and product candidates would be adversely affected.
Third-party claims of intellectual property infringement, misappropriation or other violation against us or our collaborators may prevent or delay the development and commercialization of our ABC Platform, product candidates and other technologies.
We may become involved in lawsuits to protect or enforce our patents and other intellectual property rights, which could be expensive, time consuming and unsuccessful.
We are highly dependent on our key personnel, and if we are not successful in attracting, motivating and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.
Our business is currently affected and could be materially and adversely affected in the future by the effects of disease outbreaks, epidemics and pandemics, including the ongoing effects of the COVID-19 pandemic. The COVID-19 pandemic continues to impact our business and could materially and adversely affect our operations, as well as the business or operations of our manufacturers, CROs or other third parties with whom we conduct business. Our manufacturers are also engaged in the manufacturing of COVID-19 related vaccines and therapeutic treatments, and the success of and demand for these vaccines and therapeutic treatments means we and our programs are competing for scarce manufacturing resources.

 

iv


 

Table of Contents

 

 

 

Page

PART I.

FINANCIAL INFORMATION

1

Item 1.

Financial Statements (Unaudited)

1

 

Condensed Consolidated Balance Sheets

1

 

Condensed Consolidated Statements of Operations and Comprehensive Loss

2

 

Condensed Consolidated Statements of Stockholders’ Equity

3

 

Condensed Consolidated Statements of Cash Flows

4

 

Notes to Unaudited Condensed Consolidated Financial Statements

5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

12

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

20

Item 4.

Controls and Procedures

20

PART II.

OTHER INFORMATION

21

Item 1.

Legal Proceedings

21

Item 1A.

Risk Factors

21

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

62

Item 3.

Defaults Upon Senior Securities

62

Item 4.

Mine Safety Disclosures

62

Item 5.

Other Information

62

Item 6.

Exhibits

63

Signatures

64

 

v


 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited).

Kodiak Sciences Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

(Unaudited)

 

 

 

September 30,
2021

 

 

December 31,
2020

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

799,247

 

 

$

944,396

 

Marketable securities

 

 

 

 

 

24,578

 

Prepaid expenses and other current assets

 

 

6,259

 

 

 

3,031

 

Total current assets

 

 

805,506

 

 

 

972,005

 

Restricted cash

 

 

6,324

 

 

 

6,324

 

Property and equipment, net

 

 

22,939

 

 

 

5,136

 

Operating lease right-of-use asset

 

 

68,450

 

 

 

73,672

 

Other assets

 

 

54,987

 

 

 

10,210

 

Total assets

 

$

958,206

 

 

$

1,067,347

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

13,761

 

 

$

8,646

 

Accrued and other current liabilities

 

 

39,016

 

 

 

20,402

 

Operating lease liability

 

 

1,619

 

 

 

2,374

 

Total current liabilities

 

 

54,396

 

 

 

31,422

 

Operating lease liability, net of current portion

 

 

77,338

 

 

 

75,028

 

Liability related to sale of future royalties

 

 

99,929

 

 

 

99,890

 

Other liabilities

 

 

223

 

 

 

256

 

Total liabilities

 

 

231,886

 

 

 

206,596

 

Commitments and contingencies (Note 6)

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Preferred stock, $0.0001 par value, 10,000,000 shares authorized;
   
0 shares issued and outstanding at September 30, 2021 and
   December 31, 2020, respectively

 

 

 

 

 

 

Common stock, $0.0001 par value, 490,000,000 shares authorized
   at September 30, 2021 and December 31, 2020;
51,698,775 and
   
51,112,302 shares issued and outstanding at September 30, 2021 and
   December 31, 2020, respectively

 

 

5

 

 

 

5

 

Additional paid-in capital

 

 

1,191,367

 

 

 

1,151,920

 

Accumulated other comprehensive income

 

 

 

 

 

53

 

Accumulated deficit

 

 

(465,052

)

 

 

(291,227

)

Total stockholders’ equity

 

 

726,320

 

 

 

860,751

 

Total liabilities and stockholders’ equity

 

$

958,206

 

 

$

1,067,347

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

1


 

Kodiak Sciences Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share and per share amounts)

(Unaudited)

 

 

 

Three Months Ended
  September 30,

 

 

Nine Months Ended
  September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

56,002

 

 

$

29,306

 

 

$

141,743

 

 

$

70,033

 

General and administrative

 

 

11,533

 

 

 

7,357

 

 

 

32,259

 

 

 

19,132

 

Total operating expenses

 

 

67,535

 

 

 

36,663

 

 

 

174,002

 

 

 

89,165

 

Loss from operations

 

 

(67,535

)

 

 

(36,663

)

 

 

(174,002

)

 

 

(89,165

)

Interest income

 

 

40

 

 

 

645

 

 

 

270

 

 

 

2,551

 

Interest expense

 

 

(6

)

 

 

(6

)

 

 

(17

)

 

 

(19

)

Other income (expense), net

 

 

(25

)

 

 

(98

)

 

 

(76

)

 

 

120

 

Net loss

 

$

(67,526

)

 

$

(36,122

)

 

$

(173,825

)

 

$

(86,513

)

Net loss per common share, basic and diluted

 

$

(1.30

)

 

$

(0.80

)

 

$

(3.36

)

 

$

(1.92

)

Weighted-average common shares outstanding used in
   computing net loss per common share, basic and diluted

 

 

51,875,315

 

 

 

45,119,885

 

 

 

51,722,611

 

 

 

44,972,085

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

Change in unrealized gains related to available-for-sale
   debt securities, net of tax

 

 

 

 

 

(349

)

 

 

(53

)

 

 

235

 

Total other comprehensive income (loss)

 

 

 

 

 

(349

)

 

 

(53

)

 

 

235

 

Comprehensive loss

 

$

(67,526

)

 

$

(36,471

)

 

$

(173,878

)

 

$

(86,278

)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2


 

Kodiak Sciences Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share and per share amounts)

(Unaudited)

 

 

 

Common Stock

 

 

Additional
Paid-In

 

 

Accumulated
Other
Comprehensive

 

 

Accumulated

 

 

Total
Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income (Loss)

 

 

Deficit

 

 

Equity

 

Balances at December 31, 2020

 

 

51,112,302

 

 

$

5

 

 

$

1,151,920

 

 

$

53

 

 

$

(291,227

)

 

$

860,751

 

Issuance of common stock upon
   exercise of stock options

 

 

113,559

 

 

 

 

 

 

1,483

 

 

 

 

 

 

 

 

 

1,483

 

Stock-based compensation
   expense

 

 

 

 

 

 

 

 

9,925

 

 

 

 

 

 

 

 

 

9,925

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(35

)

 

 

 

 

 

(35

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(50,447

)

 

 

(50,447

)

Balances at March 31, 2021

 

 

51,225,861

 

 

 

5

 

 

 

1,163,328

 

 

 

18

 

 

 

(341,674

)

 

 

821,677

 

Issuance of common stock upon
   exercise of stock options

 

 

131,276

 

 

 

 

 

 

2,228

 

 

 

 

 

 

 

 

 

2,228

 

Issuance of common stock upon
   vesting of restricted stock units,
   net of taxes withheld

 

 

72,976

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock pursuant
   to employee stock purchase plans

 

 

4,295

 

 

 

 

 

 

305

 

 

 

 

 

 

 

 

 

305

 

Stock-based compensation
   expense

 

 

 

 

 

 

 

 

11,087

 

 

 

 

 

 

 

 

 

11,087

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(18

)

 

 

 

 

 

(18

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(55,852

)

 

 

(55,852

)

Balances at June 30, 2021

 

 

51,434,408

 

 

 

5

 

 

 

1,176,948

 

 

 

 

 

 

(397,526

)

 

 

779,427

 

Issuance of common stock upon
   exercise of stock options

 

 

103,585

 

 

 

 

 

 

2,042

 

 

 

 

 

 

 

 

 

2,042

 

Issuance of common stock upon
   vesting of restricted stock units,
   net of taxes withheld

 

 

10,799

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock upon
   exercise of common stock warrants

 

 

149,983

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation
   expense

 

 

 

 

 

 

 

 

12,377

 

 

 

 

 

 

 

 

 

12,377

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(67,526

)

 

 

(67,526

)

Balances at September 30, 2021

 

 

51,698,775

 

 

$

5

 

 

$

1,191,367

 

 

$

 

 

$

(465,052

)

 

$

726,320

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Additional
Paid-In

 

 

Accumulated
Other
Comprehensive

 

 

Accumulated

 

 

Total
Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income (Loss)

 

 

Deficit

 

 

Equity

 

Balances at December 31, 2019

 

 

44,413,404

 

 

$

5

 

 

$

503,475

 

 

$

10

 

 

$

(158,131

)

 

$

345,359

 

Issuance of common stock upon
   exercise of stock options

 

 

39,297

 

 

 

 

 

 

159

 

 

 

 

 

 

 

 

 

159

 

Stock-based compensation
   expense

 

 

 

 

 

 

 

 

6,082

 

 

 

 

 

 

 

 

 

6,082

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

479

 

 

 

 

 

 

479

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(24,392

)

 

 

(24,392

)

Balances at March 31, 2020

 

 

44,452,701

 

 

 

5

 

 

 

509,716

 

 

 

489

 

 

 

(182,523

)

 

 

327,687

 

Issuance of common stock upon
   exercise of stock options

 

 

203,373

 

 

 

 

 

 

720

 

 

 

 

 

 

 

 

 

720

 

Issuance of common stock upon
   vesting of restricted stock units,
   net of taxes withheld

 

 

10,942

 

 

 

 

 

 

(206

)

 

 

 

 

 

 

 

 

(206

)

Stock-based compensation
   expense

 

 

 

 

 

 

 

 

6,890

 

 

 

 

 

 

 

 

 

6,890

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

105

 

 

 

 

 

 

105

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(25,999

)

 

 

(25,999

)

Balances at June 30, 2020

 

 

44,667,016

 

 

 

5

 

 

 

517,120

 

 

 

594

 

 

 

(208,522

)

 

 

309,197

 

Issuance of common stock upon
   exercise of stock options

 

 

93,497

 

 

 

 

 

 

813

 

 

 

 

 

 

 

 

 

813

 

Stock-based compensation
   expense

 

 

 

 

 

 

 

 

8,241

 

 

 

 

 

 

 

 

 

8,241

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(349

)

 

 

 

 

 

(349

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(36,122

)

 

 

(36,122

)

Balances at September 30, 2020

 

 

44,760,513

 

 

$

5

 

 

$

526,174

 

 

$

245

 

 

$

(244,644

)

 

$

281,780

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3


 

Kodiak Sciences Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(Unaudited)

 

 

 

Nine Months Ended
  September 30,

 

 

 

2021

 

 

2020

 

Cash flows from operating activities

 

 

 

 

 

 

Net loss

 

$

(173,825

)

 

$

(86,513

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

Depreciation

 

 

722

 

 

 

317

 

Stock-based compensation

 

 

33,389

 

 

 

21,213

 

Amortization (accretion) of premium (discount) on marketable securities

 

 

25

 

 

 

(145

)

Amortization of operating lease right-of-use asset

 

 

5,811

 

 

 

1,793

 

Amortization of issuance costs

 

 

39

 

 

 

36

 

Changes in assets and liabilities:

 

 

 

 

 

 

Prepaid expenses and other current assets

 

 

(3,228

)

 

 

1,518

 

Other assets

 

 

(936

)

 

 

(3,654

)

Accounts payable

 

 

3,255

 

 

 

1,616

 

Accrued and other current liabilities

 

 

10,547

 

 

 

7,566

 

Operating lease liability

 

 

966

 

 

 

(156

)

Net cash used in operating activities

 

 

(123,235

)

 

 

(56,409

)

Cash flows from investing activities

 

 

 

 

 

 

Purchase of property and equipment

 

 

(8,598

)

 

 

(1,855

)

Deposits on property and equipment

 

 

(43,841

)

 

 

 

Purchase of marketable securities

 

 

 

 

 

(86,317

)

Maturities of marketable securities

 

 

24,500

 

 

 

134,148

 

Net cash provided by (used in) investing activities

 

 

(27,939

)

 

 

45,976

 

Cash flows from financing activities

 

 

 

 

 

 

Proceeds from issuance of common stock upon options exercise

 

 

5,753

 

 

 

1,692

 

Payments for restricted stock units, net of taxes withheld

 

 

 

 

 

(206

)

Proceeds from issuance of common stock pursuant to employee stock purchase plans

 

 

305

 

 

 

 

Proceeds from sale of future royalties, net of issuance costs

 

 

 

 

 

99,643

 

Principal payments of capital lease

 

 

 

 

 

(5

)

Principal payments of tenant improvement allowance payable

 

 

(33

)

 

 

(28

)

Net cash provided by financing activities

 

 

6,025

 

 

 

101,096

 

Net increase (decrease) in cash, cash equivalents and restricted cash

 

 

(145,149

)

 

 

90,663

 

Cash, cash equivalents and restricted cash, at beginning of period

 

 

950,720

 

 

 

211,937

 

Cash, cash equivalents and restricted cash, at end of period

 

$

805,571

 

 

$

302,600

 

Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets

 

 

 

 

 

 

Cash and cash equivalents

 

$

799,247

 

 

$

291,585

 

Restricted cash

 

 

6,324

 

 

 

11,015

 

Cash, cash equivalents and restricted cash in consolidated balance sheets

 

$

805,571

 

 

$

302,600

 

 

 

 

 

 

 

 

Supplemental disclosures of non-cash investing and financing information:

 

 

 

 

 

 

Operating lease right-of-use asset obtained in exchange for operating lease liability

 

$

583

 

 

$

75,545

 

Purchase of property and equipment under accounts payable and accruals

 

$

10,730

 

 

$

1,034

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


 

Kodiak Sciences Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share data)

1. The Company

Kodiak Sciences Inc. (the “Company”) is a clinical stage biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases in the United States and additional international markets. The Company devotes substantially all of its resources to the research and development of its product platforms and product candidates including activities to conduct clinical studies of its product candidates, manufacture product candidates and provide general and administrative support for these operations.

Liquidity

As of September 30, 2021, the Company had cash and cash equivalents of $799.2 million. Although the Company has incurred significant operating losses since inception and expects to continue to incur operating losses and negative operating cash flows for the foreseeable future, the Company believes that the cash and cash equivalents will be sufficient to meet the anticipated operating and capital expenditure requirements for the 12 months following the date of this Form 10-Q.

2. Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) applicable to interim periods. The condensed consolidated financial statements, in the opinion of management, include all normal and recurring adjustments necessary to present fairly the Company's financial position and results of operations for the reported periods.

These condensed consolidated financial statements have been prepared on a basis substantially consistent with, and should be read in conjunction with the audited financial statements for the year ended December 31, 2020 and notes thereto, the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 1, 2021. Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or omitted from this report. The results of operations for any interim period are not necessarily indicative of the results for the year ending December 31, 2021, or for any future period.

The accompanying condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.

Reclassification

Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no impact on subtotals in the prior year condensed consolidated financial statements.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and expenses during the reporting period. The impact of the ongoing COVID-19 pandemic continues to evolve. As a result, certain estimates and assumptions required increased judgment and carried a higher degree of variability and volatility, including but not limited to, the fair value of marketable securities, performance-based equity awards, and research and development accruals for the three and nine months ended September 30, 2021. As events continue to unfold and additional information becomes available, these estimates may change materially in future periods. Actual results could differ from those estimates.

5


Kodiak Sciences Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (Continued)

 

Risks and Uncertainties

In March 2020, the World Health Organization declared a pandemic due to the global COVID-19 outbreak. The significant uncertainties caused by the ongoing COVID-19 pandemic may negatively impact the Company’s operations, liquidity, and capital resources and will depend on certain evolving developments, including the duration and spread of the outbreak, regulatory and private sector responses and the impact on employees and vendors including supply chain and clinical partners, all of which are uncertain and cannot be predicted. During this pandemic, the Company continues to work closely with clinical sites towards maximal patient safety and the lowest number of missed visits and study discontinuations. The Company has taken and continues to take proactive measures to maintain the integrity of its ongoing clinical studies. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact clinical trial enrollment and completion of its clinical studies. During this pandemic, the Company continues to work closely with its manufacturing suppliers, partners and facilities to maintain the supply of its product candidates needed for the expansion of clinical trials and to retain the number, scale and design of manufacturing runs that regulatory authorities may require to obtain marketing approval, including those required to support a BLA submission. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact the timing or likelihood of clinical resupply and of regulatory filings and approvals. The Company will continue to monitor the COVID-19 situation and its impact on the ability to continue the development of, and seek regulatory approvals for, the Company’s product candidates, and begin to commercialize any approved products.

Summary of Significant Accounting Policies

The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and nine months ended September 30, 2021, respectively, are consistent with those discussed in Note 2 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, except as noted within the “Recent Accounting Pronouncements – Recently Adopted Accounting Pronouncements” section.

Recent accounting pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”), under its Accounting Standards Codification or other standard setting bodies, and adopted by the Company as of the specified effective date, unless otherwise discussed below.

Recently Adopted Accounting Pronouncements

In October 2020, the FASB issued Accounting Standards Update 2020-10, Codification Improvements, which updates various codification topics and disclosure requirements to improve alignment with the SEC's regulations. The Company adopted this new guidance as of January 1, 2021, and this guidance did not have a material impact on its consolidated financial statements and related disclosures.

New Accounting Pronouncements Not Yet Adopted

The Company continues to monitor new accounting pronouncements issued by the FASB. All other newly issued accounting pronouncements issued through the date of this report have been deemed either immaterial or not applicable. 

3. Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following (in thousands):

 

 

 

September 30,
2021

 

 

December 31,
2020

 

Accrued clinical trial and related costs

 

$

21,762

 

 

$

11,119

 

Accrued leasehold improvements

 

 

7,470

 

 

 

19

 

Accrued salaries and benefits

 

 

4,790

 

 

 

5,094

 

Accrued research and development

 

 

3,392

 

 

 

3,082

 

Accrued legal fees

 

 

582

 

 

 

252

 

Accrued professional fees

 

 

223

 

 

 

253

 

Accrued other liabilities

 

 

797

 

 

 

583

 

Total accrued and other current liabilities

 

$

39,016

 

 

$

20,402

 

 

6


Kodiak Sciences Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (Continued)

 

4. Fair Value Measurements

The following tables present the Company’s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):

 

 

 

Fair Value Measurements at September 30, 2021

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

762,550

 

 

$

 

 

$

 

 

$

762,550

 

Total

 

$

762,550

 

 

$

 

 

$

 

 

$

762,550

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements at December 31, 2020

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

917,485

 

 

$

 

 

$

 

 

$

917,485

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasury securities

 

 

 

 

 

10,006

 

 

 

 

 

 

10,006

 

Corporate notes

 

 

 

 

 

14,572

 

 

 

 

 

 

14,572

 

Total

 

$

917,485

 

 

$

24,578

 

 

$

 

 

$

942,063

 

 

As of September 30, 2021 and December 31, 2020, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (“BBA”), which are considered Level 3 inputs. 

5. Marketable Securities

The marketable securities are classified as available-for-sale and consist of U.S. treasury securities and corporate notes. The fair value measurement data for marketable securities is obtained from independent pricing services. The Company validates the prices provided by the third-party pricing services by understanding the valuation methods and data sources used and analyzing the pricing data in certain instances.

The Company had no marketable securities at September 30, 2021. The following table summarizes the marketable securities (in thousands):

 

As of December 31, 2020

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

U.S. treasury securities

 

$

10,003

 

 

$

3

 

 

$

 

 

$

10,006

 

Corporate notes

 

 

14,522

 

 

 

50

 

 

 

 

 

 

14,572

 

Total marketable securities, current

 

$

24,525

 

 

$

53

 

 

$

 

 

$

24,578

 

 

All marketable securities held at December 31, 2020 had effective maturities of less than one year. There were no realized gains or losses recognized on the sale or maturity of available-for-sale debt securities during the three and nine months ended September 30, 2021, respectively and, as a result, the Company did not reclassify any amounts out of accumulated comprehensive loss. As of September 30, 2021 and December 31, 2020, the Company had no allowance for credit losses for available-for-sale debt securities. There were no impairment charges or recoveries recorded during each of the nine months ended September 30, 2021 and September 30, 2020, respectively.

 

6. Commitments and Contingencies

Embedded Lease

In August 2020, the Company and its wholly-owned subsidiary Kodiak Sciences GmbH entered into a manufacturing agreement with Lonza Ltd (“Lonza”) for the clinical and commercial supply of drug substance for KSI-301. A custom-built manufacturing facility is planned to be completed and dedicated to the manufacture of the Company’s drug substance. The manufacturing agreement has an initial term of eight years, and the Company has the right to extend the term up to a total of 16 years. The Company and Lonza each have the ability to terminate this agreement upon the occurrence of certain conditions.

7


Kodiak Sciences Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (Continued)

 

In April 2021, the agreement was amended to provide for higher annual manufacturing capacity. The Company expanded and finalized the design and scope of the bioconjugate manufacturing facility with a revised estimated capital contribution of approximately 75.0 million Swiss Francs of which the Company has paid 35.0 million Swiss Francs of the capital contribution, equivalent to $38.7 million U.S. Dollars, which is recorded in other assets on the consolidated balance sheet as of September 30, 2021. Over the period from 2022 through 2029, manufacturing payments totaling approximately 150.0 million Swiss Francs may be incurred for potential commercial supply of KSI-301 drug substance.

The Company concluded that this agreement contains an embedded lease as the custom-built manufacturing suite will be dedicated for the Company’s use. As of September 30, 2021, the Company did not have control of this manufacturing space and therefore, did not record a right-of-use asset and corresponding lease liability.

Manufacturing Agreements

The Company has entered into service and equipment purchase agreements in the normal course of business with various providers, pursuant to which such providers agreed to perform activities in connection with the manufacturing process of certain materials. These agreements, and any related amendments, state that planned activities and purchases that are included in the signed work orders are, in some cases, binding and, hence, obligate the Company to pay the full price of the work order upon satisfactory delivery of products and services or obligate the Company to the binding amount regardless of whether such planned activities are in fact performed. Per the terms of the agreements, the Company has the option to cancel signed orders at any time upon written notice, which may or may not be subject to payment of a cancellation fee. The level of cancellation fees may be dependent on the timing of the written notice in relation to the commencement date of the work, with the maximum cancellation amount dependent on the agreement or the work order.

Other Funding Commitments

In the normal course of business, the Company enters into agreements with third-parties for services to be provided to the Company. Generally, these agreements provide for termination upon notice, with specified amounts due upon termination based on the timing of termination and the terms of the applicable agreement. The actual amounts and timing of payments under these agreements are uncertain and contingent upon the initiation and completion of services to be provided to the Company.

The Company has also entered into various cancellable license agreements for certain technology. The Company may be obligated to make payments on future sales of specified products associated with such license agreements. Such payments are dependent on future product sales and are not estimable.

Indemnification

To the extent permitted under Delaware law, the Company has agreed to indemnify its directors and officers for certain events or occurrences while the director or officer is, or was serving, at the Company’s request in such capacity. The indemnification period covers all pertinent events and occurrences during the director’s or officer’s service. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is not specified in the agreements; however, the Company has director and officer insurance coverage that reduces its exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.

8


Kodiak Sciences Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (Continued)

 

7. Stock-Based Compensation

In January 2021 and 2020, the number of shares of common stock available for issuance under the 2018 Equity Incentive Plan (the "2018 Plan") was increased by approximately 2.0 million and 1.8 million shares, respectively, as a result of the automatic increase provision in the 2018 Plan.

Stock Options

Stock option activity under the 2018 Plan and 2015 Equity Incentive Plan (the "2015 Plan") is summarized as follows:

 

 

 

Number
of
Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2020

 

 

6,897,276

 

 

$

24.52

 

 

 

8.07

 

 

$

841,704

 

Granted

 

 

1,478,994

 

 

$

94.80

 

 

 

 

 

 

 

Exercised

 

 

(348,420

)

 

$

17.06

 

 

 

 

 

 

 

Forfeited or canceled

 

 

(228,118

)

 

$

41.86

 

 

 

 

 

 

 

Outstanding at September 30, 2021

 

 

7,799,732

 

 

$

37.62

 

 

 

7.74

 

 

$

431,288

 

 

Restricted Shares

Restricted share activity, including restricted stock awards, restricted stock units, and performance-based restricted stock units, under the 2018 Plan and 2015 Plan is summarized as follows:

 

 

 

Number of
Restricted
Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Unvested at December 31, 2020

 

 

359,945

 

 

$

59.54

 

Granted

 

 

170,150

 

 

$

90.75

 

Vested

 

 

(83,775

)

 

$

57.98

 

Canceled

 

 

(34,033

)

 

$

61.24

 

Unvested at September 30, 2021

 

 

412,287

 

 

$

72.59

 

 

Performance-Based Stock Options and Restricted Stock Units

The Company granted 669,581 performance-based stock options during the nine months ended September 30, 2021 (the "2021 PSAs"). The Company did not grant any performance-based equity awards during 2020. The Company granted 170,150 performance-based options and 128,900 performance-based restricted stock units to employees in 2019 (the "2019 PSAs").

The performance-based equity awards granted will vest one-quarter upon the achievement of specific clinical development milestones. The remaining shares will then vest ratably over three years thereafter. Performance-based stock options and performance-based restricted stock units are recorded as expense beginning when vesting events are determined to be probable.

The milestone for the 2019 PSAs was achieved during the second quarter of 2021. As of September 30, 2021, 42,536 performance-based stock options and 28,905 performance-based restricted stock units granted during 2019 have vested. The Company believes that the achievement of the requisite performance condition for 2021 PSAs granted in the first quarter of 2021 continues to be probable.

Stock-based compensation expense recognized was $2.1 million and $8.3 million during the three and nine months ended September 30, 2021, respectively, and $1.8 million and $5.5 million during the three and nine months ended September 30, 2020, respectively.

9


Kodiak Sciences Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (Continued)

 

2018 Employee Share Purchase Plan

 

In August 2018, the Company adopted the 2018 Employee Share Purchase Plan (“ESPP”), which became effective on the business day prior to the effectiveness of the registration statement relating to the Company's initial public offering. A total of 460,000 shares of common stock were initially reserved for issuance under the ESPP. The initial offering period of the ESPP was authorized by the Company’s board of directors and commenced on January 4, 2021. Each offering period is approximately twelve months long, with two purchase periods. ESPP participants will purchase shares of common stock at a price per share equal to 85% of the lesser of (1) the fair market value per share of the common stock on the enrollment date or (2) the fair market value of the common stock on the exercise date.

The Company issued no shares and 4,295 shares under the ESPP during the three and nine months ended September 30, 2021, respectively. The stock-based compensation expense related to the ESPP was less than $0.1 million and $0.2 million during the three and nine months ended September 30, 2021, respectively.

Stock-Based Compensation Expense

Stock-based compensation for options, restricted shares, and ESPP is classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended
  September 30,

 

 

Nine Months Ended
  September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Research and development

 

$

6,429

 

 

$

4,759

 

 

$

17,598

 

 

$

11,983

 

General and administrative

 

 

5,948

 

 

 

3,482

 

 

 

15,791

 

 

 

9,230

 

Total stock-based compensation

 

$

12,377

 

 

$

8,241

 

 

$

33,389

 

 

$

21,213

 

 

As of September 30, 2021, total unrecognized compensation cost related to the unvested share-based awards and ESPP was $122.4 million, which is expected to be recognized over a weighted-average period of 2.8 years.

8. Net Loss per Common Share

The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:

 

 

 

As of September 30,

 

 

 

2021

 

 

2020

 

Outstanding stock options

 

 

7,799,732

 

 

 

7,238,363

 

Unvested restricted shares

 

 

412,287

 

 

 

363,195

 

Total

 

 

8,212,019

 

 

 

7,601,558

 

 

9. Subsequent Events

On October 13, 2021, stockholders of the Company approved the Kodiak Sciences Inc. 2021 Long-Term Performance Incentive Plan (the “LTPIP”) as described in the Company's Definitive Proxy Statement on Schedule 14A filed with the SEC on September 13, 2021. Stock options were granted under the LTPIP, contingent on stockholder approval of the LTPIP, to named executive officers and other eligible employees at the vice president level who made a one-time election to participate in the LTPIP and agreed to forgo a portion of their annual long-term incentive awards over the seven-year performance period ending on August 11, 2028. A total of 5,502,334 shares of common stock were reserved for issuance under the LTPIP.

The options can be earned based on the achievement of the performance-based requirement and/or certain operational milestones. The performance-based requirement consists of seven tranches of options that are earned based on meeting or exceeding stock price goals between $200 and $800 per share for 90 consecutive trading days.

Up to 35% of the options may be earned through the attainment of certain operational milestones to the extent that number of options has not yet been earned from stock appreciation. A participant may earn up to 25% upon approval by the U.S. Food and Drug Administration of a Biologics License Application for KSI-301 in the three major anti-VEGF indications and up to 10% from generating sales of at least $2.5 billion in a fiscal year. Once earned, options are subject to a service-based requirement and will vest through the remainder of the seven-year performance period in equal monthly installments.

10


Kodiak Sciences Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (Continued)

 

Performance-based stock options totaling 1,920,625 with the same terms and conditions as the LTPIP were also granted to employees below the vice president level under the 2018 Plan. These stock option awards were also contingent on stockholder approval of the LTPIP. As discussed above, the LTPIP was approved by the stockholders of the Company on October 13, 2021.

The Company is currently evaluating the LTPIP approved in October 2021 and its accounting impact as a modification of the portion of the annual long-term incentive awards granted in 2021 that were foregone.


 

11


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this report and with our audited financial statements and related notes thereto and management’s discussion and analysis of financial condition and results of operations for the year ended December 31, 2020, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on March 1, 2021. This discussion and analysis and other parts of this report contain forward-looking statements based upon current beliefs, plans and expectations related to future events and our future financial performance that involve risks, uncertainties and assumptions, such as statements regarding our intentions, plans, objectives, expectations, forecasts and projections. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under the section of this report titled “Part II, Item 1A — Risk Factors” and elsewhere in this report.

Overview

Since its founding in 2009, Kodiak Sciences Inc. (“Kodiak,” the “Company,” “we” or “our”) has developed a new technology platform for retinal medicines. Our goal is to prevent and treat the major causes of blindness by developing and commercializing next-generation therapeutics for chronic, high-prevalence retinal diseases.

Kodiak has progressed its lead investigational therapy, KSI-301, into six registrational clinical trials. The comprehensive clinical program targets high prevalence anti-VEGF dependent retinal diseases with studies designed as a package to support a broad product label, which we hope will include the key diseases and the longest dosing intervals. KSI-301 is being developed as a first line therapy for use in any patient who may benefit from anti-VEGF therapy. At the same time, Kodiak is investing in commercial scale manufacturing with a capacity goal to supply 100% of today’s branded anti-VEGF market. We hope to be able to provide a pre-filled syringe early in commercialization, with a stretch goal of having this available at launch. Combining these ambitious clinical and manufacturing efforts sets the stage for early market share capture when and if KSI-301 is approved.

In addition, Kodiak is investing in its pipeline. The Company is progressing its Antibody Biopolymer Conjugate (or ABC) PlatformTM towards suboptimal anti-VEGF responder patients, a group as large as 30% of treated patients, with its bispecific conjugate KSI-501. And beyond today’s anti-VEGF market, Kodiak’s new triplet medicines are being designed on its ABC Platform in an effort to bring new capabilities to treat the retina in the even higher prevalence diseases of dry AMD and glaucoma.
 

Notably, up to this point, Kodiak has retained all global rights to make, use and sell its products, preserving future value and allowing for agile decision-making.

While engaged in these research and development efforts, the Company has also demonstrated a disciplined and creative approach to building and financing the company, so Kodiak today is well capitalized with more than $799.2 million in cash as of September 30, 2021.

Our objective is to develop our retina-focused product candidates, seek FDA and worldwide health authority marketing authorization approvals, and ultimately commercialize our product candidates.

Following from these efforts, we believe Kodiak has the potential to achieve our ambition of becoming a significant incumbent retinal development and commercialization franchise on a global basis.

Recent Updates

KSI-301 Clinical Program Highlights

We are engaged in a broad development program for KSI-301 with concurrent late-stage development activities across all of the major disease indications for which intravitreal anti-VEGF therapies are used and have made considerable progress in prosecuting the KSI-301 pivotal study program over this past quarter. We expect to include the results of all our pivotal clinical trials in wet AMD, DME and RVO in a single initial BLA. The ambitious program for KSI-301 reflects our conviction in KSI-301 (and our ABC Platform) and seeks labeling at launch that is supportive of a broad range of individualized dosing intervals, from every 4-week dosing up to once every 20-week dosing for wet AMD patients; from every 4-week dosing up to once every 24-week dosing for DME patients; and from every 4-week dosing up to once every 8-week dosing for RVO patients.

DAZZLE – Phase 2b/3 Study in Patients with Treatment-Naïve Wet Age-Related Macular Degeneration (Wet AMD)

The Phase 2b/3 DAZZLE study is a global, multi-center, randomized pivotal study designed to evaluate the durability efficacy and safety of KSI-301 in patients with treatment-naïve wet AMD. Patients are randomized to receive either KSI-301 on an individualized dosing regimen as infrequently as every five months and no more often than every three months or to receive aflibercept on its labeled every eight-week dosing regimen, each after three monthly initiating doses.

12


 

We initiated the DAZZLE pivotal study in October 2019 and completed enrollment in November 2020 with over 550 patients enrolled globally. We expect the last patient’s primary endpoint visit to occur in the fourth quarter of 2021 and to announce topline data in the first quarter of 2022.

BEACON – Phase 3 Study in Patients with Treatment-Naïve Retinal Vein Occlusion (RVO)

We began enrolling patients into BEACON in the third quarter of 2020. With over 475 patients randomized, we believe we are on track to complete enrollment into BEACON before the end of this year. Based on the 24-week primary endpoint for BEACON, we expect to announce topline data in mid-2022.

GLEAM / GLIMMER – Paired Phase 3 Studies in Patients with Treatment-Naïve Diabetic Macular Edema (DME)

The Phase 3 GLEAM and GLIMMER studies are global, multi-center, randomized pivotal studies designed to evaluate the durability, efficacy and safety of KSI-301 in patients with treatment-naïve diabetic macular edema (DME). In each study, patients are randomized to receive either intravitreal KSI-301 on an individualized dosing regimen every eight to 24 weeks after only three loading doses or intravitreal aflibercept every eight weeks after five loading doses per its label. Each study is expected to enroll approximately 450 patients worldwide. The primary endpoint for both studies is at one year, and patients will be treated and followed for a total of two years.

We initiated GLEAM and GLIMMER in the third quarter of 2020. Continued elevated COVID-19 transmission rates globally have impacted enrollment rates for patients with treatment naïve DME. With GLEAM more than two-thirds enrolled and GLIMMER more than three-quarters enrolled, we expect to complete enrollment in the first quarter of 2022.

DAYLIGHT – Phase 3 Study in Patients with Treatment-Naïve Wet AMD

The Phase 3 DAYLIGHT study is a global, multi-center, randomized pivotal study designed to evaluate the efficacy and safety of high-frequency KSI-301 in patients with treatment-naïve wet AMD. Patients are randomized to receive either KSI-301 on a monthly dosing regimen or to receive standard-of-care aflibercept. The study is expected to enroll approximately 500 patients worldwide. The primary endpoint is at 40 weeks, and the study is being planned and executed to allow for inclusion of its results in the initial BLA for KSI-301.

In June 2021, we randomized the first patients into DAYLIGHT. Study enrollment has been strong with recruitment now underway both in the US and EU. Additional global study sites will be activated through the fourth quarter of 2021, and we believe we can complete enrollment in the first half of 2022.

GLOW – Phase 3 Study in Patients with Non-Proliferative Diabetic Retinopathy without DME

We began screening patients into GLOW in the second quarter of 2021 and randomized the first patients in September. We are not planning for this study and indication to be included in our initial BLA filing given our expectations for a longer recruitment timeframe. We are excited to be recruiting patients in this chronic, more preventive disease indication and believe KSI-301 can be a new longest-interval therapeutic option for patients with diabetic retinopathy.

 

To date, we are pleased with the continued operational progress across our pivotal program. We believe we are on track for a series of KSI-301 topline data readouts beginning in early 2022 with DAZZLE in the first quarter of 2022, BEACON in mid-2022 and then DAYLIGHT and GLEAM/GLIMMER tracking towards early 2023.
 


 

13


 

img6467664_0.jpg 

Our KSI-301 pivotal program is designed to support a full range of individualized dosing regimens and we hope to position KSI-301 to be the therapy of choice for all patients with retinal vascular disease and which can meet the distinct needs of patients, physicians, caregivers and payors.

img6467664_1.jpg 

14


 

Kodiak Stockholder Approval of the Kodiak 2021 Long-term Performance Incentive Plan (LTPIP)

On August 12, 2021, the Board of Directors of Kodiak Sciences Inc. approved the Kodiak 2021 Long-Term Performance Incentive Plan (LTPIP), subject to approval by Kodiak stockholders. The LTPIP was approved by Kodiak’s stockholders on October 13, 2021, with 75% of all votes cast voting in favor of approving the LTPIP, excluding votes cast by any participant in the LTPIP.

We believe the LTPIP aligns management incentives to significant value creation. The plan covers the next seven years and was open to a significant number of our existing employees – not just senior management. Employees had a one-time opportunity to “opt-in” to the plan by agreeing to forego up to 75% of their annual equity incentive compensation for the next seven years via a one-time election. Shares can be earned based on significant stock price appreciation over the seven-year performance period, with the possibility to earn up to 35% of the award based on achieving substantive operational goals. Earned awards begin vesting once earned and vest through the remainder of the seven-year period in equal monthly increments, ensuring what we believe is a true long-term incentive program.
 

China INDs

In March 2021, our investigational new drug (IND) applications for KSI-301 in RVO and DME were approved by China’s National Medicinal Products Administration (NMPA). The IND approval allows Kodiak to enroll patients from China into the BEACON and GLIMMER studies; we believe that inclusion of patients from China in these studies could be beneficial for the potential future approval of KSI-301 in China.

The first Chinese patients are expected to be randomized in the fourth quarter of 2021. We are excited to embark on this important milestone in China as we believe there is substantial clinical unmet need in China for the type of long-interval dosing which KSI-301 and our ABC Platform may provide.

KSI-301 Phase 1b Study

In February 2021, we presented Year 1 durability, efficacy and safety data from our ongoing Phase 1b trial of KSI-301 in patients with treatment naïve wet AMD, DME or RVO at the Angiogenesis, Exudation, and Degeneration 2021 – Virtual Edition meeting. The data showed 2 in every 3 patients are on a 6-month or longer treatment-free interval at Year 1 in each of the three major retinal vascular diseases after only three loading doses. Robust vision gains (particularly notable in the context of very good baseline vision) and robust retinal drying (when baseline anatomical characteristics are considered) were seen across all three diseases being studied. Strong anti-VEGF efficacy (achieving at Year 1 approximately 20/40 eye chart vision on average in wet AMD and approximately 20/32 vision on average in DME and RVO) and an encouraging safety profile continued to be observed across all three diseases. We believe the data support the “anti-VEGF Generation 2.0” profile of KSI-301.

Track Record of KSI-301 Safety

We believe the safety profile of KSI-301 continues to be very encouraging. In the pivotal study program, in which the data remain masked (blinded) as the studies are ongoing, we estimate that over 4,500 KSI-301 injections have been given. Additionally, more than 750 injections have been given in the open-label Phase 1a/1b program. The total safety database now includes an estimated >800 patient-years of exposure to KSI-301. Our ongoing reviews of safety data from the open-label Phase 1b study and the masked pivotal studies continue to suggest that the safety of KSI-301 is tracking with the expectations set by the safety profile of the current standard of care intravitreal medicines.

COVID-19

We are continuing to monitor the global ongoing COVID-19 pandemic. We and our key clinical and manufacturing partners have been able to continue to advance our operations. Through this pandemic, we continue to work closely with our clinical sites towards patient safety and low number of missed visits and study discontinuations. The overall rate of missed study visits remains <5%.

In response to the COVID-19 pandemic with regards to business operations, clinical trials, and manufacturing activities, we have taken steps in line with guidance from the U.S. Centers for Disease Control and Prevention, or CDC, and the State of California to protect the health and safety of our employees and our community.

We will continue to monitor the COVID-19 situation closely. The ultimate impact of the ongoing COVID-19 pandemic on our business operations remains uncertain and subject to change. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, healthcare systems or the global economy as a whole. See also the section titled “Risk Factors” for additional information on risks and uncertainties related to the evolving COVID-19 pandemic.

15


 

Components of Operating Results

Operating Expenses

Research and Development Expenses

Substantially all of our research and development expenses consist of expenses incurred in connection with the development of our ABC Platform and product candidates. These expenses include certain payroll and personnel expenses, including stock-based compensation, for our research and product development employees; laboratory supplies and facility costs; consulting costs; contract manufacturing and fees paid to CROs to conduct certain research and development activities on our behalf; and allocated overhead, including rent, equipment, depreciation and utilities. We expense both internal and external research and development expenses as they are incurred. Costs of certain activities, such as manufacturing and preclinical and clinical studies, are generally recognized based on an evaluation of the progress to completion of specific tasks. Nonrefundable payments made prior to the receipt of goods or services that will be used or rendered for future research and development activities are deferred and capitalized. The capitalized amounts are recognized as expense as the goods are delivered or the related services are performed.

We are focusing substantially all of our resources and development efforts on the development of our product candidates, in particular KSI-301. We expect our research and development expenses to increase substantially during the next few years as we conduct our Phase 3 clinical studies, complete our clinical program, pursue regulatory approval of our drug candidates and prepare for a possible commercial launch. Predicting the timing or the final cost to complete our clinical program or validation of our commercial manufacturing and supply processes is difficult and delays may occur because of many factors, including factors outside of our control. For example, if the FDA or other regulatory authorities were to require us to conduct clinical trials beyond those that we currently anticipate, or if we experience significant delays in enrollment in any of our clinical trials, we could be required to expend significant additional financial resources and time on the completion of clinical development. Furthermore, we are unable to predict when or if our drug candidates will receive regulatory approval with any certainty.

General and Administrative Expenses

General and administrative expenses consist principally of payroll and personnel expenses, including stock-based compensation; professional fees for legal, consulting, accounting and tax services; allocated overhead, including rent, equipment, depreciation and utilities; and other general operating expenses not otherwise classified as research and development expenses.

We anticipate that our general and administrative expenses will increase as a result of increased personnel costs, including stock-based compensation, expanded infrastructure and higher consulting, legal and accounting services associated with maintaining compliance with requirements of the stock exchange listing and Securities and Exchange Commission, or SEC, investor relations costs and director and officer insurance premiums associated with being a public company.

Interest Income

Interest income consists primarily of interest income earned on our cash, cash equivalents and marketable securities.

Other Income (Expense), Net

Other income (expense), net consists primarily of accretion income and amortization expense on marketable debt securities net of amortized issuance costs from the liability related to the future sale of royalties to BBA in 2019.

Results of Operations

The following table summarizes the results of our operations for the periods indicated, in thousands:

 

 

 

Three Months Ended
  September 30,

 

 

 

 

 

Nine Months Ended
  September 30,

 

 

 

 

 

 

2021

 

 

2020

 

 

Change

 

 

2021

 

 

2020

 

 

Change

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

56,002

 

 

$

29,306

 

 

$

26,696

 

 

$

141,743

 

 

$

70,033

 

 

$

71,710

 

General and administrative

 

 

11,533

 

 

 

7,357

 

 

 

4,176

 

 

 

32,259

 

 

 

19,132

 

 

 

13,127

 

Loss from operations

 

 

(67,535

)

 

 

(36,663

)

 

 

(30,872

)

 

 

(174,002

)

 

 

(89,165

)

 

 

(84,837

)

Interest income

 

 

40

 

 

 

645

 

 

 

(605

)

 

 

270

 

 

 

2,551

 

 

 

(2,281

)

Interest expense

 

 

(6

)

 

 

(6

)

 

 

 

 

 

(17

)

 

 

(19

)

 

 

2

 

Other income (expense), net

 

 

(25

)

 

 

(98

)

 

 

73

 

 

 

(76

)

 

 

120

 

 

 

(196

)

Net loss

 

$

(67,526

)

 

$

(36,122

)

 

$

(31,404

)

 

$

(173,825

)

 

$

(86,513

)

 

$

(87,312

)

 

16


 

Research and Development Expenses

 

The following table summarizes our research and development expenses for the periods indicated, in thousands:

 

 

 

Three Months Ended
  September 30,

 

 

 

 

 

Nine Months Ended
  September 30,

 

 

 

 

 

 

2021

 

 

2020

 

 

Change

 

 

2021

 

 

2020

 

 

Change

 

KSI-301 program expenses

 

$

38,371

 

 

$

15,415

 

 

$

22,956

 

 

$

89,557

 

 

$

37,587

 

 

$

51,970

 

KSI-501 program expenses

 

 

951

 

 

 

453

 

 

 

498

 

 

 

4,357

 

 

 

922

 

 

 

3,435

 

ABC Platform and other program expenses

 

 

1,745

 

 

 

2,174

 

 

 

(429

)

 

 

5,173

 

 

 

5,345

 

 

 

(172

)

Payroll and personnel expenses

 

 

10,679

 

 

 

8,104

 

 

 

2,575

 

 

 

30,483

 

 

 

20,850

 

 

 

9,633

 

Facilities and other research and development expenses

 

 

4,256

 

 

 

3,160

 

 

 

1,096

 

 

 

12,173

 

 

 

5,329

 

 

 

6,844

 

Total research and development expenses

 

$

56,002

 

 

$

29,306

 

 

$

26,696

 

 

$

141,743

 

 

$

70,033

 

 

$

71,710

 

 

KSI-301 program expenses increased $23.0 million and $52.0 million during the three and nine months ended September 30, 2021, respectively, as compared to 2020. The increase was primarily due to clinical trial costs to support ongoing trials, as well as manufacturing progress for KSI-301. We initiated two pivotal Phase 3 clinical studies in DME (GLEAM and GLIMMER) and one pivotal Phase 3 clinical study in RVO (BEACON) in the third quarter of 2020. In June 2021, we randomized the first patients into an additional Phase 3 study in wet AMD (DAYLIGHT) designed to broaden KSI-301’s product labeling.

KSI-501 program increased $0.5 million and $3.4 million during the three and nine months ended September 30, 2021, respectively, as compared to 2020, primarily due to increased research and development activities for KSI-501.

Payroll and personnel expenses increased $2.6 million and $9.6 million during the three and nine months ended September 30, 2021, respectively, as compared to 2020, due to increased headcount and stock-based compensation expense.

Facilities and other research and development expenses increased $1.1 million and $6.8 million during the three and nine months ended September 30, 2021, respectively, as compared to 2020, primarily due to lease costs for our Palo Alto and Switzerland facilities expansion.

General and Administrative Expenses

General and administrative expenses increased $4.2 million and $13.1 million during the three and nine months ended September 30, 2021, respectively, as compared to 2020, primarily driven by increased headcount and stock-based compensation expense, professional services related to consulting, legal and accounting, and lease costs for Palo Alto facilities expansion.

Liquidity and Capital Resources; Plan of Operations

Sources of Liquidity

We have funded our operations primarily through the sale and issuance of common stock, redeemable convertible preferred stock, convertible notes, warrants and the sale of royalties. As of September 30, 2021, we had cash and cash equivalents of $799.2 million.

Future Funding Requirements

We have incurred net losses since our inception. For the three and nine months ended September 30, 2021, we had net loss of $67.5 million and $173.8 million, respectively, and we expect to continue to incur additional losses in future periods. As of September 30, 2021, we had an accumulated deficit of $465.1 million.

We have based these estimates on assumptions that may prove to be wrong, and we could deplete our available capital resources sooner than we expect. Because of the risks and uncertainties associated with research, development and commercialization of product candidates, we are unable to estimate the exact amount of our working capital requirements. Our future funding requirements will depend on and could increase significantly as a result of many factors.

To date, we have not generated any product revenue. We do not expect to generate any product revenue unless and until we obtain regulatory approval of and commercialize any of our product candidates or enter into collaborative agreements with third parties, and we do not know when, or if, either will occur. We expect to continue to incur significant losses for the foreseeable future, and we expect our losses to increase as we continue the development of, and seek regulatory approvals for, our product candidates, and begin to commercialize any approved products. We are subject to all of the risks typically related to the development of new product candidates, and we may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business.

17


 

We have based these estimates on assumptions that may prove to be wrong, and we could deplete our capital resources sooner than we expect. The timing and amount of our operating expenditures and capital requirements will depend on many factors, including:

the scope, timing, rate of progress and costs of our drug discovery, preclinical development activities, laboratory testing and clinical trials for our product candidates;
the number and scope of clinical programs we decide to pursue;
the scope and costs of manufacturing development and commercial manufacturing activities;
the extent to which we acquire or in-license other product candidates and technologies;
the cost, timing and outcome of regulatory review of our product candidates;
the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims;
our ability to establish and maintain collaborations on favorable terms, if at all;
our efforts to enhance operational systems and our ability to attract, hire and retain qualified personnel, including personnel to support the development of our product candidates; and
the cost and timing associated with commercializing our product candidates, if they receive marketing approval.

A change in the outcome of any of these or other variables with respect to the development of any of our product candidates could significantly change the costs and timing associated with the development of that product candidate. Furthermore, our operating plans may change in the future, and we will continue to require additional capital to meet operational needs and capital requirements associated with such operating plans. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments and engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. If we are unable to raise additional funds when needed, we may be required to delay, reduce, or terminate some or all of our development programs and clinical trials. We may also be required to sell or license rights to our product candidates in certain territories or indications to others that we would prefer to develop and commercialize ourselves.

The significant uncertainties caused by the evolving effects of the ongoing COVID-19 pandemic may also negatively impact our operations and capital resources. We and our key clinical and manufacturing partners have been able to continue to advance our operations, and we continue to monitor the impact of COVID-19 on our ability to continue the development of, and seek regulatory approvals for, our product candidates, and begin to commercialize any approved products. This pandemic may ultimately have a material adverse effect on our liquidity and operating plans, although we are unable to make any prediction with certainty given the spread and rapidly changing nature of the pandemic and the evolving global actions taken to contain and treat the novel coronavirus.

Adequate additional funding may not be available to us on acceptable terms or at all. Our failure to raise capital as and when needed could have a negative impact on our financial condition and our ability to pursue our business strategies. See the section of this report titled “Part II, Item 1A — Risk Factors” for additional risks associated with our substantial capital requirements.

Summary Statement of Cash Flows

The following table sets forth the primary sources and uses of cash for each of the periods presented below, in thousands:

 

 

 

Nine Months Ended
  September 30,

 

 

 

2021

 

 

2020

 

 

 

(in thousands)

 

Net cash (used in) provided by:

 

 

 

 

 

 

Operating activities

 

$

(123,235

)

 

$

(56,409

)

Investing activities

 

 

(27,939

)

 

 

45,976

 

Financing activities

 

 

6,025

 

 

 

101,096

 

Net increase (decrease) in cash, cash equivalents and restricted cash

 

$

(145,149

)

 

$

90,663

 

 

18


 

Cash Flows from Operating Activities

Net cash used in operating activities was $123.2 million for the nine months ended September 30, 2021, primarily attributable to a net loss during this period due to increased payroll and personnel expenses and manufacturing and clinical trial costs to support overall growth. Cash used in operating activities was also driven by changes in operating assets and liabilities.

Cash Flows from Investing Activities

Net cash used in investing activities was $27.9 million for the nine months ended September 30, 2021, primarily related to maturities of marketable securities net of purchases of and deposits related to property and equipment during the quarter.

Cash Flows from Financing Activities

Net cash provided by financing activities was $6.0 million for the nine months ended September 30, 2021, primarily due to the proceeds from stock option exercises and proceeds from issuances of common stock pursuant to employee stock purchase plans.

Contractual Obligations and Commitments

The disclosure of our contractual obligations and commitments is set forth under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Contractual Obligations” in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on March 1, 2021. There have been no material changes in our contractual obligations and commitments since December 31, 2020, except as otherwise described in Note 6 to our unaudited condensed consolidated financial statements included in this report.

Critical Accounting Policies, Significant Judgments and Use of Estimates

Our consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.

During the nine months ended September 30, 2021, there were no material changes to our critical accounting policies as reported in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on March 1, 2021, except as otherwise described in Note 2 to our unaudited condensed consolidated financial statements included in this report.

Off-Balance Sheet Arrangements

Since our inception, we have not engaged in any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.

Recent Accounting Pronouncements

A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is discussed under Note 2 to our unaudited condensed consolidated financial statements included in this report.

19


 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

During the nine months ended September 30, 2021, there were no material changes to our market risk disclosures as reported in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on March 1, 2021.

Item 4. Controls and Procedures.

Management’s Evaluation of our Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (2) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of September 30, 2021. Based upon such evaluation, our principal executive officer and principal financial officer concluded that the design and operation of our disclosure controls and procedures were effective at a reasonable assurance level as of September 30, 2021.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the quarter ended September 30, 2021, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

20


 

PART II—OTHER INFORMATION

From time to time, we may become involved in litigation relating to claims arising from the ordinary course of business. As of the date of this report, there are no claims or actions pending against us, the ultimate disposition of which could have a material adverse effect on our results of operations or financial condition.

Item 1A. Risk Factors.

You should consider carefully the following risk factors, together with all the other information in this report, including the section of this report titled “Part I, Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our unaudited condensed financial statements and notes thereto. The occurrence of any events described in the following risk factors and the risks described elsewhere in this report could harm our business, operating results, financial condition, and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements that we have made in this report and those we may make from time to time. You should consider all of the risk factors described when evaluating our business.

Risks Related to the Discovery, Development and Commercialization of Our Product Candidates

Our prospects are heavily dependent on our KSI-301 product candidate, which is currently in clinical development for multiple indications.

KSI-301 is our only product candidate currently in clinical trials. It may be years before a registrational-type trial is completed, if at all. Further, we cannot be certain that either KSI-301 or any of our product candidates will be successful in clinical trials.

Our early encouraging preclinical and Phase 1/1b clinical trial results for KSI-301 in the respective indications are not necessarily predictive of the results of our ongoing or future discovery programs or any future preclinical or clinical studies. Our ability to demonstrate efficacy, safety and clinical durability in pivotal studies may be affected by the patient populations sampled and the design of our pivotal studies. Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical studies after achieving positive results in early-stage development, including early-stage clinical studies, and we cannot be certain that we will not face similar setbacks. These setbacks have been caused by, among other things, preclinical findings made while clinical studies were underway or safety or efficacy observations made in preclinical studies and clinical studies, including previously unreported or unobserved adverse events as more patients are treated with KSI-301 and followed for longer periods of time.

There can be significant variability in safety or efficacy results between different clinical studies of the same product candidate due to numerous factors, including changes in study procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the clinical study protocols and the rate of dropout among clinical study participants. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that believed their product candidates performed satisfactorily in preclinical studies and clinical studies nonetheless failed to obtain FDA approval. If approved, KSI-301 clinical study designs and data are not necessarily predictive of KSI-301’s final marketed product label. FDA may not approve a label for once every five or six months even if we believe the data demonstrate that type of durability.

We may in the future advance product candidates into clinical trials and terminate such trials prior to their completion. While we have certain preclinical programs such as KSI-501 and KSI-601 in development and intend to develop other product candidates, it will take additional investment and time for such programs to reach the same stage of development as KSI-301.

A failure of KSI-301 in clinical development may require us to discontinue development of other product candidates based on our ABC Platform.

If KSI-301 fails in development as a result of any underlying problem with our platform, then we may discontinue development of some or all of our product candidates that are based on our ABC Platform. If we discontinue development of KSI-301, or if KSI-301 were to fail to receive regulatory approval or were to fail to receive regulatory approval in one or more of our four planned key clinical indications or were to fail to achieve sufficient market acceptance, we could be prevented from or significantly delayed in achieving profitability.

21


 

Research and development of biopharmaceutical products is inherently risky. We cannot give any assurance that any of our product candidates will receive regulatory, including marketing, approval, which is necessary before they can be commercialized.

We are at an early stage of development of our product candidates. Our future success is dependent on our ability to successfully develop, obtain regulatory approval for, and then successfully commercialize our product candidates, and we may fail to do so for many reasons, including the following:

our product candidates may not successfully complete preclinical studies or clinical trials;
If a product candidate obtains regulatory approval, approval may be for indications, dosage and administration or patient populations that are not as broad as intended or desired;
a product candidate may, on further study, be shown to have harmful side effects or other characteristics that indicate it is unlikely to be effective or otherwise does not meet applicable regulatory criteria, for example a positive benefit-risk profile;
our competitors may develop therapeutics that render our product candidates obsolete or less attractive;
our competitors may develop platform technologies that render our ABC Platform obsolete or less attractive;
the product candidates and ABC Platform that we develop may not be sufficiently covered by intellectual property for which we hold exclusive rights or may be covered by third party patents or other intellectual property or exclusive rights;
the market for a product candidate may change so that the continued development of that product candidate is no longer reasonable or commercially attractive;
a product candidate may not be capable of being produced in commercial quantities at an acceptable cost, or at all;
if a product candidate obtains regulatory approval, we may be unable to establish sales and marketing capabilities, or successfully market such approved product candidate, to gain market acceptance; and
a product candidate may not be accepted as safe and effective by patients, the medical community or third-party payors, if applicable.

If any of these events occurs, we may be forced to abandon our development efforts for a product candidate or candidates, which would have a material adverse effect on our business and could potentially cause us to cease operations. Failure of a product candidate may occur at any stage of preclinical or clinical development, and, because our product candidates and our ABC Platform are in development, there is a relatively higher risk of failure and we may never succeed in developing marketable products or generating product revenue.

We may not be successful in our efforts to further develop our ABC Platform and current product candidates in time to meet the current and identified market opportunity. We are not permitted to market or promote any of our product candidates before we receive regulatory approval from the FDA or comparable foreign regulatory authorities, and we may never receive such regulatory approval for any of our product candidates. Each of our product candidates is in the early stages of development and will require significant additional clinical development, management of preclinical, clinical, and manufacturing activities, regulatory approval, adequate manufacturing supply, a commercial organization, and significant marketing efforts before we generate any revenue from product sales, if at all. Any clinical studies that we may conduct may not demonstrate the efficacy and safety necessary to obtain regulatory approval to market our product candidates. If the results of our ongoing or future clinical studies are inconclusive with respect to the efficacy of our product candidates or if we do not meet the clinical endpoints with statistical significance or if there are safety concerns or adverse events associated with our product candidates, we may be prevented or delayed in obtaining marketing approval for our product candidates.

If any of our product candidates successfully completes clinical trials, we generally plan to seek regulatory approval to market our product candidates in the United States, the EU, and in additional foreign countries where we believe there is a viable commercial opportunity. We have never commenced, compiled or submitted an application seeking regulatory approval to market any product candidate. We may never receive regulatory approval to market any product candidates even if such product candidates successfully complete clinical trials, which would adversely affect our viability. To obtain regulatory approval in countries outside the United States, we must comply with numerous and varying regulatory requirements of such other countries regarding safety, efficacy, chemistry, manufacturing and controls, clinical trials, commercial sales, pricing, and distribution of our product candidates. We may also rely on our collaborators or partners to conduct the required activities to support an application for regulatory approval, and to seek approval, for one or more of our product candidates. We cannot be sure that our collaborators or partners will conduct these activities successfully or do so within the timeframe we desire. Even if we (or our collaborators or partners) are successful in obtaining approval in one jurisdiction, we cannot ensure that we will obtain approval in any other jurisdictions. If we are unable to obtain approval for our product candidates in multiple jurisdictions, our revenue and results of operations could be negatively affected.

22


 

Even if we receive regulatory approval to market any of our product candidates, we cannot assure you that any such product candidate will be successfully commercialized, widely accepted in the marketplace or more effective than other commercially available alternatives. That approval may be for indications, dosage and administration or patient populations that are not as broad as intended or desired or may require labeling that includes significant use or distribution restrictions or safety warnings. We may also be required to perform additional or unanticipated clinical studies to obtain approval or be subject to additional post-marketing testing requirements to maintain regulatory approval. In addition, regulatory authorities may withdraw their approval of a product or impose restrictions on its distribution, such as in the form of a modified Risk Evaluation and Mitigation Strategy, or REMS. The failure to obtain timely regulatory approval of product candidates, any product marketing limitations or a product withdrawal would negatively impact our business, results of operations and financial condition.

Investment in biopharmaceutical product development involves significant risk that any product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile, gain regulatory approval, and become commercially viable. We cannot provide any assurance that we will be able to successfully advance any of our product candidates through the development process or, if approved, successfully commercialize any of our product candidates.

We may encounter substantial delays in our clinical trials, or may not be able to conduct or complete our clinical trials on the timelines we expect, if at all.

Clinical testing is expensive, time consuming, and subject to uncertainty. We cannot guarantee that any clinical trials will be conducted as planned or completed on schedule, if at all. We cannot be sure that submission of an IND application or a clinical trial application, or CTA, will result in the FDA, European Medicines Agency, or EMA, China National Medical Products Administration, or NMPA, or any other regulatory authority as applicable, allowing clinical trials to begin in a timely manner, if at all. Moreover, even if these trials begin, issues may arise that could suspend or terminate such clinical trials. A failure of one or more clinical trials can occur at any stage of testing, and our future clinical trials may not be successful. Events that may prevent successful or timely initiation or completion of clinical trials include:

inability to generate sufficient preclinical, toxicology, or other in vivo or in vitro data to support the initiation or continuation of clinical trials;
delays in reaching a consensus with regulatory agencies on study design or, in the case of China, the registration category for the drug candidate to be studied in the clinical trial;
the determination by the reviewing regulatory authority to require more costly or lengthy clinical trials than we currently anticipate;
delays in reaching agreement on acceptable terms with prospective CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites;
delays in identifying, recruiting and training suitable clinical investigators;
delays in obtaining required Institutional Review Board, or IRB, approval at each clinical trial site;
imposition of a temporary or permanent clinical hold by regulatory agencies for a number of reasons, including after review of an IND or amendment, CTA or amendment, or equivalent application or amendment; as a result of a new safety finding that presents unreasonable risk to clinical trial participants; a negative finding from an inspection of our clinical trial operations or study sites; developments on trials conducted by competitors for related technology that raises FDA, EMA, NMPA or any other regulatory authority concerns about risk to patients of the technology broadly; or if the FDA, EMA, NMPA or any other regulatory authority finds that the investigational protocol or plan is clearly deficient to meet its stated objectives;
delays in identifying, recruiting and enrolling suitable patients to participate in our clinical trials, and delays caused by patients withdrawing from clinical trials or failing to return for post-treatment follow-up;
difficulty collaborating with patient groups and investigators;
failure by our CROs, other third parties, or us to adhere to clinical trial requirements;
failure to perform in accordance with the FDA’s or any other regulatory authority’s current good clinical practices, or cGCPs, requirements, or applicable EMA, NMPA or other regulatory guidelines in other countries;
occurrence of adverse events associated with the product candidate that are viewed to outweigh its potential benefits;
changes in regulatory requirements and guidance that require amending or submitting new clinical protocols;
changes in the standard of care on which a clinical development plan was based, which may require new or additional trials;
the cost of clinical trials of our product candidates being greater than we anticipate;

23


 

clinical trials of our product candidates producing negative or inconclusive results, which may result in our deciding, or regulators requiring us, to conduct additional clinical trials or abandon development of such product candidates;
transfer of manufacturing processes to larger-scale facilities operated by CMOs or by us, and delays or failure by our CMOs or us to make any necessary changes to such manufacturing process; and
delays in manufacturing, testing, releasing, validating, or importing/exporting sufficient stable quantities of our product candidates for use in clinical trials and for use in regulatory filings or the inability to do any of the foregoing.

Any inability to successfully initiate or complete clinical trials could result in additional costs to us or impair our ability to generate revenue. In addition, if we make manufacturing or formulation changes to our product candidates, we may be required to or we may elect to conduct additional studies to bridge our modified product candidates to earlier versions. Clinical trial delays could also shorten any periods during which our products have patent protection and may allow our competitors to bring products to market before we do, which could impair our ability to successfully commercialize our product candidates and may harm our business and results of operations.

We could also encounter delays if a clinical trial is suspended or terminated by us, by the data safety monitoring board for such trial or by the FDA, EMA, NMPA or any other regulatory authority, or if the IRBs of the institutions in which such trials are being conducted suspend or terminate the participation of their clinical investigators and sites subject to their review. Such authorities may suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA, EMA, NMPA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a product candidate, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. We may also face delays if we are unable to reach agreement with the FDA, EMA, NMPA or other regulatory authorities regarding CMC matters, including methodologies for, and assessment of, comparability of manufacturing procedures and lots.

Delays in the commencement or completion of any clinical trial of our product candidates will increase our costs, slow down our product candidate development and approval process and delay or potentially jeopardize our ability to commence product sales and generate revenue. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.

Our product candidates may cause undesirable side effects or have other properties that could halt their clinical development, prevent their regulatory approval, limit their commercial potential or result in significant negative consequences.

Adverse events or other undesirable side effects caused by our product candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA, EMA, NMPA or other comparable foreign regulatory authorities.

During the conduct of clinical trials, patients report changes in their health, including illnesses, injuries, and discomforts, to their study doctor. Often, it is not possible to determine whether or not the product candidate being studied caused these conditions. It is possible that as we test our product candidates in larger, longer and more extensive clinical trials, or as use of these product candidates becomes more widespread if they receive regulatory approval, illnesses, injuries, discomforts and other adverse events that were not observed in earlier trials, as well as conditions that did not occur or went undetected in previous trials, will be reported by patients. Many times, side effects are only detectable after investigational products are tested in large-scale Phase 3 clinical trials or, in some cases, after they are made available to patients on a commercial scale after approval. If additional clinical experience indicates that any of our product candidates has side effects or causes serious or life-threatening side effects, the development of the product candidate may fail or be delayed, or, if the product candidate has received regulatory approval, such approval may be revoked, which would severely harm our business, prospects, operating results and financial condition. For example, the safety profile we have observed in the Phase 1a/1b study of KSI-301 and in the masked (blinded) pivotal data thus far may not be representative of the safety profile we observe when data is unmasked. We may still observe significant safety events that may negatively impact the KSI-301 program and the ABC platform. Even with a safety database through pivotal studies of approximately 1,500 patients, a safety profile for KSI-301 in line with today’s standard of care agents may not be sustained when administered to 100,000s of patients at varying dose intervals after commercialization.

Our most advanced product candidate, KSI-301, is an anti-VEGF biologic that we are studying in wet AMD, DME/DR and RVO. There are some potential side effects associated with intravitreal anti-VEGF therapies such as intraocular hemorrhage, intraocular pressure elevation, retinal detachment, inflammation, vasculitis, artery occlusion or infection inside the eye and over-inhibition of VEGF, as well as the potential for potential systemic side effects such as heart attack, stroke, wound healing problems, and high blood pressure.

24


 

Recent trends in the development of anti-VEGF therapies have favored increased molar dosages, as compared to currently marketed treatments. To date these heightened dosages have not exhibited a safety profile significantly worse than that of current treatments, as attributable to molar dose. However, anti-VEGF product candidates featuring higher molar dosages, including KSI-301, may heighten the risk of adverse effects associated with anti-VEGF treatments generally, both in the eye and in the rest of the body. There are risks inherent in the intravitreal injection procedure of drugs like KSI-301 which can cause injury to the eye and other complications including conjunctival hemorrhage, punctate keratitis, eye pain, conjunctival hyperemia, intra-ocular inflammation, and endophthalmitis. KSI-301 is also being explored clinically with higher frequency dosing. Although not predicated with today’s standard of care agents historically, higher frequency dosing may increase the risk of potential adverse events. Our expectation is for KSI-301 to be used at high frequency (for example, monthly dosing) in a minority of patients, yet any additional toxicology signal observed, be it real or perceived, may negatively impact perceptions of KSI-301 in broader populations and impact clinical trial enrollment, regulatory approval and commercial success.

Drug-related side effects could affect patient recruitment, the ability of enrolled patients to complete the study and/or result in potential product liability claims. We may not be able to maintain insurance coverage at a reasonable cost or in sufficient amounts to protect us against losses due to liability. A successful product liability claim or series of claims brought against us could cause our stock price to decline and, if judgments exceed our insurance coverage, could adversely affect our results of operations and business. In addition, regardless of merit or eventual outcome, product liability claims may result in impairment of our business reputation, withdrawal of clinical trial participants, costs due to related litigation, distraction of management’s attention from our primary business, initiation of investigations by regulators, substantial monetary awards to patients or other claimants, the inability to commercialize our product candidates and decreased demand for our product candidates, if approved for commercial sale.

Additionally, if one or more of our product candidates receives marketing approval, and we or others later identify undesirable side effects or adverse events caused by such products, a number of potentially significant negative consequences could result, including but not limited to:

regulatory authorities may withdraw approvals of such product;
regulatory authorities may require additional warnings on the label;
we may be required to change the way the product is administered or conduct additional clinical trials or post-approval studies;
we may be required to create a REMS plan, which could include a medication guide outlining the risks of such side effects for distribution to patients, a communication plan for healthcare providers and/or other elements to assure safe use;
we could be sued and held liable for harm caused to patients; and
our reputation may suffer.

Any of these events could prevent us from achieving or maintaining market acceptance of the particular product candidate, if approved, and could significantly harm our business, results of operations, and prospects.

We may encounter difficulties enrolling patients in our clinical trials, and our clinical development activities could thereby be delayed or otherwise adversely affected.

The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients who remain in the trial until its conclusion. We may experience difficulties in patient enrollment in our clinical trials for a variety of reasons, including:

the size and nature of the patient population;
the patient eligibility criteria defined in the protocol, including certain highly-specific criteria related to stage of disease progression, which may limit the patient populations eligible for our clinical trials to a greater extent than competing clinical trials for the same indication that do not have such patient eligibility criteria;
the size of the study population required for analysis of the trial’s primary endpoints;
the proximity of patients to a trial site;
the effects of health epidemics, including the ongoing COVID-19 pandemic and the resulting shelter-in-place, travel or similar restrictions;
the design of the trial;
new safety events may cause physicians to decrease patient enrollment in our studies;
our ability to recruit clinical trial investigators with the appropriate competencies and experience;
competing clinical trials for similar therapies or targeting patient populations meeting our patient eligibility criteria;

25


 

clinicians’ and patients’ perceptions as to the potential advantages and side effects of the product candidate being studied in relation to other available therapies and product candidates;
our ability to obtain and maintain patient consents; and
the risk that patients enrolled in clinical trials will not complete such trials, for any reason.

For example, because patients with early stages of DR often lack symptoms, it may be challenging to identify and enroll patients at early stages of disease that may be required for a clinical trial. Our inability to enroll a sufficient number of patients for our clinical trials could result in significant delays or may require us to abandon one or more clinical trials altogether. Enrollment delays in our clinical trials may result in increased development costs for our product candidates, delay or halt the development of and approval processes for our product candidates and jeopardize our ability to commence sales of and generate revenues from our product candidates, which may harm our business and results of operation.

Our clinical trials may fail to demonstrate substantial evidence of the safety and efficacy or durability of our product candidates, which would prevent, delay or limit the scope of regulatory approval and commercialization.

Before obtaining regulatory approvals for the commercial sale of any of our product candidates, we must demonstrate through lengthy, complex and expensive preclinical studies and clinical trials that our product candidates are both safe and effective for use in each target indication. For those product candidates that are subject to regulation as biological drug products, we will need to demonstrate that they are safe, pure, and potent for use in their target indications. Each product candidate must demonstrate an adequate risk versus benefit profile in its intended patient population and for its intended use. This is especially true for anti-VEGF biologic agents, where Lucentis and Eylea are established products with accepted safety profiles.

Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process. The results of preclinical studies of our product candidates may not be predictive of the results of early-stage or later-stage clinical trials, and results of early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. The results of clinical trials in one set of patients or disease indications may not be predictive of those obtained in another. In some instances, there can be significant variability in safety, efficacy or durability results between different clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the dosing regimen and other clinical trial protocols and the rate of dropout among clinical trial participants. Product candidates in later stages of clinical trials may fail to show the desired safety, efficacy and durability profile despite having progressed through preclinical studies and initial clinical trials. A number of companies in the biopharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or unacceptable safety issues, notwithstanding promising results in earlier trials. Most product candidates that begin clinical trials are never approved by regulatory authorities for commercialization.

We may be unable to design and execute clinical trials that support marketing approval. We cannot be certain that our planned clinical trials or any other future clinical trials will be successful. Additionally, any safety concerns observed in any one of our clinical trials in our targeted indications could limit the prospects for regulatory approval of our product candidates in those and other indications, which could have a material adverse effect on our business, financial condition and results of operations.

In addition, even if such clinical trials are successfully completed, we cannot guarantee that the FDA or foreign regulatory authorities will interpret the results as we do, and more trials or trials of a different design could be required before we submit our product candidates for approval. Our KSI-301 pivotal study program relies on a single active arm in each study at a single dose (5 mg), such that if a safety observation is observed there is no fallback position at a lower dose to rely on. To the extent that the results of the trials are not satisfactory to the FDA or foreign regulatory authorities for support of a marketing application, we may be required to expend significant resources, which may not be available to us, to conduct additional trials in support of potential approval of our product candidates. Even if regulatory approval is secured for any of our product candidates, the terms of such approval may limit the scope and use of our product candidate, which may also limit its commercial potential. Even if trial results are successful at the primary endpoint, clinical trial results may be different or worse in the extended treatment periods following the primary endpoint, and such data may negatively impact perceptions by regulatory authorities, the clinical community or commercial payors of the benefits of our product candidate.

26


 

We may not be successful in our efforts to continue to create a pipeline of product candidates or to develop commercially successful products. If we fail to successfully identify and develop additional product candidates, our commercial opportunity may be limited.

One of our strategies is to identify and pursue clinical development of additional product candidates through our ABC Platform. Our ABC Platform may not produce a pipeline of viable product candidates, or our competitors may develop platform technologies that render our ABC Platform obsolete or less attractive. Our research methodology may be unsuccessful in identifying potential product candidates, or our potential product candidates may be shown to have harmful side effects or may have other characteristics that may make them unmarketable or unlikely to receive marketing approval. Identifying, developing, obtaining regulatory approval and commercializing additional product candidates for the treatment of retinal diseases will require substantial additional funding and is prone to the risks of failure inherent in drug development. If we are unable to successfully identify, acquire, develop and commercialize additional product candidates, our commercial opportunity may be limited.

We face significant competition in an environment of rapid technological and scientific change, and there is a possibility that our competitors may retain their market share with existing drugs, or achieve regulatory approval before us or develop therapies that are safer, more advanced or more effective than ours, which may negatively impact our ability to successfully market or commercialize any product candidates we may develop and ultimately harm our financial condition.

The development and commercialization of new drug products is highly competitive. We may face competition with respect to any product candidates that we seek to develop or commercialize in the future from major pharmaceutical companies, specialty pharmaceutical companies, and biotechnology companies worldwide. Potential competitors also include academic institutions, government agencies, and other public and private research organizations that conduct research, seek patent protection, and establish collaborative arrangements for research, development, manufacturing, and commercialization.

There are a number of large pharmaceutical and biotechnology companies that are currently pursuing the development of products for the treatment of the retinal disease indications for which we have product candidates, including wet AMD, DME/DR, and RVO. Certain of our competitors have commercially approved products for the treatment of retinal diseases that we are pursuing or may pursue in the future, including Roche, Regeneron and Novartis for the treatment of wet AMD, DME/DR, and RVO. These drugs are well established therapies and are widely accepted by physicians, patients and third-party payors, which may make it difficult to educate these parties on the benefits of switching to KSI-301. Companies that we are aware are developing therapeutics in the retinal disease area include large companies with significant financial resources, such as Roche, Novartis, Bayer and Regeneron, AbbVie/Allergan, Mylan, Momenta, and Samsung Bioepis. In addition to competition from other companies targeting retinal indications, any products we may develop may also face competition from other types of therapies, such as gene-editing therapies and drug delivery devices.

The first Lucentis biosimilar was approved this year in the USA, and its approval may impact market dynamics and payor policies negatively for KSI-301. Roche’s product candidate, faricimab, was filed for approval in May 2021 for wet AMD and DME and is currently enrolling pivotal studies in RVO. We believe faricimab’s clinical profile together with physician enthusiasm for a new branded anti-VEGF will make it an important product in the marketplace. Even if KSI-301 presents a compelling clinical profile, we may not be able to market our product candidates as effectively as our competitors. For example, entrenched franchises may seek to impede adoption of KSI-301 through significant discounts or rebates.

Many of our current or potential competitors, either alone or with their strategic partners, have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals, and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our product candidates. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any products that we may develop. Furthermore, currently approved products could be discovered to have application for treatment of retinal disease indications, which could give such products significant regulatory and market timing advantages over any of our product candidates. Our competitors also may obtain FDA, EMA, NMPA or other regulatory approval for their products more rapidly than we may obtain approval for ours. Additionally, products or technologies developed by our competitors may render our potential product candidates uneconomical or obsolete, and we may not be successful in marketing any product candidates we may develop against competitors.

In addition, we could face litigation or other proceedings with respect to the scope, ownership, validity and/or enforceability of our patents relating to our competitors’ products and our competitors may allege that our products infringe, misappropriate or otherwise violate their intellectual property. For more information regarding potential disputes concerning intellectual property, see the subsection of this report titled “Risks Related to Our Intellectual Property.”

27


 

The manufacture of our product candidates is highly complex and requires substantial lead time to produce.

Manufacturing our product candidates involves complex processes, including developing cells or cell systems to produce the biologic, growing large quantities of such cells, and harvesting and purifying the biologic produced by them. These processes require specialized facilities, highly specific raw materials and other production constraints. As a result, the cost to manufacture a biologic is generally far higher than traditional small molecule chemical compounds, and the biologics manufacturing process is less reliable and is difficult to reproduce. Because of the complex nature of our products, we need to oversee the manufacture of multiple components that require a diverse knowledge base and specialized personnel. Commercial manufacturing scale-up timelines may be negatively affected by material shortages, construction delays and supply chain challenges due to, among other factors, global supply chain shortages due to COVID-19 or other reasons.

Moreover, unlike chemical pharmaceuticals, the physical and chemical properties of a biologic such as our product candidates generally cannot be adequately characterized prior to manufacturing the final product. As a result, an assay of the finished product is not sufficient to ensure that the product will perform in the intended manner. Accordingly, we expect to employ multiple steps to attempt to control our manufacturing process to assure that the process works, and the product or product candidate is made strictly and consistently in compliance with the process

Manufacturing biologics is highly susceptible to product loss due to contamination, equipment failure, improper installation or operation of equipment, vendor or operator error, improper storage or transfer, inconsistency in yields and variability in product characteristics. Even minor deviations from normal manufacturing, distribution or storage processes could result in reduced production yields, product defects and other supply disruptions. Some of the raw materials required in our manufacturing process are derived from biological sources. Such raw materials are difficult to procure and may also be subject to contamination or recall. A material shortage, contamination, recall or restriction on the use of biologically derived substances in the manufacture of our product candidates could adversely impact or disrupt commercialization. Production of additional drug substance and drug product for any of our product candidates may require substantial lead time. For example, currently any new large-scale batches of KSI-301 would require at least 12 months to manufacture. In the event of significant product loss and materials shortages, we may be unable to produce adequate amounts of our product candidates or products for our operational needs.

Further, as product candidates are developed through preclinical studies to late-stage clinical trials towards approval and commercialization, it is common that various aspects of the development program, such as manufacturing methods, are altered along the way in an effort to optimize processes and results. Such changes carry the risk that they will not achieve these intended objectives, and any of these changes could cause our product candidates to perform differently and affect the results of planned clinical trials or other future clinical trials.

We rely on third parties for raw materials needed for manufacturing KSI-301. We may not be able to obtain adequate amounts in the future. These challenges are magnified by the international nature of our supply chain, which, for KSI-301, requires drug substance and drug product sourced from single source suppliers from China, Japan, the United Kingdom, the United States and Switzerland. For example, the effects of health epidemics, including the ongoing COVID-19 pandemic and the resulting shelter-in-place, travel or similar restrictions may impact the timing of clinical resupply facing and BLA facing manufacturing activities.

We have no experience manufacturing any of our product candidates at a commercial scale. If we or any of our third-party manufacturers encounter difficulties in production, or fail to meet rigorously enforced regulatory standards, our ability to provide supply of our product candidates for clinical trials and regulatory applications or our products for patients, if approved, could be delayed or stopped, or we may be unable to establish a commercially viable cost structure.

In order to conduct clinical trials of our product candidates, or supply commercial products, if approved, we will need to manufacture them in small and large quantities. Our third-party manufacturer has made only a limited number of lots of KSI-301 to date and has not made any commercial lots. The manufacturing processes for KSI-301 have never been tested at commercial scale and the process validation requirement (the requirement to consistently produce the active pharmaceutical ingredient used in KSI-301 in commercial quantities and of specified quality on a repeated basis and document its ability to do so) has not yet been satisfied. Our manufacturing partners may be unable to successfully increase the manufacturing capacity for any of our product candidates in a timely or cost-effective manner, or at all. In addition, quality issues may arise during scale-up activities. If our manufacturing partners are unable to successfully scale up the manufacture of our product candidates in sufficient quality and quantity, the development, testing and clinical trials of our product candidates may be delayed or become infeasible, and regulatory approval or commercial launch of any resulting product may be delayed or not obtained, which could significantly harm our business. The same risks would apply to any internal manufacturing facilities, should we in the future decide to build internal manufacturing capacity.

28


 

In addition, the manufacturing process for any products that we may develop is subject to FDA, EMA, NMPA and foreign regulatory authority approval processes and continuous oversight. We will need to contract with manufacturers who can meet all applicable FDA, EMA, NMPA and foreign regulatory authority requirements, including complying with current good manufacturing practices, or cGMPs, on an ongoing basis. If we or our third-party manufacturers are unable to reliably produce products to specifications acceptable to the FDA, EMA, NMPA or other regulatory authorities, we may not obtain or maintain the approvals we need to commercialize such products. Even if we obtain regulatory approval for any of our product candidates, there is no assurance that either we or our CMOs will be able to manufacture the approved product to specifications acceptable to the FDA, EMA, NMPA or other regulatory authorities, to produce it in sufficient quantities to meet the requirements for the potential launch of the product, or to meet potential future demand. Our manufacturers are also engaged in the manufacturing of COVID-19 related vaccines and therapeutic treatments, and the success of and demand for these vaccines and therapeutic treatments means we and our programs are competing for scarce manufacturing resources. We aim to distribute KSI-301 in a prefilled syringe early in our commercial rollout. We may not be able to complete our prefilled syringe activities in a timely manner, or we may fail technically to design and develop a prefilled syringe for KSI-301. If we require large volumes of glass vials, we may not be able to secure a sufficient supply due to COVID-19 related shortages of glass and vials. Any of these challenges could delay completion of clinical trials, require bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our product candidate, impair commercialization efforts, increase our cost of goods, and have an adverse effect on our business, financial condition, results of operations and growth prospects.

If, in the future, we are unable to establish sales and marketing capabilities or enter into agreements with third parties to sell and market any product candidates we may develop, we may not be successful in commercializing those product candidates if and when they are approved.

We do not have a sales or marketing infrastructure and have no experience in the sale, marketing or distribution of pharmaceutical products. To achieve commercial success for any approved product for which we retain sales and marketing responsibilities, we must either develop a sales and marketing organization or outsource these functions to third parties. In the future, we may choose to build a focused sales, marketing and commercial support infrastructure to sell, or participate in sales activities with our collaborators for, some of our product candidates if and when they are approved.

There are risks involved with both establishing our own commercial capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force or reimbursement specialists is expensive and time consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing and other commercialization capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or reposition our commercialization personnel.

Factors that may inhibit our efforts to commercialize any approved product on our own include:

our inability to recruit and retain adequate numbers of effective sales, marketing, reimbursement, customer service, medical affairs and other support personnel;
the inability of sales personnel to obtain access to physicians or educate adequate numbers of physicians on the benefits of prescribing any future approved products;
the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement, and other acceptance by payors;
the inability to price our products at a sufficient price point to ensure an adequate and attractive level of profitability;
restricted or closed distribution channels that make it difficult to distribute our products to segments of the patient population;
the lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; and
unforeseen costs and expenses associated with creating an independent commercialization organization.

If we enter into arrangements with third parties to perform sales, marketing, commercial support and distribution services, our product revenue or the profitability of product revenue may be lower than if we were to market and sell any products we may develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to commercialize our product candidates or may be unable to do so on terms that are favorable to us. We may have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market our products effectively. If we do not establish commercialization capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our product candidates if approved.

29


 

Even if any product candidates we develop receive marketing approval, they may fail to achieve the degree of market acceptance by physicians, patients, healthcare payors and others in the medical community necessary for commercial success.

The commercial success of any of our product candidates will depend upon its degree of market acceptance by physicians, patients, third-party payors and others in the medical community. Even if any product candidates we may develop receive marketing approval, they may nonetheless fail to gain sufficient market acceptance by physicians, patients, healthcare payors, and others in the medical community. The degree of market acceptance of any product candidates we may develop, if approved for commercial sale, will depend on a number of factors, including:

the efficacy and safety of such product candidates as demonstrated in pivotal clinical trials and published in peer-reviewed journals;
the potential and perceived advantages of our product or product label as compared to alternative treatments;
the ability to offer our products for sale at competitive prices;
the ability to offer appropriate patient access programs, such as co-pay assistance;
the extent to which physicians recommend our products to their patients;
convenience and ease of dosing and administration compared to alternative treatments;
the clinical indications for which the product candidate is approved by FDA, EMA, NMPA or other regulatory agencies;
product labeling or product insert requirements of the FDA, EMA, NMPA or other comparable foreign regulatory authorities, including any limitations, contraindications or warnings contained in a product’s approved labeling;
restrictions on how the product is distributed;
the timing of market introduction of competitive products;
publicity concerning our products or competing products and treatments;
the strength of marketing and distribution support;
sufficient third-party coverage or reimbursement; and
the prevalence and severity of any side effects.

If any product candidates we develop do not achieve an adequate level of acceptance, we may not generate significant product revenue, and we may not become profitable.

Even if we are able to commercialize any product candidates, such products may become subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives, which would harm our business.

Drug pricing and access policies in the U.S. and abroad may change and negatively impact KSI-301’s commercial viability. Proposed policy changes, including the potential for Medicare to negotiate with drug manufacturers, may limit our ability to competitively price KSI-301. Further, commercial insurers may limit patient access to KSI-301 and other branded therapies. The regulations that govern marketing approvals, pricing and reimbursement for new drugs vary widely from country to country. In the United States, recently enacted legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay our commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenue we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if any product candidates we may develop obtain marketing approval.

Our ability to successfully commercialize any products that we may develop also will depend in part on the extent to which reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers, and other organizations. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Government authorities currently impose mandatory discounts for certain patient groups, such as Medicare, Medicaid and Veterans Affairs, or VA, hospitals, and may seek to increase such discounts at any time. Future regulation may negatively impact the price of our products, if approved. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging

30


 

the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, that the level of reimbursement will be sufficient.

Reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. In order to get reimbursement, physicians may need to show that patients have superior treatment outcomes with our products compared to standard of care drugs, including lower-priced generic versions of standard of care drugs. If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize any product candidate for which we obtain marketing approval. In the United States, no uniform policy of coverage and reimbursement for products exists among third-party payors and coverage and reimbursement levels for products can differ significantly from payor to payor. As a result, the coverage determination process is often a time consuming and costly process that may require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance.

There may be significant delays in obtaining reimbursement for newly approved drugs, and coverage may be more limited than the purposes for which the medicine is approved by the FDA, EMA, NMPA or other comparable foreign regulatory authorities. Moreover, eligibility for reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale, and distribution. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement policies. Further, coverage policies and third-party payor reimbursement rates may change at any time. Therefore, even if favorable coverage and reimbursement status is attained, less favorable coverage policies and reimbursement rates may be implemented in the future. Our inability to promptly obtain and maintain coverage and profitable payment rates from both government-funded and private payors for any approved products we may develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize product candidates, and our overall financial condition.

Our product candidates may face competition from biological products that are biosimilar to or interchangeable with our product candidates sooner than anticipated.

The Biologics Price Competition and Innovation Act of 2009, or BPCIA, created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-licensed reference biological product. Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing the sponsor’s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of their product. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation and meaning are subject to uncertainty.

We believe that any of our product candidates approved as a biological product under a BLA should qualify for the 12-year period of exclusivity. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider our product candidates to be reference products for competing products, potentially creating the opportunity for generic competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. Moreover, the extent to which a biosimilar, once approved, will be substituted for any one of our reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing.

If product liability lawsuits are brought against us, we may incur substantial liabilities and may be required to limit commercialization of our product candidates.

We face an inherent risk of product liability as a result of the clinical testing of our product candidates and will face an even greater risk when and if we commercialize any products. For example, we may be sued if our product candidates cause or are perceived to cause injury or are found to be otherwise unsuitable during clinical testing, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. Claims could also be asserted under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit testing and commercialization of our product candidates. Even successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in:

decreased or interrupted demand for our products;
injury to our reputation;

31


 

withdrawal of clinical trial participants and inability to continue clinical trials;
initiation of investigations by regulators;
costs to defend the related litigation;
a diversion of management’s time and our resources;
substantial monetary awards to trial participants or patients;
product recalls, withdrawals or labeling, marketing or promotional restrictions;
loss of revenue;
exhaustion of any available insurance and our capital resources;
the inability to commercialize any product candidate; and
a decline in our share price.

Our inability to obtain sufficient product liability insurance at an acceptable cost to protect against potential product liability claims could prevent or inhibit the commercialization of products we develop, alone or with collaborators. Our insurance policies may have various exclusions, and we may be subject to a product liability claim for which we have no coverage. We may have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts. Even if our agreements with any future corporate collaborators entitle us to indemnification against losses, such indemnification may not be available or adequate should any claim arise.

Risks Related to Regulatory Approval and Other Legal Compliance Matters

The regulatory approval processes of the FDA, EMA, NMPA and comparable foreign regulatory authorities are lengthy, time consuming, and inherently unpredictable. If we are ultimately unable to obtain regulatory approval for our product candidates, we will be unable to generate product revenue and our business will be substantially harmed.

The time required to obtain approval by the FDA, EMA, NMPA and comparable foreign regulatory authorities is unpredictable, typically takes many years following the commencement of clinical trials and depends upon numerous factors, including the type, complexity and novelty of the product candidates involved. In addition, approval policies, regulations or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate’s clinical development and may vary among jurisdictions, which may cause delays in the approval or the decision not to approve an application. Regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional preclinical, clinical or other studies. We have not submitted for or obtained regulatory approval for any product candidate, and it is possible that none of our existing product candidates or any product candidates we may seek to develop in the future will ever obtain regulatory approval.

Applications for our product candidates could fail to receive regulatory approval for many reasons, including but not limited to the following:

the FDA, EMA, NMPA or comparable foreign regulatory authorities may disagree with the design, implementation or results of our clinical trials or the portfolio of clinical trials planned for submission in our BLA;
the FDA, EMA, NMPA or comparable foreign regulatory authorities may determine that our product candidates are not safe and effective, only moderately effective or have undesirable or unintended side effects, toxicities or other characteristics that preclude our obtaining marketing approval or prevent or limit commercial use of our products;
the population studied in the clinical program may not be sufficiently broad or representative to assure efficacy and safety in the full population for which we seek approval;
we may be unable to demonstrate to the FDA, EMA, NMPA or comparable foreign regulatory authorities that a product candidate’s risk-benefit ratio for its proposed indication(s), when compared to the standard of care, is acceptable;
the FDA, EMA, NMPA or comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials;
the data collected from clinical trials of our product candidates may not be sufficient to support the submission of a BLA or other submission or to obtain regulatory approval in the United States or elsewhere;
study data may not be positive in all clinical trials demonstrating a mix of positive and negative clinical trial results;
the FDA, EMA, NMPA or comparable foreign regulatory authorities may fail to approve the chemistry, manufacturing and controls processes, test procedures and specifications, or facilities or third-party manufacturers with which we contract for clinical and commercial supplies; and

32


 

the approval policies or regulations of the FDA, EMA, NMPA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval.

This lengthy approval process, as well as the unpredictability of the results of clinical trials, may result in our failing to obtain regulatory approval to market any of our product candidates, which would significantly harm our business, results of operations, and prospects.

We plan to conduct clinical trials for our product candidates outside the United States (or the respective jurisdictions of other regulatory authorities), and the FDA, (or EMA, NMPA and applicable foreign regulatory authorities) may not accept data from such trials.

We plan to conduct one or more of our clinical trials outside the United States, including Europe, China and other foreign countries. The acceptance of study data from global clinical trials by the FDA, EMA, NMPA or applicable foreign regulatory authority may be subject to certain conditions. In cases where data from foreign clinical trials are intended to serve as the basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (1) the data are applicable to the U.S. population and U.S. medical practice and (2) the trials were performed by clinical investigators of recognized competence and pursuant to cGCP regulations. Additionally, the FDA’s clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory bodies have similar approval requirements. In addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA, EMA, NMPA or any applicable foreign regulatory authority will accept data from trials conducted outside of their respective jurisdictions. If the FDA, EMA, NMPA or any applicable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which would be costly and time-consuming, would delay aspects of our business plan and which may result in our product candidates not receiving approval or clearance for commercialization in the applicable jurisdiction.

Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions.

Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, but a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even if the FDA, EMA or NMPA grants marketing approval of a product candidate, we would not be permitted to manufacture, market or promote the product candidate in other countries unless and until comparable regulatory authorities in foreign jurisdictions had approved the candidate for use in their countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from those in the United States, including additional preclinical studies or clinical trials. There can be no assurance that any clinical trials conducted in one jurisdiction will be accepted by regulatory authorities in other jurisdictions.

Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we or any collaborator we work with fail to comply with the regulatory requirements in international markets or fail to receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed.

Even if we obtain regulatory approval for a product candidate, our products will remain subject to extensive regulatory scrutiny.

If any of our product candidates are approved, they will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies and submission of safety, efficacy and other post-market information, including both federal and state requirements in the United States and requirements of comparable foreign regulatory authorities.

Manufacturers and manufacturers’ facilities are required to comply with extensive requirements imposed by the FDA, EMA, NMPA and comparable foreign regulatory authorities, including ensuring that quality control and manufacturing procedures conform to cGMP regulations. As such, we and our contract manufacturers will be subject to continual review and inspections to assess compliance with cGMP and adherence to commitments made in any BLA or marketing authorization application, or MAA. Accordingly, we and others with whom we work must continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production and quality control.

Any regulatory approvals that we receive for our product candidates will be subject to limitations on the approved indicated uses for which the product may be marketed and promoted or to the conditions of approval (including the requirement to implement a REMS), or contain requirements for potentially costly post-marketing testing. We will be required to report certain adverse reactions and production problems, if any, to the FDA, EMA, NMPA and comparable foreign regulatory authorities. Any new legislation addressing drug safety issues could result in delays in product development or commercialization, or increased costs to assure compliance. The FDA and other agencies, including the Department of Justice, closely regulate and monitor the post-approval marketing and promotion of products to ensure that they are manufactured, marketed and distributed only for the approved indications and in accordance with the provisions of the approved labeling. We will have to comply with requirements concerning advertising and

33


 

promotion for our products. Promotional communications with respect to prescription drugs are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product’s approved label. As such, we may not promote our products for indications or uses for which they do not have approval. The holder of an approved BLA or MAA must submit new or supplemental applications and obtain approval for certain changes to the approved product, product labeling or manufacturing process. We could also be asked to conduct post-marketing clinical trials to verify the safety and efficacy of our products in general or in specific patient subsets. If original marketing approval was obtained via the accelerated approval pathway, we could be required to conduct a successful post-marketing clinical trial to confirm clinical benefit for our products. An unsuccessful post-marketing study or failure to complete such a study could result in the withdrawal of marketing approval.

If a regulatory agency discovers previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facility where the product is manufactured, or disagrees with the promotion, marketing or labeling of a product, such regulatory agency may impose restrictions on that product or us, including requiring withdrawal of the product from the market. If we fail to comply with applicable regulatory requirements, a regulatory agency or enforcement authority may, among other things:

issue warning letters that would result in adverse publicity;
impose civil or criminal penalties;
suspend or withdraw regulatory approvals;
suspend any of our ongoing clinical trials;
refuse to approve pending applications or supplements to approved applications submitted by us;
impose restrictions on our operations, including closing our contract manufacturers’ facilities;
seize or detain products; or
require a product recall.

Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. Any failure to comply with ongoing regulatory requirements may significantly and adversely affect our ability to commercialize and generate revenue from our products. If regulatory sanctions are applied or if regulatory approval is withdrawn, the value of our company and our operating results will be adversely affected.

Healthcare legislative measures aimed at reducing healthcare costs may have a material adverse effect on our business and results of operations.

Third-party payors, whether domestic or foreign, or governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In both the United States and certain international jurisdictions, there have been a number of legislative and regulatory changes to the health care system that could impact our ability to sell our products profitably. In particular, in 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively the ACA, was enacted, which, among other things, subjected biologic products to potential competition by lower-cost biosimilars, addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program, extended the Medicaid Drug Rebate Program to utilization of prescriptions of individuals enrolled in Medicaid managed care organizations, subjected manufacturers to new annual fees and taxes for certain branded prescription drugs, and provided incentives to programs that increase the federal government’s comparative effectiveness research.

Since the ACA’s enactment, there have been numerous challenges to the ACA. For example, President Trump signed several Executive Orders and other directives designed to delay the implementation of certain provisions of the ACA. Concurrently, Congress considered legislation that would repeal or repeal and replace all or part of the ACA. While Congress has not passed comprehensive repeal legislation, it has enacted laws that modify certain provisions of the ACA such as removing penalties, starting January 1, 2019, for not complying with the ACA’s individual mandate to carry health insurance and delaying the implementation of certain ACA-mandated fees. On June 17, 2021, the U.S. Supreme Court dismissed a challenge on procedural grounds that argued that the ACA is unconstitutional in its entirety because the individual mandate was repealed by Congress. Thus, the ACA will remain in effect in its current form. Further, prior to the U.S. Supreme Court ruling, on January 28, 2021, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the ACA marketplace, which began on February 15, 2021 and remained open through August 15, 2021. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is possible that the ACA will be subject to judicial or

34


 

Congressional challenges in the future. It is unclear how such challenges and the healthcare reform measures of the Biden administration will impact the ACA and our business.

In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. In August 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation’s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2% per fiscal year, which went into effect in 2013, and due to subsequent legislative amendments to the statute, will remain in effect through 2030 unless additional Congressional action is taken. However, COVID-19 relief support legislation suspended the 2% Medicare sequester from May 1, 2020 through December 31, 2021. The American Taxpayer Relief Act of 2012 further reduced Medicare payments to several providers, including hospitals and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. Further, on March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 into law, which eliminates the statutory Medicaid drug rebate cap for single source and innovator multiple source drugs, beginning January 1, 2024. In addition, Congress is considering additional health reform measures as part of the budget reconciliation process. In addition, Congress is considering additional health reform measures, such as capping the costs for prescription drugs covered by Medicare Part D and by setting the annual out-of-pocket limit at $2,000 beginning in 2024, as part of the budget reconciliation process.

There have been, and likely will continue to be, legislative and regulatory proposals at the foreign, federal and state levels directed at containing or lowering the cost of healthcare. We cannot predict the initiatives that may be adopted in the future. The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect:

the demand for our product candidates, if we obtain regulatory approval;
our ability to receive or set a price that we believe is fair for our products;
our ability to generate revenue and achieve or maintain profitability;
the level of taxes that we are required to pay; and
the availability of capital.

Moreover, there has been heightened governmental scrutiny in the United States of pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several recent congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies. At the federal level, the Trump administration used several means to propose or implement drug pricing reform, including through federal budget proposals, executive orders and policy initiatives. For example, on July 24, 2020 and September 13, 2020, the Trump administration announced several executive orders related to prescription drug pricing that attempt to implement several of the administration’s proposals. The FDA also released a final rule, effective November 30, 2020, implementing a portion of the importation executive order providing guidance for states to build and submit importation plans for drugs from Canada. Further, on November 20, 2020, the Department of Health and Human Services, or HHS, finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The implementation of the rule has been delayed by the Biden administration from January 1, 2022 to January 1, 2023 in response to ongoing litigation. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers, the implementation of which have also been delayed until January 1, 2023. On November 20, 2020, the Centers for Medicare & Medicaid Services, or CMS, issued an interim final rule implementing President Trump’s Most Favored Nation, or MFN, executive order, which would tie Medicare Part B payments for certain physician-administered drugs to the lowest price paid in other economically advanced countries, effective January 1, 2021. As a result of litigation challenging the MFN Model, on August 10, 2021, CMS published a proposed rule that seeks to rescind the MFN Model interim final rule. In July 2021, the Biden administration released an executive order, “Promoting Competition in the American Economy,” with multiple provisions aimed at prescription drugs. In response to Biden’s executive order, on September 9, 2021, HHS released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. No legislation or administrative actions have been finalized to implement these principles. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.

We expect that the ACA, as well as other healthcare reform measures that may be adopted in the future, may result in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, lower reimbursement and new payment methodologies. This could lower the price that we receive for any approved product. Any denial in coverage or reduction in

35


 

reimbursement from Medicare or other government-funded programs may result in a similar denial or reduction in payments from private payors, which may prevent us from being able to generate sufficient revenue, attain profitability or commercialize our product candidates, if approved. Further, it is possible that additional governmental action is taken in response to the COVID-19 pandemic.

Our employees, independent contractors, consultants, commercial partners and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements or insider trading violations, which could significantly harm our business.

We are exposed to the risk of fraud, misconduct or other illegal activity by our employees, independent contractors, consultants, commercial partners and vendors. Misconduct by these parties could include intentional, reckless and negligent conduct that fails to: comply with the laws of the FDA, EMA, NMPA and other comparable foreign regulatory authorities; provide true, complete and accurate information to the FDA, EMA, NMPA and other comparable foreign regulatory authorities; comply with manufacturing standards we have established; comply with healthcare fraud and abuse laws in the United States and similar foreign fraudulent misconduct laws; or report financial information or data accurately or to disclose unauthorized activities to us. If we obtain FDA approval of any of our product candidates and begin commercializing those products in the United States, our potential exposure under such laws will increase significantly, and our costs associated with compliance with such laws are also likely to increase. In particular, research, sales, marketing, education and other business arrangements in the healthcare industry are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, educating, marketing and promotion, sales and commission, certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. Employee misconduct could also involve the improper use of, including improper trading based upon, information obtained in the course of clinical studies, which could result in regulatory sanctions and serious harm to our reputation.

In connection with our IPO, we adopted a code of business conduct and ethics that applies to all our employees, including management, and our directors. However, it is not always possible to identify and deter misconduct by employees and third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.

If we fail to comply with healthcare laws, we could face substantial penalties and our business, operations and financial conditions could be adversely affected.

Our current and future arrangements with healthcare providers, third-party payors, customers, and others may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations, which may constrain the business or financial arrangements and relationships through which we research, as well as, sell, market and distribute any products for which we obtain marketing approval. The laws that may impact our operations include:

the federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, receiving, offering or paying any remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act;
federal civil and criminal false claims laws, including the False Claims Act, which can be enforced by private citizens on behalf of the government through civil whistleblower or qui tam actions, and civil monetary penalty laws, which impose criminal and civil penalties against individuals or entities from knowingly presenting, or causing to be presented, claims for payment or approval from Medicare, Medicaid or other third-party payors that are false or fraudulent or knowingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal government;
the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created new federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of these statutes or specific intent to violate them in order to have committed a violation;
HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective implementing regulations, which impose requirements on certain covered healthcare providers, health plans

36


 

and healthcare clearinghouses and their respective business associates that perform services for them that involve the use, or disclosure of, individually identifiable health information as well as their covered subcontractors, relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization;
the federal Physician Payments Sunshine Act, created under the ACA, and its implementing regulations, which require manufacturers of drugs, devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid or the Children’s Health Insurance Program to report annually to the CMS under the Open Payments Program, information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Beginning in 2022, applicable manufacturers also will be required to report such information related to payments or other transfers of value made during the previous year to physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists and certified nurse midwives;
federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers; and
analogous state and foreign laws and regulations, such as state and foreign anti-kickback, false claims, consumer protection and unfair competition laws which may apply to pharmaceutical business practices, including but not limited to, research, distribution, sales and marketing arrangements as well as submitting claims involving healthcare items or services reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry’s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government that otherwise restricts payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to file reports with states regarding pricing and marketing information, such as the tracking and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; state and local laws that require the registration of pharmaceutical sales representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.

Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could, despite our efforts to comply, be subject to challenge under one or more of such laws. Efforts to ensure that our business arrangements will comply with applicable healthcare laws may involve substantial costs. It is possible that governmental and enforcement authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties, damages, disgorgement, monetary fines, imprisonment, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations. In addition, the approval and commercialization of any of our product candidates outside the United States will also likely subject us to foreign equivalents of the healthcare laws mentioned above, among other foreign laws.

Our business is subject to complex and evolving U.S. and foreign laws and regulations relating to privacy and data protection. These laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, or monetary penalties, and otherwise may harm our business.

A wide variety of provincial, state, national, and foreign laws and regulations, as well as policies, contracts and other obligations apply to the collection, use, retention, protection, disclosure and transfer of personal data. These data protection and privacy-related laws and regulations are evolving and may result in ever-increasing regulatory and public scrutiny and escalating levels of enforcement and sanctions.

For example, the European Union’s General Data Protection Regulation, or GDPR, which took effect on May 25, 2018, imposes stringent data protection requirements and provides for material penalties for noncompliance. The GDPR applies to processing operations carried out in the context of the activities of an establishment in the European Economic Area, or EEA, and any processing relating to the offering of goods or services to individuals in the EEA and/or the monitoring of their behavior in the EEA. Also, notwithstanding the United Kingdom’s withdrawal from the EU, by operation of the so-called UK GDPR, the GDPR continues to apply in substantially equivalent form to processing operations carried out in the context of the activities of an establishment in the United Kingdom and any processing relating to the offering of goods or services to individuals in the United Kingdom and/or monitoring of their behavior in the United Kingdom—so, when we refer to the GDPR in this section, we are also making reference to the UK GDPR in the context of the United Kingdom, unless the context requires otherwise. These laws may apply in the context of our processing of personal data related to the conduct of clinical trials in the EEA and/or UK.

37


 

The GDPR requires organizations to give detailed disclosures about how they collect, use and share personal information; in certain cases, obtain explicit consent to process special categories of personal data, such as the health or genetic information referred to above; contractually require vendors to meet data protection requirements; maintain adequate data security measures; notify regulators and affected individuals of certain data breaches; meet extensive privacy governance and documentation requirements; and honor individuals’ data protection rights, including their rights to access, correct and delete their personal information.

European data protection laws, including the GDPR, also restrict transfers of personal data from Europe, including the EEA, the United Kingdom and Switzerland, to the United States and most other countries unless the parties to the transfer have implemented specific safeguards to protect the transferred personal data. One of the primary safeguards that allowed U.S. companies to import personal data from Europe had been certification to the EU-U.S. Privacy Shield and Swiss-U.S. Privacy Shield frameworks administered by the U.S. Department of Commerce. However, the Court of Justice of the European Union, or CJEU, adopted a decision in July 2020 that invalidated the EU U.S. Privacy Shield. Following this decision, the United Kingdom government has similarly invalidated use of the EU U.S. Privacy Shield as a mechanism for lawful personal data transfers from the United Kingdom to the United States under the UK GDPR; and the Swiss Federal Data Protection and Information Commissioner announced that the Swiss-U.S. Privacy Shield does not provide adequate safeguards for the purposes of personal data transfers from Switzerland to the United States. The CJEU’s decision in this case also raised questions about whether one of the primary alternatives to the EU-U.S. Privacy Shield, namely, the European Commission’s Standard Contractual Clauses, can lawfully be used for personal data transfers from Europe to the United States or other third countries that are not the subject of an adequacy decision of the European Commission. While the CJEU upheld the adequacy of the Standard Contractual Clauses in principle, it made clear that reliance on the Standard Contractual Clauses alone may not necessarily be sufficient in all circumstances. Despite updated forms of the Standard Contractual Clauses having been issued by the European Commission following this case, use of the Standard Contractual Clauses must be assessed on a case-by-case basis. In the context of any given transfer, where the legal regime applicable in the destination country may or does conflict with the intended operation of the Standard Contractual Clauses and/or applicable European data protection laws, the CJEU’s decision in this case, subsequent guidance from the European Data Protection Board, or EDPB, and those updated Standard Contractual Clauses, would require the parties to that transfer to implement supplementary technical, organizational and/or contractual measures in order to rely on the Standard Contractual Clauses as a compliant ‘transfer mechanism.’ However, the EDPB draft guidance appears to conclude that no combination of supplementary measures could be sufficient to allow effective reliance on the Standard Contractual Clauses in the context of transfers of personal data ‘in the clear’ to recipients in countries where the power granted to public authorities to access the transferred personal data goes beyond that which is ‘necessary and proportionate in a democratic society’ – which may, following the CJEU’s conclusions in this case on relevant powers of United States public authorities and commentary in that EDPB guidance, include the United States in certain circumstances. At present, there are few, if any, viable alternatives to the Standard Contractual Clauses.

On June 28, 2021, the European Commission issued an adequacy decision under the GDPR which allows transfers (other than those carried out for the purposes of United Kingdom immigration control) of personal data from the EEA to the United Kingdom to continue without restriction for a period of four years ending June 27, 2025. After that period, the adequacy decision may be renewed only if the United Kingdom continues to ensure an adequate level of data protection. During these four years, the European Commission will continue to monitor the legal situation in the United Kingdom and could intervene at any point if the United Kingdom deviates from the level of data protection in place at the time of issuance of the adequacy decision. If the adequacy decision is withdrawn or not renewed, transfers of personal data from the EEA to the United Kingdom will require a valid ‘transfer mechanism’ and we may be required to implement new processes and put new agreements in place, such as Standard Contractual Clauses, to enable transfers of personal data from the EEA to the United Kingdom to continue, which could disrupt our operations.

If we are unable to implement a valid solution for personal data transfers from Europe, including, for example, obtaining individuals’ explicit consent to transfer their personal data from Europe to the United States or other countries, we will face increased exposure to regulatory actions, substantial fines and injunctions against processing personal data from Europe. Inability to import personal data from Europe, including the EEA, United Kingdom or Switzerland, may also (i) restrict our activities in Europe; (ii) limit our ability to collaborate with partners as well as other service providers, contractors and other companies subject to European data protection laws; or (iii) require us to increase our data processing capabilities in Europe at significant expense or otherwise cause us to change the geographical location or segregation of our relevant systems and operations—any or all of which could adversely affect our financial results.

Additionally, other countries outside of Europe have enacted or are considering enacting similar cross-border data transfer restrictions and laws requiring local data residency, which could increase the cost and complexity of operating our business. The type of challenges we face in Europe will likely also arise in other jurisdictions that adopt laws similar in construction to the GDPR or regulatory frameworks of equivalent complexity.

38


 

As noted above, the GDPR also provides for more robust regulatory enforcement and greater penalties for noncompliance than previously applicable data protection laws, including fines of up to €20 million or 4% of an undertaking’s total worldwide annual turnover for the preceding financial year, whichever is higher. In addition to administrative fines, supervisory authorities have extensive audit and inspection rights, and powers to order temporary or permanent bans on all or some processing of personal data carried out by noncompliant actors. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies and obtain compensation for damages resulting from violations of the GDPR. Additionally, as noted above, the United Kingdom has transposed the GDPR into the laws of the United Kingdom, which could expose us to two parallel regimes, each of which potentially authorizes similar fines, with the UK GDPR permitting fines of up to the higher of £17.5 million or 4% of global annual revenue of any noncompliant organizations for the preceding financial year, as well as other potentially divergent enforcement actions for certain violations.
 

Privacy laws in the U.S. are also increasingly complex and changing rapidly. For example, the California legislature enacted the California Consumer Privacy Act, or CCPA, which took effect on January 1, 2020. The CCPA requires covered companies to provide new disclosures to California residents, and honor their requests to access, delete and opt-out of certain sharing of their personal information. The CCPA provides for civil penalties for violations. Since the enactment of the CCPA, new privacy and data security laws have been proposed in more than half of the states and in the U.S. Congress, reflecting a trend toward more stringent privacy legislation in the U.S. The CCPA itself will expand substantially as a result of California voters approving a November 2020 ballot measure that adopted the California Privacy Rights Act of 2020, or CPRA, which will, among other things, create a new administrative agency to implement and enforce California’s privacy laws effective January 1, 2023. While certain clinical trial activities are exempt from the CCPA’s requirements, other personal information that we handle may be subject to the CCPA, which may increase our compliance costs, exposure to regulatory enforcement action and other liabilities.

The GDPR, CCPA and many other laws and regulations relating to privacy and data protection are still being tested in courts, and they are subject to new and differing interpretations by courts and regulatory officials. We are working to comply with the privacy and data protection laws and regulations that apply to us, and we anticipate needing to devote significant additional resources to complying with these laws and regulations. It is possible that the GDPR, CCPA or other laws and regulations relating to privacy and data protection may be interpreted and applied in a manner that is inconsistent from jurisdiction to jurisdiction or inconsistent with our current policies and practices.

Our actual or perceived failure to adequately comply with applicable laws, regulations, policies, contracts and other obligations relating to privacy and data protection, or to protect personal data and other data we process or maintain, could result in regulatory fines and bans on processing personal information, investigations and enforcement actions, penalties and other liabilities, interruptions to our development process, claims for damages by affected individuals, and damage to our reputation, any of which could materially affect our business, financial condition, results of operations and growth prospects.

If we or any contract manufacturers and suppliers we engage fail to comply with environmental, health, and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.

We and any contract manufacturers and suppliers we engage are subject to numerous federal, state and local environmental, health, and safety laws, regulations, and permitting requirements, including those governing laboratory procedures; the generation, handling, use, storage, treatment and disposal of hazardous and regulated materials and wastes; the emission and discharge of hazardous materials into the ground, air and water; and employee health and safety. Our operations involve the use of hazardous and flammable materials, including chemicals and biological and radioactive materials. Our operations also produce hazardous waste. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. Under certain environmental laws, we could be held responsible for costs relating to any contamination at our current or past facilities and at third-party facilities. We also could incur significant costs associated with civil or criminal fines and penalties.

Compliance with applicable environmental laws and regulations may be expensive, and current or future environmental laws and regulations may impair our research, product development and manufacturing efforts. In addition, we cannot entirely eliminate the risk of accidental injury or contamination from these materials or wastes. Although we maintain workers’ compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not carry specific biological or hazardous waste insurance coverage, and our property, casualty, and general liability insurance policies specifically exclude coverage for damages and fines arising from biological or hazardous waste exposure or contamination. Accordingly, in the event of contamination or injury, we could be held liable for damages or be penalized with fines in an amount exceeding our resources, and our clinical trials or regulatory approvals could be suspended, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.

39


 

Our business activities may be subject to the Foreign Corrupt Practices Act, or FCPA, and similar anti-bribery and anti-corruption laws.

Our business activities may be subject to the FCPA and similar anti-bribery or anti-corruption laws, regulations or rules of other countries in which we operate or may operate in the future, including the UK Bribery Act. The FCPA generally prohibits offering, promising, giving or authorizing others to give anything of value, either directly or indirectly, to a non-U.S. government official in order to influence official action, or otherwise obtain or retain business. The FCPA also requires public companies to make and keep books and records that accurately and fairly reflect the transactions of the corporation and to devise and maintain an adequate system of internal accounting controls. Our business is heavily regulated and therefore involves significant interaction with public officials, including officials of non-U.S. governments. Additionally, in many other countries, the health care providers who prescribe pharmaceuticals are employed by their government, and the purchasers of pharmaceuticals are government entities; therefore, our dealings with these prescribers and purchasers are subject to regulation under the FCPA. Recently the SEC and Department of Justice have increased their FCPA enforcement activities with respect to biotechnology and pharmaceutical companies. There can be no assurance that all of our employees, agents, contractors or collaborators, or those of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers, or our employees, the closing down of our facilities, requirements to obtain export licenses, cessation of business activities in sanctioned countries, implementation of compliance programs and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to offer our products in one or more countries and could materially damage our reputation, our brand, our ability to attract and retain employees, and our business, prospects, operating results, and financial condition.

Risks Related to Our Reliance on Third Parties

We expect to rely on third parties to conduct our clinical trials and some aspects of our research and preclinical testing, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research or testing.

We currently rely and expect to continue to rely on third parties, such as CROs, clinical data management organizations, medical institutions and clinical investigators, to conduct some aspects of our research, preclinical testing and clinical trials. Any of these third parties may terminate their engagements with us or be unable to fulfill their contractual obligations. If we need to enter into alternative arrangements, it would delay our product development activities.

Our reliance on these third parties for research and development activities reduces our control over these activities, but does not relieve us of our responsibilities. For example, we remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires us to comply with cGCPs for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible, reproducible and accurate and that the rights, integrity and confidentiality of trial participants are protected. We are also required to register ongoing clinical trials and to post the results of completed clinical trials on a government-sponsored database within certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.

If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical trials in accordance with regulatory requirements or our stated protocols, we will not be able to obtain, or may be delayed in obtaining, marketing approvals for any product candidates we may develop and will not be able to, or may be delayed in our efforts to, successfully commercialize our medicines.

We also expect to rely on other third parties to store and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development or marketing approval of any product candidates we may develop or commercialization of our medicines, producing additional losses and depriving us of potential product revenue.

We contract with third parties for the manufacture of materials for our product candidates and preclinical studies and clinical trials and for commercialization of any product candidates that we may develop. This reliance on third parties carries and may increase the risk that we will not have sufficient quantities of such materials, product candidates or any medicines that we may develop and commercialize, or that such supply will not be available to us at an acceptable cost, which could delay, prevent or impair our development or commercialization efforts.

We do not have any manufacturing facilities. We currently rely exclusively on a third-party manufacturer, Lonza AG, for the manufacture of our materials for preclinical studies and clinical trials and expect to continue to do so for preclinical studies, clinical trials and for commercial supply of any product candidates that we may develop.

40


 

We may be unable to establish any further agreements with third-party manufacturers or to do so on acceptable terms. Even if we are able to establish agreements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including:

the possible breach of the manufacturing agreement by the third party or us;
the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us;
the possible early termination of the agreement by us at a time that requires us to pay a cancellation fee;
reliance on the third party for regulatory compliance, quality assurance, safety and pharmacovigilance and related reporting; and
the inability to produce required volume in a timely manner and to quality standards.

Third-party manufacturers may not be able to comply with cGMP regulations or similar regulatory requirements outside the United States. Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in clinical holds on our trials, sanctions being imposed on us, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocations, seizures or recalls of product candidates or medicines, operating restrictions, and criminal prosecutions, any of which could significantly and adversely affect supplies of our medicines and harm our business, financial condition, results of operations, and prospects.

Any medicines that we may develop may compete with other product candidates and products for access to manufacturing facilities. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for us.

Any performance failure on the part of our existing or future manufacturers could delay clinical development or marketing approval. We do not currently have arrangements in place for redundant supply for any of our product candidates. If any one of our current contract manufacturers cannot perform as agreed, we may be required to replace that manufacturer and may incur added costs and delays in identifying and qualifying any such replacement. Furthermore, securing and reserving production capacity with contract manufacturers may result in significant costs.

Our current and anticipated future reliance upon others for the manufacture of any product candidates we may develop or medicines may adversely affect our future profit margins and our ability to commercialize any medicines that receive marketing approval on a timely and competitive basis.

Reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.

Reliance on third parties to conduct clinical trials, assist in research and development and to manufacture our product candidates, will at times require us to share trade secrets with them. We seek to protect our proprietary technology by in part entering into confidentiality agreements and, if applicable, material transfer agreements, consulting agreements or other similar agreements with our advisors, employees, third-party contractors and consultants prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information, including our trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor’s independent discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may have a material adverse effect on our business.

We rely on third-party suppliers for key raw materials used in our manufacturing processes, and the loss of these third-party suppliers or their inability to supply us with adequate raw materials could harm our business.

We rely on third-party suppliers for the raw materials required for the production of our product candidates. Our reliance on these third-party suppliers and the challenges we may face in obtaining adequate supplies of raw materials involve several risks, including limited control over pricing, availability, quality and delivery schedules. As a small company, our negotiation leverage is limited and we are likely to get lower priority than our competitors who are larger than we are. We cannot be certain that our suppliers will continue to provide us with the quantities of these raw materials that we require or satisfy our anticipated specifications and quality requirements. Any supply interruption in limited or sole sourced raw materials could materially harm our ability to manufacture our product candidates until a new source of supply, if any, could be identified and qualified. We may be unable to find a sufficient alternative supply channel in a reasonable time or on commercially reasonable terms. Any performance failure on the part of our suppliers could delay the development and potential commercialization of our product candidates, including limiting supplies necessary for clinical trials and regulatory approvals, which would have a material adverse effect on our business.

41


 

We may depend on collaborations with third parties for the research, development and commercialization of certain of the product candidates we may develop. If any such collaborations are not successful, we may not be able to realize the market potential of those product candidates.

We may seek third-party collaborators for the research, development and commercialization of certain of the product candidates we may develop. Our likely collaborators for any other collaboration arrangements include large and mid-size pharmaceutical companies, regional and national pharmaceutical companies, biotechnology companies and academic institutions. If we enter into any such arrangements with any third parties, we will likely have shared or limited control over the amount and timing of resources that our collaborators dedicate to the development or potential commercialization of any product candidates we may seek to develop with them. Our ability to generate revenue from these arrangements with commercial entities will depend on our collaborators’ abilities to successfully perform the functions assigned to them in these arrangements. We cannot predict the success of any collaboration that we enter into.

Collaborations involving our product candidates we may develop, pose the following risks to us:

collaborators generally have significant discretion in determining the efforts and resources that they will apply to these collaborations;
collaborators may not properly obtain, maintain, enforce or defend intellectual property or proprietary rights relating to our product candidates or may use our proprietary information in such a way as to expose us to potential litigation or other intellectual property related proceedings, including proceedings challenging the scope, ownership, validity and enforceability of our intellectual property;
collaborators may own or co-own intellectual property covering our product candidates that result from our collaboration with them, and in such cases, we may not have the exclusive right to commercialize such intellectual property or such product candidates;
disputes may arise with respect to the ownership of intellectual property developed pursuant to collaborations;
we may need the cooperation of our collaborators to enforce or defend any intellectual property we contribute to or that arises out of our collaborations, which may not be provided to us;
collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability;
disputes may arise between the collaborators and us that result in the delay or termination of the research, development, or commercialization of our product candidates or that result in costly litigation or arbitration that diverts management attention and resources;
collaborators may decide not to pursue development and commercialization of any product candidates we develop or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in the collaborator’s strategic focus or available funding or external factors such as an acquisition that diverts resources or creates competing priorities;
collaborators may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials, or require a new formulation of a product candidate for clinical testing;
collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours;
collaborators with marketing and distribution rights to one or more product candidates may not commit sufficient resources to the marketing and distribution of such product candidates;
we may lose certain valuable rights under circumstances identified in our collaborations, including if we undergo a change of control;
collaborators may undergo a change of control and the new owners may decide to take the collaboration in a direction which is not in our best interest;
collaborators may become party to a business combination transaction and the continued pursuit and emphasis on our development or commercialization program by the resulting entity under our existing collaboration could be delayed, diminished or terminated;
collaborators may become bankrupt, which may significantly delay our research or development programs, or may cause us to lose access to valuable technology, know-how or intellectual property of the collaborator relating to our products, product candidates;

42


 

key personnel at our collaborators may leave, which could negatively impact our ability to productively work with our collaborators;
collaborations may require us to incur short and long-term expenditures, issue securities that dilute our stockholders, or disrupt our management and business;
collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates or our ABC Platform; and
collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all.

We may face significant competition in seeking appropriate collaborations. Recent business combinations among biotechnology and pharmaceutical companies have resulted in a reduced number of potential collaborators. In addition, the negotiation process is time-consuming and complex, and we may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate or delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop product candidates or bring them to market and generate product revenue.

If we enter into collaborations to develop and potentially commercialize any product candidates, we may not be able to realize the benefit of such transactions if we or our collaborator elect not to exercise the rights granted under the agreement or if we or our collaborator are unable to successfully integrate a product candidate into existing operations and company culture. In addition, if our agreement with any of our collaborators terminates, our access to technology and intellectual property licensed to us by that collaborator may be restricted or terminate entirely, which may delay our continued development of our product candidates utilizing the collaborator’s technology or intellectual property or require us to stop development of those product candidates completely. We may also find it more difficult to find a suitable replacement collaborator or attract new collaborators, and our development programs may be delayed or the perception of us in the business and financial communities could be adversely affected. Any collaborator may also be subject to many of the risks relating to product development, regulatory approval, and commercialization described in this “Risk Factors” section, and any negative impact on our collaborators may adversely affect us.

Risks Related to Our Intellectual Property

If we are unable to obtain and maintain patent protection for any product candidates we develop or for our ABC Platform, our competitors could develop and commercialize products or technology similar or identical to ours, and our ability to successfully commercialize any product candidates we may develop, and our technology may be adversely affected.

Our success depends in large part on our ability to obtain and maintain patent protection in the United States and other countries with respect to our ABC Platform and any proprietary product candidates and other technologies we may develop. We seek to protect our proprietary position by in-licensing intellectual property and filing patent applications in the United States and abroad relating to our ABC Platform, product candidates and other technologies that are important to our business. Given that the development of our technology and product candidates is at an early stage, our intellectual property portfolio directed to certain aspects of our technology and product candidates is also at an early stage. We have filed or intend to file patent applications on core aspects of our technology and product candidates; however, there can be no assurance that any such patent applications will issue as granted patents. Furthermore, in some cases, we only have filed provisional patent applications on certain aspects of our technology and product candidates, and none of these provisional patent applications is eligible to become an issued patent until, among other things, we file a non-provisional patent application within 12 months of the filing date of the applicable provisional patent application. Any failure to file a non-provisional patent application within this timeline could cause us to lose the ability to obtain patent protection for the inventions disclosed in the associated provisional patent applications. Furthermore, in some cases, we may not be able to obtain issued claims covering compositions relating to our ABC Platform and product candidates, as well as other technologies that are important to our business, and instead may need to rely on filing patent applications with claims covering a method of use and/or method of manufacture for protection of such ABC Platform, product candidates and other technologies. There can be no assurance that any such patent applications will issue as granted patents, and even if they do issue, such patent claims may be insufficient to prevent third parties, such as our competitors, from utilizing our technology. Any failure to obtain or maintain patent protection with respect to our ABC Platform and product candidates could have a material adverse effect on our business, financial condition, results of operations, and prospects.

43


 

If any of our patent applications does not issue as a patent in any jurisdiction, we may not be able to compete effectively.

Changes in either the patent laws or their interpretation in the United States and other countries may diminish our ability to protect our inventions, and obtain, maintain and enforce our intellectual property rights and, more generally, could affect the value of our intellectual property or narrow the scope of our owned and licensed patents. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient protection from competitors or other third parties.

The patent prosecution process is expensive, time-consuming and complex, and we may not be able to file, prosecute, maintain, enforce or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output in time to obtain patent protection. Although we enter into non-disclosure and confidentiality agreements with parties who have access to confidential or patentable aspects of our research and development output, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties, any of these parties may breach the agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection. In addition, our ability to obtain and maintain valid and enforceable patents depends on whether the differences between our inventions and the prior art allow our inventions to be patentable over the prior art. In addition, our own fixed applications may become prior art against our current or future patent applications. Furthermore, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, and in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in any of our patents or pending patent applications, or that we were the first to file for patent protection of such inventions.

If the scope of any patent protection we obtain is not sufficiently broad, or if we lose any of our patent protection, our ability to prevent our competitors from commercializing similar or identical technology and product candidates would be adversely affected.

The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions, and has been the subject of much litigation in recent years. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued that protect our ABC Platform, product candidates or other technologies or that effectively prevent others from commercializing competitive technologies and product candidates.

Moreover, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. Even if patent applications we license or own currently or in the future issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors or other third parties from competing with us, or otherwise provide us with any competitive advantage. Any patents may be challenged, narrowed, circumvented, rendered unenforceable or invalidated by third parties. Consequently, we do not know whether our ABC Platform, product candidates or other technologies will be protectable or remain protected by valid and enforceable patents. Our competitors or other third parties may be able to circumvent our patents by developing similar or alternative technologies or products in a non-infringing manner which could materially adversely affect our business, financial condition, results of operations and prospects.

The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the United States and abroad. We may be subject to a third party preissuance submission of prior art to the U.S. Patent and Trademark Office, or USPTO, or become involved in opposition, derivation, revocation, reexamination, post-grant and inter partes review, or interference proceedings or other similar proceedings challenging our patent rights. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate or render unenforceable, our patent rights, allow third parties to commercialize our ABC Platform, product candidates or other technologies and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third-party patent rights. Moreover, we may have to participate in interference proceedings declared by the USPTO to determine priority of invention or in post-grant challenge proceedings, such as oppositions and other challenges in a foreign patent office or administrative tribunal, that challenge our or our licensor’s priority of invention or other features of patentability with respect to our owned or in-licensed patents and patent applications. Such challenges may result in loss of patent rights, loss of exclusivity, or in patent claims being narrowed, invalidated, or held unenforceable, which could limit our ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our ABC Platform, product candidates and other technologies. Such proceedings also may result in substantial cost and require significant time from our scientists and management, even if the eventual outcome is favorable to us.

In addition, given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such product candidates might expire before or shortly after such product candidates are commercialized. As a result, our intellectual property may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.

44


 

We may not be able to protect our intellectual property and proprietary rights throughout the world.

Filing, prosecuting and defending patents relating to our ABC Platform, product candidates and other technologies in all countries throughout the world would be prohibitively expensive, and the laws of foreign countries may not protect our rights to the same extent as U.S. laws. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection but enforcement is not as strong as that in the United States. These products may compete with our products, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.

Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult, costly or impossible for us to stop the infringement of our patents or marketing of competing products in violation of our intellectual property and proprietary rights generally. Proceedings to enforce our intellectual property and proprietary rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly, could put our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property and proprietary rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.

Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired, and our business, financial condition, results of operations and prospects may be adversely affected.

Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by government patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.

Periodic maintenance fees, renewal fees, annuity fees and various other government fees on patents and applications will be due to be paid to the USPTO and various government patent agencies outside of the United States over the lifetime of our owned or licensed patents and applications. The USPTO and various non-U.S. government agencies require compliance with several procedural, documentary, fee payment and other similar provisions during the patent application process. In some cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. Payment within these late fee windows may be employed in order to simplify the payment of these fees generally. There are situations, however, in which non-compliance can result in abandonment or lapse of the patent or patent application, resulting in a partial or complete loss of patent rights in the relevant jurisdiction. In such an event, potential competitors might be able to enter the market with similar or identical products or technology, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, while not relevant for KSI-301, if we rely on a different product, its development could involve the use of government funds, which can require additional compliance aspects to make certain all rights are transferred to or remain with us.

Issued patents may be challenged or invalidated, and recent changes in U.S. patent law have diminished and may further diminish the value of patents in general. We rely on patents to protect our products, and any diminishment in the scope or value of our patents would adversely affect our business.

If we initiated legal proceedings against a third party to enforce a patent directed to our ABC Platform, product candidates or other technologies, the defendant could allege that such patent is invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and unenforceability are commonplace. Grounds for a validity challenge include alleged failures to meet any of several statutory requirements, including obviousness, lack of novelty, lack of written description, or non-enablement. Grounds for an unenforceability challenge include an allegation that someone connected with prosecution of the patent withheld material information from the USPTO with an intent to deceive the USPTO, or made a misleading statement, during prosecution. The filing of a legal proceeding could also result in the third party challenging the patent at the USPTO, such as in post-grant and inter partes review.

45


 

Changes in either the patent laws or interpretation of the patent laws in the United States could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. For patent filings beginning in March 2013, the United States employs a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. Under the current patent laws, a third party that files a patent application in the USPTO before us could therefore be awarded a patent covering an invention of ours even if we had made the invention before it was made by such third party. This will require us to be cognizant going forward of the time from invention to filing of a patent application. Since patent applications in the United States and most other countries are confidential for a period of time after filing or until issuance, we cannot be certain that we were the first to either (1) file any patent application related to our ABC Platform, product candidates or other technologies or (2) invent any of the inventions claimed in our or our licensor’s patents or patent applications.

Changes to U.S. patent laws since 2011 also include allowing third party submissions of prior art to the USPTO during patent prosecution and additional procedures for attacking the validity of a patent through USPTO administered post-grant proceedings, including re-examination, post-grant review, inter partes review, interference proceedings and derivation proceedings. Some of these changes apply to patents issued prior to 2011. These and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings) could result in the revocation of, cancellation of or amendment to our patents in such a way that they no longer cover our ABC Platform, product candidates or other technologies. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standards applied in United States federal courts that apply to actions seeking to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if challenged in a district court action. Accordingly, a third party may attempt to use the USPTO procedures to invalidate our patent claims that would not otherwise have been invalidated if first challenged by the third party as a defendant in a district court action.

As compared to intellectual property-reliant companies generally, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. These rulings have created uncertainty with respect to the validity and enforceability of patents, even once obtained. Depending on future actions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future.

In addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the validity and enforceability of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future.

Any future changes to patent laws could increase the uncertainties and costs surrounding the prosecution of our owned or in-licensed patent applications and the enforcement or defense of our owned or in-licensed issued patents. If a third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our ABC Platform, product candidates or other technologies. Increased uncertainty with respect to, or loss of, patent protection would have a material adverse impact on our business, financial condition, results of operations and prospects.

If we do not obtain patent term extension and data exclusivity for any product candidates we may develop, our business may be materially harmed.

Depending upon the timing, duration and specifics of any FDA marketing approval of any product candidates we may develop, one or more of our owned or in-licensed U.S. patents may be eligible for limited patent term extension under the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent term extension of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar extensions as compensation for patent term lost during regulatory review processes are also available in certain foreign countries and territories, such as in Europe under a Supplementary Patent Certificate. Patent term extension in the United States and/or foreign countries and territories may not be available if, among other things, we fail to exercise due diligence during the testing phase or regulatory review process, fail to apply within applicable deadlines, fail to apply prior to the expiration of relevant patents, or otherwise fail to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or the term of any such extension received is shorter than what we request, our competitors may obtain approval of competing products following our patent expiration, and our business, financial condition, results of operations and prospects could be materially harmed.

46


 

We may be subject to claims challenging the inventorship of our patents and other intellectual property.

We may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or in-licensed patents, trade secrets or other intellectual property as an inventor or co-inventor or owner or co-owner. For example, we may have inventorship disputes arise from conflicting obligations of employees, collaborators, consultants or others who are involved in developing our ABC Platform, product candidates or other technologies. Litigation may be necessary to defend against these and other claims challenging inventorship or our ownership of our owned or in-licensed patents, trade secrets or other intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our ABC Platform, product candidates and other technologies. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.

If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.

In addition to seeking patents for our ABC Platform, product candidates and other technologies, we also rely on trade secrets and confidentiality agreements to protect our unpatented know-how, technology and other proprietary information and to maintain our competitive position. Trade secrets and know-how can be difficult to protect. Over time, we expect our trade secrets and know-how to be disseminated within the industry through independent development, the publication of journal articles describing the methodology and the movement of personnel from academic to industry scientific positions.

We seek to protect these trade secrets and other proprietary technology, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants, train our employees not to bring or use proprietary information or technology from former employers to us or in their work and remind former employees when they leave their employment of their confidentiality obligations to us. We cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary technology and processes. Despite our efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to contain such breaches or disclosures or obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed without the protection of a confidentiality agreement found unenforceable by relevant courts or independently developed by a competitor or other third party, our competitive position would be materially and adversely harmed.

We may be subject to claims that our employees, consultants, or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers or claims asserting ownership of what we regard as our own intellectual property.

Many of our employees, consultants and advisors are currently or were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors and potential competitors. Although we try to ensure that our employees, consultants and advisors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these individuals have improperly used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual’s current or former employer. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.

In addition, while it is our policy to require our employees and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Such claims could have a material adverse effect on our business, financial condition, results of operations, and prospects. Where post-filing date patent assignments are not executed by an inventor, it is our practice to employ and record the assignment provision that can be found in the employee’s employment agreement. This is done when possible, and when the intellectual property is of interest to us.

47


 

Third-party claims of intellectual property infringement, misappropriation or other violation against us or our collaborators may prevent or delay the development and commercialization of our ABC Platform, product candidates and other technologies.

The field of discovering treatments for retinal diseases is highly competitive and dynamic. Due to the focused research and development that is taking place in this field by several companies, including us and our competitors, the intellectual property landscape is in flux, and it may remain uncertain in the future. As such, there may be significant intellectual property related litigation and proceedings relating to our owned, and other third party, intellectual property and proprietary rights in the future.

Our commercial success depends in part on our and our collaborators’ ability to avoid infringing, misappropriating and otherwise violating the patents and other intellectual property rights of third parties. There is a substantial amount of complex litigation involving patents and other intellectual property rights in the biotechnology and pharmaceutical industries, as well as administrative proceedings challenging patents, including interference, derivation and reexamination proceedings before the USPTO or oppositions and other comparable proceedings in foreign jurisdictions. As discussed above, due to changes in U.S. law referred to as patent reform, new procedures including inter partes review and post-grant review have been implemented. As stated above, this reform adds uncertainty to the possibility of challenge to our patents in the future.

Numerous U.S. and foreign issued patents and pending patent applications owned by third parties exist relating to ABC technology and in the fields in which we are developing our product candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our ABC Platform, product candidates and other technologies may give rise to claims of infringement of the patent rights of others. We cannot assure you that our ABC Platform, product candidates and other technologies that we have developed, are developing or may develop in the future will not infringe existing or future patents owned by third parties. We may not be aware of patents that have already been issued or that a third party, including a competitor in the fields in which we are developing our ABC Platform, product candidates and other technologies, might assert are infringed by our current or future ABC Platform, product candidates or other technologies. Such a dispute may concern claims to compositions, formulations, methods of manufacture or methods of use or treatment that cover our ABC Platform, product candidates or other technologies. It is also possible that patents owned by third parties of which we are aware, but which we do not believe are relevant to our ABC Platform, product candidates or other technologies, could be found to be infringed by our ABC Platform, product candidates or other technologies. In addition, because patent applications can take many years to issue, there may be currently pending patent applications that later result in issued patents that our ABC Platform, product candidates or other technologies may infringe.

Third parties may have patents or obtain patents in the future and claim that the manufacture, use or sale of our ABC Platform, product candidates or other technologies infringes these patents. If a third party alleges that we infringe their patents or that we are otherwise employing their proprietary technology without authorization and initiates litigation against us, a court of competent jurisdiction could hold that such patents are valid, enforceable and infringed by our ABC Platform, product candidates or other technologies, even if we believe such claims are without merit. In that event, the successful plaintiff may be able to impede our ability to commercialize the applicable product candidate or technology unless we obtain a license under the applicable patents, or such patents expire or are finally determined to be invalid or unenforceable. Such a license may not be available on commercially reasonable terms or at all. Even if we are able to obtain a license, the license would likely obligate us to pay license fees, royalties or both. Any license granted to us might be nonexclusive, which could result in our competitors gaining access to the same intellectual property. If we are unable to obtain a necessary license to a third-party patent on commercially reasonable terms, we may be unable to commercialize our ABC Platform, product candidates or other technologies, or our commercialization efforts may be significantly delayed, which could in turn significantly harm our business.

We are aware of a number of patents and applications that are directed to one or more aspects of KSI-301. Our intent is to maintain our development efforts under 35 U.S.C. Section 271(e)(1) (which provides a safe harbor from patent infringement claims related to certain drug development activities) through to at least the launch of any KSI-301 product. As such, we do not intend to launch KSI-301 when any valid patent is still in force. We are aware of at least one pending application with claims that are directed to some aspect of KSI-301, and that could, if issued, result in a patent term beyond our intended launch date of KSI-301. If this were to occur, we may challenge the validity of the claims, obtain a license, modify KSI-301, or delay launch.

If we choose to further the pipeline and develop a different product, such a product would be delayed until the expiration of any valid patent that is still in force on such product. Alternatively, our options for addressing any such patents relating to these non-KSI-301 products would include the following: challenge the validity of the claims, obtain a license, or modify the non-KSI-301 product.

Defending against infringement claims, regardless of their merit, would involve substantial litigation expense, would be a substantial diversion of management and other employee resources from our business and may adversely impact our reputation. We may be subject to an injunction that prevents or delays us from commercializing our ABC Platform technology, product candidates or other technologies during ongoing litigation even if we ultimately prevail in the litigation proceedings or the litigation is settled in our favor. We may be subject to an injunction that prevents or delays us from commercializing our ABC Platform, product candidates or other technologies during ongoing litigation even if we ultimately prevail in the litigation proceedings or the litigation is settled in our favor. In the event of a successful claim of infringement against us, we may be enjoined from further developing or commercializing our infringing ABC Platform, product candidates or other technologies. In addition, we may have to pay substantial damages (including treble damages and attorneys’ fees for willful infringement) obtain one or more licenses from third parties, pay royalties and/or redesign our infringing product candidates or technologies, which may be impossible or require substantial time and monetary expenditure. If we were unable to further develop and commercialize our ABC Platform, product candidates or other technologies, it would harm our business significantly.

48


 

Engaging in litigation to defend against third parties alleging that we have infringed, misappropriated or otherwise violated their patents or other intellectual property rights is very expensive, particularly for a company of our size, and time-consuming. Some of our competitors may be able to sustain the costs of litigation or administrative proceedings more effectively than we can because of greater financial resources. Patent litigation and other proceedings may also absorb significant management time. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings against us could impair our ability to compete in the marketplace. The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition or results of operations.

We may become involved in lawsuits to protect or enforce our patents and other intellectual property rights, which could be expensive, time consuming and unsuccessful.

Competitors may infringe our patents or the patents of our licensing partners, or we may be required to defend against claims of infringement. If we assert our intellectual property against others, it could increase the likelihood that our patents or the patents of our licensing partners become involved in inventorship, priority or validity disputes. As discussed above, countering or defending against such claims can be expensive and time consuming. In an infringement proceeding, a court may decide that a patent owned or in-licensed by us is invalid or unenforceable, the other party’s use of our patented technology falls under the safe harbor to patent infringement under 35 U.S.C. §271(e)(1), or may refuse to stop the other party from using the technology at issue on the grounds that our owned and in-licensed patents do not cover the technology in question. An adverse result in any litigation proceeding could put one or more of our owned or in-licensed patents at risk of being invalidated, rendered unenforceable or interpreted narrowly. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation.

Even if we prevail in asserting our intellectual property, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately or to assert all claims we believe to be viable. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.

If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.

We rely on trademarks, service marks, tradenames and brand names. We cannot assure you that our trademark applications will be approved. During trademark registration proceedings, we may receive rejections. Although we are given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, any registered or unregistered trademarks or trade names that we currently have or may in the future acquire may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors or other third parties may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. We own a registered trademark for the mark “KODIAK” and “KODIAK SCIENCES” in the United States. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. We engage a third party watching service to monitor use by third parties of names that are identical or similar to our name. We have identified at least two companies that are using names that we continue to monitor. We have sent cease and desist letters to two companies and filed a trademark opposition proceeding against one company. If we deem it appropriate, we may decide to take further action with respect to those companies. Our efforts to enforce or protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely affect our business, financial condition, results of operations and prospects.

49


 

Intellectual property rights do not necessarily address all potential threats.

The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:

others may be able to make products that are similar to our product candidates or utilize similar technology but that are not covered by the claims of the patents that we may license or own;
we, or our current or future licensors or collaborators, might not have been the first to make the inventions covered by the issued patent or pending patent application that we license or own now or in the future;
we, or our current or future licensors or collaborators, might not have been the first to file patent applications covering certain of our or their inventions;
others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our owned or licensed intellectual property rights;
it is possible that our current or future pending owned or licensed patent applications will not lead to issued patents;
issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal challenges by our competitors or other third parties;
our competitors or other third parties might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;
we may not develop additional proprietary technologies that are patentable;
the patents of others may harm our business; and
we may choose not to file a patent in order to maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property.

Should any of these events occur, they could have a material adverse effect on our business, financial condition, results of operations and prospects.

Risks Related to Our Operations

We are highly dependent on our key personnel, and if we are not successful in attracting, motivating and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.

Developing and commercializing new medicines is a challenging exercise and requires diverse expertise in a variety of scientific, clinical, manufacturing, commercial, financial, people and legal functions. Failure to adequately develop these functions at Kodiak will hurt our ability to compete effectively.

Our ability to compete in the highly competitive biotechnology and pharmaceutical industries depends upon our ability to attract, motivate and retain highly qualified managerial, scientific and medical personnel. We are highly dependent on our management, particularly our Chief Executive Officer, Dr. Victor Perlroth, and our scientific and medical personnel. The loss of the services provided by any of our executive officers, other key employees, and other scientific and medical advisors, and our inability to find suitable replacements, could result in delays in the development of our product candidates and harm our business.

We conduct our U.S. operations at our facilities in Palo Alto, California, in a region that is headquarters to many other biopharmaceutical companies and many academic and research institutions. Competition for skilled personnel is intense and the turnover rate can be high, which may limit our ability to hire and retain highly qualified personnel on acceptable terms or at all. We expect that we may need to recruit talent from outside of our region and doing so may be costly and difficult.

To induce valuable employees to remain at our company, in addition to salary and cash incentives, we have provided restricted stock and stock option grants, including early exercise stock options exercisable for restricted stock that vest over time. The value to employees of these equity grants that vest over time may be significantly affected by movements in our stock price that are beyond our control and may at any time be insufficient to counteract more lucrative offers from other companies. Although we have employment agreements with our key employees, these employment agreements provide for at-will employment, which means that any of our employees could leave our employment at any time, with or without notice. We do not maintain “key man” insurance policies on the lives of all of these individuals or the lives of any of our other employees. If we are unable to attract, incentivize and retain quality personnel on acceptable terms, or at all, it may cause our business and operating results to suffer.

50


 

We will need to grow the size and capabilities of our organization, and we may experience difficulties in managing this growth.

As of September 30, 2021, we had 85 employees, all of whom were full-time. As our development plans and strategies develop, and as we continue operating as a public company, we must add a significant number of additional managerial, operational, financial and other personnel. Future growth will impose significant added responsibilities on members of management, including:

identifying, recruiting, integrating, retaining and motivating additional employees;
managing our internal development efforts effectively, including the clinical and FDA review process for our current and future product candidates, while complying with our contractual obligations to contractors and other third parties;
expanding our operational, financial and management controls, reporting systems and procedures; and
managing increasing operational and managerial complexity.

Our future financial performance and our ability to continue to develop and, if approved, commercialize our product candidates will depend, in part, on our ability to effectively manage any future growth. Our management may also have to divert a disproportionate amount of its attention away from day-to-day activities in order to manage these growth activities.

We currently rely, and for the foreseeable future will continue to rely, in substantial part on certain independent organizations, advisors and consultants to provide certain services. There can be no assurance that the services of these independent organizations, advisors and consultants will continue to be available to us on a timely basis when needed, or that we can find qualified replacements. In addition, if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by consultants is compromised for any reason, our clinical trials may be extended, delayed, or terminated, and we may not be able to obtain regulatory approval of our product candidates or otherwise advance our business. There can be no assurance that we will be able to manage our existing consultants or find other competent outside contractors and consultants on economically reasonable terms, if at all.

If we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors, we may not be able to successfully implement the tasks necessary to further develop our product candidates and, accordingly, may not achieve our research, development, and commercialization goals.

If we engage in acquisitions, in-licensing or strategic partnerships, this may increase our capital requirements, dilute our stockholders, cause us to incur debt or assume contingent liabilities and subject us to other risks.

We may engage in various acquisitions and strategic partnerships in the future, including licensing or acquiring complementary products, intellectual property rights, technologies or businesses. Any acquisition or strategic partnership may entail numerous risks, including:

increased operating expenses and cash requirements;
the assumption of indebtedness or contingent liabilities;
the issuance of our equity securities which would result in dilution to our stockholders;
assimilation of operations, intellectual property, products and product candidates of an acquired company, including difficulties associated with integrating new personnel;
the diversion of our management’s attention from our existing product candidates and initiatives in pursuing such an acquisition or strategic partnership;
retention of key employees, the loss of key personnel, and uncertainties in our ability to maintain key business relationships;
risks and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing products or product candidates and regulatory approvals; and
our inability to generate revenue from acquired intellectual property, technology and/or products sufficient to meet our objectives or even to offset the associated transaction and maintenance costs.

In addition, if we undertake such a transaction, we may incur large one-time expenses and acquire intangible assets that could result in significant future amortization expense.

51


 

If our security measures, or those maintained on our behalf by CROs, service providers or other third parties, are compromised now, or in the future, or the security, confidentiality, integrity or availability of our information technology, software, services, networks, communications or data is compromised, limited or fails, this could result in significant fines or other liability, interrupt our development programs, harm our reputation, or otherwise adversely affect our business.

In the course of our business, we collect, store and transmit proprietary, confidential and sensitive information, including personal information. The information and data processed and stored in our technology systems, and those of our research collaborators, CROs, contractors, consultants, and other third parties on which we depend to operate our business, may be vulnerable to security breaches, loss, damage, corruption, unauthorized access, use or disclosure, or misappropriation. Such incidents may also result from errors or malfeasance by our personnel or the personnel of the third parties with which we work, malware, viruses, software vulnerabilities, hacking, denial of service attacks, social engineering (including phishing), ransomware, credential stuffing or other cyberattacks, including attacks by state-sponsored organizations or sophisticated groups of hackers.

While we have developed systems and processes designed to protect the integrity, confidentiality and security of the confidential and personal information under our control, we cannot assure you that our security measures or those of the third parties we depend on will be effective in preventing cybersecurity incidents. There are many different and rapidly evolving cybercrime and hacking techniques, and we may be unable to anticipate attempted security breaches, identify them before our information is exploited, or react in a timely manner.

Additionally, as a result of the ongoing COVID-19 pandemic, certain employees remain in a remote work environment and outside of our corporate network security protection boundaries, which imposes additional risks to our business, including increased risk of industrial espionage, phishing and other cybersecurity attacks, and unauthorized dissemination of proprietary or confidential information, any of which could have a material adverse effect on our business.

We may be required to expend significant resources, fundamentally change our business activities and practices, or modify our operations, including our clinical trial activities, or information technology in an effort to protect against security breaches and to mitigate, detect and remediate actual or potential vulnerabilities. Although to our knowledge, we have not experienced a material system failure or cybersecurity incident to date, if such an event were to occur, it could result in a material disruption of our development programs and our business operations, whether due to a loss of trade secrets or other proprietary information or other similar disruptions. For example, the loss of clinical trial data from completed, ongoing or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we rely on third-party research institution collaborators, CROs, other contractors and consultants for many aspects of our business, including research and development activities and manufacturing of our product candidates, and similar events relating to their computer systems could also have a material adverse effect on our business.

Cybersecurity incidents and any unauthorized access or disclosure of our information or intellectual property could also compromise our intellectual property, expose sensitive business information, expose the personal information of our employees, require us to incur significant remediation costs, disrupt key business operations and divert attention of management and key information technology resources. Such incidents could also subject us to significant liability, harm our competitive position and delay the further development and commercialization of our product candidates.

Additionally, applicable data protection requirements, including, without limitation, laws, regulations, guidance as well as our internal and external policies and our contractual obligations, may require us to notify relevant stakeholders of security breaches, including affected individuals, partners, collaborators, regulators, law enforcement agencies, and others. Such disclosures are costly, and the disclosure or the failure to comply with such requirements could lead to litigation or other liability, fines, harm to our reputation, significant costs, or other materially adverse effects. There can be no assurance that any limitations or exclusions of liability in our contracts would be enforceable or adequate or protect us from liability or damages.

We cannot be certain that our insurance coverage will be adequate for cybersecurity liabilities, will continue to be available to us on economically reasonable terms, or at all, or that any insurer will not deny coverage as to any future claim. The successful assertion of one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could adversely affect our reputation, business, financial condition and results of operations.

 

52


 

Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.

Our operations, and those of our CROs, CMOs, suppliers, and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics and other natural or man-made disasters or business interruptions, for which we are partly uninsured. In addition, we rely on our third-party research institution collaborators for conducting research and development of our product candidates, and they may be affected by government shutdowns or withdrawn funding. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses. For example, in connection to the ongoing COVID-19 pandemic, the various quarantines, shelter-in-place and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, related to COVID-19 or other infectious diseases, could adversely affect our business, financial condition or results of operations by limiting our ability to manufacture product, forcing temporary closure of facilities that we rely upon or increasing the costs associated with obtaining clinical supplies of our product candidates. The extent to which the ongoing COVID-19 pandemic impacts our results will depend on future developments, which are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning the severity of the COVID-19 pandemic and the actions to contain the coronavirus or treat its impact, among others.

Our operations are located at facilities in Palo Alto, California and Switzerland. Damage or extended periods of interruption to our corporate, development or research facilities due to fire, natural disaster, power loss, communications failure, unauthorized entry or other events could cause us to cease or delay development of some or all of our product candidates. Although we maintain property damage and business interruption insurance coverage on these facilities, our insurance might not cover all losses under such circumstances and our business may be seriously harmed by such delays and interruption.

We implemented a new enterprise resource planning, or ERP, system as well as other systems as part of our ongoing technology and process improvements. Our ERP system is critical to our ability to accurately maintain books and records and prepare our financial statements. If we encounter unforeseen problems with our ERP system or other systems and infrastructure, our business, operations, and financial results could be adversely affected.

Our business is subject to economic, political, regulatory and other risks associated with international operations.

Our business is subject to risks associated with conducting business internationally. Some of our suppliers and collaborative relationships are located outside the United States. Accordingly, our future results could be harmed by a variety of factors, including:

economic weakness, including inflation or political instability in particular non-U.S. economies and markets;
differing and changing regulatory requirements, pricing and reimbursement regimes in non-U.S. countries;
challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the United States;
difficulties in compliance with non-U.S. laws and regulations;
changes in non-U.S. regulations and customs, tariffs and trade barriers;
changes in non-U.S. currency exchange rates and currency controls;
changes in a specific country’s or region’s political or economic environment;
trade protection measures, import or export licensing requirements or other restrictive actions by U.S. or non-U.S. governments;
negative consequences from changes in tax laws;
compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;
workforce uncertainty in countries where labor unrest is more common than in the United States;
difficulties associated with staffing and managing international operations, including differing labor relations;
potential liability under the FCPA or comparable foreign laws; and
business interruptions resulting from geo-political actions, including war and terrorism or natural disasters.

Following the result of a referendum in 2016, the United Kingdom, or UK, left the European Union, or EU, on January 31, 2020, commonly referred to as Brexit. Pursuant to the formal withdrawal arrangements agreed between the UK and the EU, the UK was subject to a transition period until December 31, 2020, or the Transition Period, during which EU rules continued to apply. A trade and cooperation agreement, or the Trade and Cooperation Agreement, that outlines the future trading relationship between the United Kingdom and the European Union applied provisionally from January 1, 2021, and formally entered into force on May 1, 2021.

53


 

Since a significant proportion of the regulatory framework in the UK, is derived from EU directives and regulations, Brexit may have a material impact upon the regulatory regime applicable to our operations, including with respect to our ability to obtain regulatory approvals of our product candidates in the EU. For example, Great Britain is no longer covered by the centralized procedures for obtaining EU-wide marketing authorization from the European Medicines Agency, or EMA, and a separate marketing authorization will be required to market our product candidates in Great Britain. Any delay in obtaining, or an inability to obtain, any marketing approvals, would restrict our ability to generate revenue and achieve and sustain profitability.

While the Trade and Cooperation Agreement provides for the tariff-free trade of medicinal products between the UK and the EU there are additional non-tariff costs to such trade which did not exist prior to the end of the Transition Period. Further, should the UK diverge from the EU from a regulatory perspective in relation to medicinal products, tariffs could be put into place in the future. We could therefore, both now and in the future, face significant additional expenses (when compared to the position prior to the end of the Transition Period) to operate our business, which could significantly and materially harm or delay our ability to generate revenues or achieve profitability of our business. Any further changes in international trade, tariff and import/export regulations as a result of Brexit or otherwise may impose unexpected duty costs or other non-tariff barriers on us. These developments, or the perception that any of them could occur, may significantly reduce global trade and, in particular, trade between the impacted nations and the UK It is also possible that Brexit may negatively affect our ability to attract and retain employees, particularly those from the EU.

These and other risks associated with our planned international operations may materially adversely affect our ability to attain profitable operations.

Our business is currently affected and could be materially and adversely affected in the future by the effects of disease outbreaks, epidemics and pandemics, including the ongoing effects of the COVID-19 pandemic. The COVID-19 pandemic continues to impact our business and could materially and adversely affect our operations, as well as the business or operations of our manufacturers, CROs or other third parties with whom we conduct business.

Our business could be materially and adversely affected by health epidemics in regions where we have concentrations of clinical trial sites or other business operations and could cause significant disruption in the operations of third-party manufacturers and CROs upon whom we rely. For example, in March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. In response, we delayed initiation of the next set of KSI-301 pivotal studies by one quarter from June to September 2020 in order to assess how best to minimize the impact of COVID-19 on clinical trial conduct. We implemented and continue to implement various enhancements into our ongoing study execution to help ensure the safety of patients, physicians, study site staff and Kodiak operations team members during the ongoing COVID-19 pandemic, including the use of remote study monitoring.

The COVID-19 pandemic continues to unfold, and we will continue to monitor our operations in response. We continue to observe government recommendations. Quarantines for COVID-19 or other viruses could impact personnel at third party manufacturing facilities, or the availability or cost of materials, which would disrupt our supply chain. While many of these materials may be obtained by more than one supplier, port closures and other restrictions resulting from the coronavirus outbreak in the region may disrupt our supply chain or limit our ability to obtain sufficient materials for our drug products. As we work towards commercial scale-up and manufacturing activities to support BLA submission, there is increasing competition with COVID-19 related vaccine and therapeutic programs for manufacturing related (i) materials such as resins, filters, sterile tubesets, pipette tips; (ii) personnel such as facility engineering and construction as well as plant engineers and workers; and (iii) production slots in cGMP facilities.

In addition, our current and future clinical trials may be materially and adversely affected by the COVID-19 outbreak in the future. Site initiation and patient enrollment may be further delayed due to prioritization of hospital resources toward the COVID-19 outbreak. Some patients may not be able to comply with clinical trial protocols if quarantines impede patient movement or interrupt healthcare services. Our ability to recruit and retain patients and principal investigators and site staff who, as healthcare providers, may have heightened exposure to COVID-19, and may adversely impact our clinical trial operations. Kodiak staff and/or our CRO partners may not be able to travel to study sites, impacting further site initiations and in-person monitoring of study data quality. Other Kodiak vendors on whom we depend, such as supply chain and logistics partners and our image reading centers may be disrupted, and our operations could be affected. Our clinical studies enroll patients who have underlying risk factors such as advanced age, hypertension and/or diabetes which could lead to higher than expected study discontinuation rates and/or missed visit rates if these patients are adversely affected by the COVID-19 outbreak. To date, we continue to see low levels of patient missed visits. Additionally, the pandemic could result in delayed recruitment in some or all of our clinical studies that are currently recruiting patients, for example if as a consequence of the pandemic patients are not willing to be seen by their physician as frequently as our study protocols require.

The global outbreak of COVID-19 continues to rapidly evolve. The ultimate impact of the COVID-19 outbreak or a similar health epidemic is highly uncertain and subject to change.

54


 

The extent to which the risks and evolving effects of the COVID-19 pandemic impact our business and our clinical development and regulatory efforts will depend on future developments that are highly uncertain and cannot be predicted with confidence, such as the ultimate duration and severity of the pandemic, government actions, such as travel restrictions, quarantines and social distancing requirements, business closures or business disruptions and the effectiveness of actions taken in the U.S. and in other countries to contain and treat the disease, including the effectiveness and timing of vaccine programs in the U.S. and worldwide. The COVID-19 pandemic may also have the effect of heightening many of the other risks described in this “Risk Factors” section.

Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.

As of December 31, 2020, the Company had $50.1 million of federal and $171.0 million of state net operating loss, or NOLs, that may be available to offset future taxable income. A portion of the federal NOL carryforwards begin to expire in 2035 and the state NOL carryforwards begin to expire in 2035, if not utilized. Under Sections 382 and 383 of the United States Internal Revenue Code of 1986, as amended, or the Code, if a corporation undergoes an “ownership change” (generally defined as a greater than 50-percentage-point cumulative change (by value) in the equity ownership of certain stockholders over a rolling three-year period), the corporation’s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change taxable income or taxes may be limited. We may also experience ownership changes in the future as a result of subsequent shifts in our stock ownership, some of which are outside our control. As a result, our ability to use our pre-change net operating loss carryforwards and other pre-change tax attributes to offset post-change taxable income or taxes may be subject to limitation.

The Tax Act, as modified by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) enacted in March 2020, among other things, includes changes to U.S. federal tax rates and the rules governing NOL carryforwards. Federal NOLs arising in tax years beginning after December 31, 2017 are permitted to be carried forward indefinitely, but carryback of such NOLs is generally permitted to the prior five taxable years only for NOLs arising in taxable years beginning before 2021. In addition, under the Tax Act, as modified by the CARES Act, the deductibility of federal NOLs incurred in taxable years beginning after December 31, 2017 is limited in taxable years beginning after December 31, 2020. For state income tax purposes, there may be periods during which the use of net operating loss carryforwards is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. For example, California recently imposed limits on the usability of California state net operating losses to offset taxable income in tax years beginning after 2019 and before 2023. The new limitations on use of NOLs may significantly impact our ability to utilize our NOLs to offset taxable income in the future.

Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.
 

New income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could adversely affect our business operations and financial performance. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, the Tax Act enacted many significant changes to the U.S. tax laws. Future guidance from the Internal Revenue Service and other tax authorities with respect to the Tax Act may affect us, and certain aspects of the Tax Act could be repealed or modified in future legislation. For example, the CARES Act, modified certain provisions of the Tax Act and proposals have recently been made in Congress (which have not yet been enacted) to increase the federal income tax rate applicable to corporate income and make other tax law changes that could have a material adverse impact on us. In addition, it is uncertain if and to what extent various states will conform to the Tax Act, the CARES Act or any newly enacted federal tax legislation. Changes in corporate tax rates, the realization of net deferred tax assets relating to our operations, the taxation of foreign earnings, and the deductibility of expenses under the Tax Act or future reform legislation could have a material impact on the value of our net deferred tax assets, could result in significant one-time charges, and could increase our future U.S. tax expense.
 

Risks Related to Our Business, Financial Condition and Capital Requirements

We are in the clinical stage of drug development and have a very limited operating history and no products approved for commercial sale, which may make it difficult to evaluate our current business and predict our future success and viability.

We are a clinical stage biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. We commenced operations in June 2009, have no products approved for commercial sale and have not generated any revenue. Drug development is a highly uncertain undertaking and involves a substantial degree of risk. Except for KSI-301, we have not initiated clinical trials for any of our other product candidates. To date, we have not completed a pivotal clinical trial, obtained marketing approval for any product candidates, manufactured a commercial scale product, or conducted sales and marketing activities necessary for successful product commercialization. Our limited operating history as a company and early stage of drug development make any assessment of our future success and viability subject to significant uncertainty. We will encounter risks and difficulties frequently experienced by early-stage biopharmaceutical companies in rapidly evolving fields, and we have not yet demonstrated an ability to successfully overcome such risks and difficulties. If we do not address these risks and difficulties successfully, our business will suffer.

55


 

We have incurred significant net losses in each period since our inception and anticipate that we will continue to incur significant and increasing net losses for the foreseeable future.

We have incurred net losses in each reporting period since our inception, including net losses of $173.8 million for the nine months ended September 30, 2021. As of September 30, 2021, we had an accumulated deficit of $465.1 million.

We have invested significant financial resources in research and development activities, including for our product candidates and our ABC Platform. We do not expect to generate revenue from product sales for several years, if at all. The amount of our future net losses will depend, in part, on the level of our future expenditures and our ability to generate revenue. Moreover, our net losses may fluctuate significantly from quarter to quarter and year to year, such that a period-to-period comparison of our results of operations may not be a good indication of our future performance.

We expect to continue to incur significant and increasingly higher expenses and operating losses for the foreseeable future. We anticipate that our expenses will increase substantially if and as we:

progress our current and any future product candidates through preclinical and clinical development;
work with our contract manufacturers to scale up the manufacturing processes for our product candidates or, in the future, establish and operate a manufacturing facility;
continue our research and discovery activities;
continue the development of our ABC Platform;
initiate and conduct additional preclinical, clinical or other studies for our current and any future product candidates;
change or add additional contract manufacturers or suppliers;
seek regulatory approvals and marketing authorizations for our product candidates, including KSI-301;
establish sales, marketing and distribution infrastructure to commercialize any products for which we obtain approval;
acquire or in-license product candidates, intellectual property and technologies;
make milestone, royalty or other payments due under any current or future collaboration or license agreements;
obtain, maintain, expand, protect and enforce our intellectual property portfolio;
attract, hire and retain qualified personnel;
experience any delays or encounter other issues related to our operations;
meet the requirements and demands of being a public company; and
defend against any product liability claims or other lawsuits related to our products.

Our prior losses and expected future losses have had and will continue to have an adverse effect on our stockholders’ equity and working capital. In any particular quarter or quarters, our operating results could be below the expectations of securities analysts or investors, which could cause our stock price to decline.

Drug development is a highly uncertain undertaking and involves a substantial degree of risk. We have never generated any revenue from product sales, and we may never generate revenue or be profitable.

We have no products approved for commercial sale and have not generated any revenue from product sales. We do not anticipate generating any revenue from product sales until after we have successfully completed clinical development and received regulatory approval for the commercial sale of a product candidate, if ever.

Our ability to generate revenue and achieve profitability depends significantly on many factors, including:

successfully completing research and preclinical and clinical development of our product candidates;
obtaining regulatory approvals and marketing authorizations for product candidates for which we successfully complete clinical development and clinical trials;
developing a sustainable and scalable manufacturing process for our product candidates, as well as establishing and maintaining commercially viable supply relationships with third parties that can provide adequate products and services to support clinical activities and any commercial demand for our product candidates;
identifying, assessing, acquiring and/or developing new product candidates;
negotiating favorable terms in any collaboration, licensing or other arrangements into which we may enter;

56


 

launching and successfully commercializing product candidates for which we obtain regulatory and marketing approval, either by collaborating with a partner or, if launched independently, by establishing a sales, marketing and distribution infrastructure;
obtaining and maintaining an adequate price for our product candidates, both in the United States and in foreign countries where our products are commercialized;
obtaining adequate reimbursement for our product candidates from payors;
obtaining market acceptance of our product candidates as viable treatment options;
addressing any competing technological and market developments;
maintaining, protecting, expanding and enforcing our portfolio of intellectual property rights, including patents, trade secrets and know-how; and
attracting, hiring and retaining qualified personnel.

Because of the numerous risks and uncertainties associated with drug development, we are unable to predict the timing or amount of our expenses, or when we will be able to generate any meaningful revenue or achieve or maintain profitability, if ever. In addition, our expenses could increase beyond our current expectations if we are required by the FDA or foreign regulatory agencies, to perform studies in addition to those that we currently anticipate, or if there are any delays in any of our or our future collaborators’ clinical trials or the development of any of our product candidates. Even if one or more of our product candidates is approved for commercial sale, we anticipate incurring significant costs associated with commercializing any approved product candidate and ongoing compliance efforts.

Even if we are able to generate revenue from the sale of any approved products, we may not become profitable, and we will need to obtain additional funding through one or more debt or equity financings in order to continue operations. Revenue from the sale of any product candidate for which regulatory approval is obtained will be dependent, in part, upon the size of the markets in the territories for which we gain regulatory approval, the accepted price for the product, the ability to get reimbursement at any price and whether we own the commercial rights for that territory. If the number of addressable patients is not as significant as we anticipate, the indication approved by regulatory authorities is narrower than we expect, or the reasonably accepted population for treatment is narrowed by competition, physician choice or treatment guidelines, we may not generate significant revenue from sales of such products, even if approved. Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis.

Our failure to become and remain profitable could decrease the value of our company and could impair our ability to raise capital, expand our business, maintain our research and development efforts, diversify our pipeline of product candidates or continue our operations and cause a decline in the value of our common stock, all or any of which may adversely affect our viability.

If we fail to obtain additional financing, we may be unable to complete the development and, if approved, commercialization of our product candidates.

Our operations have required substantial amounts of cash since inception. To date, we have funded our operations primarily through the sale of equity securities. Developing our product candidates is expensive, and we expect to continue to increase our spending as we conduct the Phase 3 clinical trials for our KSI-301 product candidate. Even if we are successful in developing our product candidates, obtaining regulatory approvals and launching and commercializing any product candidate will require substantial additional funding.

Our estimate as to how long we expect our existing cash, cash equivalents and marketable securities to be available to fund our operations is based on assumptions that may prove inaccurate, and we could deplete our available capital resources sooner than we currently expect. In addition, changing circumstances may cause us to increase our spending significantly faster than we currently anticipate, and we may need to spend more money than currently expected because of circumstances beyond our control. We may need to raise additional funds sooner than we anticipate if we choose to expand more rapidly than we presently anticipate.

We will require additional capital for the further development and, if approved, commercialization of our product candidates. Additional capital may not be available when we need it, on terms acceptable to us or at all. We currently have no committed source of additional capital. If adequate capital is not available to us on a timely basis, we may be required to significantly delay, scale back or discontinue our research and development programs or the commercialization of any product candidates, if approved, or be unable to continue or expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, financial condition and results of operations and cause the price of our common stock to decline.

57


 

Due to the significant resources required for the development of our product candidates, and depending on our ability to access capital, we must prioritize development of certain product candidates. Moreover, we may expend our limited resources on product candidates that do not yield a successful product and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.

Due to the significant resources required for the development of our product candidates, we must decide which product candidates and indications to pursue and advance and the amount of resources to allocate to each. Our decisions concerning the allocation of research, development, collaboration, management and financial resources toward particular product candidates or therapeutic areas may not lead to the development of any viable commercial product and may divert resources away from better opportunities. Similarly, our potential decisions to delay, terminate or collaborate with third parties in respect of certain product candidates may subsequently also prove to be suboptimal and could cause us to miss valuable opportunities. If we make incorrect determinations regarding the viability or market potential of any of our product candidates or misread trends in the biopharmaceutical industry, in particular for retinal diseases, our business, financial condition and results of operations could be materially adversely affected. As a result, we may fail to capitalize on viable commercial products or profitable market opportunities, be required to forego or delay pursuit of opportunities with other product candidates or other diseases and disease pathways that may later prove to have greater commercial potential than those we choose to pursue, or relinquish valuable rights to such product candidates through collaboration, licensing or other royalty arrangements in cases in which it would have been advantageous for us to invest additional resources to retain sole development and commercialization rights.

 

Risks Related to Ownership of Our Common Stock

The market price of our common stock may be volatile, which could result in substantial losses for investors purchasing shares.

The market price of our common stock may be volatile. As a result, you may not be able to sell your common stock at or above the price that you paid for such shares. Some of the factors that may cause the market price of our common stock to fluctuate include:

the success of existing or new competitive products or technologies;
the timing and results of clinical trials for our current product candidates and any future product candidates that we may develop;
commencement or termination of collaborations for our product candidates;
failure or discontinuation of any of our product candidates;
failure to develop our ABC Platform;
results of preclinical studies, clinical trials or regulatory approvals of product candidates of our competitors, or announcements about new research programs or product candidates of our competitors;
regulatory or legal developments in the United States and other countries;
developments or disputes concerning patent applications, issued patents or other proprietary rights;
the recruitment or departure of key personnel;
the commencement of litigation;
the level of expenses related to any of our research programs, product candidates that we may develop;
the results of our efforts to develop additional product candidates or products;
actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts;
announcement or expectation of additional financing efforts;
sales of our common stock by us, our insiders, or other stockholders;
expiration of market standoff or lock-up agreements;
variations in our financial results or those of companies that are perceived to be similar to us;
changes in estimates or recommendations by securities analysts, if any, that cover our stock;
changes in the structure of healthcare payment systems;
market conditions in the pharmaceutical and biotechnology sectors;

58


 

general economic, industry, and market conditions, including fluctuations attributable to the ongoing COVID-19 pandemic and other unforeseeable circumstances; and
the other factors described in this “Risk Factors” section.

In recent years, the stock market in general, and the market for pharmaceutical and biotechnology companies in particular, has experienced significant price and volume fluctuations that have often been unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing those price and volume fluctuations. Broad market and industry factors may seriously affect the market price of our common stock, regardless of our actual operating performance. Following periods of such volatility in the market price of a company’s securities, securities class action litigation has often been brought against that company. Because of the potential volatility of our stock price, we may become the target of securities litigation in the future. Securities litigation could result in substantial costs and divert management’s attention and resources from our business.

Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.

We will seek additional capital through one or a combination of public and private equity offerings, debt financings, strategic partnerships and alliances and licensing arrangements. We, and indirectly, our stockholders, will bear the cost of issuing and servicing such securities. Because our decision to issue debt or equity securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of any future offerings. To the extent that we raise additional capital through the sale of equity securities, your ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a stockholder. The incurrence of indebtedness would result in increased fixed payment obligations and could involve restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. Additionally, any future collaborations we enter into with third parties may provide capital in the near term but limit our potential cash flow and revenue in the future. If we raise additional funds through strategic partnerships and alliances and licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies or product candidates, or grant licenses on terms unfavorable to us.

Our principal stockholders own a significant percentage of our common stock, which could limit your ability to affect the outcome of key transactions, including a change of control.

Our directors, executive officers, significant holders of outstanding common stock and their respective affiliates beneficially own a significant amount of our common stock. As a result, these stockholders, if they act together, will be able to influence our management and affairs and all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions. This concentration of ownership may have the effect of delaying or preventing a change in control of our company and might affect the market price of our common stock.

Delaware law and provisions in our certificate of incorporation and bylaws might discourage, delay, or prevent a change in control of our company or changes in our management and, therefore, depress the trading price of our common stock.

Provisions in our certificate of incorporation and bylaws may discourage, delay, or prevent a merger, acquisition, or other change in control that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares of our common stock. These provisions may also prevent or frustrate attempts by our stockholders to replace or remove our management. Therefore, these provisions could adversely affect the price of our common stock. Among other things, our charter documents:

provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;
eliminate cumulative voting in the election of directors;
authorize our board of directors to issue shares of preferred stock and determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval;
provide our board of directors with the exclusive right to elect a director to fill a vacancy or newly created directorship;
permit stockholders to only take actions at a duly called annual or special meeting and not by written consent;
prohibit stockholders from calling a special meeting of stockholders;
require that stockholders give advance notice to nominate directors or submit proposals for consideration at stockholder meetings;
authorize our board of directors, by a majority vote, to amend the bylaws; and

59


 

require the affirmative vote of at least 66 2/3% or more of the outstanding shares of common stock to amend many of the provisions described above.

In addition, Section 203 of the General Corporation Law of the State of Delaware, or DGCL, prohibits a publicly-held Delaware corporation from engaging in a business combination with an interested stockholder, generally a person which together with its affiliates owns, or within the last three years has owned, 15% of our voting stock, for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner.

Any provision of our certificate of incorporation, bylaws, or Delaware law that has the effect of delaying or preventing a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our capital stock and could also affect the price that some investors are willing to pay for our common stock.

Our bylaws provide that the Court of Chancery of the State of Delaware and the federal district courts of the United States of America will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.

Our bylaws provide that the Court of Chancery of the State of Delaware will be the exclusive forum for:

any derivative action or proceeding brought on our behalf;
any action asserting a claim of breach of fiduciary duty;
any action asserting a claim against us arising under the DGCL, our certificate of incorporation, or our bylaws; and
any action asserting a claim against us that is governed by the internal-affairs doctrine.

Our bylaws further provide that the U.S. federal district courts will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended.

These exclusive-forum provisions may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers, and other employees. If a court were to find either exclusive-forum provision in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could seriously harm our business. Our bylaws further provide that unless we otherwise consent in writing, the U.S. federal district courts will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated certificate of incorporation. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.

General Risk Factors

If securities analysts do not publish research or reports about our business or if they publish negative evaluations of our stock, the price of our stock could decline.

The trading market for our common stock will rely in part on the research and reports that industry or financial analysts publish about us or our business. If one or more of the analysts covering our business downgrade their evaluations of our stock, the price of our stock could decline. If one or more of these analysts cease to cover our stock, we could lose visibility in the market for our stock, which in turn could cause our stock price to decline.

Future sales of our common stock in the public market could cause our share price to decline, even if our business is doing well.

Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales might occur, could depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict the effect that sales, particularly sales by our directors, executive officers and significant stockholders, may have on the prevailing market price of our common stock. All of our outstanding shares of common stock are available for sale in the public market, subject only to the restrictions of Rule 144 under the Securities Act in the case of our affiliates. In addition, the shares of common stock subject to outstanding options under our equity incentive plans and the shares reserved for future issuance under our equity incentive plans, as well as shares issuable upon vesting of restricted stock unit awards, will become eligible for sale in the public market in the future, subject to certain legal and contractual limitations. In addition, certain holders of our common stock have the right, subject to various conditions and limitations, to request we include their shares of our common stock in registration statements we may file relating to our securities. If any of these additional shares are sold, or if it is perceived that they will be sold, in the public market, the market price of our common stock could decline.

60


 

A failure to maintain an effective system of internal control over financial reporting could result in material misstatements of our financial statements in future periods and may impair our ability to comply with the accounting and reporting requirements applicable to public companies. Furthermore, our business, financial position, and results of operations could be adversely affected.

As a public company, we are subject to reporting and other obligations under the Exchange Act, including the requirements of SOX Section 404, which require annual management assessments of the effectiveness of our internal control over financial reporting.

The rules governing the standards that must be met for management to determine that our internal control over financial reporting is effective are complex and require significant documentation, testing and possible remediation to meet the detailed standards under the rules. During the course of its testing, our management may identify material weaknesses or deficiencies which may not be remedied in time to meet the deadline imposed by SOX. These reporting and other obligations place significant demands on our management and administrative and operational resources, including accounting resources.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of annual or interim consolidated financial statements will not be prevented or detected on a timely basis. Any failure to maintain effective internal controls could also have an adverse effect on our business, financial position and results of operations.

61


 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

None.

Item 5. Other Information.

None.

62


 

Item 6. Exhibits.

(a)
Exhibits.

 

 

 

 

 

Incorporated by Reference

Exhibit

Number

 

Description

 

Form

 

File No.

 

Exhibit

 

Filing Date

 

 

 

 

 

 

 

 

 

 

 

  10.1

 

2021 Long-Term Performance Incentive Plan

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.2

 

Letter Agreement, dated July 22, 2021, between Kodiak Sciences Inc., Kodiak Sciences GmbH and Edison ICAV, as assignee of Baker Bros. Advisors, LP

 

8-K

 

001-38682

 

10.1

 

7/23/2021

 

 

 

 

 

 

 

 

 

 

 

  31.1

 

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  31.2

 

Certification of Principal Accounting and Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  32.1*

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  32.2*

 

Certification of Principal Accounting and Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.INS

 

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

104

 

Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* The certifications attached as Exhibits 32.1 and 32.2 are deemed “furnished” and not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of Kodiak Sciences Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof irrespective of any general incorporation by reference language contained in any such filing, except to the extent that the registrant specifically incorporates it by reference.

63


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

KODIAK SCIENCES INC.

 

 

 

 

Date: November 9, 2021

 

By:

/s/ Victor Perlroth

 

 

 

Victor Perlroth, M.D.

 

 

 

Chairman and Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

Date: November 9, 2021

 

By:

/s/ John Borgeson

 

 

 

John Borgeson

 

 

 

Senior Vice President and Chief Financial Officer

(Principal Accounting and Financial Officer)

 

64


EX-10.1 2 kod-ex10_1.htm EX-10.1 EX-10.1

Exhibit 10.1

Kodiak Sciences Inc.

2021 Long-Term Performance Incentive Plan

1. General.

(a) Purpose. As part of its employee compensation program, Kodiak Sciences Inc. (the “Company”) has adopted this 2021 Long-Term Performance Incentive Plan (the “Plan”), effective as of August 12, 2021 (the “Effective Date”), subject to Section 2 below. The purpose of the Plan is to help attract and retain key employees by providing them with additional incentives and to encourage such employees to contribute maximum effort towards supporting the Company’s next phase of transformational performance and growth.

(b) Eligible Employees. An employee of the Company shall be eligible to participate in the Plan if (i) such employee is at Grade Level 10 or above at the Company and (ii) such employee has agreed to participate in the Plan by executing and returning an Election Form to the Company within the time period required therein. Notwithstanding the foregoing, the determination of whether an employee may participate in the Plan shall be made by the Administrator, in its sole discretion, and such determination shall be binding and conclusive on all persons.

2. Stockholder Approval Required. The Plan shall be subject to stockholder approval at a special meeting of the Company’s stockholders to be held as soon as practicable following the Effective Date. If such stockholder approval is not obtained, then each Award granted under the Plan will be forfeited and each Participant will receive 100% of his or her Annual LTI Awards for fiscal year 2021. If such stockholder approval is obtained, each Participant will forego a portion of each Annual LTI Award that may be granted by the Company to the Participant during the Performance Period, with such foregone portion being specified in his or her Election Form.

3. Administration of the Plan.

(a) Powers of the Administrator. The Administrator shall have the authority, in its discretion:

(1) to select the employees to whom Awards may be granted pursuant to the Plan;

(2) to determine the number of Shares to be covered by each Award granted pursuant to the Plan;

(3) to approve the forms of Award Agreements for use under the Plan;

(4) to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted pursuant to the Plan. Such terms and conditions include, but are not limited to, the exercise price, the time or times when Awards may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator shall determine;

(5) to construe and interpret the terms of the Plan and the Awards granted pursuant to the Plan;

(6) to modify or amend each Award, including but not limited to the discretionary authority to extend the post-termination exercisability period of Awards and to extend the maximum term of Awards;

(7) to authorize any person to execute on behalf of the Company any instrument required to effect the grant of an Award previously granted by the Administrator; and

(8) to make all other determinations deemed necessary or advisable for administering the Plan.

(b) Rule 16b-3. To the extent desirable to qualify transactions hereunder as exempt under Rule 16b-3, the transactions contemplated hereunder will be structured to satisfy the requirements for exemption under Rule 16b-3.

(c) Effect of Administrator’s Decision. The Administrator’s decisions, determinations and interpretations shall be final and binding on all Participants.

1


 

4. Stock Subject to the Plan. Subject to the provisions of Section 6 of the Plan, the maximum aggregate number of Shares that may be issued under the Plan is 5,502,334 Shares. The Shares may be authorized, but unissued, or reacquired Common Stock.

5. Awards.

(a) Each Award granted under the Plan will be a Nonstatutory Stock Option.

(b) The term of each Award will be stated in the Award Agreement.

(c) Exercise Price.

(1) The per Share exercise price of each Award will be no less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.

(2) At the time an Award is granted, the Administrator will fix the period within which the Award may be exercised and will determine any conditions that must be satisfied before the Award may be exercised.

(3) The Administrator will determine the acceptable form of consideration for exercising an Award, including the method of payment. Such consideration may consist entirely of: (1) cash; (2) check; (3) promissory note, to the extent permitted by Applicable Laws, (4) other Shares, provided that such Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which such Award will be exercised and provided that accepting such Shares will not result in any adverse accounting consequences to the Company, as the Administrator determines in its sole discretion; (5) consideration received by the Company under a broker-assisted (or other) cashless exercise program (whether through a broker or otherwise) implemented by the Company in connection with the Plan; (6) by net exercise; (7) such other consideration and method of payment for the issuance of Shares to the extent permitted by Applicable Laws; or (8) any combination of the foregoing methods of payment.

(d) Exercise of Award.

(1) Any Award granted hereunder will be exercisable according to the terms of the Plan and at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement. An Award may not be exercised for a fraction of a Share.

(2) An Award will be deemed exercised when the Company receives: (i) a notice of exercise (in such form as the Administrator may specify from time to time) from the person entitled to exercise the Award, and (ii) full payment for the Shares with respect to which the Award is exercised (together with applicable withholding taxes). Full payment may consist of any consideration and method of payment authorized by the Administrator and permitted by the Award Agreement and the Plan. Shares issued upon exercise of an Award will be issued in the name of the Participant or, if requested by the Participant, in the name of the Participant and his or her spouse, or, if approved by the Administrator, in the name of an estate planning vehicle established for the exclusive benefit of the Participant and the Participant’s family members within the meaning of Instruction A.1.(a)(5) of Form S-8 under the Securities Act. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to an Award, notwithstanding the exercise of the Award. The Company will issue (or cause to be issued) such Shares promptly after the Award is exercised. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 6 of the Plan.

(3) Exercising an Award in any manner will decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under the Award, by the number of Shares as to which the Award is exercised.

(4) If a Participant ceases to be a Service Provider, the Participant may exercise his or her Award, to the extent vested, within such period of time as is specified in the Award Agreement (but in no event later than the expiration of the term of such Award as set forth in the Award Agreement). If after termination the Participant does not exercise his or her Award within the time specified by the Administrator, the Award will terminate, and the Shares covered by such Award will revert to the Plan.

A-2


 

(e) Vesting of Award. A Participant’s Award shall be subject to the vesting requirements set forth in the Award Agreement.

6. Adjustments; Dissolution or Liquidation; Merger or Change in Control.

(a) Adjustments. In the event that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Shares or other securities of the Company, or other change in the corporate structure of the Company affecting the Shares occurs, the Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will adjust the number and class of Shares that may be delivered under the Plan and/or the number, class, and price of Shares covered by each outstanding Award, and the numerical Share limits in Section 4 of the Plan.

(b) Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, the Administrator will notify each Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it has not been previously exercised, an Award will terminate immediately prior to the consummation of such proposed action.

(c) Change in Control. In the event of a Change in Control, each outstanding Award will be treated as set forth in the applicable Award Agreement.

7. Tax.

(a) Withholding Requirements. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof) or such earlier time as any tax withholding obligations are due, the Company will have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy U.S. federal, state, or local taxes, non-U.S. taxes, or other taxes (including the Participant’s FICA obligation) required to be withheld with respect to such Award (or exercise thereof).

(b) Withholding Arrangements. The Administrator, in its sole discretion and pursuant to such procedures as it may specify from time to time, may permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without limitation) (i) paying cash, (ii) electing to have the Company withhold otherwise deliverable cash or Shares having a fair market value not in excess of the maximum statutory amount required to be withheld, or (iii) delivering to the Company already-owned Shares having a fair market value not in excess of the maximum statutory amount required to be withheld. The fair market value of the Shares to be withheld or delivered will be determined as of the date that the taxes are required to be withheld.

(c) Compliance With Section 409A. Awards will be designed and operated in such a manner that they are either exempt from the application of, or comply with, the requirements of Section 409A such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Section 409A, except as otherwise determined in the sole discretion of the Administrator. The Plan and each Award Agreement under the Plan is intended to meet the requirements of Section 409A and will be construed and interpreted in accordance with such intent, except as otherwise determined in the sole discretion of the Administrator. To the extent that an Award or payment, or the settlement or deferral thereof, is subject to Section 409A the Award will be granted, paid, settled or deferred in a manner that will meet the requirements of Section 409A, such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Section 409A. In no event will the Company (or any Parent or Subsidiary of the Company, as applicable) reimburse a Participant for any taxes imposed or other costs incurred as a result of Section 409A.

8. Amendment and Termination of the Plan. Subject to Section 2 above, the Plan is effective as of the Effective Date and will continue in effect for a term of ten (10) years following the Effective Date, unless terminated earlier in accordance with this Section 8. The Board may modify, amend, or terminate the Plan at any time, provided that such modification, amendment or termination shall not cancel, reduce, or otherwise adversely affect the amount of any Award previously determined and granted to any Participant as of the date of any such modification, amendment, or termination, without the consent of the Participant unless such modification, amendment or termination is required to conform the Plan to Applicable Laws.

9. No Guarantee of Employment. Neither the Plan nor any Award shall confer upon a Participant any right with respect to continuing the Participant’s relationship as a Service Provider, nor shall they interfere in any way with the

A-3


 

Participant’s right or the right of the Company to terminate such relationship at any time, with or without cause, to the extent permitted by Applicable Laws.

10. Choice of Law. This Plan and any controversy arising out of or relating to this Plan shall be governed by, and construed in accordance with, the internal laws of the State of California, without regard to conflict of law principles that would result in any application of any law other than the law of the State of California.

11. Definitions. For purposes of the Plan, the following definitions shall apply. Capitalized terms used but not otherwise defined in the Plan will have the meanings ascribed to such terms in the Equity Plan.

(a) Annual LTI Award” means an annual long-term incentive equity award that may be granted to a Participant with respect to any given fiscal year during the Performance Period.

(b) Award” or means each Nonstatutory Stock Option granted to a Participant pursuant to the Plan.

(c) Award Agreement” means an agreement between a Participant and the Company evidencing the terms and conditions of the Award, in substantially the form attached hereto as Exhibit A.

(d) Award Notice” means the “Notice of Stock Option Grant” that accompanies the Award Agreement.

(e) Election Form” means the Election Form for Special Equity Award in substantially the form attached hereto as Exhibit B.

(f) Equity Plan” means the Kodiak Sciences Inc. 2018 Equity Incentive Plan, as amended from time to time, or any successor plan thereto.

(g) Participant” means an Employee of the Company who meets the eligibility requirements set forth in Section 1 hereof to receive, and who has received, an Award.

(h) Performance Period” shall mean the period commencing as of the Date of Grant and ending on August 11, 2028; provided, that the Performance Period may be extended as set forth in the Award Agreement.

A-4


 

Exhibit A

 

Award Agreement

 

Kodiak Sciences Inc.

2021 LONG-TERM PERFORMANCE INCENTIVE PLAN

STOCK OPTION AGREEMENT

Unless otherwise defined herein, the terms defined in the Kodiak Sciences Inc. 2021 Long-Term Performance Incentive Plan (the “Plan”) will have the same defined meanings in this Stock Option Agreement, which includes the Notice of Stock Option Grant (the “Notice of Grant”), the Terms and Conditions of Stock Option Grant attached hereto as Exhibit A, and all appendices and exhibits attached thereto (all together, the “Option Agreement”).

NOTICE OF STOCK OPTION GRANT

Participant:

Address:

The undersigned Participant has been granted an Option to purchase Common Stock of Kodiak Sciences Inc. (the “Company”), subject to the terms and conditions of the Kodiak Sciences Inc. 2021 Long-Term Performance Incentive Plan attached hereto as Exhibit B (the “Plan”) and this Option Agreement, as follows:

 

Date of Grant:

 

 

Number of Shares Granted:

 

 

Exercise Price per Share:

 

$

 

Total Exercise Price:

 

$

 

Type of Option:

 

Nonstatutory Stock Option

Term/Expiration Date:

 

 

 

1. Vesting Schedule. The Option will be earned, vest and become exercisable based on the attainment of the Performance-Based Requirement and Service-Based Requirement, as described below. [FOR CEO ONLY: Notwithstanding the foregoing, the Option will be immediately exercisable pursuant to the Restricted Stock Purchase Agreement and related documents attached as Exhibit D hereto.]

(a) Performance-Based Requirement. Subject to the Participant continuing to be a Service Provider through each applicable date, the Option will be earned as to an applicable percentage of the Option based on the Stock Price meeting or exceeding the corresponding Stock Price Goal for a period of ninety (90) consecutive trading days during the Performance Period (such earned portion of the Option, the “Earned Option”), in accordance with the table below.

 

Option Tranche

Stock Price Goal

Tranche Earning Percentage

Cumulative Earning

Percentage

Tranche 1

$200

7.5%

7.5%

Tranche 2

$300

12.5%

20%

Tranche 3

$400

25.0%

45%

Tranche 4

$500

25.0%

70%

Tranche 5

$600

20.0%

90%

Tranche 6

$700

5.0%

95%

Tranche 7

$800

5.0%

100%

 

A-5


 

(b) Service-Based Requirement. Following the attainment of the Stock Price Goal in accordance with Section 1(a) above, the Earned Option will be subject to additional time-based vesting and will vest in substantially equal monthly installments on the first day of each complete calendar month that occurs during the Service-Based Period, subject to the Participant continuing to be a Service Provider through each applicable vesting date.

(c) Operational and Sales Milestones.

(i) Notwithstanding Section 1(a) above, subject to the Participant continuing to be a Service Provider through each applicable date, the Option will be earned as to an applicable percentage of the Option based on the Company’s achievement of the corresponding Operational Milestone or Sales Milestone during the Performance Period, in accordance with the table below. Any such portion of the Option that is earned based on the Company’s achievement of the corresponding Operational Milestone or Sales Milestone during the Performance Period in accordance with this Section 1(c)(i) shall constitute the “Earned Option” for purposes of this Option Agreement.

 

Operational/Sales Milestone

Operational/Sales Milestone

Earning Percentage

First Operational Milestone

15%

Second Operational Milestone

5%

Third Operational Milestone

5%

Sales Milestone

10%

 

(ii) Following the attainment of the Operational Milestone or Sales Milestone in accordance with Section 1(c)(i) above, the Earned Option will be subject to additional time-based vesting and will vest in substantially equal monthly installments on the first day of each complete calendar month that occurs during the Service-Based Period, subject to the Participant continuing to be a Service Provider through each applicable vesting date.

(iii) Notwithstanding anything herein to the contrary, the portion of the Option that is eligible to be earned based on the attainment of an Operational Milestone or Sales Milestone shall be inclusive of, and not in addition to, any portion of the Option that may be earned based on attainment of the Stock Price Goal. To the extent a portion of the Option becomes earned based on the attainment of an Operational Milestone or Sales Milestone, the subsequent tranche(s) of the Option that is eligible to be earned based on attainment of the Stock Price Goal shall be reduced by the excess, if any, of the number of Options earned over the “Cumulative Earning Percentage” set forth in the table in Section 1(a) above. For purposes of illustration only, (A) if fewer than 25% of the Option has been earned based on the Stock Price Goal, then up to 25% of the Option (inclusive of any portion previously earned based on the Stock Price Goal) shall be eligible to be earned based on attainment of the Operational Milestones and (B) if all three Operational Milestones are achieved following attainment of the Stock Price Goal for tranche 1 (i.e., $200) but prior to attainment of the Stock Price Goal for tranche 2 (i.e., $300) resulting in a Cumulative Earning Percentage equal to 25% of the Option, then (I) the portion of the Option eligible to be earned based on the Stock Price Goal in tranche 2 shall be reduced to zero and (II) the portion of the Option eligible to be earned based on the Stock Price Goal in tranche 3 shall be reduced to 20% in order to account for the 25% of the Option that has previously vested based on achievement of all three Operational Milestones. These principles are further illustrated in the table set forth below.

 

Option

Tranche

Stock Price Goal

Tranche Earning

Percentage

Cumulative Earning

Percentage

Tranche 1

$200

7.5%

7.5%

Operational Milestones Achieved

-

17.5%

25%

Tranche 2

$300

12.5%

20%

Tranche 3

$400

25.0% 20.0%

45%

Tranche 4

$500

25.0%

70%

Tranche 5

$600

20.0%

90%

Tranche 6

$700

5.0%

95%

Tranche 7

$800

5.0%

100%

 

A-6


 

2. Treatment Upon Termination of Employment.

(a) Termination for Cause. In the event that the Participant’s employment with the Company is terminated by the Company for Cause, the Unvested Option shall immediately terminate and be forfeited without consideration.

(b) Voluntary Resignation. In the event that the Participant’s employment with the Company is terminated due to the Participant’s voluntary resignation other than for Good Reason, the Unvested Option shall immediately terminate and be forfeited without consideration.

(c) Termination without Cause/for Good Reason. Subject to the Participant’s execution and delivery of a release and waiver of claims agreement drafted by and satisfactory to counsel for the Company, and such release and waiver of claims agreement must be executed and become effective within sixty (60) days following the employment termination date (the date such release and waiver of claims agreement becomes effective, the “Release Effective Date”), in the event that the Participant’s employment with the Company is terminated by the Company without Cause or due to the Participant’s resignation for Good Reason, a pro-rata portion of the Option that has been earned as of the date of such termination based on the attainment of the Stock Price Goal, Operational Milestones and/or Sales Milestone, as applicable, shall become vested and exercisable as of the Release Effective Date, based on a fraction the numerator of which is the number of completed Months of Service between the Date of Grant and the date of such termination and the denominator of which is eighty four (84). Any portion of the Option that remains unvested after giving effect to the preceding sentence shall immediately terminate and be forfeited without consideration.

(d) Retirement. In the event that the Participant’s employment with the Company is terminated due to the Participant’s Retirement, the portion of the Option that has been earned as of the date of such termination based on the attainment of the Stock Price Goal, Operational Milestones and/or Sales Milestone, as applicable, shall continue to vest and become exercisable based on the original monthly vesting schedule during the Service-Based Period as if such termination had not occurred. Any portion of the Option that is unearned as of the date of termination shall immediately terminate and be forfeited without consideration.

(e) Death/Severe Disability. In the event that the Participant’s employment with the Company is terminated due to the Participant’s death or Severe Disability, the portion of the Option that has been earned based on the attainment of the Stock Price Goal, Operational Milestones and/or Sales Milestone, as applicable, prior to the date of such termination shall become vested and exercisable as of the date of such termination. Any portion of the Option that is unearned as of the date of termination shall immediately terminate and be forfeited without consideration.

3. Post-Termination Exercise Period. The Option, to the extent earned and vested, will be exercisable for the following periods after the Participant ceases to be a Service Provider.

(a) Death. In the event of the death of the Participant during the period of continuous Service Provider status since the date of grant of the Option, or within three (3) months following termination of the Participant’s continuous Service Provider status, the Vested Option may be exercised by the Participant’s estate, or by a person who acquired the right to exercise the Option by bequest or inheritance, at any time within nine (9) months following the date of death or, if earlier, the date the Participant’s continuous Service Provider status terminated.

(b) Severe Disability. In the event of termination of Participant’s continuous Service Provider status as a result of the Participant’s Severe Disability, the Participant may exercise the Vested Option at any time within six (6) months following such termination.

(c) Retirement. In the event of termination of Participant’s continuous Service Provider status as a result of the Participant’s Retirement, the Participant may exercise the Vested Option at any time prior to the first (1st) anniversary of the end of the Performance Period.

(d) Other Termination. In the event of termination of the Participant’s continuous Service Provider status for any reason other than death, Severe Disability or Retirement, the Participant may exercise the Option at any time within three (3) months following such termination.

(e) Notwithstanding anything to the contrary in this Section 3, in no event may this Option be exercised after the Term/Expiration Date as provided above and may be subject to earlier termination as provided in Section 4 below.

A-7


 

4. Change in Control.

(a) In the event that a Change in Control occurs during the Performance Period, the Option will be earned as to an applicable percentage of the Option based on the per Share consideration received by the Company’s shareholders in such Change in Control transaction meeting or exceeding the corresponding Stock Price Goal, in accordance with the table set forth in Section 1(a) above, subject to straight-line interpolation to the extent such per Share consideration falls between two Stock Price Goals. For the avoidance of doubt, to the extent that less than thirty five percent (35%) of the Option has vested in such Change in Control based on the Stock Price Goal, then the Option shall remain eligible to be earned based on the attainment of the Operational Milestones and Sales Milestone in accordance with Section 1(c) above. Thereafter, the earned portion of the Option shall vest and become exercisable in accordance with Section 1(b) above; provided, however, that if (i) on the date twenty-four (24) months immediately following the consummation of such Change in Control, the Participant is providing services to the acquiring company (or its subsidiaries or parent) as either an employee or a consultant or (ii) within twenty-four (24) months following the consummation of such Change in Control, the Participant’s employment is terminated by the Company without Cause or by the Participant for Good Reason, then in either the case of (i) or (ii), one hundred percent (100%) of the Option that has previously been earned based on the Stock Price Goal, Operational Milestones and/or Sales Milestone but that remains unvested based on the Service-Based Period shall vest and become exercisable in full, subject to the Participant’s execution and delivery of a release and waiver of claims agreement drafted by and satisfactory to counsel for the Company, and such release and waiver of claims agreement must be executed and become effective within sixty (60) days following the employment termination date or the second (2nd) anniversary of the Change in Control, as applicable.

(b) Notwithstanding the foregoing, in the event that the successor corporation does not assume or substitute for the Option, the Participant will fully vest in and have the right to exercise the portion of the Option that has been earned as of the date of such Change in Control after giving effect to Section 4(a) above. In addition, if an Award is not assumed or substituted in the event of a Change in Control, the Administrator will notify the Participant in writing or electronically that the Award will be exercisable for a period of time determined by the Administrator in its sole discretion, and the Award will terminate upon the expiration of such period.

5. Stockholder Approval Required. Notwithstanding anything to the contrary in this Option Agreement, the Option is subject to approval of the Plan by the stockholders of the Company at a special meeting of the Company’s stockholders to be held as soon as practicable following the Date of Grant. If such stockholder approval of the Plan is not obtained, then the Option granted hereunder will be forfeited and the Participant will receive 100% of the Participant’s Annual LTI Award for fiscal year 2021. If such stockholder approval is obtained, the Participant will forego a portion of each Annual LTI Award that may be granted by the Company to the Participant during the Performance Period (including, for the avoidance of doubt, the Annual LTI Award for fiscal year 2021), with such foregone portion being specified in the Participant’s Election Form.

6. Definitions. For purposes of this Option Agreement, the following definitions shall apply.

(a) “Annual LTI Award” means an annual long-term incentive equity award that may be granted to a Participant with respect to any given fiscal year during the Performance Period.

(b) Cause” shall mean: (i) the Participant’s conviction of, including pleading guilty or nolo contendere to, any felony or any crime involving dishonesty; (ii) the Participant’s participation in any fraud or act of dishonesty against the Company that has caused or is reasonably expected to result in injury to the Company; (iii) a material violation by the Participant of any of the Company’s written policies or other serious misconduct, in each case that results in or is reasonably likely to result in material harm to Company; (iv) the Participant’s willful and continued failure substantially to perform any of the Participant’s job duties (other than as a result of total or partial Severe Disability) that is not cured within thirty (30) days following written notice of Cause from the Company; (v) conduct by the Participant which, in the good faith and reasonable determination of the Administrator, demonstrates gross unfitness to serve; or (vi) the Participant’s material breach of any agreement with the Company (or its subsidiaries or successors).

A-8


 

(c) Corporate Transaction” shall mean any (i) consolidation or merger of the Company with or into any other corporation or other entity or person, or any other corporate reorganization in which the members/shareholders of the Company prior to such consolidation, merger or reorganization shall own less than fifty percent (50%) of the voting equity of the continuing or surviving entity after such consolidation, merger or reorganization, (ii) any transaction or series of related transactions to which the Company is a party, in which in excess of fifty percent (50%) of the Company’s voting equity securities is transferred, except for bona fide sales of the Company’s equity securities to investors for primarily fundraising purposes, or (iii) a sale of substantially all of the assets of the Company.

(d) Election Form” means the Election Form for Special Equity Award pursuant to which the Participant elected to forego a portion of each Annual LTI Award that may be granted by the Company to the Participant during the Performance Period.

(e) Employment Agreement” shall mean the Executive Employment Agreement by and between the Company and Participant.

(f) First Operational Milestone” shall mean U.S. Food and Drug Administration approval of a Biologics License Application in respect of a first major indication (RVO, DME and/or wAMD).

(g) Good Reason” means the occurrence of any one or more of the following events without the prior written consent of Participant: (i) a material reduction in Base Salary or Targeted Incentive Bonus (as such terms are defined in the Employment Agreement) opportunity or benefits, provided that any reduction in Base Salary (and any reduction in the dollar amount of Participant’s Targeted Incentive Bonus opportunity resulting from such reduction in Base Salary) that is related to a cross executive team base salary reduction shall not constitute “Good Reason”; (ii) a material reduction in Participant’s title, duties, or responsibilities or change in reporting line; provided that a reassignment following a Corporate Transaction to a position that is substantially similar to the position held prior to the Corporate Transaction shall not constitute a material reduction in job responsibilities or duties; (iii) a relocation of Participant’s primary work location that increases Participant’s one-way commute by more than fifty (50) miles; (iv) failure of the successor company to assume obligations contained in this Option Agreement or any other equity compensation agreement in place between Participant and the Company at the time of the Corporate Transaction; (v) any written directive given to Participant by the Chief Executive Officer or the Board, as applicable, that is in conflict with Participant’s professional obligations or otherwise in violation of applicable law or regulation, in all cases, of which the Chief Executive Officer or the Board, as applicable, has knowledge of such obligations or law or regulation prior to the issuance of such directive; or (vi) the Company’s material breach of any terms of this Option Agreement, any other equity compensation agreement in place between Participant and the Company, or the Employment Agreement; provided, however, that no such event or condition shall constitute Good Reason unless (A) Participant gives the Company a written notice of termination for Good Reason not more than ninety (90) days after the initial existence of the condition, (B) the grounds for termination (if susceptible to correction) are not corrected by the Company within thirty (30) days of its receipt of such notice, and (C) the termination date occurs within ninety (90) days following the Company’s receipt of such notice.

(h) Month of Service” shall mean a consecutive period of 30 calendar days during which the Participant is continuously employed with, and is actively providing service, to the Company or any Parent or Subsidiary of the Company.

(i) Operational Milestone” shall mean each of the First Operational Milestone, Second Operational Milestone and Third Operational Milestone.

(j) Performance Period” shall mean the period commencing as of the Date of Grant and ending on August 11, 2028; provided, that the Performance Period may be extended by up to ninety (90) trading days if as of the last day of the Performance Period (without regard to any extension) the Stock Price has reached or exceeded a Stock Price Goal for less than ninety (90) trading days.

(k) Retirement” shall mean the Participant’s voluntary resignation from the Company on or after the date on which the Participant attains 65 years of age.

(l) Sales Milestone” shall mean the first completed fiscal year of the Company in which the Company has generated sales of at least $2.5 billion.

A-9


 

(m) Second Operational Milestone” shall mean U.S. Food and Drug Administration approval of a Biologics License Application in respect of a second major indication (RVO, DME and/or wAMD).

(n) Service-Based Period” shall mean the period commencing on either (i) the date on which the applicable Stock Price Goal was attained in accordance with this Option Agreement or (ii) the date on which the applicable Operational Milestone or Sales Milestone was attained in accordance with this Option Agreement and ending, in either case, on the last day of the Performance Period.

(o) Severe Disability” shall mean that the Participant is unable, due to a physical or mental impairment, to perform the essential functions of the Participant’s job position, with or without reasonable accommodation, for a period of two hundred seventy (270) consecutive calendar days. Any determination as to Severe Disability will be made by a licensed physician selected by the Administrator.

(p) Stock Price” shall mean the closing sales price per share Common Stock as quoted on any established stock exchange or national market system (including without limitation the New York Stock Exchange, NASDAQ Global Select Market, the NASDAQ Global Market or the NASDAQ Capital Market of The NASDAQ Stock Market) on which the Common Stock is listed (or the closing bid, if no sales were reported), as reported in The Wall Street Journal in the Common Stock.

(q) Stock Price Goal” shall mean each Stock Price target amount based on which the Option will be earned, as indicated in the table set forth in Section 1(a) above.

(r) Third Operational Milestone” shall mean U.S. Food and Drug Administration approval of a Biologics License Application in respect of a third major indication (RVO, DME and/or wAMD).

(s) Unvested Option” shall mean the portion of the Option other than the Vested Option.

(t) Vested Option” shall mean the portion of the Option that has become earned and vested based on attainment of (i) the Stock Price Goal, Operational Milestone and/or Sales Milestone, as applicable, and (ii) the Participant’s continued employment with the Company through the Service-Based Period.

[Signature page follows.]

 

 

A-10


 

By Participant’s signature and the signature of the representative of the Company below, Participant and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan, attached hereto as Exhibit B, and this Option Agreement, including the Terms and Conditions of Stock Option Grant, attached hereto as Exhibit A, all of which are made a part of this document. Participant acknowledges receipt of a copy of the Plan. Participant has reviewed the Plan and this Option Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Option Agreement, and fully understands all provisions of the Plan and this Option Agreement. Participant hereby agrees to accept as binding, conclusive, and final all decisions or interpretations of the Administrator upon any questions relating to the Plan and the Option Agreement. Participant further agrees to notify the Company upon any change in the residence address indicated below.

 

PARTICIPANT

 

Kodiak Sciences Inc.

 

 

 

Signature

 

Signature

 

 

 

 

 

 

Print Name

 

Print Name

 

 

 

 

 

 

 

 

Title

 

 

 

Address:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A-11


 

EXHIBIT A

TERMS AND CONDITIONS OF STOCK OPTION GRANT

1. Grant of Option. The Company hereby grants to the individual (the “Participant”) named in the Notice of Stock Option Grant of this Option Agreement (the “Notice of Grant”) an option (the “Option”) to purchase the number of Shares, as set forth in the Notice of Grant, at the exercise price per Share set forth in the Notice of Grant (the “Exercise Price”), subject to all of the terms and conditions in this Option Agreement and the Plan, each of which is incorporated herein by reference. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Option Agreement, the terms and conditions of the Plan will prevail. The Option will be designated as a Nonstatutory Stock Option.

2. Vesting Schedule. Except as provided in Section ‎3, the Option awarded by this Option Agreement will vest in accordance with the vesting provisions set forth in the Notice of Grant. Shares scheduled to vest on a certain date or upon the occurrence of a certain condition will not vest in Participant in accordance with any of the provisions of this Option Agreement, unless Participant will have been continuously a Service Provider from the Date of Grant until the date such vesting occurs.

3. Administrator Discretion. The Administrator, in its discretion, may accelerate the vesting of the balance, or some lesser portion of the balance, of the unvested Option at any time, subject to the terms of the Plan. If so accelerated, such Option will be considered as having vested as of the date specified by the Administrator.

4. Exercise of Option.

(a) Right to Exercise. This Option may be exercised only within the term set out in the Notice of Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Option Agreement.

(b) Method of Exercise. This Option is exercisable by delivery of an exercise notice (the “Exercise Notice”) in the form attached as Exhibit C or in a manner and pursuant to such procedures as the Administrator may determine, which will state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised (the “Exercised Shares”), and such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Exercise Notice will be completed by Participant and delivered to the Company. The Exercise Notice will be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares together and of any Tax Obligations (as defined in Section 6(a)). This Option will be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by the aggregate Exercise Price.

5. Method of Payment. Payment of the aggregate Exercise Price will be by any of the following, or a combination thereof, at the election of Participant:

(a) cash;

(b) check;

(c) consideration received by the Company under a formal cashless exercise program adopted by the Company in connection with the Plan; or

(d) if Participant is a U.S. employee, surrender of other Shares which have a Fair Market Value on the date of surrender equal to the aggregate Exercise Price of the Exercised Shares and that are owned free and clear of any liens, claims, encumbrances, or security interests, provided that accepting such Shares, in the sole discretion of the Administrator, will not result in any adverse accounting consequences to the Company.

A-12


 

6. Tax Obligations.

(a) Participant acknowledges that, regardless of any action taken by the Company or, if different, Participant’s employer (the “Employer”) or Parent or Subsidiary to which Participant is providing services (together, the Company, Employer and/or Parent or Subsidiary to which the Participant is providing services, the “Service Recipient”), the ultimate liability for any tax and/or social insurance liability obligations and requirements in connection with the Option, including, without limitation, (i) all federal, state, and local taxes (including the Participant’s Federal Insurance Contributions Act (FICA) obligation) that are required to be withheld by the Company or the Service Recipient or other payment of tax-related items related to Participant’s participation in the Plan and legally applicable to Participant, (ii) the Participant’s and, to the extent required by the Company (or Service Recipient), the Company’s (or Service Recipient’s) fringe benefit tax liability, if any, associated with the grant, vesting, or exercise of the Option or sale of Shares, and (iii) any other Company (or Service Recipient) taxes the responsibility for which the Participant has, or has agreed to bear, with respect to the Option (or exercise thereof or issuance of Shares thereunder) (collectively, the “Tax Obligations”), is and remains Participant’s responsibility and may exceed the amount actually withheld by the Company or the Service Recipient. Participant further acknowledges that the Company and/or the Service Recipient (A) make no representations or undertakings regarding the treatment of any Tax Obligations in connection with any aspect of the Option, including, but not limited to, the grant, vesting or exercise of the Option, the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends or other distributions, and (B) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Option to reduce or eliminate Participant’s liability for Tax Obligations or achieve any particular tax result. Further, if Participant is subject to Tax Obligations in more than one jurisdiction between the Date of Grant and the date of any relevant taxable or tax withholding event, as applicable, Participant acknowledges that the Company and/or the Service Recipient (or former employer, as applicable) may be required to withhold or account for Tax Obligations in more than one jurisdiction. If Participant fails to make satisfactory arrangements for the payment of any required Tax Obligations hereunder at the time of the applicable taxable event, Participant acknowledges and agrees that the Company may refuse to issue or deliver the Shares.

(b) Tax Withholding. When the Option is exercised, Participant generally will recognize immediate U.S. taxable income if Participant is a U.S. taxpayer. If Participant is a non-U.S. taxpayer, Participant will be subject to applicable taxes in his or her jurisdiction. Pursuant to such procedures as the Administrator may specify from time to time, the Company and/or Service Recipient shall withhold the amount required to be withheld for the payment of Tax Obligations. The Administrator, in its sole discretion and pursuant to such procedures as it may specify from time to time, may permit Participant to satisfy such Tax Obligations, in whole or in part (without limitation), if permissible by applicable local law, by (i) paying cash, (ii) electing to have the Company withhold otherwise deliverable Shares having a fair market value equal to the minimum amount that is necessary to meet the withholding requirement for such Tax Obligations (or such greater amount as Participant may elect if permitted by the Administrator, if such greater amount would not result in adverse financial accounting consequences), (iii) withholding the amount of such Tax Obligations from Participant’s wages or other cash compensation paid to Participant by the Company and/or the Service Recipient, (iv) delivering to the Company already vested and owned Shares having a fair market value equal to such Tax Obligations, or (v) selling a sufficient number of such Shares otherwise deliverable to Participant through such means as the Company may determine in its sole discretion (whether through a broker or otherwise) equal to the minimum amount that is necessary to meet the withholding requirement for such Tax Obligations (or such greater amount as Participant may elect if permitted by the Administrator, if such greater amount would not result in adverse financial accounting consequences). To the extent determined appropriate by the Company in its discretion, it will have the right (but not the obligation) to satisfy any Tax Obligations by reducing the number of Shares otherwise deliverable to Participant. Further, if Participant is subject to tax in more than one jurisdiction between the Date of Grant and a date of any relevant taxable or tax withholding event, as applicable, Participant acknowledges and agrees that the Company and/or the Service Recipient (and/or former employer, as applicable) may be required to withhold or account for tax in more than one jurisdiction. If Participant fails to make satisfactory arrangements for the payment of any required Tax Obligations hereunder at the time of the Option exercise, Participant acknowledges and agrees that the Company may refuse to honor the exercise and refuse to deliver the Shares if such amounts are not delivered at the time of exercise.

A-13


 

(c) Notice of Disqualifying Disposition of ISO Shares. If the Option granted to Participant herein is an ISO, and if Participant sells or otherwise disposes of any of the Shares acquired pursuant to the ISO on or before the later of (i) the date two (2) years after the Date of Grant, or (ii) the date one (1) year after the date of exercise, Participant will immediately notify the Company in writing of such disposition. Participant agrees that Participant may be subject to income tax withholding by the Company on the compensation income recognized by Participant.

(d) Code Section 409A. Under Code Section 409A, a stock right (such as the Option) that vests after December 31, 2004 (or that vested on or prior to such date but which was materially modified after October 3, 2004) that was granted with a per share exercise price that is determined by the Internal Revenue Service (the “IRS”) to be less than the fair market value of an underlying share on the date of grant (a “discount option”) may be considered “deferred compensation.” A stock right that is a “discount option” may result in (i) income recognition by the recipient of the stock right prior to the exercise of the stock right, (ii) an additional twenty percent (20%) federal income tax, and (iii) potential penalty and interest charges. The “discount option” may also result in additional state income, penalty and interest tax to the recipient of the stock right. Participant acknowledges that the Company cannot and has not guaranteed that the IRS will agree that the per Share exercise price of this Option equals or exceeds the fair market value of a Share on the date of grant in a later examination. Participant agrees that if the IRS determines that the Option was granted with a per Share exercise price that was less than the fair market value of a Share on the date of grant, Participant shall be solely responsible for Participant’s costs related to such a determination.

7. Rights as Stockholder. Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares (which may be in book entry form) will have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to Participant (including through electronic delivery to a brokerage account). After such issuance, recordation, and delivery, Participant will have all the rights of a stockholder of the Company with respect to voting such Shares and receipt of dividends and distributions on such Shares.

8. No Guarantee of Continued Service. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER, WHICH UNLESS PROVIDED OTHERWISE UNDER APPLICABLE LAW IS AT THE WILL OF THE COMPANY (OR THE SERVICE RECIPIENT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS OPTION AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT’S RIGHT OR THE RIGHT OF THE COMPANY (OR THE SERVICE RECIPIENT) TO TERMINATE PARTICIPANT’S RELATIONSHIP AS A SERVICE PROVIDER, SUBJECT TO APPLICABLE LAW, WHICH TERMINATION, UNLESS PROVIDED OTHERWISE UNDER APPLICABLE LAW, MAY BE AT ANY TIME, WITH OR WITHOUT CAUSE.

9. Nature of Grant. In accepting the Option, Participant acknowledges, understands and agrees that:

(a) the grant of the Option is voluntary and occasional and does not create any contractual or other right to receive future grants of options, or benefits in lieu of options, even if options have been granted in the past;

(b) all decisions with respect to future option or other grants, if any, will be at the sole discretion of the Company;

(c) Participant is voluntarily participating in the Plan;

(d) the Option and any Shares acquired under the Plan are not intended to replace any pension rights or compensation;

(e) the Option and Shares acquired under the Plan and the income and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;

(f) the future value of the Shares underlying the Option is unknown, indeterminable, and cannot be predicted with certainty;

A-14


 

(g) if the underlying Shares do not increase in value, the Option will have no value;

(h) if Participant exercises the Option and acquires Shares, the value of such Shares may increase or decrease in value, even below the Exercise Price;

(i) for purposes of the Option, Participant’s engagement as a Service Provider will be considered terminated as of the date Participant is no longer actively providing services to the Company or any Parent or Subsidiary (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is a Service Provider or the terms of Participant’s employment or service agreement, if any), and unless otherwise expressly provided in this Option Agreement (including by reference in the Notice of Grant to other arrangements or contracts) or determined by the Administrator, (i) Participant’s right to vest in the Option under the Plan, if any, will terminate as of such date and will not be extended by any notice period (e.g., Participant’s period of service would not include any contractual notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where Participant is a Service Provider or Participant’s employment or service agreement, if any, unless Participant is providing bona fide services during such time); and (ii) the period (if any) during which Participant may exercise the Option after such termination of Participant’s engagement as a Service Provider will commence on the date Participant ceases to actively provide services and will not be extended by any notice period mandated under employment laws in the jurisdiction where Participant is employed or terms of Participant’s engagement agreement, if any; the Administrator shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of his or her Option grant (including whether Participant may still be considered to be providing services while on a leave of absence and consistent with local law);

(j) unless otherwise provided in the Plan or by the Company in its discretion, the Option and the benefits evidenced by this Option Agreement do not create any entitlement to have the Option or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; and

(k) the following provisions apply only if Participant is providing services outside the United States:

(i) the Option and the Shares subject to the Option are not part of normal or expected compensation or salary for any purpose;

(ii) Participant acknowledges and agrees that none of the Company, the Service Recipient, or any Parent or Subsidiary shall be liable for any foreign exchange rate fluctuation between Participant’s local currency and the United States Dollar that may affect the value of the Option or of any amounts due to Participant pursuant to the exercise of the Option or the subsequent sale of any Shares acquired upon exercise; and

(iii) no claim or entitlement to compensation or damages shall arise from forfeiture of the Option resulting from the termination of Participant’s engagement as a Service Provider (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is a Service Provider or the terms of Participant’s employment or service agreement, if any), and in consideration of the grant of the Option to which Participant is otherwise not entitled, Participant irrevocably agrees never to institute any claim against the Company, any Parent, any Subsidiary or the Service Recipient, waives his or her ability, if any, to bring any such claim, and releases the Company, any Parent or Subsidiary and the Service Recipient from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, Participant shall be deemed irrevocably to have agreed not to pursue such claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such claim.

10. No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan, or Participant’s acquisition or sale of the underlying Shares. Participant is hereby advised to consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.

11. Data Privacy. Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s personal data as described in this Option Agreement and any other Option grant materials by and among, as applicable, the Employer or other Service Recipient, the Company and any Parent or Subsidiary for the exclusive purpose of implementing, administering and managing Participant’s participation in the Plan.

A-15


 

Participant understands that the Company and the Employer may hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Shares or directorships held in the Company, details of all Options or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

Participant understands that Data will be transferred to a stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration, and management of the Plan. Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient’s country of operation (e.g., the United States) may have different data privacy laws and protections than Participant’s country. Participant understands that if he or she resides outside the United States, he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. Participant authorizes the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing Participant’s participation in the Plan. Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant’s participation in the Plan. Participant understands that if he or she resides outside the United States, he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his or her consent, his or her engagement as a Service Provider and career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing Participant’s consent is that the Company would not be able to grant Participant Options or other equity awards or administer or maintain such awards. Therefore, Participant understands that refusing or withdrawing his or her consent may affect Participant’s ability to participate in the Plan. For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.

12. Address for Notices. Any notice to be given to the Company under the terms of this Option Agreement will be addressed to the Company at Kodiak Sciences Inc., 1200 Page Mill Road, Palo Alto, CA 94304, or at such other address as the Company may hereafter designate in writing.

13. Non-Transferability of Option. This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised during the lifetime of Participant only by Participant; provided, that, if approved by the Administrator, the Option may be transferred to an estate planning vehicle established for the exclusive benefit of Participant and Participant’s family members within the meaning of Instruction A.1.(a)(5) of Form S-8 under the Securities Act.

14. Successors and Assigns. The Company may assign any of its rights under this Option Agreement to single or multiple assignees, and this Option Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Option Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns. The rights and obligations of Participant under this Option Agreement may only be assigned with the prior written consent of the Company.

15. Additional Conditions to Issuance of Stock. If at any time the Company will determine, in its discretion, that the listing, registration, qualification or rule compliance of the Shares upon any securities exchange or under any state, federal or non-U.S. law, the tax code and related regulations or under the rulings or regulations of the United States Securities and Exchange Commission or any other governmental regulatory body or the clearance, consent or approval of the United States Securities and Exchange Commission or any other governmental regulatory authority is necessary or desirable as a condition to the purchase by, or issuance of Shares, to Participant (or his or her estate) hereunder, such purchase or issuance will not occur unless and until such listing, registration, qualification, rule compliance, clearance, consent or approval will have been completed, effected or obtained free of any conditions not acceptable to the Company. Subject to the terms of the Option Agreement and the Plan, the Company shall not be required to issue any certificate or certificates for Shares hereunder prior to the lapse of such reasonable period of time following the date of exercise of the Option as the Administrator may establish from time to time for reasons of administrative convenience.

A-16


 

16. Language. If Participant has received this Option Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

17. Interpretation. The Administrator will have the power to interpret the Plan and this Option Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any Shares subject to the Option have vested). All actions taken and all interpretations and determinations made by the Administrator in good faith will be final and binding upon Participant, the Company and all other interested persons. Neither the Administrator nor any person acting on behalf of the Administrator will be personally liable for any action, determination, or interpretation made in good faith with respect to the Plan or this Option Agreement.

18. Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to the Option awarded under the Plan or future options that may be awarded under the Plan by electronic means or request Participant’s consent to participate in the Plan by electronic means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through any on-line or electronic system established and maintained by the Company or a third party designated by the Company.

19. Captions. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Option Agreement.

20. Agreement Severable. In the event that any provision in this Option Agreement will be held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this Option Agreement.

21. Amendment, Suspension or Termination of the Plan. By accepting this Option, Participant expressly warrants that he or she has received an Option under the Plan, and has received, read, and understood a description of the Plan. Participant understands that the Plan is discretionary in nature and may be amended, suspended or terminated by the Company at any time.

22. Governing Law and Venue. This Option Agreement will be governed by the laws of California, without giving effect to the conflict of law principles thereof. For purposes of litigating any dispute that arises under this Option or this Option Agreement, the parties hereby submit to and consent to the jurisdiction of the State of California, and agree that such litigation will be conducted in the courts of Santa Clara County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this Option is made and/or to be performed.

23. Country Addendum. Notwithstanding any provisions in this Option Agreement, this Option shall be subject to any special terms and conditions set forth in the appendix (if any) to this Option Agreement for Participant’s country (the “Country Addendum”). Moreover, if Participant relocates to one of the countries included in the Country Addendum (if any), the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The Country Addendum constitutes part of this Option Agreement.

24. Modifications to the Agreement. This Option Agreement constitutes the entire understanding of the parties on the subjects covered. Participant expressly warrants that he or she is not accepting this Option Agreement in reliance on any promises, representations, or inducements other than those contained herein. Modifications to this Option Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company. Notwithstanding anything to the contrary in the Plan or this Option Agreement, the Company reserves the right to revise this Option Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Code Section 409A or to otherwise avoid imposition of any additional tax or income recognition under Section 409A of the Code in connection with the Option.

25. No Waiver. Either party’s failure to enforce any provision or provisions of this Option Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party from thereafter enforcing each and every other provision of this Option Agreement. The rights granted both parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances.

A-17


 

26. Tax Consequences. Participant has reviewed with its own tax advisors the U.S. federal, state, local and non-U.S. tax consequences of this investment and the transactions contemplated by this Option Agreement. With respect to such matters, Participant relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral. Participant understands that Participant (and not the Company) shall be responsible for Participant’s own tax liability that may arise as a result of this investment or the transactions contemplated by this Option Agreement.

 

 

A-18


 

EXHIBIT B

 

Kodiak Sciences Inc.

2021 LONG-TERM PERFORMANCE INCENTIVE PLAN

STOCK OPTION AGREEMENT

COUNTRY ADDENDUM

 

TERMS AND CONDITIONS

This Country Addendum includes additional terms and conditions that govern the Option granted to Participant under the Plan if Participant works in one of the countries listed below. If Participant is a citizen or resident of a country (or is considered as such for local law purposes) other than the one in which he or she is currently working or if Participant relocates to another country after receiving the Option, the Company will, in its discretion, determine the extent to which the terms and conditions contained herein will be applicable to Participant.

Certain capitalized terms used but not defined in this Country Addendum shall have the meanings set forth in the Plan, and/or the Stock Option Agreement to which this Country Addendum is attached.

NOTIFICATIONS

This Country Addendum also includes notifications relating to exchange control and other issues of which Participant should be aware with respect to his or her participation in the Plan. The information is based on the exchange control, securities and other laws in effect in the countries listed in this Country Addendum, as of (except as otherwise noted below). Such laws are often complex and change frequently. As a result, the Company strongly recommends that Participant not rely on the notifications herein as the only source of information relating to the consequences of his or her participation in the Plan because the information may be outdated when Participant exercises the Option or sells Shares acquired under the Plan.

In addition, the notifications are general in nature and may not apply to Participant’s particular situation, and the Company is not in a position to assure Participant of any particular result. Accordingly, Participant is advised to seek appropriate professional advice as to how the relevant laws in Participant’s country may apply to Participant’s situation.

Finally, if Participant is a citizen or resident of a country other than the one in which Participant is currently working (or is considered as such for local law purposes) or if Participant moves to another country after the Option is granted, the information contained herein may not be applicable to Participant.

 

 

A-19


 

EXHIBIT C

Kodiak Sciences Inc.

2021 LONG-TERM PERFORMANCE INCENTIVE PLAN

EXERCISE NOTICE

Kodiak Sciences Inc.

1200 Page Mill Road

Palo Alto, CA 94304

Attention: Stock Administration

1. Exercise of Option. Effective as of today, ________________, _____, the undersigned (“Purchaser”) hereby elects to purchase ______________ shares (the “Shares”) of the Common Stock of Kodiak Sciences Inc. (the “Company”) under and pursuant to the 2021 Long-Term Performance Incentive Plan (the “Plan”) and the Stock Option Agreement, dated ________ and including the Notice of Grant, the Terms and Conditions of Stock Option Grant, and exhibits attached thereto (the “Option Agreement”). The purchase price for the Shares will be $_____________, as required by the Option Agreement.

[FOR CEO ONLY: Exercise of Option. Effective as of today, ________________, _____, the undersigned (“Purchaser”) hereby elects to purchase ______________ shares (the “Shares”) of the Common Stock of Kodiak Sciences Inc. (the “Company”) under and pursuant to the 2021 Long-Term Performance Incentive Plan (the “Plan”) and the Stock Option Agreement, dated ________ and including the Notice of Grant, the Terms and Conditions of Stock Option Grant, the Restricted Stock Purchase Agreement and exhibits attached thereto (the “Option Agreement”). The Purchaser further acknowledges and agrees that the purchase of the Shares hereunder shall be subject to and conditioned upon the Participant entering into the Restricted Stock Purchase Agreement (in the form attached to the Option Agreement as Exhibit D) with respect to any Shares acquired by the Participant hereunder, and such Shares shall be subject to, and shall become vested and non-forfeitable in accordance with, the vesting schedule set forth in the Notice of Grant. The purchase price for the Shares will be $_____________, as required by the Option Agreement.]

2. Delivery of Payment. Purchaser herewith delivers to the Company the full purchase price of the Shares and any Tax Obligations (as defined in Section 6(a) of the Option Agreement) to be paid in connection with the exercise of the Option.

3. Representations of Purchaser. Purchaser acknowledges that Purchaser has received, read and understood the Plan and the Option Agreement and agrees to abide by and be bound by their terms and conditions.

4. Rights as Stockholder. Until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the Shares, no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to the Option, notwithstanding the exercise of the Option. The Shares so acquired will be issued to Purchaser as soon as practicable after exercise of the Option. No adjustment will be made for a dividend or other right for which the record date is prior to the date of issuance, except as provided in Section 6 of the Plan.

5. Tax Consultation. Purchaser understands that Purchaser may suffer adverse tax consequences as a result of Purchaser’s purchase or disposition of the Shares. Purchaser represents that Purchaser has consulted with any tax consultants Purchaser deems advisable in connection with the purchase or disposition of the Shares and that Purchaser is not relying on the Company for any tax advice.

6. Entire Agreement; Governing Law. The Plan and the Option Agreement are incorporated herein by reference. This Exercise Notice, the Plan and the Option Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Purchaser with respect to the subject matter hereof, and may not be modified adversely to the Purchaser’s interest except by means of a writing signed by the Company and Purchaser. This Option Agreement is governed by the internal substantive laws, but not the choice of law rules, of California.

A-20


 

Submitted by: Accepted by:

 

PURCHASER

 

Kodiak Sciences Inc.

 

 

 

Signature

 

Signature

 

 

 

 

 

 

Print Name

 

Print Name

Address:

 

 

 

 

 

 

 

Title

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Date Received

 

 

A-21


 

EXHIBIT D-1

KODIAK SCIENCES INC.

2021 LONG-TERM PERFORMANCE INCENTIVE PLAN

RESTRICTED STOCK PURCHASE AGREEMENT

THIS RESTRICTED STOCK PURCHASE AGREEMENT (the “Agreement”) is made between Victor Perlroth (the “Purchaser”) and Kodiak Sciences Inc. (the “Company”) or its assignees of rights hereunder as of __________________, ____.

Unless otherwise defined herein, capitalized terms used in this Agreement shall have the meanings ascribed to such terms defined in the Company’s 2021 Long-Term Performance Incentive Plan (the “Plan”).

RECITALS

A. Pursuant to the exercise of the Option granted to Purchaser under the Plan and pursuant to the Stock Option Agreement (the “Option Agreement”) dated as of _______, 2021 by and between the Company and Purchaser, which Plan and Option Agreement are hereby incorporated by reference, Purchaser has elected to purchase _________ of those Shares of Common Stock which have not become vested under the vesting schedule set forth in the Option Agreement (“Unvested Shares”).

B. As required by the Option Agreement, as a condition to Purchaser’s election to exercise the Option, Purchaser must execute this Agreement, which sets forth the rights and obligations of the parties with respect to Shares acquired upon exercise of the Option.

1. Repurchase Option.

(a) If Purchaser’s status as a Service Provider is terminated for any reason, the Company shall have the right and option for one hundred and eighty (180) days from such date to purchase from Purchaser, or Purchaser’s personal representative, as the case may be, all of the Purchaser’s Unvested Shares as of the date of such termination at the price paid by the Purchaser for such Shares (the “Repurchase Option”).

(b) Upon the occurrence of such termination, the Company may exercise its Repurchase Option by delivering personally or by registered mail, to Purchaser (or his or her transferee or legal representative, as the case may be) with a copy to the escrow agent described in Section 2 below, a notice in writing indicating the Company’s intention to exercise the Repurchase Option and by delivering to the Purchaser (or the Purchaser’s transferee or legal representative) a check in the amount of the aggregate repurchase price. Upon delivery of such notice and payment of the aggregate repurchase price, the Company shall become the legal and beneficial owner of the Unvested Shares being repurchased and the rights and interests therein or relating thereto, and the Company shall have the right to retain and transfer to its own name the number of Unvested Shares being repurchased by the Company.

(c) Whenever the Company shall have the right to repurchase Unvested Shares hereunder, the Company may designate and assign one or more employees, officers, directors or stockholders of the Company or other persons or organizations to exercise all or a part of the Company’s Repurchase Option under this Agreement and purchase all or a part of such Unvested Shares.

(d) If the Company does not elect to exercise the Repurchase Option conferred above by giving the requisite notice within one hundred and eighty (180) days following the termination, the Repurchase Option shall terminate.

(e) The Repurchase Option shall terminate in accordance with the vesting schedule contained in Purchaser’s Option Agreement.

2. Transferability of the Shares; Escrow.

(a) Purchaser hereby authorizes and directs the Secretary of the Company, or such other person designated by the Company, to transfer the Unvested Shares as to which the Repurchase Option has been exercised from Purchaser to the Company.

A-22


 

(b) To insure the availability for delivery of Purchaser’s Unvested Shares upon repurchase by the Company pursuant to the Repurchase Option under Section 1, Purchaser hereby appoints the Secretary, or any other person designated by the Company as escrow agent (the “Escrow Agent”), as its attorney-in-fact to sell, assign and transfer unto the Company, such Unvested Shares, if any, repurchased by the Company pursuant to the Repurchase Option and shall, upon execution of this Agreement, deliver and deposit with the Escrow Agent, the share certificates representing the Unvested Shares, together with the stock assignment duly endorsed in blank, attached hereto as Exhibit D-2. The Unvested Shares and stock assignment shall be held by the Escrow Agent in escrow, pursuant to the Joint Escrow Instructions of the Company and Purchaser attached as Exhibit D-3 hereto, until the Company exercises its Repurchase Option, until such Unvested Shares are vested, or until such time as this Agreement no longer is in effect. Upon vesting of the Unvested Shares, the Escrow Agent shall promptly deliver to the Purchaser the certificate or certificates representing such Shares in the Escrow Agent’s possession belonging to the Purchaser, and the Escrow Agent shall be discharged of all further obligations hereunder; provided, however, that the Escrow Agent shall nevertheless retain such certificate or certificates as Escrow Agent if so required pursuant to other restrictions imposed pursuant to this Agreement.

(c) Neither the Company nor the Escrow Agent shall be liable for any act it may do or omit to do with respect to holding the Shares in escrow and while acting in good faith and in the exercise of its judgment.

(d) Transfer or sale of the Shares is subject to restrictions on transfer imposed by any applicable state and federal securities laws. Any transferee shall hold such Shares subject to all the provisions hereof and the Exercise Notice executed by the Purchaser with respect to any Unvested Shares purchased by Purchaser and shall acknowledge the same by signing a copy of this Agreement.

3. Ownership, Voting Rights, Duties. This Agreement shall not affect in any way the ownership, voting rights or other rights or duties of Purchaser, except as specifically provided herein.

4. Legends. The share certificate evidencing the Shares issued hereunder shall be endorsed with the following legend (in addition to any legend required under applicable federal and state securities laws):

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS UPON TRANSFER AND RIGHTS OF REPURCHASE AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY.

5. Adjustment for Stock Split. All references to the number of Shares and the purchase price of the Shares in this Agreement shall be appropriately adjusted to reflect any stock split, stock dividend or other change in the Shares, which may be made by the Company pursuant to Section 6 of the Plan after the date of this Agreement.

6. Notices. Notices required hereunder shall be given in person or by registered mail to the address of Purchaser shown on the records of the Company, and to the Company at their respective principal executive offices.

7. Survival of Terms. This Agreement shall apply to and bind Purchaser and the Company and their respective permitted assignees and transferees, heirs, legatees, executors, administrators and legal successors.

8. Section 83(b) Election. Purchaser hereby acknowledges that he has been informed that, with respect to the exercise of an Option for Unvested Shares, an election (the “Election”) may be filed by the Purchaser with the Internal Revenue Service, within thirty (30) days of the purchase of the exercised Shares, electing pursuant to Section 83(b) of the Code to be taxed currently on any difference between the purchase price of the exercised Shares and their Fair Market Value on the date of purchase. A form of Election under Section 83(b) is attached hereto as Exhibit D-4 for reference.

PURCHASER ACKNOWLEDGES THAT IT IS PURCHASER’S SOLE RESPONSIBILITY AND NOT THE COMPANY’S TO FILE TIMELY THE ELECTION UNDER SECTION 83(b) OF THE CODE, EVEN IF PURCHASER REQUESTS THE COMPANY OR ITS REPRESENTATIVE TO MAKE THIS FILING ON PURCHASER’S BEHALF.

9. Representations. Purchaser has reviewed with his or her own tax advisors the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. Purchaser is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. Purchaser understands that he or she (and not the Company) shall be responsible for his or her own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.

A-23


 

10. Entire Agreement; Governing Law. The Plan and Option Agreement are incorporated herein by reference. The Plan, the Option Agreement, the Exercise Notice, and this Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Purchaser with respect to the subject matter hereof, and may not be modified adversely to the Purchaser’s interest except by means of a writing signed by the Company and Purchaser. This Agreement is governed by the internal substantive laws but not the choice of law rules of California.

Purchaser represents that he has read this Agreement and is familiar with its terms and provisions. Purchaser hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board upon any questions arising under this Agreement.

[Signature page follows]

 

 

A-24


 

IN WITNESS WHEREOF, this Agreement is deemed made as of the date first set forth above.

 

PURCHASER

 

KODIAK SCIENCES INC.

Signature

 

By

Print Name

 

Print Name

 

 

Title

Residence Address

 

 

 

Dated: _________________________, ____

 

 

A-25


 

EXHIBIT D-2

ASSIGNMENT SEPARATE FROM CERTIFICATE

FOR VALUE RECEIVED I, Victor Perlroth, hereby sell, assign and transfer unto Kodiak Sciences Inc. (the “Company”) _____________ shares of the common stock of the Company standing in my name of the books of the Company and represented by Certificate No. ___ herewith and do hereby irrevocably constitute and appoint the Company’s Secretary to transfer the said stock on the books of the Company with full power of substitution in the premises.

This Stock Assignment may be used only in accordance with the Restricted Stock Purchase Agreement between the Company and the undersigned dated ______________, _____ (the “Agreement”).

 

Dated: ___________________ Signature:

Name: Victor Perlroth

 

 

 

INSTRUCTIONS: Please do not fill in any blanks other than the signature line. The purpose of this assignment is to enable the Company to exercise its “repurchase option,” as set forth in the Agreement, without requiring additional signatures on the part of the Purchaser.

 

 

A-26


 

EXHIBIT D-3

JOINT ESCROW INSTRUCTIONS

_________________, ____

Corporate Secretary

Kodiak Sciences Inc.

____________________

____________________

 

Dear _________________:

As Escrow Agent for both Kodiak Sciences. (the “Company”), and the undersigned purchaser of stock of the Company (the “Purchaser”), you are hereby authorized and directed to hold the documents delivered to you pursuant to the terms of that certain Restricted Stock Purchase Agreement (the “Agreement”) between the Company and the undersigned, in accordance with the following instructions:

1. In the event the Company and/or any assignee of the Company (referred to collectively for convenience herein as the “Company”) exercises the Company’s repurchase option set forth in the Agreement, the Company shall give to Purchaser and you a written notice specifying the number of shares of stock to be purchased, the purchase price, and the time for a closing hereunder at the principal office of the Company. Purchaser and the Company hereby irrevocably authorize and direct you to close the transaction contemplated by such notice in accordance with the terms of said notice.

2. At the closing, you are directed (a) to date the stock assignments necessary for the transfer in question, (b) to fill in the number of shares being transferred, and (c) to deliver the stock assignments, together with the certificate evidencing the shares of stock to be transferred, to the Company or its assignee, against the simultaneous delivery to you of the purchase price (by cash, a check, or some combination thereof) for the number of shares of stock being purchased pursuant to the exercise of the Company’s repurchase option.

3. Purchaser irrevocably authorizes the Company to deposit with you any certificates evidencing shares of stock to be held by you hereunder and any additions and substitutions to said shares as defined in the Agreement. Purchaser does hereby irrevocably constitute and appoint you as Purchaser’s attorney-in-fact and agent for the term of this escrow to execute with respect to such securities all documents necessary or appropriate to make such securities negotiable and to complete any transaction herein contemplated, including but not limited to the filing with any applicable state blue sky authority of any required applications for consent to, or notice of transfer of, the securities. Subject to the provisions of this paragraph 3, Purchaser shall exercise all rights and privileges of a stockholder of the Company while the stock is held by you.

4. Upon written request of the Purchaser, but no more than once per calendar year, unless the Company’s repurchase option has been exercised, you shall deliver to Purchaser a certificate or certificates representing so many shares of stock as are not then subject to the Company’s repurchase option. Within two hundred (200) days after cessation of Purchaser’s continuous employment by or services to the Company, or any parent or subsidiary of the Company, you shall deliver to Purchaser a certificate or certificates representing the aggregate number of shares held or issued pursuant to the Agreement and not purchased by the Company or its assignees pursuant to exercise of the Company’s repurchase option.

5. If at the time of termination of this escrow you should have in your possession any documents, securities, or other property belonging to Purchaser, you shall deliver all of the same to Purchaser and shall be discharged of all further obligations hereunder.

6. Your duties hereunder may be altered, amended, modified or revoked only by a writing signed by all of the parties hereto.

7. You shall be obligated only for the performance of such duties as are specifically set forth herein and may rely and shall be protected in relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties. You shall not be personally liable for any act you may do or omit to do hereunder as Escrow Agent or as attorney-in-fact for Purchaser while acting in good faith, and any act done or omitted by you pursuant to the advice of your own attorneys shall be conclusive evidence of such good faith.

A-27


 

8. You are hereby expressly authorized to disregard any and all warnings given by any of the parties hereto or by any other person or corporation, excepting only orders or process of courts of law and are hereby expressly authorized to comply with and obey orders, judgments or decrees of any court. In case you obey or comply with any such order, judgment or decree, you shall not be liable to any of the parties hereto or to any other person, firm or corporation by reason of such compliance, notwithstanding any such order, judgment or decree being subsequently reversed, modified, annulled, set aside, vacated or found to have been entered without jurisdiction.

9. You shall not be liable in any respect on account of the identity, authorities or rights of the parties executing or delivering or purporting to execute or deliver the Agreement or any documents or papers deposited or called for hereunder.

10. You shall not be liable for the outlawing of any rights under the Statute of Limitations with respect to these Joint Escrow Instructions or any documents deposited with you.

11. You shall be entitled to employ such legal counsel and other experts as you may deem necessary properly to advise you in connection with your obligations hereunder, may rely upon the advice of such counsel, and may pay such counsel reasonable compensation therefor.

12. Your responsibilities as Escrow Agent hereunder shall terminate if you shall cease to be an officer or agent of the Company or if you shall resign by written notice to each party. In the event of any such termination, the Company shall appoint a successor Escrow Agent.

13. If you reasonably require other or further instruments in connection with these Joint Escrow Instructions or obligations in respect hereto, the necessary parties hereto shall join in furnishing such instruments.

14. It is understood and agreed that should any dispute arise with respect to the delivery and/or ownership or right of possession of the securities held by you hereunder, you are authorized and directed to retain in your possession without liability to anyone all or any part of said securities until such disputes shall have been settled either by mutual written agreement of the parties concerned or by a final order, decree or judgment of a court of competent jurisdiction after the time for appeal has expired and no appeal has been perfected, but you shall be under no duty whatsoever to institute or defend any such proceedings.

15. Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery or upon deposit in the United States Post Office, by registered or certified mail with postage and fees prepaid, addressed to each of the other parties thereunto entitled at the following addresses or at such other addresses as a party may designate by ten (10) days’ advance written notice to each of the other parties hereto.

16. By signing these Joint Escrow Instructions, you become a party hereto only for the purpose of said Joint Escrow Instructions; you do not become a party to the Agreement.

17. This instrument shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted assigns.

18. These Joint Escrow Instructions shall be governed by the internal substantive laws, but not the choice of law rules, of California.

[Signature page follows]

 

 

A-28


 

 

PARTICIPANT

 

KODIAK SCIENCES INC.

Signature

 

By

Print Name

 

Print Name

 

 

Title

Residence Address

 

 

 

ESCROW AGENT

 

Corporate Secretary

Dated:

 

 

A-29


 

EXHIBIT D-4

ELECTION UNDER SECTION 83(b)

OF THE INTERNAL REVENUE CODE OF 1986

The undersigned taxpayer hereby elects, pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in taxpayer’s gross income or alternative minimum taxable income, as the case may be, for the current taxable year the amount of any compensation taxable to taxpayer in connection with taxpayer’s receipt of the property described below.

1. The name, address and taxpayer identification (social security) number of the undersigned, and the taxable year in which this election is being made, are:

TAXPAYER’S NAME:

TAXPAYER’S SOCIAL SECURITY NUMBER:

ADDRESS:

TAXABLE YEAR:

The name, address and taxpayer identification (social security) number of the undersigned’s spouse are (complete if applicable):

SPOUSE’S NAME:

SPOUSE’S SOCIAL SECURITY NUMBER:

ADDRESS:

2. The property with respect to which the election is made is described as follows: __________ shares (the “Shares”) of the Common Stock of Kodiak Sciences Inc. (the “Company”).

3. The date on which the property was transferred is:___________________ ,______.

4. The property is subject to the following restrictions:

The Shares may not be transferred and are subject to forfeiture under the terms of an agreement between the taxpayer and the Company. These restrictions lapse upon the satisfaction of certain conditions contained in such agreement.

5. The Fair Market Value at the time of transfer, determined without regard to any restriction other than a restriction which by its terms shall never lapse, of such property is: $_________________.

6. The amount (if any) paid for such property is: $_________________.

The undersigned has submitted a copy of this statement to the person for whom the services were performed in connection with the undersigned’s receipt of the above-described property. The transferee of such property is the person performing the services in connection with the transfer of said property.

[Signature page follows]

 

 

A-30


 

The undersigned understands that the foregoing election may not be revoked except with the consent of the Commissioner.

Dated: ___________________

Taxpayer

 

A-31


 

Exhibit B

 

Election Form

Kodiak Sciences Inc.

Election Form for Special Equity Award

The Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Kodiak Sciences Inc. (the “Company”) is providing you the opportunity to receive a one-time special equity award in the form of a stock option under the Kodiak Sciences Inc. 2018 Equity Incentive Plan (the “Plan”), pursuant to the terms and conditions set forth in this Election Form for Special Equity Award (“Election Form”) and as described in the attached Q&A (the “Special Award”).

Specifically, the Committee is giving you the opportunity in this Election Form to (1) elect whether you wish to receive the Special Award (such election, the “Opt-In Election”), which would be granted to you in lieu of a portion of each annual long term incentive award that may be granted by the Company to you during fiscal year 2021 and continuing through and including fiscal year 2027 (the “Election Period”), in each case subject to your continued status as a Service Provider (as defined in the Plan) on the applicable grant date (collectively, the “Annual Long Term Incentive Awards”), and, to the extent you make the Opt-In Election, (2) indicate your preference regarding the portion of the Annual Long Term Incentive Awards that you wish to forego (the “Percentage Election”).

We will be sending a DocuSign to complete this Election Form. Please complete the DocuSign before 5:00 p.m., Pacific Time on __________. To the extent that your completed Election Form is not received by such time, you will be deemed to have declined the Special Award.

Opt-In Election. I hereby make the following election with respect to the Special Award:

 

 

 

Accept. I wish to accept the Special Award and forego a percentage of my Annual Long Term Incentive Award for each of the next seven years. I have indicated my Percentage Election below.

 

 

Decline. I wish to decline the Special Award.

Percentage Election. I hereby elect to forego the following percentage of each Annual Long Term Incentive Award in exchange for the Special Award:

 

 

 

0% of the Annual Long Term Incentive Awards in the form of the Special Award; or

 

 

25% of the Annual Long Term Incentive Awards in the form a Special Award of _____non-qualified stock options; or

 

 

50% of the Annual Long Term Incentive Awards in the form of a Special Award of _____non-qualified stock options; or

 

 

75% of the Annual Long Term Incentive Awards in the form of a Special Award of ____non-qualified stock options.

By signing below, you acknowledge that you understand that, after 5:00 p.m., Pacific Time on __________, you may not withdraw or change your elections.

 

 

 

 

Signature

 

Date

 

 

 

 

 

 

Name (please print)

 

 

 

(Exhibit A). – Special Award Q&A

 

A-32


 

Exhibit A

Kodiak Sciences Inc.

Special Award Q&A

The following information in this Special Award Q&A (“Q&A”) is intended as a summary. It may not answer all of the questions you may have about the Special Award and is not intended to go into every detail regarding the Special Award. Please note that if there are any inconsistencies between the information in this Q&A and the terms of the Special Award (as set forth in the documentation evidencing the Special Award that will, in the event you make the Opt-In Election, be provided to you upon grant), the terms of the Special Award will control. Capitalized terms not explicitly defined in this Q&A or the Election Form will have the same meanings ascribed to them in the Plan.

Why am I receiving the Election Form?

To motivate and reward the next phase of transformational performance and growth, the Committee is considering approving a new long-term incentive compensation program (the “KSO Program”), pursuant to which each participant will be granted a Special Award that will vest subject to both time-based and performance-based vesting conditions (as described further below). You are receiving the Election Form because you are grade-level six or above and the Committee believes you are in a position to lead and influence the Company’s next phase of performance and growth, and therefore wants you to be a participant in the KSO Program. By electing to receive the Special Award, you will confirm your wish to participate in the KSO Program.

Is there an overview document to review details of KSO Program?

Eligible participants should read the “KSO Program 7-year Performance Award Participant Overview” . Please note that the KSO Program is subject to modification or cancellation based on shareholder voting from special proxy filing.

What is the potential value of the Special Award?

The Special Award is designed to provide approximately three times the value at the end of the seven year performance measurement period, based on assumptions used prior to grant date, as compared to the foregone portion of the Annual Long Term Incentive Awards.

How will the Special Award vest?

Subject to certain exceptions, the Special Award will be earned based upon the achievement of stock price performance objectives ranging from $200 to $800 over the next seven years. These performance objectives will need to be achieved, and sustained, over ninety (90) consecutive trading days at any time during the Election Period. Once earned, the Special Award will also be subject to time-based vesting conditions. Specifically, upon the achievement of any performance objective under the KSO Program, the underlying tranche of options will vest in equal monthly installments between the date of achievement of such performance objective and the end of the Election Period, subject to your continued status as a Service Provider through each such vesting date. Subject to certain exceptions, any stock price performance objectives that are not achieved by the end of the Election Period will result in the cancellation of any relevant tranches of the Special Award.

Are there any other ways for the Special Award to be earned and to vest?

A threshold level of the Special Award will be earned upon the attainment of certain operational performance objectives. Up to 25% of the Special Award will be earned upon the attainment of regulatory milestones tied to KSI-301. An additional 10% of the Special Award will be earned in the first fiscal year in which KSI-301 and/or KSI-501 has sales of $2.5 billion. To prevent double counting, the KSOs that are earned based on (Exhibit A). Please note that attainment of the stock price performance objectives (that is, the same KSOs cannot be earned twice).

A-33


 

Are there any other conditions applicable to the Special Award?

The Special Award will be subject to stockholder approval at a special meeting of the Company’s stockholders to be held as soon as practicable following the Committee’s approval of the KSO Program and the Special Award. If such shareholder approval is not obtained, then the Special Award will be forfeited and you will receive 100% of the value of your Annual Long Term Incentive Award for fiscal year 2021.

Who can I contact to answer any questions regarding the Special Award?

You are encouraged to direct questions to KSOQuestions@InfiniteEquity.com or contact John Borgeson at the Company to the extent you have any questions regarding the Special Award.

A-34


EX-31.1 3 kod-ex31_1.htm EX-31.1 EX-31.1

 

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Victor Perlroth, M.D., certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Kodiak Sciences Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 9, 2021

 

By:

/s/ Victor Perlroth

 

 

 

Victor Perlroth, M.D.

 

 

 

Chairman and Chief Executive Officer

(Principal Executive Officer)

 

 


EX-31.2 4 kod-ex31_2.htm EX-31.2 EX-31.2

 

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, John Borgeson, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Kodiak Sciences Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 9, 2021

 

By:

/s/ John Borgeson

 

 

 

John Borgeson

 

 

 

Senior Vice President and Chief Financial Officer

(Principal Accounting and Financial Officer)

 

 


EX-32.1 5 kod-ex32_1.htm EX-32.1 EX-32.1

 

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Kodiak Sciences Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 9, 2021

 

By:

/s/ Victor Perlroth

 

 

 

Victor Perlroth, M.D.

 

 

 

Chairman and Chief Executive Officer

(Principal Executive Officer)

 

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Kodiak Sciences Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.

 

 


EX-32.2 6 kod-ex32_2.htm EX-32.2 EX-32.2

 

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Kodiak Sciences Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 9, 2021

 

By:

/s/ John Borgeson

 

 

 

John Borgeson

 

 

 

Senior Vice President and Chief Financial Officer

(Principal Accounting and Financial Officer)

 

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Kodiak Sciences Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.

 

 


GRAPHIC 7 img6467664_1.jpg GRAPHIC begin 644 img6467664_1.jpg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ǰ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img6467664_0.jpg GRAPHIC begin 644 img6467664_0.jpg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�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
3:M+\6U_P""B'[.3_%.#P7:W<"3MNK6T/]C/Q8O[37PZ^-'BGXB+XL\1Z&NHQZKNLC:0-#-:O M!;6]G K,L,<1ED9BS%G+LQ.3@=C^TM\%?AA\\4-X/\ B?9B2^\, MZKH^HI::Q$$8;S$#S(F[!*X/0E2.30![MK+Z?'H]\VK&V72U@D-VUX5$ AVG M>9-WR[-NL>(Y-!\K.\8MD-MM[Y^YCO7H M/B+]D/6;CP[6([1Y0D05>RXBX]L8XH \K_8 M;C_:'L_V6_ W_"M]/^#S^%);>66"75;S4TO9)#,_FFX$4)7S-X8'!/0#/%>A M>(O@A^T=\3OC)\)O&'BT?"O1X_!6M?;7N_#EYJ1O9;.0".YMU\V#:0\>>"5& M>XYK5G_9$^(7P<\2:SJ?[/GQ'L_".AZQ=27UWX*\2:?]LTJ.X;EI+=E.^ ' M!51T[X55'=_!_P""/Q-TCQ\/&OQ0^+5UXNU&&S>RL]!T6S&FZ1;JY!=WB#$S MR95=K-C;COQ@ E^+W_#3/_"92?\ "K?^%3_\(GY,>S_A+_[3^W>;C]YG[/\ M)MSC'?UKJ/!7_"R?^%2ZQ_PM7_A%?^$J\JZS_P (=]I^P^3Y?R?\?'S[_O9[ M=,5Z;5/6;%M4T>^LU8(UQ!)"&;H"RD9_6@#Y5_X)6^&;'P_^Q+X(N;6%([C5 MI[^_NY%4 RR_:Y8@Q]2(XHU^BBO+O$#?%2Y_X*8_$23P+;>"[O7+/PA8)IB^ M.)KN-(]/;RS,UMY$;'/VAG#9_O'U(KZM_91^"][^SS^S_P"$OA[J.HV^KWFB MQW"27EJC)')YES+,,!N1@2 ?A6-^T/\ LNV_QHUO0/&/A_Q-??#[XF^'4>/2 M?%.F1K*RQMG=!/$V!-"=S?(2/O-V9@0#A?&/AW]K'QUX3UGPYJ^C_ VYTO5K M.6RN8FO=7(:.1"K<&#'0UF>+_AKXF^#O_!,7Q1X)\8:A9:IK^A^#+^RFNM/E M>2 QJ)/)5&=$8A8O+7E1]W\:NW/P'_:8^(%FVA>-?CII&B^')2L=W-X,T/[- MJ5W#U=1.[?Z.QY7<@/'..2*]N^,WPLN/B7\!_%?P^LM2:"YU?1)=)BU#4&:9 M@S1;!)(>K'N3U)S0!Y=I_P =-+_9T_89^'7C35+*XU4P^%M$M;/3+4@2WMU+ M:PI%"I((7)/)P< $X/0I#KG[76M6EO>V_A7X0^'UF3>=-U;6-2N+F DGY7>& M#RR0,9VDCW[5TGC#]EO3?B1^RQH7P?\ $.I2PRZ9I&GV<.LZ>,/!=VD<:QW$ M8/;1-K^A^')$UJ>(_*VTO- MY,,A4<2*C%68D X% '&_\$N&U)?AC\7(=7%HFHP?$W6(YXM/9C;1R>5:EUAW M -Y>\MMR,X//-;/[!Y_XK/\ :;'?_A:>J?R2NZ_8[_9E;]E7P7XP\,IJ4>I: M?JGBF\UO3]F\O;VLL<$<4,C-R[J(>6[YKAM8_99^*WP^^,?C?QG\%OB+HWA[ M3/&\ZWVLZ)XCTIKN.&["D&X@93G)+,VTX&3SN 4 Y+_ (*0?\))=?$+]FRQ MT6/1Y[>;Q>[I#XC:5=,DU!4C^QK<&-6;!+3 8'.?3->F?:?VPO\ H'? _P#\ M#]8_^,UW_P 3OV?]+^.WP5M_ 7Q&O7URZ6"W>77+&);.=;Z)<"\@4;A$^[<= MHR,.R\@XKR*Q^"O[5?A^W70=/^/?AZ_T2,%(=21 ;I+PRN)RY'5@Z ME>>0$ Z 5ZW\%_AG=?"?P#:^']0\6:SXWU$2R7-WK6NS>9-/-(Q>3:.D<>XG M;&"0HXR>M?/+_L=?$;X+^+-:U/\ 9Y^)=EX/\.:W=-?7G@KQ%IHO--BN#G<] MNP^>%3P-B@=!\Q"J% .?_P""KVEZ#-\*?AQ?WT< UZW\:V$6FRD#SMKAS,@/ M780JD]LHGM7W!7PQ\2/^"??CKXU6MGX@^(OQ63Q7X_L[RU?3W_L_['I6E6J3 M+)-'!!&#-3FM(FNK7X=2ZBK% !?$>@PS+;S:I MIMS8I-("51I8F0,0.P+9H ^>?REW M2-'$[HB*.[$*JCMDCI4OA?XE?M2?%+POIOBGPYX'^&?A/1]5B6[L[#Q5K-_- M??9W4-$TGV>#8I*G.,Y&<$ BNS^&G[,-GH?[)&G_ 0\77::Q9#2)M*O;NQS M%O#N[;X]W*LNX$9SRHZUQ/@WX)_M*> ?#MGX*TKXP>$9O#&GP+9V&N:CX8DG MU>WMT7;&I03K"[*N!N;.=@)ZF@#B?V#F\5+^U%^U7#XS31X/$8OM!EO8?#SR MO8+*UO=$F(R@.?X,^,]7O45O&NH>,]4;Q+,XS/]L$H^ M20GGA6! /0NQ[FNW_99_9)G_ &:_B-\5]=_X26;Q'9>,GTV=);]FDO3-!'-] MHFG<\,TLL[O\N ,X]*R?B%^R'XJT7XJ:U\2O@9\0A\./$7B JVOZ/?6"WNDZ MK(#GSFC/,4OWB74$DDX*[G+ 'U%)#'(\;O&KM&=R,P!*G!&1Z'!(_$U\B>#5 M-G_P5*^("3?NWO/AS:7$"G_EI&MU$C,/HW%=-\/?V>?BWK'Q*T'QM\7_ (N- MK1T%GET[POX1MFTW31,Z%&>=@=]P,,P"L,>^&93L?M&?LNWGQ6\8^&?B)X'\ M6S?#_P"*7AJ)[:RUI+9;F"ZM7)+6US$<;X\L^.>#(QP>, ';?M,:G;:/^SG\ M4;V[E6&WA\+ZFS,W_7K( ![DX ',OV4OC M9\>_"^I>'_B[\6]*N/#[02>5H7A72FLX;VX"G[/)=S,V\QI($D,2C#$=>!7N MWP5^$MW\+?V>_#7P[NK^&^O=)T8:8]["A6.1@A7> ><"_L._$;2/A#_P M37\(^-->>1=(T/3-2O;@0KN=@M]#8I*G.,Y&<$ BNG^#_[*=IX3_8^L M_@7XPO8];LSI]YI][>6 :(.LT\LH>/=RK+YBX)SROI7*^#?@G^TIX!\.V?@K M2OC!X1F\,:? MG8:YJ/AB2?5[>W1=L:E!.L+LJX&YLYV GJ: .)_8.;Q4O[4 M7[5F:".;[1-.YX9I99W?Y< 9QZ5U/P@^!-_P##7XW_ !G\/+O3KBVM(HV62U%M \3!R>#N+9&/2@#V:BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH _/?]J:1E_: \2@,0,VG?_IUAK[YT+_D!Z?\ M]>T?_H(KX$_:G_Y. \3?6T_])8:]9_:-_:";2]"M_!7ANX_TQ[6./4KR(Y\L M%!F%2.Y_B/;[O7./T'&X.KC\/@J-/^75]E:.I^<8''4LOQ./K5?YM%W?-+0P M/VG_ -H)_%E]+X/\,W!;28GVW=U"?^/N0'[JG^X#_P!]$9Z $^F_LR_L^CP+ M8Q>)?$,._P 07";K>WE&?L2$=<'I(0>>X!QU)KE?V6/V>3#]E\;>);?,C8ET MVSE'3N)W'ZJ/^!?W37U;7FYEC:>%I?V=@G[J^)]WU7^?W;'J97@:N,K?VGCE M[S^%=ET?^7W[A7E?Q\^-]K\'?#\?DHEWKUZ"+2V8_*H'61_]D=AW/T)'JE?G M1^T%XFN/''QFUT[FE2WNCI]N@_A6)BF!]6#-]6-<.28"&.Q-JOPQ5WY]D>AG MV83P&%O2^.3LO+NR31O#_P 0_P!I#Q%/W![#LH_V5'X= M:]);]AC7OL>Y?$>G&ZQ_JRD@3/\ O8S^E?4?PU\#V?PZ\%Z9H5G&J_9X@9Y% M',LQ WN?J?R [5T]=V)XBKJIR81*,%MHOZ^X\_"\-X=TU/&-RJ/?5[_ *_, M_.C5-*^(/[.'BB&1I;C3)F.Z.>!]]O5T2TUJSPEY:J?EYZ2)_LG!X[$8]"=SXO> [7XC?#_5M(N(E>,#W_ +,G M_P#0#7;5Q'QN(7X0^,"2 /[+GY/^X:^,PO\ O%/U7YGV^+_W>I_A?Y'P!\,O MAOK'Q7\1/HVCW%O#=) UP6NY61-JE0>0I.?F':O4I/V+?B#&A9;W1Y"/X4NY M,GZ9C _6J_[$]Q%)\8+E4FC=O[*F.U7!/WX^V:^[*^[SC.<5@<5[*BU:R>Q^ M?Y+DF$QV$]M63O=K1GYT-/\ $C]G?7HTD>^T5BVX1EM]M< 'GU1_U(SV-?8O MP(^.%E\8M#D+QI9:Y9@?:[13\I!Z2)GG:3VZ@\=P3U'Q,\ V'Q*\&ZAHE]&C M&5"UO,PYAF .QP?8]?4$CO7P+\ _'4/@7XU:$HU"W1IKQ=.N(1<(2RR,(RI& M><$@X]5%<[E1SW"5*DHJ-:'5=?\ A[6\CI4:W#^,ITXR_FC])* MYWXC?\D]\3_]@NZ_]$M715SOQ&_Y)[XG_P"P7=?^BFKXBC_%CZH^\K?PI>C/ MBW]D1V;XV6F23^XN.I_Z9M7WI7P5^R#_ ,EKM3V\BX_]%M7WK7T_$W^^K_"O MS9\IPK_N#_Q/\D%%%<#\&0=U8 C^=?FOH?PXUGQ9X-\1> M+( 9+/27C\_<"6D+G!VGOMX)] 0:^G?V+?B5_:WA^\\'WDN;K3LW-IN/+0LW MSJ/]USG_ +:>U?<9SEM*.$C*AJZ7NOYZ_F[_ #9\%DF9U98R4<1HJWO1^6FG MR5ODCZ8HHHKX$_0SXI_;A8K\1]&()'_$I3I_UVFKZ8^ O_)'?"?_ %Y+_,U\ MS?MQ?\E&T7_L$I_Z.FKIM>^/B_#/X#^%=$T>96\37FFJ=ZX/V2,Y^<_[9_A' M;J>P/WM;#5<9EF%HTE=M_P">I^>T<52P6:XNO5=DE]^VB-+]JC]H/^Q8;CP9 MX;N?^)A(-FH7D1YA4]8E/]X_Q'MTZYQE_LL_L]FX6V\:>)X"\?$FFV,PR&[B M9P>W]T=^O3&>7_9I^ ,OQ$U(>+/$T;R:)%*6CBFR3?2@\YSU0'KZGCUQ]M*H MC4*H"JHP !@ 5RX_%4\LH?V?@W[WVY?I_6RTWN=67X2KFM?^TL:O=^Q']?ZW M>NUA:***^,/N HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH ***^>_V(?C5XF^._PEUCQ!XJEMIM1M?$>H:9&UK (E\F%U" @=\$Y/ M>@#Z$HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN&\-_&3PWXJ M^*GC#X>V$MPWB/PK#:3ZE')"5B5;F/S(MC_Q?+U]*O\ Q4;Q@GP[U\^ $TV3 MQG]E;^RUU9Y>>=N[.*Z*@ HHHH **** "BBB@ HKX?^$/[9GQ_P#CQX1;Q1X) M^ NB:GH7VN:S2XF\7QV[%XVPPV/I:I^V5\4_A/#_:/Q>_9TUOPYX6A_X^ M?$7A?6K?7([<9YDEAC"M'& >69NW /2@#ZZHK \!^//#_P 3O".F>*/"VJV^ MMZ#J47G6M]:ME)%R01SR""""I ((((!%>(:/^V5I4W[9WB/X ZMIL>F7=K90 M7.DZI]HW"_E:VCGDA*;1L8([%>3D1MT. 0#Z.HHKQ/\ :\_:>TC]D_X/W?C' M4+9=4U&29+/2])\WRS>7#<[=V#M55#.S8/"XZD"@#VRBN=^'/BI_'?P]\+^) M9+9;-]9TNUU%K=7WB(S0K(4#8&<;L9QVKY!^$/[9GQ_^/'A%O%'@GX"Z)J>A M?:YK-+B;Q?';L7C;##8\8- 'W!17S5X3^+'[3&I>*M&M->^ VAZ/H=Q>PQ7^ MHP^,8)WM;=I%$LJQA,N50LP4=<8[U]*T %%%% !117SW^Q#\:O$WQW^$NL>( M/%4MM-J-KXCU#3(VM8!$ODPNH0$#O@G)[T ?0E%>9_ V3XK2:?XD/Q6B\/Q7 MG]L3?V./#Y+$27ZE=A/R^M 'OM%%% !1110!#=VD&H6LUK=0QW-M,C1 MRPS(&21",%6!X(()!!J+2=)L?#^EV>F:796^FZ;9PI;VUG:1+%#!$@"HB(H M50 !@ 5R-S\9/#=I\9[/X722W \5W6BMK\48A/D_95F,1)?H&W _+Z5UFM M-J"Z/?G25MVU06\AM%N]WDF;:=@?;SMW8SCG&: +M% M/QQNF^V+H1;[-M\QO*QGOLVYQQFN_H **** "BBB@ HHHH **** "BBB@ HH MHH ***\"^)WQD\2>%?VN?@M\/;"6W7PYXJLM9GU*.2$-*S6UOYD6Q_X?FZ^M M 'OM%%% !1110 4444 %%%% !117SWXT^-7B;0_VV/AW\,K66V'A;6_#E]J= MY&T ,QFB+A"K]0/E'% 'T)1110 4444 %%%% !1110 4444 %%%?)/CC]K/X MJ-^TAXV^%/PV^$^F>,YO"]I9WEQ>7GB%; E)X8Y =KICAI-O!/3- 'U+K7AW M2O$D-M%JVF6>J16MS%>0)>VZ3+%/&VZ.5 P.UT8 JPY!&0:T:^3KK]H[]I/P MK&;O7_V7FU'3$PTTOAOQA:W5Q&G?9;[-\K>BKCZUZ]\ /VDO!?[2'AV[U+PK M-==\<7=W9VUO=ZG]A6-X5A(&\HP^;S3UQC;[U@?\+W_:@T ML&?4/V9+'4;902Z:5XZL_.4 9+!73Y^F-HY)(H ^JJ*\E_9]_:3\-_M#:7JX MTVSU+P]XDT*X%GK?AG7(/(O]-F(R Z9Y4X;:PX.T]""!ZU0 4444 %%?/?[; MWQJ\3? CX2Z/X@\*RVT.HW7B/3],D:Z@$J^3,[!P >^ ,'M7>_'Z3XH1_#JX M/PACT.7QE]HA$8\0%A;>3N_>'Y2/FQZ]L]\4 >CT5%:^?]EA^T^7]IV+YOE9 MV;L<[<\XSTS4M !15#7KR33]#U&ZA($L%M)*FX9&Y5)'ZBO(/V*_BQK_ , ;3QCX4EN)M%NIIH(VNH3%)NBD:-\J?]I369\9)/BLFH>"A\,XO#[V M;:Q%_P )&=<+AUT_(W^1M/W\;O?.W'>@#TRBBB@ HHHH **** "BBL?QAXJL M/ WA'6_$FJ-(FF:/8SZA=-$F]Q#%&TCD+W.U3Q0!L45SOP\\=Z5\3_ NA>+= M#>631]:LX[ZT:>/RW,3J&4LO8X/2N5\8R?%8?&;P2GAJ+P^?AF8KC_A(Y+TO M]O$FT^5Y.#C&=O;^]GM0!Z91110 4444 %%%% !1110 5G:AX=TK5M2TS4;[ M3+.\U#2W>6PN[BW1Y;1W0H[1.1E"R,5)4C()!X-:-% !17#7/QD\-VGQGL_A M=)+<#Q7=:*VOQ1B$^3]E68Q$E^@;<#\OI75:]>2:?H>HW4) E@MI)4W#(W*I M(_44 7Z*\1_8K^+&O_'+]F/P1XX\426\NO:M'HH M ^SJ*^?_ (6_$S]H+Q!X[TS3_''P7T?PGX7F\W[9K%KXJAO9+?$3M'B%5!;= M($7CH&)[5SWQ[_:F\?> ?VAM ^$WP]^'-AXXUG5= .NA[W6AI^Q5FEC9>(/V83J&FQ+YDTGASQC:75S&HZ[;*]J^!OQV\*?M#>!8_%7A*XG>T\Y[6ZL[V+R;NQN$/SP3QY.QQD'& M2""""0A45XG^SW^T-)9M CFCN#*;M49AYI!4; M"=OW1GKUKVR@ HHKY7^('Q<^+'Q(_:4U[X2_"C4?#_A2T\)Z7:ZAKWB'6[%[ MZ5IK@%H8(80ZKC9AB6/KR, , ?5%%>%:M#^T1I_ACX"-6UY=8"^+KP M0SP0/IXD(#6Z%B1(8\%O]O[HVU[K0 4444 %%%<-\&/C)X;^/7@&T\8^%);B M;1;J::"-KJ$Q2;HI&C?*G_:4T =S1110 5YG\:/V;?AO^T%9VD/COPM:ZU-9 MG-I?*[V]W;'.?W<\3+(HS@[=V"0,@UZ910!\NV__ 3C^$$ES!_;#>*O%.F6 MT@DM]&UWQ)=7-C%@@A1$7&5!R<,2#DYS7TQI>EV>AZ;::=IUI!8:?:1)!;VM MM&(XH8U 5410 %4 #@ 5:HH **X;QI\9/#?@'Q]X&\':M+<)K7C*:Z@TE8 MH2\;-;QK))O;^'Y6&/6NYH **\S^!LGQ6DT_Q(?BM%X?BO/[8F_L<>'RY3^S M\+Y?F;C]_.[WQC->F4 %%%% !1110 45PWPT^,GAOXL:AXQL_#\MQ)/X4UJ; M0-2%Q"8PMU%C>$)^\O(^:NYH **\X^/TGQ0C^'5P?A#'H<9Z9H EHHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH _/3]JI=WQ^\3CIDVH_\ )6&L MSQY\,];^"_B;3+V\MXM4L9&CNK6YEAWP7 &&V.I[]F4_R()\D_;Z^-FN>%?V MI_&NC:9;V<2VWV'%Q*AD=MUC;OTS@8W8_"OU!U?P)I'Q6^$]OX?\0P//8ZAI M\0D:%S%+&QC&)(W'*,"<@CZ<@D5^AO.HX.AAHI6TE\EMZ:GYQ_8,\77Q, MY/EES7B]^KW7GH5?@W\9-'^+F@K/:%;/58% N]-9OGB/3(]'U:[GL&F9M)\0?,T=W'U:WN%)QNQPR'@CD>WZ:_LH_M M8^&_VH/!OVJS,>F>*;%%&JZ(SY:%NGF1YY>)CT/8G!YQGX_&4()NMAU[C^=C M[;"5:G*J6(=YKY7/=:_'G]HKXX7'PG_:&\8:.WAUYKG3]8EE#W%SL61'?S8V M "G@HZG\:_8:O@C_ (*4?L>ZE\3((OB;X+L'OM?T^W$&K:;;KF6[MTR4FC4? M>D09!7JRXQ]W!WRO&3PE1J+MS:&&98&GC(1]I&_*[]?T/N#PAXIT_P <>%=( M\0Z5,MQINJ6D5Y;R*^*?B%^U5\/K1]7U&[2/5%OYU:X?^BFKUNO)/VN/^38 M?BC_ -B]>?\ HIJ\>E_$CZH]2I\#/S9_X)/J!^T]?''/_".W7_HZ"OV!K\,/ MV)_V@=!_9L^,%SXL\1V.H:A82:5-8K%IB(TH=Y(F!(=U&,(>_<5]SW7_ 5T M^%\=N[6_A3Q9--CY4DBMD4GW(F./R->KC:%6I5YH1NCS\+6A"G:3/M'Q=XJT MWP/X6U;Q#K%PMKI>EVLEW%C12Q_'C@=S@5^%7[/FCW7Q5_:N\&"V@"SZ MAXFAU"14&=D:S^?*?P17/X5Z)^U#^W5XU_:C6/POI^G'P]X4DF7;HUF[3SWL M@;Y/.< ;^<$(J@9P?F(!'V'_ ,$ZOV,-0^#=O+\0_&]F;3Q9J%N8+#3)1\^G MV[8+-(.TKX QU5<@\LP%4X?4Z,I5/B?0F4OK-2*ALC[EKB/CE_R1/X@?]B]J M'_I-)7;UQ'QR_P"2)_$'_L7M0_\ 2:2O&A\2/3E\+/R=_P""8<\K?M9:.AED M*?V?>_*7)'^I/:OV9K\8_P#@F'_R=IHW_8/O?_1)K]G*]',?XR]/\SAP7\-^ MH5^3_P#P4&_:HU_Q-\>!X)\&WF[3/#I^P/''"LWVF_8CS< C)VG;&!_>1O6O MT&_:H^-T'[/_ ,$/$7BPNG]I)%]ETN)^?-O) 1$,=PO+D?W4:OS1_P"";7P5 MG^,G[0$OC/6T>\TKPNPU.>:?+>??.Q, )/4A@\N?6,9ZU>!O1YL5>W+MZ_UI M\R,9%5TL.U=/<_3OX'?"U_ _P3T?PMKZ0W>I7%EG6=B!4EGE7]ZN!U SL![A M17YK>)/CQXB_9%_::O=)U/04N(]%U#Y9H)V1KNR?E7 ((RT3=,X#9':OUVK\ M_?\ @K!\!_\ A(/!NC_%'3+?=>Z*5T_5"B\M:R-^Z<_[DC%?^VWM6N!QU6-6 M<92TJ;^9AB\OH3A"2AK3VMI;[C[R\/Z]8>*=!T[6=+N%O--U"WCN[:XC^[)$ MZAD8?4$&M"OA+_@E7\>O^$R^&VH?#?4[C?JOAH_:+#>WS26,C<@>OER$CV$B M =*^[:\FM3=&HX/H>K3FJD%)'Q#^W-J%K#\4-#MY+J".X;2$80O*JN1YTPR M3DCBO-?%_P (]9\*^$=!\58^W:-J=NDGVA%/[A^GEOZ=.#T/Z5P/_!7A0?CU MX2) S_PC4?/_ &]7-?>?[(^EVFO_ +(OP\L-1@2]L[G0XXYH9AN#J<\&OLZ& MBS^SC\U5^6/[5?PS^*'[(7BN+QAX4OVUSP(]P'MKV: M'-QIDA/RQ3.F#C/"R=^AYQN^I/V,/VX]'_:4T_\ L'6T@T/Q_:H6>R5_W5_& M!S+!G^(#[R=1U&1G;X>84*$W]9P=^5[I]/\ @?D>_EU3$TX_5\9;F6S77_@_ MF?55%%%>$>X%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M?)?Q^^+'Q&^)7Q^LO@'\(=7A\)W=OIR:SXL\8/"L\NF6CL D-NC<>+/%]E^RO_P % -:\7>-F.F^ _BGHUG86OB.48M;'4;55C$$[ MDXC5D7=N.!\X/1790#J]6_9K^+7P?TL^)_AO\:O&?CGQ%8 7$_ACQ[>QWNGZ MNJ\O A$:M;,P!VL"<-@$@$FN6_X)=^++2T_9'\1>)M4_XEEC'XBU?4KKS#G[ M/& DCY.!]T9[=J^@_C!^T_\ #WX->!)_$NJ>(;'4-T8_L_3--N4GN]3F;B.* MWC4DNS,0,C@9R2 ":^9O^"=WA6\^)'[#OC_PUJ _LO4->U77M.N 01]GDGC$ M;\=?E+G\J -3X6>'OBI^W!H;_$K7/B=XG^%'P_U.>7_A&O#/@J:.SO#:H[(M MQ=715F9W*GY -N!D8!Q70>&?$_Q&_97^.7@WP#XY\:77Q)^''CF62PT3Q!K$ M2)J>EZBB[UMIY%QYR2C(5B,[B!\H7GY__8]^!W[./BOP%K> M+5/B'I?_ !/K&*S\1ZIJ*6;6[J1)(?M#Q(P8C"2=<'@YY -CX]?%#XD?$_X_ M6OP&^$>LP^#YK/34UGQ;XQ>W6>;3[=V CM[=&^7S7!!SUPX(*[6-$G[+?Q=^ M%]F/$'@#X]^+O%OB2T3SGT'QY.E[I>J,.L/0-;!@,!E)(/.>37*?%CQ0_P"Q M]^V=J?Q8\2:==S?"SXAZ39Z5JFO6L+2C1;^WPD33*H)$3(J^Y+-C.S!]-\:_ M\% /@SX?\/+<>'/%=I\0/$5XH32O#/AEC=WU_.QPD(1 3&2>I<# R<$X! .9 M_8%^-FM>//@#X\\<>/+^]B-GXIU>:6/4[AIFTRUC6.3[/N('RQ L,8'0\"N8 M^%GA[XJ?MP:&_P 2M<^)WB?X4?#_ %.>7_A&O#/@J:.SO#:H[(MQ=715F9W* MGY -N!D8!Q6=_P $_/#&J?$S]C_XN^'=;":7K/B#Q)XAT^^"G*V\\\*1R8VD M\*SGH>U>8?L>_ []G'Q7X.7P+\3M%?P[\9?#4\FFZWH^I>*-1L7G=7(2>!%N ME1T="G^K&,]L%20#Z \,^)_B-^RO\3LMAYI6,+=3QK_ *P0*7E"]3MP.M2>!_@/^R+I_P =O#N@>%K>+5/B'I?_ M !/K&*S\1ZIJ*6;6[J1)(?M#Q(P8C"2=<'@YYU/CHJM_P4._9D)4$KIOB0@D M=#]CQD?@3^= #-:_8Y^*\.DRZSH_[3GCZ7Q['%YL37S0C19IP 0K62IM2,D$ M=6P&'#8P>\_92_:0F^,7[-T7CWQ?##HNK:/]KM/$(BXABFM"1-(HR<*5 ?'; M)'.,U[[7PW^PCX0_X6#^RG\:?"WG?9O[<\5>)-,\XY_=^=$L>[CTW9H G^%G MA[XJ?MP:&_Q*USXG>)_A1\/]3GE_X1KPSX*FCL[PVJ.R+<75T59F=RI^0#;@ M9& <5T'AGQ/\1OV5_CEX-\ ^.?&EU\2?AQXYEDL-$\0:Q$B:GI>HHN];:>1< M>33=;T?4O%&HV+S MNKD)/ BW2HZ.A3_5C&>V"I/N?@?X#_LBZ?\ ';P[H'A:WBU3XAZ7_P 3ZQBL M_$>J:BEFUNZD22'[0\2,&(PDG7!X.>0"+]L;XL?$KP/^U!\#O#7PZNRU[XGM M=5LO[/NYW6P\XK&J75Q&O^L6W5GEV]3LP.M>T?"?X,>.?A;X:\5R7WQ5U;XA M^+]8ME-M=^)X@-/LKI$DVF*VB(\N)G=2Z*V2$4 C%>7_ !TC63_@H=^S&64, M5TWQ(RY'0_8\9_4U[1^T]XP\2?#_ /9[^(/B/PC 9_$FF:/<7-D%C\PHZKS( M%_B*#+X[[: /)(_V0_B9XFLO[0\7?M*^/H_$[YEV^%7@TW3('/\ +<1DR(H MX&Y@3@$X-+^RS\0/&WQ A^,GP;^(7B.:^\6^!KI=)/B[1U6TNKFTNX9#;7*K MM*QW"JC-G! .W[Q!+<)\'?V:O@!\3_@?X=\=^-O%-_X\O[RPBO\ 5?$>M>-; MZ+R[B2,-,CB.Y1(MK!EVD @)@DXKG_\ @F>?!I^//[3G_"O;:ZM?!7VG0?[* M6[DFD>2#RKS$H:9FD9)#F1"QR5=3QT !@_";]F.YUC]M+X\>&A\8_BE8/H]A MHM?6/[0W]J_"7]COQW_9'B36;G6-! M\+7/V;7[ZZW:@\L<)VS/*H7,F1DL .>U>1_#GQ=H_@3_ (*3?'+3/$.HVVC7 M/B70M#N])^W2K"MXD, BD$98C\2?M(7'P1_8;\'_$;4DE\2 M>)KOPWI$=G;3N6DU+4KFWB"!SU.79G;G)"MCG%W<<-Q8M_%'<(S9C93D<\'J"002 >3?LY_&/X@^$?C MIKOP!^+^I6OB+Q#::9_;GASQ9;PK VKZ=YACQ-&O"S*01P.=CYS@._F>D^*O MC/\ %W]KOX[_ L\,>-KKPMX7TZ\TZ[N?$#8NI]+MS;)_HEC$_R1O.S.QD.0 MHC)QDBNB^&>L)^TY^WI)\4?":O=?#;P'X=F\.1>(!&!!J>I22L9%MWS^\C5) M/O#C*@CAU)Z']E95'[9'[6[;1N.I: "V.2!92X'ZG\Z .)^-WP]^+'[&O@R? MXL>$?C)XM^(FE:'+%-KWA;QS1WEHSHDA@D"@PLI;=P.G<[=K_ $C\8?"_ MB/X^_!&VA^'OCN\^'>I:LEGJ-KKEK$7E6$[9"A"NI&Y3SAO;D$US7[?G_)FW MQ8_[ S_^AI6U\/\ XF>%OA+^RW\.O$7C'7+/P]HD/AS28GO;U]J!WMH@J^I) M/8>_I0!ZYI=K/8Z79VUS=M?W,,*1RW4BA6F<* 7(' ).3@<+_LE:?'\&_VO/C[\']&_<^#$%EXITG3T_P!78/^'=/\.:[X7U-6"M;ZA#:HT:[CT5^4.>/F M!P=HKZ _8J^'?BS4O$WQ&^.GQ TF7P_XG^(EU";+0[C(FTS2X$V6\<@(&)&7 M:2,9^12<$D#+^"/_ "DB_:1_[ N@?^DL= 'M/[,?QTM?VA/@_I/BH0?V=K$9 M>PUO2WR'T_48?EN(&4\KAOF /.UE)ZU\,_M**?VKO!/QN^,]T//^'G@;2+OP M]X&C;F*\NBZ+?:DH[@D>4C="!GAE->I_M(? 'XJ^'/BYKB?!A?LGA?XRQIIG MBV=5)70[E2!+J2 $;3);F5#CJ_).XI7H_P"UOX T7X5_\$^_'GA'P[:+9:)H MWAL6=K".NU60;F/=F.69NI9B3R: /8_V>_\ D@7PT_[%G3/_ $ECKX _X)]_ MMC>"?@I^SZ/#.NZ3XLO-0CUJ^G,NCZ#/=P;7D! $B#&>.1VK[_\ V>_^2!?# M3_L6=,_])8Z^5_\ @EIX]\,^'OV5X[/5?$6DZ9=C7M18V]Y?112 &08.UF!P M: /*259=7T">T@ 1=Q!D<8!QT'>ND\??" M_P 9^*/C-X"\5Z+\1;WP[X7T)9QJWAB&#?%JV\87>VX 8]U;&,K@G-=9#\5/ M!=Q*D47B_09)78*J)J%?&F@>$=7\16&G^)=>$ATS3 M)Y0LUUL&6V#^6>I! S0!U=?)?Q^^+'Q&^)7Q^LO@'\(=7A\)W=OIR:SXL\8/ M"L\NF6CL D-NC<>+/%]E^RO\ \% -:\7>-F.F^ _B MGHUG86OB.48M;'4;55C$$[DXC5D7=N.!\X/1790#J]6_9K^+7P?TL^)_AO\ M&KQGXY\16 %Q/X8\>WL=[I^KJO+P(1&K6S, =K G#8!(!)K$_P""3^I-K/[, M.I:@T#6S7?BO4YS QR8RS1MM)P.F<=.U>Z_&#]I_X>_!KP)/XEU3Q#8ZANC' M]GZ9IMRD]WJ.?$/CSPI\5I_$.LWFM3Z?\ $;6M.M)+Z9I3 M!;1F'RX5R>$7<<*.F3523]EGXK_$":\U'Q]^T-XKTN]FE9[?3?AXL>D6-HH) M\M1N6224="=[9.2"3UKF_P!@V]OM-^$_Q\N],M?MVI6_Q'\22VMKS^^E58BB M<>K #\:X+]E7X/\ PP_:D^#$'C[XL^*-5\=>-[Z>>;6X;_Q1>64>D2I,Z"!; M:">-845=N P_BR, @4 >K?LV^/O'O@;]HKQI\!/'WBAO'O\ 9NBP^)= \274 M*PWDEDTJQ/#(OAY!I[ MZY?KOBT6V^V-)+>>7C]ZZA J(>"\BYXR*R_V2--^&6C_ /!27QGI_P )89AX M2M/A]-;_ &IKVXO(;JY74;59I()IY':2,,/+W*VW=&^/4[7Q:^->F_ /_@IU M_P )+XAMYT\*77@.UTC5-6CB+QZ8LUZ3%/*1RL?FQQH6Z#S![4 >F>)/V0_B MOX;T676_ ?[1WCZ]\=VZF=+?Q3=0W6CWD@R?*-MY6(5;D9!?;D<<5T'PM_;. MLM>_93\2?%;Q=I1TC6?!IN]/\2:- V/+U*VVJT$9)./,9XMN2<>8 2<9/IOQ M!_:3^&?PR\ W'C'6_&FC+H:0F:&2UO8IWO,#(2!58F5CV"Y_ 9-?'WPW_9]\ M6_&#]A'XYS3Z7-I'B/XL:[J/C/2](G.QT1Y8I[:%@3A3(8."?X9%S0!W_P . M_@7\8/VC/">G_$#XC?&GQ?X"N]0;X8Y7*,T[[2I;= MR"2N3BNF^"?Q"^(/PG^/C_ WXH>(5\:PZEI$?%TENEO2,@X!' !XEKG[,]PO\ P4&T3PI_PN'XH%[CP!-J8U\Z MY#_:<0%\R?9DE^S[1!_%LVD[N<]J^Y/"_@J?X6_"R[T<>*?$/BN>TM[F5=9\ M27BW-^Y8,XW2*B AZ6\>8QF1B%!V[0!G)+J.K"OJ74_$6D^)/"/B-])U.SU1+6&XMIVLK MA)A#,(LF-RI.U@&4E3SAAZT ?-_[+/Q_N/#7_!/'0OBOX_U:^UZYT_2]0OKV M[NYC)]NK-B.-<^HK!^&?P6^,_[3'A.T^(/Q+^,/BOX='6XEOM( M\)_#^Y2PBTZV<*\/GR%&:5R,,RMR <%ADJO'_!'X5:E\;/\ @D#8^#=&&_5] M0TB^>SBW;?.FAU.:>.//;>T07GCYN>*^@?V5_P!J/P/\5_A#H1;7=/T7Q+I% MA'9ZYH.H7"6UUI]S"@24/&Y#!-RDAL8QZ$$ VOV?/ OQ9^&NH>(= \=^,[7 MXA>%(O*ET'7KI#%J_(/F0W*A=CA< K)N+')SUPOM->:?J%M%\\Z+&%7R<1J3\N3\I *E MLCK-"53_ ,%3/$K;1N'PKA ;'(!U),C]!^5>U_M-?\FV_%?_ +%+5O\ TCEH M ^;OA7X9^*_[;OA^(/B?XD^$OA'5B[>'_"O@>=+>>.W5F03W-V5+2,Y4 MG9@ #&,9P.A^!?C/XA?!K]J"]^!'CWQ9?E!Z-M7T_]B95C_9&^$(50H_X1JR. ,3*1 M1;=OW5W9!SD$;?GCXW:/\1?V%=)TKXG:5\7_ !7\0_!5MJEM:>(O#GCB>.\= M[:>0(TMO.$4QNK$84#&&&20NUM/XR7%O\5OVXK?X8?$?Q3J?AGX>V?AF/5M' MT>SU672X=>O&FVR&2:-D:0H P$:L"-A(Q\V?GS_@I%\$_P!GGX(_!B[L/"&G M3I\1+JXA:"WAU^_U!K6W69!--/%+<.D:'(C#.N2\BA>,M5CT+P[97?^I69^7GEY'R1KC//5ESQFN#MOV,_BAJ&C MQZIK'[3OQ"C\>.@DEFTV:&/1HY2 2JV(0!D# ?,N1G@;B*;^WSI^H>#]5^# MGQHMM/N-6TGX<>(6N=;M;5"\J:? "1[OIO[0WPPU;P6 MGBVU^('AQ_#;1^9_:+:G$D:C&<-N8%6QG*L P(((S0!XW\:O$'Q8^'O[!_CC M4O&.LV-K\2=)TJ8?VWX8EDC639*%CN%RJF.1DP651@$G&!P/7]YX?T^XN+F9BSRR/;1LSL3U))))]Z\I^*GB#3?VOOV,/B!!+N_GTE9F%O)<+=,JRLG0L%XSZ5A_'+_E(9^S-_V#/$G_I'7G?A M'XSZ-\:O^"HFDWWAB7^T?#6E>![S3+;5XU)MK^5+@M-)!)TDC5G$>Y<@M&^" M17HGQR_Y2&?LS?\ 8,\2?^D= 'I_QK^%WQ/^)_B;3+/PY\4&^'7@B.VW7XT6 MP5]7NKC3*11;=OW5W9!SD$;?GCXW:/\1?V%=)TKXG:5\7_%?Q#\%6VJ M6UIXB\.>.)X[QWMIY C2V\X13&ZL1A0,889)"[6T_C)<6_Q6_;BM_AA\1_%. MI^&?A[9^&8]6T?1[/59=+AUZ\:;;(9)HV1I"@# 1JP(V$C'S9^?/^"D7P3_9 MY^"/P8N[#PAITZ?$2ZN(6@MX=?O]0:UMUF0333Q2W#I&AR(PSKDO(H7G) !] MA_\ !1CXB:]\*_V5]>\2^&]5O-'U2SU#3MMU83&&78;N,.@8= RDJ?8U>^"O MPP^*7B3Q5HOQ4^(OQ&U:UGNH6NH_AUI(6'2+"*:$JD$Q^]<21APQD./WB\# M%+Q;K<3V%L[!8K:V1OE\Y\@[CR%<%2-IKZLK\Y/VD/A5 M\-?"G[==QXG^-VFW#_#KQ_H]O;Z?X@&I7=E;:=JENBQF&>2WE3:KQ1@@OE8>/\ ]GC]BSX:^$9O$?B":S@TI8C(AA\:ZI<27(SC$,<= MXS2DGC"@UH_M;? 2STC]C/PU9?!_09)-*\!ZM9>+M,T)7GEDN((Y))94'G,T MA.)Y)-K9;Y2H&<"@#3\(_LG_ !>\<:+#XB^)G[07CG1?&MVOGG2?!=W#9:5I MS')$'E>6PG"@@%CC)!Y;[Q\D\%7'Q)T[_@I7\.O"WQ.GM-9U;0_"VHQV/B:S MC$(UJR<2F*>2(#$,ID<$$_8GPG_:>^&GQE\ VOB[0?%FF)I\D(DN8 M+V[CAN+%OXH[A&;,;*"-1\++)>>%='\.:GI M%KK80B#49XQ(T[P-_'&ID1 PX)5B"00: /8?CE\4/'_Q0^/UM\!OA5KL?@Z: MSTQ=:\6>+Q;K<3V%L[!8K:V1OE\Y\@[CR%<%2-IK#\=?L^_&'X"^&+_QQ\-? MC=XQ\;ZKH\+7UYX7\>W$>HV>JQ(-TD,;!4:!BH^4J5-JO%&""^5RP/ #D M=UX__9X_8L^&OA&;Q'X@FLX-*6(R(8?&NJ7$ER,XQ#''>,TI)XPH- 'J?Q.^ M.A\?_L'^)_BIX.O+K1I[[PA<:I9S02[9[*<1-N4./XXY RY'=>*\O^"_PO\ MBY^U1\(_"/C7QE\8/%7P]L+W2K)8P%N[NZ96::68@2%0 H5@ M.I->A_'CP'X3^&G_ 3]^('AWP-8-IGA.U\)7\FGVK232%(Y4>4Y,S&3EI&. M&.1G'&,5Z?\ LPJL?[-?PF55"JOA+20%48 'V.+B@#XX;XC?M&_#?XY3?LQ6 M?B^W\2:IKL,6JZ%\1]9M$>[TS2=LOVAY8?NSRJT11"QY8$GAE"=U\5OV=?B[ M\$_ .M_$3P/^T%XW\1^)] M)-4N-'\5RQ7>F:C'$I>:)8-H$6Y =N">1@$9# M+T>OJK?\%2O"Y*@E?A;.02.A_M%QD?@3^=?0/QN_Y(OX^_[%_4/_ $FDH R_ MA?\ $N^^-OP!T+QMX<2UTO5_$&B+>6<=\K36]M=O&<+(%*LZ++P<$$@=C7CT M?[(?Q,\367]H>+OVE?'T?B=\R[?"KP:;ID#G^ 6XC)D11P-S G )P:Y#X'^, M/$GP_P#^"5.E^(_",!G\2:9X3NKFR"Q^84=99VDDC'"R;8VW M8]1R2"Q]%^ _PO\ &?PSC\7+XQ^(M[\03JVLS7^G_;(/+_LZV;[L"_,V0/08 M48X YS\G_P#!,\^#3\>?VG/^%>VUU:^"OM.@_P!E+=R32/)!Y5YB4-,S2,DA MS(A8Y*NIXZ#[8\ _%?P?\4O[8/A+Q%8>(!H]XVGW_P!AEW_9YUZHW^(X.#@T M =97QK\%O^4FW[1'_8OZ+_Z3P5]E5\1?#+Q/H_AG_@IC^T)+K&K6.DQ2Z#HJ MQO?7*0JY%M < L1DT ?;M?%_QZTN'X,_MY? [QUX?5;&7Q^UYX8\26\(VK?* ML<9MY7 ^\ZLR_,>T2#I7TCXD_:"^&/@_2YM2UGXA>&=.LHE+-)-JT S[ ;LL M?8 DU\P_#W4KS]MO]JGPS\4]/TZ\L_@U\-X;E/#]_?PO VNZE.-DD\2, ?*0 M*N">\:]V95 -/]L[_D[3]D/_ +_\ T5;5]E5\,_\ !07PC;>//VB/V5O# M][=W]C:ZAK6J0R7&EW3VUS&#':G,E>//' MT.LS6L@L9M6\4W5Y;)/M.WS(G)#(3PPZX)QS0!D_!_6;'QY_P4S^*7B#P=)% M?>&M,\&VVCZYJ-IAX)=4^T1M&F\<,ZQ(ZD@G'E,/I]!? ?X7^,_AG'XN7QC\ M1;WX@G5M9FO]/^V0>7_9ULWW8%^9L@>@PHQP!SGRW_@GKXH\.?\ "H;OP%:> M%;+P)XW\%W9TWQ3X?M5P?M8&T7>22TBS*FX.2?ND D*"?>_ /Q6\(?%)=7;P MEXBL/$"Z1>OI]]]AE#_9[A?O(W^/0]B: -W7-:L_#>BZAJ^HSK;:?86\EU*M->RUS7-@U;2K MN-V;R)G10)XY$W,KD @H1P,;OJC_ (*+>.?$/PY_99UW7/"^LWN@ZQ#J&G1Q MWVGS-%*JO=Q*X##G!4D'V-> _P#!3+]HKPQXKTOPG\-?"MW'XDU.U\2:;JNM M7FG,)[;3(5E,<<GVSW<5OX@G@N=*NWC4L(FM1& BM@J6 M^;&X'!Q@Z'_!0+QSK/ACP_\ #31(O$=]X)\'>)_%5OI/B;Q/ILWD365FP)V" M?_EB'(.9.P7T)!Y'XS?LQ?LL?#/X;ZAXHURUO+^8VFVQ9?%^J7-WJ;PK*D>K:[<- M=22R2F=T;R(HR_EJ%!+,KD\8Q[G_ ,$Y?^4=/@S_ *\M:_\ 3A>5Y_\ \$K_ M -HWPQ:_ /PY\+O$=W#X8\3:8MQ=:;%JC+;IJUE/=32+-;LQ D*R-+&RCD%, M^N #>\?:A\3OV"]>T/Q7J'Q"UKXJ?!&]OH=.UV'Q8Z3ZKHOFL$CNDN553(@. M 5( [8RVY?3?VIOC3XSL?'7@;X-?"JXM-/\ B#XS$US)KEY"L\6B:=""9;GR MSP\APP0-E24(/)%>;_\ !0+XGZ-\9/"-I^SIX%OK?Q/X^\;:A:13V^FR+.FD MVL-Q'/)<7#*2(P/*'RGG;N/IGFOV\/A7X1T']H'X2_$GXCZ3?:O\)DTY_"FN M7-K=74+:6Y=GM;F1[=TDV%Y&#$'&%/!)4$ ]+U3]D/XK^%=+EUOP5^TAX\O_ M !O AF2W\4S0WFCWD@&?*-L4Q$C\KN!8KD$9Q72_#/Q//^VU^SOI%_<>(/$W MPO\ $-IJ,EKK:^#[]+6ZM[ZV+Q36^]TD!B8L) O)P4R<@Y\\U#]F?]C#2_"1 M\47-YI:: (C*-07Q[J+1NH7<0N+T[FP1\HR3D<%/ M%J_%?XD:+'#J]Y)_PC^DZS%%I%?"O M[,MUX:UWQ#IFAZWX6US4[75K+4[R.WDM6-TSAG5V!"G>%W$8W!AU!KIOV\/^ M1R_9D_[*GI?\GH WOVL?C=XWT3Q=X(^$'PE^Q0_$GQH9IAJVH()(-%L(ES+= M,AR&;KL!# E&&"2H//ZE^QO\4=(TMM6\,_M,_$";QO&AE4Z]/%/H]Q*,D*;/ M9B-"20<%\ C@[0*R_P!J74U^ ?[7'PI^.6MQ2GP%)I=QX/US4(T9QI1E=I+> M=P,D(SN5+ 'UA:=+R+48I1.H&<1! M&)E8\85 220 * .H\!R>))?!FBOXPATZW\4FTC_M*/29'>U6XV_/Y1F M>G3)ZFYXFGDM?#>JS1.T81NN1NC< @X/T/4$@@U8\6?\BKK/_7E-_Z+:@#X"_8_TWXU_M@? M GPSK'B#XL>(/ WAC33-91W&BRAM6U^996,ES/=/DQQJ3Y*QJ,GRV)/W:]G^ M.7Q0\?\ Q0^/UM\!OA5KL?@Z:STQ=:\6>+Q;K<3V%L[!8K:V1OE\Y\@[CR%< M%2-IJU_P3'C6/]AOX8!%"@Q7S' [G4+DDUX-^TA\*OAKX4_;KN/$_P ;M-N' M^'7C_1[>WT_Q -2N[*VT[5+=%C,,\EO*FU7BC!!?*Y8'@!R #U/QU^S[\8?@ M+X8O_''PU^-WC'QOJNCPM?7GA?Q[<1ZC9ZK$@W20QL%1H&*CY2ISD8R,YK2^ M.S6/[5G[&:B/$\9"E M>K\\C'*>/_V>/V+/AKX1F\1^()K.#2EB,B&'QKJEQ),*#7N M'B?X7^'?!_[''BWP9\.-*DM- ;PEJD>D:>KSRO\ Z1;S2*H,Q:0EGE)PQR-V M,#&* /*/V&/V>I]/^#_PC\<'XJ_$:ZB;1+:[_P"$7N-8B;1AO@QY0@\@-Y:[ MLJN_@J.3BNO^,'CGQ#H_[<7[/WAFQUF]M/#^L:?KTFHZ;%,RP7;16NZ(R)T8 MJW(ST--_83^,'@O6/V3?A5;P^)])CO+?3;71I;2:]B29+Q?W0A*%MP=F7Y5Q ME@5(!R*Q?CE_RD,_9F_[!GB3_P!(Z ,;]L3XK?$SP7^U#\#?#/PXO,WOB:UU M6S_L^\G9;#S2L86ZGC7_ %@@4O*%ZG;@=:U=:_8Y^*\.DRZSH_[3GCZ7Q['% MYL37S0C19IP 0K62IM2,D$=6P&'#8P7_ !T56_X*'?LR$J"5TWQ(02.A^QXR M/P)_.OK:@#P3]DW]HR?XS?LY0>.O%T,&BZOI)N[/Q (^(8I[4D32 9.%*@/C MMDCG&3XQ\*-(^+/[5/#/AWP7-'9ZC/;*[Q_:;FY M*LP9B.%&1QD!1@LW]A'PB?B!^RG\:/"XG^RG6_%7B33?/Y_=^=&D>[CGC=G\ M*Z/]@3XZ:!8_"?3?A!XLNK?PE\3/ :MHVI:#JDJ02R+&S>7/!N(\U&3:2RYP M>>C*S &3J?BWXE_L3?%;P78>+O'%]\3O@SXRU2+0X]4\0>6=6T/4)=QCWRJ% M\Z)MI))' 5L!<#S%_;4^+_Q0^'_[27P5\/\ PRD:\U3Q)9:M9Q:1=7#)827! M6)8[FX4??6 ,\N/]DU4_;(\7:=^TUXZ^'?P,^'MW%XDUB#Q'9^(?$E]IQ6>V MT;3X"X8RR@[5E8N-J [CC!QO7.9^W)\23\'_ -LK]G#QD^E7FL66DVFN2WT& MGP&::.T:!8YYE00X[(: /0KC]C?XF7&CG5&_:<^(B^/ROF?:$E@71? M.P#C^SQ&!LW#INZ=NU=7^Q_\>/%'Q0T_QAX+^(MG:V/Q1\ WZ:9KAL1BWNUD M4M;W<8["558XX'RY 4,%7T;_ (:$^&0\"_\ "9GQ[X?_ .$7\GS_ .T_[1B\ MK;C..N=_;9C=GC&>*^:_V0]0UGXB>,/VB/VA=)T6ZBTOQE);0>%;.[0QR7\. MGVKPI,4ZXE8(!WR'% '8R?LL_%?X@37FH^/OVAO%>EWLTK/;Z;\/%CTBQM%! M/EJ-RR22CH3O;)R02>M5/V;?'WCWP-^T5XT^ GC[Q0WCW^S=%A\2Z!XDNH5A MO)+)I5B>&X"C#LLC@!NI )/4*OE/[*OP?^&'[4GP8@\??%GQ1JOCKQO?3SS: MW#?^*+RRCTB5)G00+;03QK"BKMP&'\61@$"L7]DC3?AEH_\ P4E\9Z?\)89A MX2M/A]-;_:FO;B\ANKE=1M5FD@FGD=I(PP\OT%K=/_:WB:[6ZOI=P=L/(J("%S@?+P *^<_BCXITOX>?\%,_A MYJWB.]@T;2M:^']UH]G?WLBPP/=+>/,8S(Q"@[=H SDEU'5A7U+J?B+2?$GA M'Q&^DZG9ZHEK#<6T[65PDPAF$63&Y4G:P#*2IYPP]: /SX_8(^&GQ.^/G[+? MA"SD^(>L?"WX>:*;NRL8O"#I%J>KR&ZDDEN)+E@WE(K.\2QJN249B?NUZUH^ MJ_$C]D7]HCX>>"O$7Q U3XH?#/X@RS:=9W?B/:^IZ5J$:!E!F&#*DF0,'ID\ M KE^R_X)DJL?[#?PP"J%'DWQP!CDZA>(_@K^V]X:M=9UN^O/AK\3M..FV-M=3,UOI>M6X!58P3A!,F %&-SO_ +-> MF?M3?&J/]G_X%>*?&2*)M5M[?[-I5KC<;B^E/EVZ!?XOG8,0.=JL>U8O[9WP M7N_C=\!=:T[16>#QAH[QZ]X9GM7SC\//B]%_P M4%^,WP?6WAQX3\!Z7%XP\46P4^4-?;=#;6I!_P">3I+*N?O*30![/IG[/_Q8 MU#X,_"'26^,&MZ#XLT.\@U3Q/J$N;N75"V7FM68N,HI8QJ#E2%!*FOIFN3\> M_%?P?\+O[&'BWQ%8: =8O%T^P^VR[/M$[=$7_'H,C)YKK* /-/VFO^3;?BO_ M -BEJW_I'+7RC^QU^W7\"?AO^S%\.O#/B3XAV6EZ[IFEK!=V_TOP!XPMO$E_8P"YN88+>>,QQE@H8F1%'4 M@<5X7XV_Y2M_#O\ [)S<_P#I3V.BZ?IDC/9V%M:.PPS00JA(]#@5\#?M M0?!W2OCI_P %(O 'A;6=3UG2+*3P!+<&YT*]-I1CF@#] KB MXBL[>6>>5(((E+R22,%5% R22> .]?&W["MU;>+/CM^T[XU\-8D\ :UXCLX MM+NH4Q!=W,,4HO)HFP RL[HVX9SN!SZ[%E_P3)^$AS%K>J^./%EBS!GL=:\3 M3O ^.Q6/9D?C7TYX0\':%\/_ W8^'_#6D6>A:)8IY=M86$*Q0Q#))PJC&22 M23U)))R30!\G?L#?\E<_:L_[*-=_^AR5[M\!_A?XS^&A7S(G((61<[E)!P0#@U^=WPF_9CN=8_;2^/'AH?&/XI M6#Z/8:'(VMV>NPIJ-_YMMNVW,IMR'5/NH JX'K7Z15\E? W_ )2&?M,_]@SP MW_Z1T 2_M.:QXB^$#?LT>'M%\7:]-'=>/M+T;4K^\O-UUJEL58.MTZA1)OP" MW !/:JW_ 4,^+WC'X-Z9\(-4\%O=SZC=>-+:T?2;>Z-NFJ!HI-MK*PZH[[ M0:D_;P_Y'+]F3_LJ>E_R>F_MZ1K+XP_9D5U#+_PM32C@CTWD?K0!U/A/X??$ M+X)Z+XS^*'COXF:U\1M?AT"\NG\,V\:VVC02(HG"6L"Y;(\KRU=CN(8DC)-> M1?L]_"WQC^UA\*M(^*.O?M'>.K+5]:#7']E^"+^&PT[2W!9?LS0B-]Y0'!W$ M$G!.3AC]J>+O%FC^!/"^J^(O$%]%IFB:7;27=Y>39*Q1(I+,0 2>!T )/0 F MODR;]FW]EKXI27'CCP/XIM?!U]=C[1-KG@'Q2=-*YYW-&K^7&03DCRU.3SS0 M!ZM8_L]^,M6^%O\ PB'BWXV^,+R_@U0W=KXG\.BWTG4?LH0JEM,PCD60 LS, MV 6(4\8Y^7_^"%/%J_%?XD:+'#J]Y)_PC^DZS%%I%_"GB%M+\/^,KG#RZC! MM+.KRCB8H=G[SG._J1MQRW_!-+XF>%?"O[,MUX:UWQ#IFAZWX6US4[75K+4[ MR.WDM6-TSAG5V!"G>%W$8W!AU!H ^VZ^1?\ @HA\8/&'P8TGX1:MX,>\N-1N M?&=O:OI%K<&%=5#0R[+60CJCN$!!KZZKXC_X*?:]?^%=/^ VMZ7I4^N:CIGQ M%L+ZWTRU3?+=R1)(ZQ(O=F*[1CG)% '4Z;^R5\5?&NCKK?CO]HCQUI'C>Y3S M39^#KF*RT:P/K;XH>+O@;\7KFUU;QSX M!8O%VD^,= M(31C%YMP][>1V\ED?XDN$=@8G4Y!#8Z>G-?.W[/_ (BA_:6_;@\9?&;PW%-) M\/?#?A=?!6G:NR%(]5NOM7VB62+/WD3++GON0]Z /1/%O[.OQ3^*7C+7+SQ+ M\=->\*^%VN'32=#^'T2:;)%;9^5IKF19'>4C&.-+O+S0]2UQ$&I6%U:H9)8I)5'[U#&N03SEA@#!W<%\ M _ _A3]K3Q-\4M2^-OB#5M5\7:7XEO=+7P9)XANM-M]'LH6!B\NW@EC)! 8F M1LAMI/4$GB]'\)_!WP+_ ,%+O@AH'PCMY"EC!K::S=QZI=:C;&Y.F3E8$FGE MD'F1H075",>:@// .H_:N^ ,\W[8'P&3_A:'Q"C_P"$LUG7)49-7B!T/;;I M)LT[]S^Y4[MA#;_E51VS7VA\'_A3+\)-#O=.E\;^+?'1N;C[0+SQAJ"7EQ#\ MJKY:,D<8"?+G&#R3S7SM^VMK]CX%_:1_97\6ZY<)IWARQU_4[*[U*X8)!;R7 M-M''%YCGY5!(8DDC 5CT!KZPT7Q;H?B2XN;?2=9T_5)[5(Y)XK*ZCF:)9 3& MSA22H8*Q4GK@XZ4 ?-_[%OQ3U36/AS\9M>\9^(+O4;70/'VO0+=:A,TGV2QM MUB81J3T1%W$ =.:XCX6>'OBI^W!H;_$K7/B=XG^%'P_U.>7_ (1KPSX*FCL[ MPVJ.R+<75T59F=RI^0#;@9& <5)^QCX0_P"%@_ 7]I#PMYWV;^W/'OBG3/.. M?W?G11Q[N/3=FO&_V/?@=^SCXK\'+X%^)VBOX=^,OAJ>33=;T?4O%&HV+SNK MD)/ BW2HZ.A3_5C&>V"I(!] >&?$_P 1OV5_CEX-\ ^.?&EU\2?AQXYEDL-$ M\0:Q$B:GI>HHN];:>1<>^ M)K75;/\ L^\G9;#S2L86ZGC7_6"!2\H7J=N!UJ3P/\!_V1=/^.WAW0/"UO%J MGQ#TO_B?6,5GXCU344LVMW4B20_:'B1@Q&$DZX/!SSJ?'15;_@H=^S(2H)73 M?$A!(Z'['C(_ G\Z &:U^QS\5X=)EUG1_P!ISQ]+X]CB\V)KYH1HLTX (5K) M4VI&2".K8##AL8/3_L\_$35?VQOV5XYM:U/5O WBB2>32=7O_"URMM=6UW;3 M+O:!V5P@<*N00<"1E'8U])5\?_\ !,7_ )(UX^_[*!K/\XJ /'?V0_V8[GQE MXH^/,"?&/XI>'SH_Q!U#3FET7788'OR@7_2+DM;MOG;/S,-H.!P*_1VUA^RV MT4/F23>6@3S)3EVP,9)[DU\8_L:^._#_ (+^,W[3_A77]8LM$UQ?'UYK:VNH MW"0-)9S*&25 Y!90J;B1P RD_>%?9>GZA:ZOI]M?6-S#>V-U$L\%S;R"2.6- M@&5T8'#*0001P0: /F[_ (*+>.?$/PY_99UW7/"^LWN@ZQ#J&G1QWVGS-%*J MO=Q*X##G!4D'V-)_P49^(FO?"O\ 96U_Q+X;U2\T?5;._P!.VW-A.89=ANXP MZ!AR RDJ?8UB?\%2O^3.?$7_ &$]+_\ 2V*D_P""IBK)^QOXD5E#*VI:6"K# M((^VQ<4 +IW[.7Q9^-FEP>+?'?QM\8> ]6U-$O+?POX%N([*RTA&"E;=V*LU MRZC(9V(!8G' &;W[*'Q/\?:;\6/B)\#OB;K,?BS7O",5MJ&E^)T@6&34M/G MVF9!P)$)4$]R3DG&YOJ>OC_P)_RE&^)G_9/['_T?%0!]@4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110!\U?%_\ X)__ N^-WQ%U;QKXBDUQ=9U/R?/ M%G>I'%^[A2)=JF,X^6->_7-?1NG6,>EZ?:V<.[R;>)84W')VJ !D^N!5BBM) M5)S24G=(B,(Q;:6YS7Q&^'/A[XL>#]1\+^*=-BU71KY-DL,@Y4_PNC=5=3R& M'(->!?#O_@G=\-?A3XOT_P 3>%M8\6:3K%C('CFAU-,,/XD<>5AD8<%3P0:^ MHJ*<:LX)QB]&*5.,G=K4****R-#P7XR?L/\ PB^.&H3:GK?AS^SM;F.Z75-& MD^RSR$]6< %';_:92?>O'Q_P21^#HDW?V_XU(S]W[?:8_P#26OMJBNB.(JQ5 ME)F,J-.3NXGB/P7_ &,_A/\ F[CU#PYX:2XUJ/[NK:HYN;E/="WRQGW15/- M>W445E*"=;\+:L9AIFL6DEE4I3=Y.YK&*BK)!69XH\/VOB[PUJVA7QD%C MJ=I-93^2VU_+D0HVT]CAC@UIT5.Q1\Z?!7]@_P"&GP%\>VWB_P ,R:VVK6\4 MD*"^O%DBVR*5;*B,=CZU]%T45I.I*H[S=V1&,8*T58\A_:"_9@\)_M+6NCVG MB^\UB.STMY)8;73;M88VD< %W!1MS # /8,WJ:UO@1\ ?"7[.G@^?PYX0@N$ ML[BZ:\GFO)1+-+(RJN68 QYR#V(!K8HJ$[:HL^;O@[^P/\-_@7X^ ML/%_A6]\10:K:+(@6>_1X94=2K)(HC&Y>#?'[]B_X>_M(^*K'Q!XN?6%O[.R6PB&GW:Q)Y8D=QD%&YS(W/TKU7X<^ M=,^%W@;1?">C&Q))XZFOK2BG"K.G=0=A2IQG\2(K6% MK>VBB::2X:- IFEQO<@8W' R>O ]JEHHK(T"BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "L;Q=X-T'Q]H%UH?B71K#7]'N@!-8:E;I/# M)@Y&48$9!Y!['D5LT4 >0?#W]D/X,_"OQ FN^%OAQH.E:S&VZ*^6V\V6!O6- MG+&,^ZXZGUKO? _P\\-_#72[G3?"^D6^BV-S=RWTT%J"%>>0YDD.3U8]:Z*B M@#S?XJ_LX?##XWR12^.? ^C^([J)/+CO+JW N43GY1,N'"\DXW8SSUK4^&GP M7\!_!NQN+3P/X1TCPM#<;3/_ &9:)$\^W[OF.!N?&3C<3C)KM** /$?V@OC9 MXE^$.K:/M^$NN?$+P%>P2)K&H>'56\N[)R0%!LL;I8RNXLV0!^&#XG9?M<_" MOP['='X1? [Q%J'Q FC:W@TS3?!!TYTE/"I2I8Y. :^VJ* /"?V*? M@IK7P)^ >E:)XHDCD\6:A=7&M:R(B&6.ZN'WO'N!(8H-JD@D$J<'&*Z[XJ_L MX?##XWR12^.? ^C^([J)/+CO+JW N43GY1,N'"\DXW8SSUKTBB@#B_AI\%_ M?P;L;BT\#^$=(\+0W&TS_P!F6B1//M^[YC@;GQDXW$XR:TM6^'GAO7/&6A>+ M+_2+>Z\1Z''/%INI2 ^;:K,NV4(<_P 2\&NBHH *YOP)\./#/PQTR\T[PMHU MMHEE>7DNH3PVH(62XDQYDAR>K8&?I7244 >;_%7]G#X8?&^2*7QSX'T?Q'=1 M)Y<=Y=6X%RB<_*)EPX7DG&[&>>M:GPT^"_@/X-V-Q:>!_".D>%H;C:9_[,M$ MB>?;]WS' W/C)QN)QDUVE% '.ZM\//#>N>,M"\67^D6]UXCT..>+3=2D!\VU M69=LH0Y_B7@UT+*&4@C(/!!I:* /$[C]B?X#W7B637IOA/X7EU&1S*^_3T,+ M,2"283^[)R/[O<^IKT?PY\-O"_A#Q)X@\0:+HEIINLZ^+<:G=VZ;6NA;H8X MW;"(2HP!P:Z6B@#SSXK?L]_#?XY?8CX\\&Z5XFELLBWGO(?WL0)R5612&"D\ ME7;V&GP)!!"N-$TJSCN M8A+<+YC#F.!7 "Y8YP >E?0%% %;3=/MM'TZUL+.);>TM8E@AB0<(B@*JCV M %6:** / 9/V!_V>YI&=_A1H#.Q+$F-^2?\ @5=5X!_97^$'POU.+4O"WPX\ M.:/J<7^KOH;!&N(^<_+(P++^!KU2B@ KF]+^''AG1/&VM^,+'1K:V\3:W%## MJ.IQ@^;B@ "NDHH *Q_&'@_1O'WAG4?#WB'3H=6T74(O)NK*X!, MC:/9>'M'L=*TZW2TT^Q@CMK:WC^[%$BA40>P _"O#9/ MV!_V>YI&=_A1H#.Q+$F-^2?^!5[]10!X/I_["?P!TG4+:^L_A9H-O=VTJS0S M)&^4=2"K#YNH(!KT[7OA9X1\4>,] \6ZOX>L-0\2Z")!IFISQ!IK7>,-L/\ MG&3C%=510 5C>+O!N@^/M NM#\2Z-8:_H]T )K#4K=)X9,'(RC C(/(/8\BM MFB@#R#X>_LA_!GX5^($UWPM\.-!TK68VW17RVWFRP-ZQLY8QGW7'4^M=[X'^ M'GAOX:Z7K'K7144 <[X*^'GAOXE>QT4 %_%5MXCT;PQIN MDZS;:2N@P7-C (?)L%D$BVR(N%6,. P ':I;[X5^$-4\4:EXBOO#NGWNLZGI MG]C7MS=0B7[39;BWD.K95DW$G!'>NKHH \2T+]B;X$>&O$B:[IWPK\-P:G') MYL%/A;H?]C>#_ YI?AG2]YE- MII5JENC.0 78*!N8@#DY/ KI** .-^*'P;\$?&K0XM(\<^&-.\3:?"_FQ1W\ M(8POT+(WWD)'!*D9%.^'OP@\%_"?PK+X;\'^&=.\.Z),SO+9V,(196889G/5 MF( &6). !T KL** ,'P+X$T#X9^%;#PUX6TJWT30; ,MM86H(CB#.SMC)[LS M'\:X/XE?LF_![XP:V=9\8?#S0]:U=MN^_DM_+GEQC'F2(59\;0/F)XXZ'%>M M44 .],\:76C6T_BG3;62RL]48'SH87SO13 MG&#D_G7244 <5\4/@MX$^-6EV^G^.?"FE^*+6W(#K5Q\)_#+7S/YC!;,) S9! M),*D1GD#JO<^IS[I10!!8V-MIEE;V=G;Q6EI;QK##;P($CC11A551P !P M *\C\M32>;->-;>6\[X(W2["!(<'^+/0>@KV. MB@#CM*^#O@C0?$>D:]IGA?3--U71]..D:?/9P"$6MF6W&"-5PJIN). *OZM\ M//#>N>,M"\67^D6]UXCT..>+3=2D!\VU69=LH0Y_B7@UT5% '%?%#X+>!/C5 MI=OI_CGPII?BBUMW,D"ZA;AVA8XR4?[R9P,[2,XYKE]-_9%^#.C^"M3\)6/P MV\/VN@:IY0O[6*T :[\IP\8ED^^^UP&&YC@_6O7:* .=\??#SPW\4O#4WA[Q M7I%OKFBS21RR65T"8V9&#H3@CHP!_"NBHHH *R?%/A/1/'&AW6B^(M(L==T> MZ&V>PU*W2>"0 Y&Y'!!P>>E:U% 'C/@O]C3X(?#W7X];T#X8^';+5895GANF MM!,\$B@;6C\PMY9& Z_'K>@?#'P[9:K#*L\-TUH)G@D4#:T?F%O+(P#E< M<\]:]FHH R_%'A?2O&OAW4M!URQBU/1]2@>VN[.<$I-$PPR-[$5-H6AV'AG0 M]/T?2[6.RTS3[>.TM;6(?)##&H1$'L% 'X5>HH YV;X>>&[CQ]!XVDTBW?Q7 M!IYTN+52#YRVIV2?SKRZX_ M8G^ ]UXEDUZ;X3^%Y=1D3 E[.1PH=DYZD*O MY5TU%% '+VWPQ\*V7Q"N_'5OH=K;^+KRS6PN=6B!2:>!2"J28.' VKC()&T> M@IO@/X6>$?A>NKKX3\/6&@+JUZ^H7WV&()]HN'^](WO[=!VKJJ* "O-/BI^S M5\+?C==0W7CGP-HWB*]A3RTO;FW"W 09PGFKA]O)^7..:]+HH \QLOV8_A3I MO@M?"-EX!T.R\."[BOVL+:T6-)+B,YCE M\5Z1;ZYHLTDN&1@0><'ZBO-O /[(OP9^%^MC6?#'PV\/Z5JRDF.^6T$DT. M5VDQN^3'D$CY,=3ZFO7J* .;\%?#CPS\.?!=KX1\-:-;:/X:M5E2'3;8$1(L MCL\@ )_B9W)_WC7'ZW^RQ\(_$G@?2/!^J?#[0[_PYHZNNG6<]J&^QAF+N(G^ M^FYCD[6&>]>J44 >?_"OX _#GX(PW">!/!FD>&6N0%GGLK<":51C"O*UNHEDBE0C!5E8$,".H-6J* /#M._8> M^ >E:\=8MOA-X76]+!@)+%9(5(8L"L+9C7D]E'8= *]O15C5550JJ,!5& !Z M4ZB@#R+Q=^R/\&?'GC1O%GB#X;^']5\0.XDEO+BT!,S@\-*H^60\#EP2:[GQ M5\.?#7CB?0)M=T:UU.30;^/4]+:93_HEU'G9*F#PPR<5TE% %75-+LM,+Q@>@Q[E10 5'<6\=W;RP3()(95*.C=&4C!'Y5)10 M!@^!? F@?#/PK8>&O"VE6^B:#8!EMK"U!$<09V=L9/=F8_C5CQ3X3T3QQH=U MHOB+2+'7='NAMGL-2MTG@D .1N1P0<'GI6M10!XSX+_8T^"'P]U^/6] ^&/A MVRU6&59X;IK03/!(H&UH_,+>61@'*XYYZU[-110!Y#9_LB?!C3_'J^-+;X:^ M'H?$R7 NTODLP-DX.1*J?<#Y^;<%SGG.>:[S5OAYX;USQEH7BR_TBWNO$>AQ MSQ:;J4@/FVJS+ME"'/\ $O!KHJ* .=U;X>>&]<\9:%XLO](M[KQ'H<<\6FZE M(#YMJLR[90AS_$O!KHJ** .;\"?#CPS\,=,O-.\+:-;:)97EY+J$\-J"%DN) M,>9(7'>75N!!_"FE>%[2=@\ZZ;;+&TS#.#(P^9R,D#<3@ M<"O!_C9H]]>?M]?LX7T5C<3Z?;:;XB6XN4A9HHBUIA0[8PN3P,]:^JJ* /#9 MOV'?@'<>(CKDGPG\,F_+^81]B @+9SDP#]WU_P!FO;;6UAL;6&VMH8[>VA18 MXH8E"HB@8"J!P , "I:* /'/%W['?P3\>>*Y?$NO_#+P]J6MS2>;/=26@!G M?G+2*N%D)SR6!SQGI79Z%\(?!7A?Q5;>(]&\,:;I.LVVDKH,%S8P"'R;!9!( MMLB+A5C#@, !VKL** .-^*'P;\$?&K0XM(\<^&-.\3:?"_FQ1W\(8POT+(WW MD)'!*D9%.^'OP@\%_"?PK+X;\'^&=.\.Z),SO+9V,(196889G/5F( &6). ! MT KL** ,'P+X$T#X9^%;#PUX6TJWT30; ,MM86H(CB#.SMC)[LS'\:A\5_#C MPSXYU/P_J.O:-;:I>Z!>#4-+FG!+6EP.DB8/7BNDHH ^:/B-^W5X>^'>O>)/ M#4_@'Q]>>+=/G>WTW2[?P],Z:RV,1R6\R@J8F; W'!Z_*>E7?V'?@/J/P7^% M>H:CXGL;6Q\>>,]4G\1Z_!:HJI;33,62V7;P%C4XVC@,SXXYKZ*HH \"_:H^ M"-U\=((8R$!XR3@#(]]H MHH HZ[H=AXFT/4-'U2UCO=,U"WDM+JUE'R30R*4=#[%21^-5?!_@_1O /AG3 MO#WA[3H=)T73XO)M;*W!$<* D[1GMR:V** "N9NOAIX7OOB#9>.9]%M9?%UG M9-IUOJS ^=';,S,8@T6UTF\ M\07K:CJDUN"&N[EB2TKY/WCD_G4?@/X6>$?A>NKKX3\/6&@+JUZ^H7WV&()] MHN'^](WO[=!VKJJ* "N=TGX>>&]#\9:[XLL-(M[7Q'KD<$6I:E&#YMTL*[8@ MYS_"O KHJ* .=\6_#SPWX\NM"N/$&D6^JSZ%J$>J::]P"3:W29V2I@_>&31X MM^'GAOQY=:%<>(-(M]5GT+4(]4TU[@$FUNDSLE3!^\,FNBHH 9-#'<0R12QK M+%(I5XW *LI&""#U%>':U^PS\ ?$&IF_O/A/X:^TLQ9C;VGD(Q)))*1E5/4] M1_*O=** ,KPOX5T7P3H=KHOA[2;'0](M5V06&G6Z001#KA44 #GVKS?Q=^R/ M\&?'GC1O%GB#X;^']5\0.XDEO+BT!,S@\-*H^60\#EP2:]=HH :BK&JJJA54 M8"J, #TKY7_;AT>_U3QA^S:]E97%XEK\3M,GN&MXF<0Q@/EWP/E4>IXKZJHH M \7\8?L8_ _Q]XHG\1:]\,O#]_K-Q(9I[K[-Y9GD)RSR*A"NQ))+,"2>M>L: M#X?TOPKH]II.BZ;::1I5HGEV]C8P+#!"O]U$4!5'L!6A10!Y3\2OV5?A%\8- M>76_&/P^T37=8 53?SV^V:0+C:'=2"X& &SQQTK:T?X#?#OP[J/A:^TCP9H M^DW/A87(T5M/M%@6Q^T)LN#&J84&1>&)&3UZUWE% '/>//A[X9^*'AJY\/>+ M="L?$6BW!!DLM0A66,L.C 'HP[,,$=C6'\*/@/\ #WX&V=[;> _"6F>&([UE M:Y:RBQ)/MSMWN268#)P"<#)QU-=[10!SO@KX>>&_AS:ZG;^&M(M]'@U/4)M4 MO$M@0)KJ7'F2MD_>;:,_2N9^*O[.'PP^-\D4OCGP/H_B.ZB3RX[RZMP+E$Y^ M43+APO).-V,\]:](HH XOX:?!?P'\&[&XM/ _A'2/"T-QM,_]F6B1//M^[YC M@;GQDXW$XR:TM6^'GAO7/&6A>++_ $BWNO$>AQSQ:;J4@/FVJS+ME"'/\2\& MNBHH *YOP)\./#/PQTR\T[PMHUMHEE>7DNH3PVH(62XDQYDAR>K8&?I7244 M>6_$W]ESX3?&77H-:\:> M&\0:O"@C6^N8,2LHZ*[*07 [!L@=J]&T?1[#P_ MI-GIFEV5OIVFV<2P6UG:Q+'%#&HPJ(B@!5 X&*N44 <[X^^'GAOXI>&IO M#WBO2+?7-%FDCEDLKH$QLR,'0G!'1@#^%'C[X>>&_BEX:F\/>*](M]G:NDHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__ !V0$! end EX-101.PRE 9 kod-20210930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 10 kod-20210930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Condensed Consolidated Balance Sheets (unaudited) link:presentationLink link:calculationLink link:definitionLink 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (unaudited) link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Condensed Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100060 - Disclosure - The Company link:presentationLink link:calculationLink link:definitionLink 100070 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 100080 - Disclosure - Accrued and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 100090 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 100100 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 100110 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 100120 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 100130 - Disclosure - Net Loss per Common Share link:presentationLink link:calculationLink link:definitionLink 100140 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 100150 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 100160 - Disclosure - Accrued and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 100170 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 100180 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 100190 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 100200 - Disclosure - Net Loss per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 100210 - Disclosure - The Company - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100220 - Disclosure - Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 100230 - Disclosure - Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 100240 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 100250 - Disclosure - Marketable Securities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100260 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100270 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100280 - Disclosure - Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details) link:presentationLink link:calculationLink link:definitionLink 100290 - Disclosure - Stock-Based Compensation - Summary of Restricted Shares (Details) link:presentationLink link:calculationLink link:definitionLink 100300 - Disclosure - Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 100310 - Disclosure - Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 100320 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 11 kod-20210930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 kod-20210930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Unvested, beginning balance Unvested, ending balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Accrued Leasehold Improvements Accrued Leasehold Improvements Common stock, $0.0001 par value Preferred stock, $0.0001 par value Other Assets [Member] Balance Sheet Location [Domain] Balance Sheet Location [Axis] Manufacturing Agreement Expense Manufacturing Agreement Expense Plan description Long-Term Performance Incentive Plan Description Long-Term Performance Incentive Plan Description Sales Sales Forecasting Sales Forecasting Stock Price Sale of Stock, Price Per Share Consecutive Trading days Consecutive Trading Days Consecutive Trading Days Performance Periods Share Based Compensation Arrangement By Share Based Payment Award Options performance period Share Based Compensation Arrangement By Share Based Payment Award Options performance period 2021 LTPIP Two Thousand Twenty One Long-Term Performance Incentive Plan [Member] Two Thousand Twenty One Long-Term Performance Incentive Plan [Member] Increase (Decrease) in Accounts Payable, Total Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Other Liabilities, Noncurrent, Total Interest Expense, Total Operating Lease, Liability, Total Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Payments to Acquire Property, Plant, and Equipment, Total Debt Securities, Available-for-sale, Current, Total APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Earnings Per Share, Basic and Diluted, Total Payments to Acquire Marketable Securities, Total Employee-related Liabilities, Current, Total Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total Debt Securities, Available-for-sale, Allowance for Credit Loss, Ending Balance Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance Debt Securities, Available-for-sale, Allowance for Credit Loss, Total Income Statement Location [Axis] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Stock based compensation expense related to ESPP Stock Issued During Period Value Employee Stock Purchase Plan Common stock purchase price percentage Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent Common stock, shares reserved for issuance Common Stock Capital Shares Reserved For Future Issuance Number of purchase periods Number Of Purchase Periods Number of purchase periods. Term of offering period Term Of Offering Period Term of offering period. Total stock-based compensation Stock-based compensation expense recognized Allocated Share Based Compensation Expense Awards vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Vesting period for achievement of specific milestone Share Based Compensation Arrangement By Share Based Payment Award Vesting Period For Achievement Of Specific Milestone Share based compensation arrangement by share based payment award vesting period for achievement of specific milestone. Unvested Restricted Shares Restricted Shares Performance expiration date Share Based Compensation Arrangement By Share Based Payment Award Options Performance Period Expiration Share based compensation arrangement by share based payment award options performance period expiration. Canceled Granted Unvested, beginning balance Unvested, ending balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Canceled Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Restricted Stock [Member] Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract] Earnings Per Share [Abstract] Stock-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Marketable Securities Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block] Investments Debt And Equity Securities [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Disclosures [Abstract] Accrued and Other Current Liabilities Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block] Accounts Payable And Accrued Liabilities Current [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Accounting Policies [Abstract] Organization Consolidation And Presentation Of Financial Statements [Abstract] The Company The Company [Text Block] The entire disclosure for the company. Purchase of property and equipment under accounts payable and accruals Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 Operating lease right-of-use asset obtained in exchange for operating lease liability Right Of Use Asset Obtained In Exchange For Operating Lease Liability Supplemental disclosures of non-cash investing and financing information: Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract] Cash, cash equivalents and restricted cash, at beginning of period Cash, cash equivalents and restricted cash, at end of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations Net increase (decrease) in cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Principal payments of capital lease Repayments Of Debt And Capital Lease Obligations Proceeds from issuance of common stock upon options exercise Proceeds From Stock Options Exercised Cash flows from financing activities Net Cash Provided By Used In Financing Activities [Abstract] Net cash provided by (used in) investing activities Net Cash Provided By Used In Investing Activities Maturities of marketable securities Proceeds From Sale And Maturity Of Marketable Securities Purchase of marketable securities Payments To Acquire Marketable Securities Purchase of property and equipment Payments To Acquire Property Plant And Equipment Cash flows from investing activities Net Cash Provided By Used In Investing Activities [Abstract] Net cash used in operating activities Accounts Payable, Current, Total General and Administrative Expense, Total Preferred Stock, Shares Issued, Total Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total Other Nonoperating Income (Expense), Total Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Common Stock, Shares, Issued, Total Research and Development Expense, Total Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Total Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Increase (Decrease) in Prepaid Expense and Other Assets, Total Depreciation, Total Property, Plant and Equipment, Net, Ending Balance Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Increase (Decrease) in Other Operating Assets, Total Proceeds from Sale and Maturity of Marketable Securities, Total Subsequent Event [Line Items] Subsequent Event [Line Items] Subsequent Event Subsequent Event [Member] Subsequent Event Type Subsequent Event Type [Domain] Subsequent Event Type Subsequent Event Type [Axis] Subsequent Event [Table] Subsequent Event [Table] Anti-dilutive securities excluded from the computation of diluted net loss per common share Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Outstanding Stock Options Employee Stock Option [Member] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Unrecognized compensation weighted-average period expected for recognition Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Unrecognized compensation cost related to unvested share based awards Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] General and Administrative General And Administrative Expense [Member] Research and Development Research And Development Expense [Member] Income Statement Location Income Statement Location [Domain] Income Statement Location Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Total Loss from operations Debt Securities, Available-for-sale, Total Additional Paid in Capital, Common Stock, Ending Balance Additional Paid in Capital, Common Stock, Beginning Balance Operating lease liability, net of current portion Operating Lease Liability Noncurrent Share-based compensation arrangement by share-based payment award, options, aggregate intrinsic value. Weighted Average Remaining Contractual Term (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Weighted Average Remaining Contractual Term (in years) Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract] Share-based compensation arrangement by share-based payment award, options, weighted average remaining contractual term. Forfeited or canceled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price Exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Granted Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Beginning balance Ending balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward Forfeited or canceled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Stock options, granted Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Beginning balance Ending balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Number of Options Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward 2018 Plan and 2015 Equity Incentive Plan Two Thousand Eighteen And Two Thousand Fifteen Equity Incentive Plan [Member] Two thousand eighteen and two thousand fifteen equity incentive plan. Number of common stock available for issuance increased Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] 2018 Employee Share Purchase Plan Two Thousand Eighteen Employee Share Purchase Plan [Member] Two thousand eighteen employee share purchase plan. Performance Based Equity Awards Performance Based Equity Awards [Member] Performance based equity awards. Performance-based Stock Options Performance Based Stock Options [Member] Performance-based stock options. Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Award Type Award Type [Axis] 2018 Equity Incentive Plan Two Thousand Eighteen Equity Incentive Plan [Member] Two thousand eighteen equity incentive plan. Plan Name Plan Name [Domain] Plan Name Plan Name [Axis] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Lease liabilities Operating Lease Liability Annual suite fees payment for 2021 Contractual Obligation Due In Next Twelve Months Lease Agreement Lease Agreements [Member] Finite-Lived Intangible Assets, Major Class Name Finite Lived Intangible Assets Major Class Name [Domain] Finite-Lived Intangible Assets by Major Class Finite Lived Intangible Assets By Major Class [Axis] Lonza Lonza [Member] Lonza. Counterparty Name Repurchase Agreement Counterparty Name [Domain] Counterparty Name Counterparty Name [Axis] Manufacturing Agreement Manufacturing Agreement [Member] Manufacturing agreement. Collaborative Arrangement and Arrangement Other than Collaborative Entity Current Reporting Status Entity Current Reporting Status Entity Registrant Name Entity Registrant Name Trading Symbol Trading Symbol Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Period End Date Document Period End Date Amendment Flag Amendment Flag Document Type Document Type Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Central Index Key Other liabilities Other Liabilities Noncurrent Fair Value, current Available For Sale Securities Debt Securities Current Marketable Securities [Line Items] Marketable Securities [Line Items] Investments Investment Type Categorization [Member] Investment Type Investment Type [Axis] Marketable Securities [Table] Marketable Securities [Table] Unrealized Losses, current Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Current Available for sale debt securities accumulated gross unrealized loss before tax current. Unrealized Gains, current Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current Available for sale debt securities accumulated gross unrealized gain before tax, current. Amortized Cost, current Available For Sale Debt Securities Amortized Cost Basis Current Available for sale debt securities amortized cost basis current. Total Assets Fair Value Disclosure Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Debt Securities, Available-for-sale, Realized Gain (Loss), Total Marketable Securities, Current, Total Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Share-based Payment Arrangement, Noncash Expense, Total Other Assets, Noncurrent, Total Cash, Cash Equivalents, and Short-term Investments, Total Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Preferred Stock, Value, Issued, Ending Balance Marketable securities Available For Sale Securities Debt Securities Cash equivalents Cash And Cash Equivalents Fair Value Disclosure Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] U.S. Treasury Securities U S Treasury Securities [Member] Corporate Notes Corporate Note Securities [Member] Money Market Funds Money Market Funds [Member] Asset Class Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain] Asset Class Fair Value By Asset Class [Axis] Fair Value, Measurements, Recurring Fair Value Measurements Recurring [Member] Measurement Frequency Fair Value Measurement Frequency [Domain] Measurement Frequency Fair Value By Measurement Frequency [Axis] Significant Unobservable Inputs (Level 3) Fair Value Inputs Level3 [Member] Significant Observable Inputs (Level 2) Fair Value Inputs Level2 [Member] Quoted Price in Active Markets (Level 1) Fair Value Inputs Level1 [Member] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Significant Observable Inputs (Level 2) Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Accrued other liabilities Other Accrued Liabilities Current Accrued professional fees Accrued Professional Fees Current Accrued salaries and benefits Employee Related Liabilities Current Accrued legal fees Accrued Legal Fees Current Accrued legal fees current. Accrued research and development Accrued Research And Development Current Accrued research and development current. Accrued clinical trial and related costs Accrued Clinical Trial And Related Costs Current Accrued clinical trial and related costs current. Cash and cash equivalents and marketable securities Cash Cash Equivalents And Short Term Investments Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block] Summary of Restricted Shares Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block] Summary of Stock Options Activity under 2018 Plan and 2015 Equity Incentive Plan Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Marketable Securities Marketable Securities [Text Block] Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis Fair Value Assets Measured On Recurring Basis [Text Block] Schedule of Accrued and Other Current Liabilities Schedule Of Accrued And Other Current Liabilities Table [Text Block] Schedule of accrued and other current liabilities. Recent Accounting Pronouncements New Accounting Pronouncements Policy Policy [Text Block] Risk and Uncertainties Risk And Uncertainties Policy [Text Block] Risk and uncertainties. Use of Estimates Use Of Estimates Reclassification Prior Period Reclassification Adjustment Description Basis of Presentation and Principles of Consolidation Basis Of Accounting Policy Policy [Text Block] Subsequent Events [Text Block] Subsequent Events [Abstract] Net Loss per Common Share Earnings Per Share [Text Block] Total current liabilities Liabilities Current Operating lease liability Operating Lease Liability Current Total accrued and other current liabilities Accrued and other current liabilities Accrued Liabilities Current Accounts payable Accounts Payable Current Current liabilities: Liabilities Current [Abstract] Liabilities and stockholders’ equity Liabilities And Stockholders Equity [Abstract] Total assets Assets Other assets Other Assets Noncurrent Operating lease right-of-use asset Operating Lease Right Of Use Asset Property and equipment, net Property Plant And Equipment Net Restricted cash Restricted Cash Noncurrent Total current assets Assets Current Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Marketable securities Marketable Securities Current Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Current assets: Assets Current [Abstract] Assets Assets [Abstract] Statement Of Financial Position [Abstract] Liability related to sale of future royalties Liability Related To Sale Of Future Royalties Liability related to sale of future royalties. Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Entity Incorporation, State or Country Code Entity Incorporation State Country Code Security Exchange Name Security Exchange Name Title of 12(b) Security Security12b Title Vested Issuance of common stock pursuant to employee stock purchase plans Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock pursuant to employee stock purchase plans, shares Payment, Tax Withholding, Share-based Payment Arrangement Payments for restricted stock units, net of taxes withheld Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised Proceeds from issuance of common stock pursuant to employee stock purchase plans Arrangements And Nonarrangement Transactions [Member] Collaborative Arrangement and Arrangement Other than Collaborative Type Of Arrangement [Axis] Clinical and Commercial Supply of Drug Substance Clinical And Commercial Supply [Member] Clinical and commercial supply. Long-Lived Tangible Asset Property Plant And Equipment Type [Domain] Long-Lived Tangible Asset Property Plant And Equipment By Type [Axis] Commitments And Contingencies Disclosure [Table] Commitments And Contingencies Disclosure [Table] Commitments and contingencies disclosure. Commitments And Contingencies Disclosure [Line Items] Commitments And Contingencies Disclosure [Line Items] Commitments and contingencies disclosure. Manufacturing agreement term that can be extended Manufacturing Agreement Term That Can Be Extended Manufacturing agreement term that can be extended. Manufacturing agreement initial term Manufacturing Agreement Initial Term Manufacturing agreement initial term. Annual suite fees payment each year after 2021 Contractual Obligation Due In Second Year And After Contractual obligation due in second year and after. Estimated Capital Contributions Estimated capital contributions. Impairment charges or recoveries related to marketable securities Other Than Temporary Impairment Loss Debt Securities Available For Sale Allowance for credit losses for available-for-sale debt securities Debt Securities Available For Sale Allowance For Credit Loss Realized gains or losses recognized on sale or maturity of available-for-sale debt securities Debt Securities Available For Sale Realized Gain Loss Marketable securities, effective maturities Debt Securities Available For Sale Term Minimum Minimum [Member] Maximum Maximum Maximum [Member] Statistical Measurement Range [Member] Statistical Measurement Range [Axis] Net Cash Provided By Used In Operating Activities Accrued and other current liabilities Increase Decrease In Accrued Liabilities And Other Operating Liabilities Accounts payable Increase Decrease In Accounts Payable Other assets Increase Decrease In Other Operating Assets Prepaid expenses and other current assets Increase Decrease In Prepaid Deferred Expense And Other Assets Changes in assets and liabilities: Increase Decrease In Operating Capital [Abstract] Amortization (accretion) of premium (discount) on marketable securities Accretion Amortization Of Discounts And Premiums Investments Stock-based compensation Share Based Compensation Depreciation Depreciation Adjustments to reconcile net loss to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Cash flows from operating activities Net Cash Provided By Used In Operating Activities [Abstract] Statement Of Cash Flows [Abstract] Principal payments of tenant improvement allowance payable Principal Payments Of Tenant Improvement Allowance Payable Principal payments of tenant improvement allowance payable. Proceeds from sale of future royalties, net of issuance costs Proceeds From Sale Of Future Royalties Net Of Issuance Costs Proceeds from sale of future royalties, net of issuance costs. Deposits on property and equipment Deposits On Property And Equipment Deposits on property and equipment. Operating lease liability Increase Decrease In Operating Lease Liability Increase decrease in operating lease liability. Amortization of issuance costs Amortization Of Issuance Costs Amortization of issuance costs. Amortization of operating lease right-of-use asset Operating Lease Right Of Use Asset Amortization Operating lease right of use asset amortization. Stock-based compensation expense Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Issuance of common stock upon exercise of common stock warrant, shares Issuance Of Common Stock Upon Exercise Of Common Stock Warrants Shares Issuance of common stock upon exercise of common stock warrants, shares. Issuance of common stock upon vesting of restricted stock units, net of taxes withheld, shares Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Net Of Taxes Withheld Shares Issuance of common stock upon vesting of restricted stock units,net of taxes withheld, shares. Exercised Issuance of common stock upon exercise of stock options, shares Stock Issued During Period Shares Stock Options Exercised Issuance of common stock upon exercise of stock options Stock Issued During Period Value Stock Options Exercised Beginning balance, shares Ending balance, shares Shares Outstanding Statement [Line Items] Statement [Line Items] Accumulated Deficit Retained Earnings [Member] Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income [Member] Additional Paid-In Capital Additional Paid In Capital [Member] Common Stock Common Stock [Member] Equity Component Equity Component [Domain] Equity Components Statement Equity Components [Axis] Statement [Table] Statement [Table] Statement Of Stockholders Equity [Abstract] Issuance of common stock upon exercise of common stock warrant Issuance Of Common Stock Upon Exercise Of Common Stock Warrants Issuance of common stock upon exercise of common stock warrants. Issuance of common stock upon vesting of restricted stock units, net of taxes withheld Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Net Of Taxes Withheld Issuance of common stock upon vesting of restricted stock units,net of taxes withheld. Comprehensive loss Comprehensive Income Net Of Tax Total other comprehensive income (loss) Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Change in unrealized gains related to available-for-sale debt securities, net of tax Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent Other comprehensive income (loss) Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent [Abstract] Weighted-average common shares outstanding used in computing net loss per common share, basic and diluted Weighted Average Number Of Share Outstanding Basic And Diluted Net loss per common share, basic and diluted Earnings Per Share Basic And Diluted Net loss Net loss Net Income Loss Other income (expense), net Other Nonoperating Income Expense Interest expense Interest Expense Interest income Investment Income Interest Loss from operations Operating Income Loss Total operating expenses Operating Expenses General and administrative General And Administrative Expense Research and development Research And Development Expense Operating expenses Operating Expenses [Abstract] Income Statement [Abstract] Common stock, shares outstanding Common Stock Shares Outstanding Common stock, shares issued Common Stock Shares Issued Common stock, shares authorized Common Stock Shares Authorized Common stock, par value Common Stock Par Or Stated Value Per Share Preferred Stock, shares outstanding Preferred Stock Shares Outstanding Preferred Stock, shares issued Preferred Stock Shares Issued Preferred stock, shares authorized Preferred Stock Shares Authorized Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Total stockholders’ equity Beginning Balance Ending Balance Stockholders Equity Accumulated deficit Retained Earnings Accumulated Deficit Accumulated other comprehensive income Accumulated Other Comprehensive Income Loss Net Of Tax Additional paid-in capital Additional Paid In Capital Common Stock Common Stock Value Preferred Stock Value Stockholders’ equity: Stockholders Equity [Abstract] Commitments and contingencies (Note 6) Commitments And Contingencies Total liabilities Liabilities Local Phone Number Local Phone Number City Area Code City Area Code Entity Address, Postal Zip Code Entity Address Postal Zip Code Entity Address, State or Province Entity Address State Or Province Entity Address, City or Town Entity Address City Or Town Entity Address, Address Line One Entity Address Address Line1 Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity Emerging Growth Company Entity Emerging Growth Company Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Entity Filer Category Entity Filer Category Current Fiscal Year End Date Current Fiscal Year End Date Revised estimated capital contribution Contractual Obligation Contractual Obligation, Total Annual suite fees payment Performance Based Restricted Stock Units [Member] Performance Based Restricted Stock Units [Member] Performance Based Restricted Stock Units Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Stock options, vested Contractual obligation under funding agreement Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Issuance of common stock pursuant to employee stock purchase plans Marketable Securities Marketable Securities, Total Availability of Marketable Securities Other comprehensive income (loss) Subsequent Events Entity Interactive Data Current Entity Interactive Data Current EX-101.CAL 13 kod-20210930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT XML 14 kod-20210930_htm.xml IDEA: XBRL DOCUMENT 0001468748 us-gaap:RetainedEarningsMember 2020-12-31 0001468748 us-gaap:CommonStockMember 2021-06-30 0001468748 2021-10-13 2021-10-13 0001468748 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001468748 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001468748 kod:TwoThousandEighteenEquityIncentivePlanMember 2021-01-01 2021-01-31 0001468748 srt:MaximumMember 2020-12-31 0001468748 us-gaap:CorporateNoteSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001468748 2020-03-31 0001468748 2021-01-01 2021-09-30 0001468748 kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember 2020-12-31 0001468748 kod:PerformanceBasedRestrictedStockUnitsMember 2021-01-01 2021-09-30 0001468748 2020-06-30 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001468748 kod:PerformanceBasedStockOptionsMember kod:TwoThousandEighteenEquityIncentivePlanMember us-gaap:SubsequentEventMember 2021-10-13 2021-10-13 0001468748 kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember 2020-01-01 2020-12-31 0001468748 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001468748 2021-01-01 2021-03-31 0001468748 2020-09-30 0001468748 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001468748 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001468748 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2020-09-30 0001468748 kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember 2021-01-01 2021-09-30 0001468748 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0001468748 2020-04-01 2020-06-30 0001468748 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-09-30 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001468748 srt:MinimumMember kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember us-gaap:SubsequentEventMember 2021-10-13 0001468748 kod:LonzaMember srt:MaximumMember kod:ClinicalAndCommercialSupplyMember kod:ManufacturingAgreementMember 2020-08-01 2020-08-31 0001468748 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001468748 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001468748 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001468748 us-gaap:OtherAssetsMember kod:ManufacturingAgreementMember 2021-01-01 2021-09-30 0001468748 kod:PerformanceBasedEquityAwardsMember 2020-07-01 2020-09-30 0001468748 srt:MaximumMember kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember us-gaap:SubsequentEventMember 2021-10-13 0001468748 kod:LonzaMember kod:ClinicalAndCommercialSupplyMember kod:ManufacturingAgreementMember 2021-04-30 0001468748 2021-06-30 0001468748 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001468748 kod:LonzaMember kod:ClinicalAndCommercialSupplyMember kod:ManufacturingAgreementMember 2020-08-01 2020-08-31 0001468748 2020-07-01 2020-09-30 0001468748 2021-07-01 2021-09-30 0001468748 us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001468748 2021-10-29 0001468748 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001468748 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001468748 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001468748 us-gaap:RetainedEarningsMember 2021-03-31 0001468748 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001468748 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001468748 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0001468748 us-gaap:CommonStockMember 2021-03-31 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001468748 us-gaap:RetainedEarningsMember 2020-09-30 0001468748 us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001468748 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2020-09-30 0001468748 2019-12-31 0001468748 2020-01-01 2020-09-30 0001468748 kod:PerformanceBasedRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001468748 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001468748 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001468748 srt:MaximumMember 2021-09-30 0001468748 kod:TwoThousandEighteenEmployeeSharePurchasePlanMember 2021-09-30 0001468748 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001468748 kod:PerformanceBasedEquityAwardsMember 2020-01-01 2020-09-30 0001468748 us-gaap:CommonStockMember 2021-09-30 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001468748 us-gaap:CommonStockMember 2020-12-31 0001468748 kod:PerformanceBasedStockOptionsMember 2019-01-01 2019-12-31 0001468748 kod:PerformanceBasedStockOptionsMember 2021-01-01 2021-09-30 0001468748 kod:TwoThousandEighteenEquityIncentivePlanMember 2020-01-01 2020-01-31 0001468748 us-gaap:RestrictedStockMember 2021-09-30 0001468748 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001468748 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001468748 us-gaap:USTreasurySecuritiesMember 2020-12-31 0001468748 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001468748 us-gaap:RetainedEarningsMember 2021-09-30 0001468748 us-gaap:RestrictedStockMember 2020-12-31 0001468748 kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember 2021-09-30 0001468748 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001468748 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001468748 us-gaap:RetainedEarningsMember 2019-12-31 0001468748 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001468748 us-gaap:RetainedEarningsMember 2021-06-30 0001468748 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001468748 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001468748 us-gaap:SubsequentEventMember 2021-10-13 2021-10-13 0001468748 us-gaap:RetainedEarningsMember 2020-03-31 0001468748 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001468748 us-gaap:CorporateNoteSecuritiesMember 2020-12-31 0001468748 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001468748 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001468748 2021-03-31 0001468748 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001468748 kod:PerformanceBasedStockOptionsMember 2020-01-01 2020-09-30 0001468748 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001468748 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001468748 us-gaap:RetainedEarningsMember 2020-06-30 0001468748 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001468748 us-gaap:LeaseAgreementsMember 2021-09-30 0001468748 us-gaap:CommonStockMember 2020-03-31 0001468748 kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember 2021-01-01 2021-09-30 0001468748 us-gaap:CommonStockMember 2020-06-30 0001468748 kod:TwoThousandEighteenEmployeeSharePurchasePlanMember 2021-07-01 2021-09-30 0001468748 2020-12-31 0001468748 kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember us-gaap:SubsequentEventMember 2021-10-13 0001468748 us-gaap:CommonStockMember 2020-09-30 0001468748 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001468748 2021-09-30 0001468748 kod:PerformanceBasedEquityAwardsMember 2021-07-01 2021-09-30 0001468748 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001468748 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001468748 us-gaap:CommonStockMember 2019-12-31 0001468748 2021-04-01 2021-06-30 0001468748 kod:TwoThousandEighteenEmployeeSharePurchasePlanMember 2021-01-01 2021-09-30 0001468748 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001468748 kod:PerformanceBasedEquityAwardsMember 2021-01-01 2021-09-30 0001468748 2020-01-01 2020-03-31 0001468748 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001468748 us-gaap:CorporateNoteSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001468748 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001468748 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001468748 kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember us-gaap:SubsequentEventMember 2021-10-13 2021-10-13 0001468748 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001468748 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001468748 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001468748 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001468748 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 pure iso4217:USD shares shares kod:Days iso4217:CHF kod:PurchasePeriod iso4217:USD --12-31 Q3 0001468748 false 10-Q true 2021-09-30 2021 false 001-38682 KODIAK SCIENCES INC. DE 27-0476525 1200 Page Mill Road Palo Alto CA 94304 650 281-0850 Common stock, par value $0.0001 KOD NASDAQ Yes Yes Large Accelerated Filer false false false 51717286 799247000 944396000 24578000 6259000 3031000 805506000 972005000 6324000 6324000 22939000 5136000 68450000 73672000 54987000 10210000 958206000 1067347000 13761000 8646000 39016000 20402000 1619000 2374000 54396000 31422000 77338000 75028000 99929000 99890000 223000 256000 231886000 206596000 0.0001 0.0001 10000000 10000000 0 0 0 0 0.0001 0.0001 490000000 490000000 51698775 51698775 51112302 51112302 5000 5000 1191367000 1151920000 53000 -465052000 -291227000 726320000 860751000 958206000 1067347000 56002000 29306000 141743000 70033000 11533000 7357000 32259000 19132000 67535000 36663000 174002000 89165000 -67535000 -36663000 -174002000 -89165000 40000 645000 270000 2551000 6000 6000 17000 19000 -25000 -98000 -76000 120000 -67526000 -36122000 -173825000 -86513000 -1.30 -0.80 -3.36 -1.92 51875315 45119885 51722611 44972085 0 -349000 -53000 235000 0 -349000 -53000 235000 -67526000 -36471000 -173878000 -86278000 51112302 5000 1151920000 53000 -291227000 860751000 113559 1483000 1483000 9925000 9925000 -35000 -35000 -50447000 -50447000 51225861 5000 1163328000 18000 -341674000 821677000 131276 2228000 2228000 72976 4295 305000 305000 11087000 11087000 -18000 -18000 -55852000 -55852000 51434408 5000 1176948000 0 -397526000 779427000 103585 2042000 2042000 10799 149983 12377000 12377000 -67526000 -67526000 51698775 5000 1191367000 0 -465052000 726320000 44413404 5000 503475000 10000 -158131000 345359000 39297 0 159000 0 0 159000 6082000 6082000 0 479000 479000 -24392000 -24392000 44452701 5000 509716000 489000 -182523000 327687000 203373 720000 0 0 720000 10942 -206000 -206000 6890000 6890000 105000 105000 -25999000 -25999000 44667016 5000 517120000 594000 -208522000 309197000 93497 813000 813000 8241000 8241000 -349000 -349000 -36122000 -36122000 44760513 5000 526174000 245000 -244644000 281780000 -173825000 -86513000 722000 317000 33389000 21213000 -25000 145000 5811000 1793000 39000 36000 3228000 -1518000 936000 3654000 3255000 1616000 10547000 7566000 966000 -156000 -123235000 -56409000 8598000 1855000 43841000 0 0 86317000 24500000 134148000 -27939000 45976000 5753000 1692000 0 206000 305000 0 0 99643000 0 5000 33000 28000 6025000 101096000 -145149000 90663000 950720000 211937000 805571000 302600000 799247000 291585000 6324000 11015000 805571000 302600000 583000 75545000 10730000 1034000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1. The Company</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc. (the “Company”) is a clinical stage biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases in the United States and additional international markets. The Company devotes substantially all of its resources to the research and development of its product platforms and product candidates including activities to conduct clinical studies of its product candidates, manufacture product candidates and provide general and administrative support for these operations.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidity</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021, the Company had cash and cash equivalents of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">799.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. Although the Company has incurred significant operating losses since inception and expects to continue to incur operating losses and negative operating cash flows for the foreseeable future, the Company believes that the cash and cash equivalents will be sufficient to meet the anticipated operating and capital expenditure requirements for the 12 months following the date of this Form 10-Q.</span></p> 799200000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2. Summary of Significant Accounting Policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) applicable to interim periods. The condensed consolidated financial statements, in the opinion of management, include all normal and recurring adjustments necessary to present fairly the Company's financial position and results of operations for the reported periods.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These condensed consolidated financial statements have been prepared on a basis substantially consistent with, and should be read in conjunction with the audited financial statements for the year ended December 31, 2020 and notes thereto, the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 1, 2021. Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or omitted from this report. The results of operations for any interim period are not necessarily indicative of the results for the year ending December 31, 2021, or for any future period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reclassification</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no impact on subtotals in the prior year condensed consolidated financial statements.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and expenses during the reporting period. The impact of the ongoing COVID-19 pandemic continues to evolve. As a result, certain estimates and assumptions required increased judgment and carried a higher degree of variability and volatility, including but not limited to, the fair value of marketable securities, performance-based equity awards, and research and development accruals for the three and nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As events continue to unfold and additional information becomes available, these estimates may change materially in future periods. Actual results could differ from those estimates.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the World Health Organization declared a pandemic due to the global COVID-19 outbreak. The significant uncertainties caused by the ongoing COVID-19 pandemic may negatively impact the Company’s operations, liquidity, and capital resources and will depend on certain evolving developments, including the duration and spread of the outbreak, regulatory and private sector responses and the impact on employees and vendors including supply chain and clinical partners, all of which are uncertain and cannot be predicted. During this pandemic, the Company continues to work closely with clinical sites towards maximal patient safety and the lowest number of missed visits and study discontinuations. The Company has taken and continues to take proactive measures to maintain the integrity of its ongoing clinical studies. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact clinical trial enrollment and completion of its clinical studies. During this pandemic, the Company continues to work closely with its manufacturing suppliers, partners and facilities to maintain the supply of its product candidates needed for the expansion of clinical trials and to retain the number, scale and design of manufacturing runs that regulatory authorities may require to obtain marketing approval, including those required to support a BLA submission. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact the timing or likelihood of clinical resupply and of regulatory filings and approvals. The Company will continue to monitor the COVID-19 situation and its impact on the ability to continue the development of, and seek regulatory approvals for, the Company’s product candidates, and begin to commercialize any approved products.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and nine months ended September 30, 2021, respectively, are consistent with those discussed in Note 2 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, except as noted within the “Recent Accounting Pronouncements – Recently Adopted Accounting Pronouncements” section.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ccounting </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">p</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”), under its Accounting Standards Codification or other standard setting bodies, and adopted by the Company as of the specified effective date, unless otherwise discussed below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Adopted Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2020, the FASB issued Accounting Standards Update 2020-10, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Codification Improvements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which updates various codification topics and disclosure requirements to improve alignment with the SEC's regulations. The Company adopted this new guidance as of January 1, 2021, and this guidance did not have a material impact on its consolidated financial statements and related disclosures.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">New Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company continues to monitor new accounting pronouncements issued by the FASB. All other newly issued accounting pronouncements issued through the date of this report have been deemed either immaterial or not applicable.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) applicable to interim periods. The condensed consolidated financial statements, in the opinion of management, include all normal and recurring adjustments necessary to present fairly the Company's financial position and results of operations for the reported periods.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These condensed consolidated financial statements have been prepared on a basis substantially consistent with, and should be read in conjunction with the audited financial statements for the year ended December 31, 2020 and notes thereto, the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 1, 2021. Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or omitted from this report. The results of operations for any interim period are not necessarily indicative of the results for the year ending December 31, 2021, or for any future period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reclassification</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no impact on subtotals in the prior year condensed consolidated financial statements.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and expenses during the reporting period. The impact of the ongoing COVID-19 pandemic continues to evolve. As a result, certain estimates and assumptions required increased judgment and carried a higher degree of variability and volatility, including but not limited to, the fair value of marketable securities, performance-based equity awards, and research and development accruals for the three and nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As events continue to unfold and additional information becomes available, these estimates may change materially in future periods. Actual results could differ from those estimates.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the World Health Organization declared a pandemic due to the global COVID-19 outbreak. The significant uncertainties caused by the ongoing COVID-19 pandemic may negatively impact the Company’s operations, liquidity, and capital resources and will depend on certain evolving developments, including the duration and spread of the outbreak, regulatory and private sector responses and the impact on employees and vendors including supply chain and clinical partners, all of which are uncertain and cannot be predicted. During this pandemic, the Company continues to work closely with clinical sites towards maximal patient safety and the lowest number of missed visits and study discontinuations. The Company has taken and continues to take proactive measures to maintain the integrity of its ongoing clinical studies. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact clinical trial enrollment and completion of its clinical studies. During this pandemic, the Company continues to work closely with its manufacturing suppliers, partners and facilities to maintain the supply of its product candidates needed for the expansion of clinical trials and to retain the number, scale and design of manufacturing runs that regulatory authorities may require to obtain marketing approval, including those required to support a BLA submission. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact the timing or likelihood of clinical resupply and of regulatory filings and approvals. The Company will continue to monitor the COVID-19 situation and its impact on the ability to continue the development of, and seek regulatory approvals for, the Company’s product candidates, and begin to commercialize any approved products.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ccounting </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">p</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”), under its Accounting Standards Codification or other standard setting bodies, and adopted by the Company as of the specified effective date, unless otherwise discussed below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Adopted Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2020, the FASB issued Accounting Standards Update 2020-10, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Codification Improvements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which updates various codification topics and disclosure requirements to improve alignment with the SEC's regulations. The Company adopted this new guidance as of January 1, 2021, and this guidance did not have a material impact on its consolidated financial statements and related disclosures.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">New Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company continues to monitor new accounting pronouncements issued by the FASB. All other newly issued accounting pronouncements issued through the date of this report have been deemed either immaterial or not applicable.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3. Accrued and Other Current Liabilities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued and other current liabilities consist of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.562%;"/> <td style="width:1.605%;"/> <td style="width:1.531%;"/> <td style="width:12.832%;"/> <td style="width:0.752%;"/> <td style="width:1.605%;"/> <td style="width:1.531%;"/> <td style="width:12.832%;"/> <td style="width:0.752%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30,<br/>2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31,<br/>2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued clinical trial and related costs</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,762</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,119</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued leasehold improvements</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,470</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued salaries and benefits</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,790</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,094</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued research and development</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,392</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,082</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued legal fees</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">582</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">252</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued professional fees</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">223</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">253</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued other liabilities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">797</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">583</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued and other current liabilities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39,016</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20,402</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table></div> <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued and other current liabilities consist of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.562%;"/> <td style="width:1.605%;"/> <td style="width:1.531%;"/> <td style="width:12.832%;"/> <td style="width:0.752%;"/> <td style="width:1.605%;"/> <td style="width:1.531%;"/> <td style="width:12.832%;"/> <td style="width:0.752%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30,<br/>2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31,<br/>2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued clinical trial and related costs</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,762</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,119</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued leasehold improvements</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,470</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued salaries and benefits</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,790</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,094</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued research and development</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,392</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,082</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued legal fees</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">582</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">252</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued professional fees</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">223</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">253</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued other liabilities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">797</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">583</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued and other current liabilities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39,016</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20,402</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table> 21762000 11119000 7470000 19000 4790000 5094000 3392000 3082000 582000 252000 223000 253000 797000 583000 39016000 20402000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4. Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following tables present the Company’s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.096%;"/> <td style="width:1.187%;"/> <td style="width:1.521%;"/> <td style="width:9.072%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.521%;"/> <td style="width:9.044%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.521%;"/> <td style="width:8.988%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.521%;"/> <td style="width:9.072%;"/> <td style="width:0.974%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair Value Measurements at September 30, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair Value Measurements at December 31, 2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. treasury securities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate notes</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,578</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">942,063</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021 and December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (“BBA”), which are considered Level 3 inputs.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div> <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following tables present the Company’s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.096%;"/> <td style="width:1.187%;"/> <td style="width:1.521%;"/> <td style="width:9.072%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.521%;"/> <td style="width:9.044%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.521%;"/> <td style="width:8.988%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.521%;"/> <td style="width:9.072%;"/> <td style="width:0.974%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair Value Measurements at September 30, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair Value Measurements at December 31, 2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. treasury securities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate notes</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,578</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">942,063</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021 and December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (“BBA”), which are considered Level 3 inputs.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p> 762550000 762550000 762550000 762550000 917485000 917485000 10006000 10006000 14572000 14572000 917485000 24578000 942063000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5. Marketable Securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The marketable securities are classified as available-for-sale and consist of U.S. treasury securities and corporate notes. The fair value measurement data for marketable securities is obtained from independent pricing services. The Company validates the prices provided by the third-party pricing services by understanding the valuation methods and data sources used and analyzing the pricing data in certain instances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> marketable securities at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </span><span style="font-size:12.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the marketable securities (in thousands):</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:48.91%;"/> <td style="width:1.187%;"/> <td style="width:1.53%;"/> <td style="width:9.098%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.53%;"/> <td style="width:9.107%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.53%;"/> <td style="width:9.107%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.521%;"/> <td style="width:9.023%;"/> <td style="width:0.974%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Amortized<br/>Cost</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized<br/>Gains</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized<br/>Losses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair<br/>Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. treasury securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,003</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate notes</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,522</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total marketable securities, current</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,525</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,578</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All marketable securities held at December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> had effective maturities of less than </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> realized gains or losses recognized on the sale or maturity of available-for-sale debt securities during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three and nine months ended September 30, 2021, respectively and, as a result, the Company did not reclassify any amounts out of accumulated comprehensive loss. As of September 30, 2021 and December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> allowance for credit losses for available-for-sale debt securities. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> impairment charges or recoveries recorded during each of the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nine months ended September 30, 2021 and September 30, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p> 0 <span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the marketable securities (in thousands):</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:48.91%;"/> <td style="width:1.187%;"/> <td style="width:1.53%;"/> <td style="width:9.098%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.53%;"/> <td style="width:9.107%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.53%;"/> <td style="width:9.107%;"/> <td style="width:0.974%;"/> <td style="width:1.187%;"/> <td style="width:1.521%;"/> <td style="width:9.023%;"/> <td style="width:0.974%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Amortized<br/>Cost</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized<br/>Gains</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized<br/>Losses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair<br/>Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. treasury securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,003</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate notes</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,522</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total marketable securities, current</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,525</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,578</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table> 10003000 3000 10006000 14522000 50000 14572000 24525000 53000 24578000 P1Y P1Y 0 0 0 0 0 0 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Embedded Lease</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2020, the Company and its wholly-owned subsidiary Kodiak Sciences GmbH entered into a manufacturing agreement with Lonza Ltd (“Lonza”) for the clinical and commercial supply of drug substance for KSI-301. A custom-built manufacturing facility is planned to be completed and dedicated to the manufacture of the Company’s drug substance. The manufacturing agreement has an initial term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">eight years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and the Company has the right to extend the term up to a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company and Lonza each have the ability to terminate this agreement upon the occurrence of certain conditions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2021, the agreement was amended to provide for higher annual manufacturing capacity. The Company expanded and finalized the design and scope of the bioconjugate manufacturing facility with a revised estimated capital contribution of approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million Swiss Francs of which the Company has paid </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million Swiss Francs of the capital contribution, equivalent to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million U.S. Dollars, which is recorded in other assets on the consolidated balance sheet as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Over the period from 2022 through 2029, manufacturing payments totaling approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">150.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million Swiss Francs may be incurred for potential commercial supply of KSI-301 drug substance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company concluded that this agreement contains an embedded lease as the custom-built manufacturing suite will be dedicated for the Company’s use. As of September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company did not have control of this manufacturing space and therefore, did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t record a right-of-use asset and corresponding lease liability.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Manufacturing Agreements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has entered into service and equipment purchase agreements in the normal course of business with various providers, pursuant to which such providers agreed to perform activities in connection with the manufacturing process of certain materials. These agreements, and any related amendments, state that planned activities and purchases that are included in the signed work orders are, in some cases, binding and, hence, obligate the Company to pay the full price of the work order upon satisfactory delivery of products and services or obligate the Company to the binding amount regardless of whether such planned activities are in fact performed. Per the terms of the agreements, the Company has the option to cancel signed orders at any time upon written notice, which may or may not be subject to payment of a cancellation fee. The level of cancellation fees may be dependent on the timing of the written notice in relation to the commencement date of the work, with the maximum cancellation amount dependent on the agreement or the work order.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Funding Commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the normal course of business, the Company enters into agreements with third-parties for services to be provided to the Company. Generally, these agreements provide for termination upon notice, with specified amounts due upon termination based on the timing of termination and the terms of the applicable agreement. The actual amounts and timing of payments under these agreements are uncertain and contingent upon the initiation and completion of services to be provided to the Company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has also entered into various cancellable license agreements for certain technology. The Company may be obligated to make payments on future sales of specified products associated with such license agreements. Such payments are dependent on future product sales and are not estimable.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Indemnification</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent permitted under Delaware law, the Company has agreed to indemnify its directors and officers for certain events or occurrences while the director or officer is, or was serving, at the Company’s request in such capacity. The indemnification period covers all pertinent events and occurrences during the director’s or officer’s service. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is not specified in the agreements; however, the Company has director and officer insurance coverage that reduces its exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.</span> P8Y P16Y 75000000.0 35000000.0 38700000 150000000.0 0 0 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7. Stock-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In January 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the number of shares of common stock available for issuance under the 2018 Equity Incentive Plan (the "2018 Plan") was increased by approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million shares, respectively, as a result of the automatic increase provision in the 2018 Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock option activity under the 2018 Plan and 2015 Equity Incentive Plan (the "2015 Plan") is summarized as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:38.581%;"/> <td style="width:1.475%;"/> <td style="width:0.983%;"/> <td style="width:11.651%;"/> <td style="width:0.993%;"/> <td style="width:1.475%;"/> <td style="width:1.531%;"/> <td style="width:11.596%;"/> <td style="width:0.983%;"/> <td style="width:1.475%;"/> <td style="width:0.993%;"/> <td style="width:11.679%;"/> <td style="width:0.983%;"/> <td style="width:1.475%;"/> <td style="width:1.531%;"/> <td style="width:11.614%;"/> <td style="width:0.983%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number<br/>of<br/>Options</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Exercise<br/>Price</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2020</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,897,276</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24.52</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.07</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">841,704</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,478,994</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">94.80</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exercised</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">348,420</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.06</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited or canceled</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">228,118</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41.86</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at September 30, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,799,732</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37.62</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.74</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">431,288</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table></div><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Shares</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted share activity, including restricted stock awards, restricted stock units, and performance-based restricted stock units, under the 2018 Plan and 2015 Plan is summarized as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.942%;"/> <td style="width:2.125%;"/> <td style="width:0.993%;"/> <td style="width:17.673%;"/> <td style="width:1.002%;"/> <td style="width:2.125%;"/> <td style="width:1.531%;"/> <td style="width:17.618%;"/> <td style="width:0.993%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number of<br/>Restricted<br/>Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at December 31, 2020</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">359,945</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59.54</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">170,150</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90.75</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,775</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57.98</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Canceled</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34,033</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61.24</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at September 30, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">412,287</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">72.59</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Performance-Based Stock Options and Restricted Stock Units</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">669,581</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based stock options during the nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (the "2021 PSAs"). The Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t grant any performance-based equity awards during </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">170,150</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based options and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">128,900</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based restricted stock units to employees in 2019 (the "2019 PSAs").</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The performance-based equity awards granted will vest </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one-quarter</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upon the achievement of specific clinical development milestones. The remaining shares will then vest ratably over three years thereafter. Performance-based stock options and performance-based restricted stock units are recorded as expense beginning when vesting events are determined to be probable.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The milestone for the 2019 PSAs was achieved during the second quarter of 2021. As of September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42,536</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based stock options and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28,905</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based restricted stock units granted during 2019 have vested. The Company believes that the achievement of the requisite performance condition for 2021 PSAs granted in the first quarter of 2021 continues to be probable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation expense recognized was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the three and nine months ended September 30, 2021, respectively, and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the three and nine months ended September 30, 2020, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2018 Employee Share Purchase Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:5.85pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.62%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.867%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2018, the Company adopted the 2018 Employee Share Purchase Plan (“ESPP”), which became effective on the business day prior to the effectiveness of the registration statement relating to the Company's initial public offering. A total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">460,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock were initially reserved for issuance under the ESPP. The initial offering period of the ESPP was authorized by the Company’s board of directors and commenced on January 4, 2021. Each offering period is approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">twelve months</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> long, with </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> purchase periods. ESPP participants will purchase shares of common stock at a price per share equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the lesser of (1) the fair market value per share of the common stock on the enrollment date or (2) the fair market value of the common stock on the exercise date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.62%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.867%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company issued </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,295</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares under the ESPP during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three and nine months ended September 30, 2021, respectively. The stock-based compensation expense related to the ESPP was less than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the three and nine months ended September 30, 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation Expense</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation for options, restricted shares, and ESPP is classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:39.745%;"/> <td style="width:1.425%;"/> <td style="width:1.528%;"/> <td style="width:11.258%;"/> <td style="width:0.975%;"/> <td style="width:1.425%;"/> <td style="width:1.528%;"/> <td style="width:11.22%;"/> <td style="width:0.975%;"/> <td style="width:0.975%;"/> <td style="width:1.528%;"/> <td style="width:11.258%;"/> <td style="width:0.975%;"/> <td style="width:1.425%;"/> <td style="width:1.528%;"/> <td style="width:11.258%;"/> <td style="width:0.975%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended <br/>  September 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended <br/>  September 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,429</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,759</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,598</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,983</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,948</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,482</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,791</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,230</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,377</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,241</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33,389</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,213</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, total unrecognized compensation cost related to the unvested share-based awards and ESPP was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">122.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.8</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> years.</span></p> 2000000.0 1800000 <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock option activity under the 2018 Plan and 2015 Equity Incentive Plan (the "2015 Plan") is summarized as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:38.581%;"/> <td style="width:1.475%;"/> <td style="width:0.983%;"/> <td style="width:11.651%;"/> <td style="width:0.993%;"/> <td style="width:1.475%;"/> <td style="width:1.531%;"/> <td style="width:11.596%;"/> <td style="width:0.983%;"/> <td style="width:1.475%;"/> <td style="width:0.993%;"/> <td style="width:11.679%;"/> <td style="width:0.983%;"/> <td style="width:1.475%;"/> <td style="width:1.531%;"/> <td style="width:11.614%;"/> <td style="width:0.983%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number<br/>of<br/>Options</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Exercise<br/>Price</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2020</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,897,276</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24.52</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.07</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">841,704</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,478,994</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">94.80</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exercised</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">348,420</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.06</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited or canceled</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">228,118</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41.86</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at September 30, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,799,732</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37.62</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.74</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">431,288</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table> 6897276 24.52 P8Y25D 841704000 1478994 94.80 348420 17.06 228118 41.86 7799732 37.62 P7Y8M26D 431288000 <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted share activity, including restricted stock awards, restricted stock units, and performance-based restricted stock units, under the 2018 Plan and 2015 Plan is summarized as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.942%;"/> <td style="width:2.125%;"/> <td style="width:0.993%;"/> <td style="width:17.673%;"/> <td style="width:1.002%;"/> <td style="width:2.125%;"/> <td style="width:1.531%;"/> <td style="width:17.618%;"/> <td style="width:0.993%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number of<br/>Restricted<br/>Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at December 31, 2020</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">359,945</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59.54</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">170,150</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90.75</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,775</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57.98</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Canceled</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34,033</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61.24</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at September 30, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">412,287</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">72.59</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table> 359945 59.54 170150 90.75 83775 57.98 34033 61.24 412287 72.59 669581 0 170150 128900 one-quarter 42536 28905 2100000 8300000 1800000 5500000 460000 P12M 2 0.85 0 4295 100000 200000 <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation for options, restricted shares, and ESPP is classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:39.745%;"/> <td style="width:1.425%;"/> <td style="width:1.528%;"/> <td style="width:11.258%;"/> <td style="width:0.975%;"/> <td style="width:1.425%;"/> <td style="width:1.528%;"/> <td style="width:11.22%;"/> <td style="width:0.975%;"/> <td style="width:0.975%;"/> <td style="width:1.528%;"/> <td style="width:11.258%;"/> <td style="width:0.975%;"/> <td style="width:1.425%;"/> <td style="width:1.528%;"/> <td style="width:11.258%;"/> <td style="width:0.975%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended <br/>  September 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended <br/>  September 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,429</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,759</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,598</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,983</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,948</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,482</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,791</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,230</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,377</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,241</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33,389</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,213</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table> 6429000 4759000 17598000 11983000 5948000 3482000 15791000 9230000 12377000 8241000 33389000 21213000 122400000 P2Y9M18D <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. Net Loss per Common Share</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.859%;"/> <td style="width:2.338%;"/> <td style="width:1.002%;"/> <td style="width:17.729%;"/> <td style="width:1.002%;"/> <td style="width:2.338%;"/> <td style="width:1.002%;"/> <td style="width:17.729%;"/> <td style="width:1.002%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of September 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding stock options</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,799,732</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,238,363</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">412,287</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">363,195</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,212,019</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,601,558</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table></div> <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.859%;"/> <td style="width:2.338%;"/> <td style="width:1.002%;"/> <td style="width:17.729%;"/> <td style="width:1.002%;"/> <td style="width:2.338%;"/> <td style="width:1.002%;"/> <td style="width:17.729%;"/> <td style="width:1.002%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of September 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding stock options</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,799,732</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,238,363</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">412,287</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">363,195</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,212,019</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,601,558</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td> </tr> </table> 7799732 7238363 412287 363195 8212019 7601558 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9. Subsequent Events</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On October 13, 2021, stockholders of the Company approved the Kodiak Sciences Inc. 2021 Long-Term Performance Incentive Plan (the “LTPIP”) as described in the Company's Definitive Proxy Statement on Schedule 14A filed with the SEC on September 13, 2021. Stock options were granted under the LTPIP, contingent on stockholder approval of the LTPIP, to named executive officers and other eligible employees at the vice president level who made a one-time election to participate in the LTPIP and agreed to forgo a portion of their annual long-term incentive awards over the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seven-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance period ending on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">August 11, 2028</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. A total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,502,334</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock were reserved for issuance under the LTPIP.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The options can be earned based on the achievement of the performance-based requirement and/or certain operational milestones. The performance-based requirement consists of seven tranches of options that are earned based on meeting or exceeding stock price goals between $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">200</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">800</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> consecutive trading days.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Up to 35% of the options may be earned through the attainment of certain operational milestones to the extent that number of options has not yet been earned from stock appreciation. A participant may earn up to 25% upon approval by the U.S. Food and Drug Administration of a Biologics License Application for KSI-301 in the three major anti-VEGF indications and up to 10% from generating sales of at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> billion in a fiscal year.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Once earned, options are subject to a service-based requirement and will vest through the remainder of the seven-year performance period in equal monthly installments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Performance-based stock options totaling </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,920,625</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> with the same terms and conditions as the LTPIP were also granted to employees below the vice president level under the 2018 Plan. These stock option awards were also contingent on stockholder approval of the LTPIP. As discussed above, the LTPIP was approved by the stockholders of the Company on October 13, 2021.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is currently evaluating the LTPIP approved in October 2021 and its accounting impact as a modification of the portion of the annual long-term incentive awards granted in 2021 that were foregone.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p> P7Y 2028-08-11 5502334 200 800 90 Up to 35% of the options may be earned through the attainment of certain operational milestones to the extent that number of options has not yet been earned from stock appreciation. A participant may earn up to 25% upon approval by the U.S. Food and Drug Administration of a Biologics License Application for KSI-301 in the three major anti-VEGF indications and up to 10% from generating sales of at least $2.5 billion in a fiscal year. 2500000000 1920625 XML 15 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2021
Oct. 29, 2021
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q3  
Trading Symbol KOD  
Entity Registrant Name KODIAK SCIENCES INC.  
Entity Central Index Key 0001468748  
Entity Current Reporting Status Yes  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Shell Company false  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Common Stock, Shares Outstanding   51,717,286
Entity File Number 001-38682  
Entity Tax Identification Number 27-0476525  
Entity Address, Address Line One 1200 Page Mill Road  
Entity Address, City or Town Palo Alto  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94304  
City Area Code 650  
Local Phone Number 281-0850  
Entity Interactive Data Current Yes  
Title of 12(b) Security Common stock, par value $0.0001  
Security Exchange Name NASDAQ  
Entity Incorporation, State or Country Code DE  
Document Quarterly Report true  
Document Transition Report false  
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 799,247 $ 944,396
Marketable securities 24,578
Prepaid expenses and other current assets 6,259 3,031
Total current assets 805,506 972,005
Restricted cash 6,324 6,324
Property and equipment, net 22,939 5,136
Operating lease right-of-use asset 68,450 73,672
Other assets 54,987 10,210
Total assets 958,206 1,067,347
Current liabilities:    
Accounts payable 13,761 8,646
Accrued and other current liabilities 39,016 20,402
Operating lease liability 1,619 2,374
Total current liabilities 54,396 31,422
Operating lease liability, net of current portion 77,338 75,028
Liability related to sale of future royalties 99,929 99,890
Other liabilities 223 256
Total liabilities 231,886 206,596
Commitments and contingencies (Note 6)
Stockholders’ equity:    
Preferred stock, $0.0001 par value
Common stock, $0.0001 par value 5 5
Additional paid-in capital 1,191,367 1,151,920
Accumulated other comprehensive income 53
Accumulated deficit (465,052) (291,227)
Total stockholders’ equity 726,320 860,751
Total liabilities and stockholders’ equity $ 958,206 $ 1,067,347
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parenthetical) (unaudited) - $ / shares
Sep. 30, 2021
Dec. 31, 2020
Statement Of Financial Position [Abstract]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred Stock, shares issued 0 0
Preferred Stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 490,000,000 490,000,000
Common stock, shares issued 51,698,775 51,112,302
Common stock, shares outstanding 51,698,775 51,112,302
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses        
Research and development $ 56,002 $ 29,306 $ 141,743 $ 70,033
General and administrative 11,533 7,357 32,259 19,132
Total operating expenses 67,535 36,663 174,002 89,165
Loss from operations (67,535) (36,663) (174,002) (89,165)
Interest income 40 645 270 2,551
Interest expense (6) (6) (17) (19)
Other income (expense), net (25) (98) (76) 120
Net loss $ (67,526) $ (36,122) $ (173,825) $ (86,513)
Net loss per common share, basic and diluted $ (1.30) $ (0.80) $ (3.36) $ (1.92)
Weighted-average common shares outstanding used in computing net loss per common share, basic and diluted 51,875,315 45,119,885 51,722,611 44,972,085
Other comprehensive income (loss)        
Change in unrealized gains related to available-for-sale debt securities, net of tax $ 0 $ (349) $ (53) $ 235
Total other comprehensive income (loss) 0 (349) (53) 235
Comprehensive loss $ (67,526) $ (36,471) $ (173,878) $ (86,278)
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2019 $ 345,359 $ 5 $ 503,475 $ 10 $ (158,131)
Beginning balance, shares at Dec. 31, 2019   44,413,404      
Issuance of common stock upon exercise of stock options 159 $ 0 159 0 0
Issuance of common stock upon exercise of stock options, shares   39,297      
Stock-based compensation expense 6,082   6,082    
Other comprehensive income (loss) 479   0 479  
Net loss (24,392)       (24,392)
Ending Balance at Mar. 31, 2020 327,687 $ 5 509,716 489 (182,523)
Ending balance, shares at Mar. 31, 2020   44,452,701      
Beginning Balance at Dec. 31, 2019 345,359 $ 5 503,475 10 (158,131)
Beginning balance, shares at Dec. 31, 2019   44,413,404      
Other comprehensive income (loss) 235        
Net loss (86,513)        
Ending Balance at Sep. 30, 2020 281,780 $ 5 526,174 245 (244,644)
Ending balance, shares at Sep. 30, 2020   44,760,513      
Beginning Balance at Mar. 31, 2020 327,687 $ 5 509,716 489 (182,523)
Beginning balance, shares at Mar. 31, 2020   44,452,701      
Issuance of common stock upon exercise of stock options 720   720 0 0
Issuance of common stock upon exercise of stock options, shares   203,373      
Issuance of common stock upon vesting of restricted stock units, net of taxes withheld (206)   (206)    
Issuance of common stock upon vesting of restricted stock units, net of taxes withheld, shares   10,942      
Stock-based compensation expense 6,890   6,890    
Other comprehensive income (loss) 105     105  
Net loss (25,999)       (25,999)
Ending Balance at Jun. 30, 2020 309,197 $ 5 517,120 594 (208,522)
Ending balance, shares at Jun. 30, 2020   44,667,016      
Issuance of common stock upon exercise of stock options 813   813    
Issuance of common stock upon exercise of stock options, shares   93,497      
Stock-based compensation expense 8,241   8,241    
Other comprehensive income (loss) (349)     (349)  
Net loss (36,122)       (36,122)
Ending Balance at Sep. 30, 2020 281,780 $ 5 526,174 245 (244,644)
Ending balance, shares at Sep. 30, 2020   44,760,513      
Beginning Balance at Dec. 31, 2020 860,751 $ 5 1,151,920 53 (291,227)
Beginning balance, shares at Dec. 31, 2020   51,112,302      
Issuance of common stock upon exercise of stock options 1,483   1,483    
Issuance of common stock upon exercise of stock options, shares   113,559      
Stock-based compensation expense 9,925   9,925    
Other comprehensive income (loss) (35)     (35)  
Net loss (50,447)       (50,447)
Ending Balance at Mar. 31, 2021 821,677 $ 5 1,163,328 18 (341,674)
Ending balance, shares at Mar. 31, 2021   51,225,861      
Beginning Balance at Dec. 31, 2020 860,751 $ 5 1,151,920 53 (291,227)
Beginning balance, shares at Dec. 31, 2020   51,112,302      
Other comprehensive income (loss) (53)        
Net loss (173,825)        
Ending Balance at Sep. 30, 2021 726,320 $ 5 1,191,367 0 (465,052)
Ending balance, shares at Sep. 30, 2021   51,698,775      
Beginning Balance at Mar. 31, 2021 821,677 $ 5 1,163,328 18 (341,674)
Beginning balance, shares at Mar. 31, 2021   51,225,861      
Issuance of common stock upon exercise of stock options 2,228   2,228    
Issuance of common stock upon exercise of stock options, shares   131,276      
Issuance of common stock upon vesting of restricted stock units, net of taxes withheld, shares   72,976      
Issuance of common stock pursuant to employee stock purchase plans 305   305    
Issuance of common stock pursuant to employee stock purchase plans, shares   4,295      
Stock-based compensation expense 11,087   11,087    
Other comprehensive income (loss) (18)     (18)  
Net loss (55,852)       (55,852)
Ending Balance at Jun. 30, 2021 779,427 $ 5 1,176,948 0 (397,526)
Ending balance, shares at Jun. 30, 2021   51,434,408      
Issuance of common stock upon exercise of stock options 2,042   2,042    
Issuance of common stock upon exercise of stock options, shares   103,585      
Issuance of common stock upon vesting of restricted stock units, net of taxes withheld, shares   10,799      
Issuance of common stock upon exercise of common stock warrant, shares   149,983      
Stock-based compensation expense 12,377   12,377    
Other comprehensive income (loss) 0        
Net loss (67,526)       (67,526)
Ending Balance at Sep. 30, 2021 $ 726,320 $ 5 $ 1,191,367 $ 0 $ (465,052)
Ending balance, shares at Sep. 30, 2021   51,698,775      
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net loss $ (173,825) $ (86,513)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 722 317
Stock-based compensation 33,389 21,213
Amortization (accretion) of premium (discount) on marketable securities 25 (145)
Amortization of operating lease right-of-use asset 5,811 1,793
Amortization of issuance costs 39 36
Changes in assets and liabilities:    
Prepaid expenses and other current assets (3,228) 1,518
Other assets (936) (3,654)
Accounts payable 3,255 1,616
Accrued and other current liabilities 10,547 7,566
Operating lease liability 966 (156)
Net cash used in operating activities (123,235) (56,409)
Cash flows from investing activities    
Purchase of property and equipment (8,598) (1,855)
Deposits on property and equipment (43,841) 0
Purchase of marketable securities 0 (86,317)
Maturities of marketable securities 24,500 134,148
Net cash provided by (used in) investing activities (27,939) 45,976
Cash flows from financing activities    
Proceeds from issuance of common stock upon options exercise 5,753 1,692
Payments for restricted stock units, net of taxes withheld 0 (206)
Proceeds from issuance of common stock pursuant to employee stock purchase plans 305 0
Proceeds from sale of future royalties, net of issuance costs 0 99,643
Principal payments of capital lease 0 (5)
Principal payments of tenant improvement allowance payable (33) (28)
Net cash provided by financing activities 6,025 101,096
Net increase (decrease) in cash, cash equivalents and restricted cash (145,149) 90,663
Cash, cash equivalents and restricted cash, at beginning of period 950,720 211,937
Cash, cash equivalents and restricted cash, at end of period 805,571 302,600
Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets    
Cash and cash equivalents 799,247 291,585
Restricted cash 6,324 11,015
Cash, cash equivalents and restricted cash, at end of period 805,571 302,600
Supplemental disclosures of non-cash investing and financing information:    
Operating lease right-of-use asset obtained in exchange for operating lease liability 583 75,545
Purchase of property and equipment under accounts payable and accruals $ 10,730 $ 1,034
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.21.2
The Company
9 Months Ended
Sep. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
The Company

1. The Company

Kodiak Sciences Inc. (the “Company”) is a clinical stage biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases in the United States and additional international markets. The Company devotes substantially all of its resources to the research and development of its product platforms and product candidates including activities to conduct clinical studies of its product candidates, manufacture product candidates and provide general and administrative support for these operations.

Liquidity

As of September 30, 2021, the Company had cash and cash equivalents of $799.2 million. Although the Company has incurred significant operating losses since inception and expects to continue to incur operating losses and negative operating cash flows for the foreseeable future, the Company believes that the cash and cash equivalents will be sufficient to meet the anticipated operating and capital expenditure requirements for the 12 months following the date of this Form 10-Q.

XML 22 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) applicable to interim periods. The condensed consolidated financial statements, in the opinion of management, include all normal and recurring adjustments necessary to present fairly the Company's financial position and results of operations for the reported periods.

These condensed consolidated financial statements have been prepared on a basis substantially consistent with, and should be read in conjunction with the audited financial statements for the year ended December 31, 2020 and notes thereto, the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 1, 2021. Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or omitted from this report. The results of operations for any interim period are not necessarily indicative of the results for the year ending December 31, 2021, or for any future period.

The accompanying condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.

Reclassification

Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no impact on subtotals in the prior year condensed consolidated financial statements.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and expenses during the reporting period. The impact of the ongoing COVID-19 pandemic continues to evolve. As a result, certain estimates and assumptions required increased judgment and carried a higher degree of variability and volatility, including but not limited to, the fair value of marketable securities, performance-based equity awards, and research and development accruals for the three and nine months ended September 30, 2021. As events continue to unfold and additional information becomes available, these estimates may change materially in future periods. Actual results could differ from those estimates.

Risks and Uncertainties

In March 2020, the World Health Organization declared a pandemic due to the global COVID-19 outbreak. The significant uncertainties caused by the ongoing COVID-19 pandemic may negatively impact the Company’s operations, liquidity, and capital resources and will depend on certain evolving developments, including the duration and spread of the outbreak, regulatory and private sector responses and the impact on employees and vendors including supply chain and clinical partners, all of which are uncertain and cannot be predicted. During this pandemic, the Company continues to work closely with clinical sites towards maximal patient safety and the lowest number of missed visits and study discontinuations. The Company has taken and continues to take proactive measures to maintain the integrity of its ongoing clinical studies. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact clinical trial enrollment and completion of its clinical studies. During this pandemic, the Company continues to work closely with its manufacturing suppliers, partners and facilities to maintain the supply of its product candidates needed for the expansion of clinical trials and to retain the number, scale and design of manufacturing runs that regulatory authorities may require to obtain marketing approval, including those required to support a BLA submission. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact the timing or likelihood of clinical resupply and of regulatory filings and approvals. The Company will continue to monitor the COVID-19 situation and its impact on the ability to continue the development of, and seek regulatory approvals for, the Company’s product candidates, and begin to commercialize any approved products.

Summary of Significant Accounting Policies

The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and nine months ended September 30, 2021, respectively, are consistent with those discussed in Note 2 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, except as noted within the “Recent Accounting Pronouncements – Recently Adopted Accounting Pronouncements” section.

Recent accounting pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”), under its Accounting Standards Codification or other standard setting bodies, and adopted by the Company as of the specified effective date, unless otherwise discussed below.

Recently Adopted Accounting Pronouncements

In October 2020, the FASB issued Accounting Standards Update 2020-10, Codification Improvements, which updates various codification topics and disclosure requirements to improve alignment with the SEC's regulations. The Company adopted this new guidance as of January 1, 2021, and this guidance did not have a material impact on its consolidated financial statements and related disclosures.

New Accounting Pronouncements Not Yet Adopted

The Company continues to monitor new accounting pronouncements issued by the FASB. All other newly issued accounting pronouncements issued through the date of this report have been deemed either immaterial or not applicable. 

XML 23 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued and Other Current Liabilities
9 Months Ended
Sep. 30, 2021
Accounts Payable And Accrued Liabilities Current [Abstract]  
Accrued and Other Current Liabilities

3. Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following (in thousands):

 

 

 

September 30,
2021

 

 

December 31,
2020

 

Accrued clinical trial and related costs

 

$

21,762

 

 

$

11,119

 

Accrued leasehold improvements

 

 

7,470

 

 

 

19

 

Accrued salaries and benefits

 

 

4,790

 

 

 

5,094

 

Accrued research and development

 

 

3,392

 

 

 

3,082

 

Accrued legal fees

 

 

582

 

 

 

252

 

Accrued professional fees

 

 

223

 

 

 

253

 

Accrued other liabilities

 

 

797

 

 

 

583

 

Total accrued and other current liabilities

 

$

39,016

 

 

$

20,402

 

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements

4. Fair Value Measurements

The following tables present the Company’s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):

 

 

 

Fair Value Measurements at September 30, 2021

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

762,550

 

 

$

 

 

$

 

 

$

762,550

 

Total

 

$

762,550

 

 

$

 

 

$

 

 

$

762,550

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements at December 31, 2020

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

917,485

 

 

$

 

 

$

 

 

$

917,485

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasury securities

 

 

 

 

 

10,006

 

 

 

 

 

 

10,006

 

Corporate notes

 

 

 

 

 

14,572

 

 

 

 

 

 

14,572

 

Total

 

$

917,485

 

 

$

24,578

 

 

$

 

 

$

942,063

 

 

As of September 30, 2021 and December 31, 2020, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (“BBA”), which are considered Level 3 inputs. 

XML 25 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities
9 Months Ended
Sep. 30, 2021
Investments Debt And Equity Securities [Abstract]  
Marketable Securities

5. Marketable Securities

The marketable securities are classified as available-for-sale and consist of U.S. treasury securities and corporate notes. The fair value measurement data for marketable securities is obtained from independent pricing services. The Company validates the prices provided by the third-party pricing services by understanding the valuation methods and data sources used and analyzing the pricing data in certain instances.

The Company had no marketable securities at September 30, 2021. The following table summarizes the marketable securities (in thousands):

 

As of December 31, 2020

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

U.S. treasury securities

 

$

10,003

 

 

$

3

 

 

$

 

 

$

10,006

 

Corporate notes

 

 

14,522

 

 

 

50

 

 

 

 

 

 

14,572

 

Total marketable securities, current

 

$

24,525

 

 

$

53

 

 

$

 

 

$

24,578

 

 

All marketable securities held at December 31, 2020 had effective maturities of less than one year. There were no realized gains or losses recognized on the sale or maturity of available-for-sale debt securities during the three and nine months ended September 30, 2021, respectively and, as a result, the Company did not reclassify any amounts out of accumulated comprehensive loss. As of September 30, 2021 and December 31, 2020, the Company had no allowance for credit losses for available-for-sale debt securities. There were no impairment charges or recoveries recorded during each of the nine months ended September 30, 2021 and September 30, 2020, respectively.

XML 26 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2021
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

6. Commitments and Contingencies

Embedded Lease

In August 2020, the Company and its wholly-owned subsidiary Kodiak Sciences GmbH entered into a manufacturing agreement with Lonza Ltd (“Lonza”) for the clinical and commercial supply of drug substance for KSI-301. A custom-built manufacturing facility is planned to be completed and dedicated to the manufacture of the Company’s drug substance. The manufacturing agreement has an initial term of eight years, and the Company has the right to extend the term up to a total of 16 years. The Company and Lonza each have the ability to terminate this agreement upon the occurrence of certain conditions.

In April 2021, the agreement was amended to provide for higher annual manufacturing capacity. The Company expanded and finalized the design and scope of the bioconjugate manufacturing facility with a revised estimated capital contribution of approximately 75.0 million Swiss Francs of which the Company has paid 35.0 million Swiss Francs of the capital contribution, equivalent to $38.7 million U.S. Dollars, which is recorded in other assets on the consolidated balance sheet as of September 30, 2021. Over the period from 2022 through 2029, manufacturing payments totaling approximately 150.0 million Swiss Francs may be incurred for potential commercial supply of KSI-301 drug substance.

The Company concluded that this agreement contains an embedded lease as the custom-built manufacturing suite will be dedicated for the Company’s use. As of September 30, 2021, the Company did not have control of this manufacturing space and therefore, did not record a right-of-use asset and corresponding lease liability.

Manufacturing Agreements

The Company has entered into service and equipment purchase agreements in the normal course of business with various providers, pursuant to which such providers agreed to perform activities in connection with the manufacturing process of certain materials. These agreements, and any related amendments, state that planned activities and purchases that are included in the signed work orders are, in some cases, binding and, hence, obligate the Company to pay the full price of the work order upon satisfactory delivery of products and services or obligate the Company to the binding amount regardless of whether such planned activities are in fact performed. Per the terms of the agreements, the Company has the option to cancel signed orders at any time upon written notice, which may or may not be subject to payment of a cancellation fee. The level of cancellation fees may be dependent on the timing of the written notice in relation to the commencement date of the work, with the maximum cancellation amount dependent on the agreement or the work order.

Other Funding Commitments

In the normal course of business, the Company enters into agreements with third-parties for services to be provided to the Company. Generally, these agreements provide for termination upon notice, with specified amounts due upon termination based on the timing of termination and the terms of the applicable agreement. The actual amounts and timing of payments under these agreements are uncertain and contingent upon the initiation and completion of services to be provided to the Company.

The Company has also entered into various cancellable license agreements for certain technology. The Company may be obligated to make payments on future sales of specified products associated with such license agreements. Such payments are dependent on future product sales and are not estimable.

Indemnification

To the extent permitted under Delaware law, the Company has agreed to indemnify its directors and officers for certain events or occurrences while the director or officer is, or was serving, at the Company’s request in such capacity. The indemnification period covers all pertinent events and occurrences during the director’s or officer’s service. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is not specified in the agreements; however, the Company has director and officer insurance coverage that reduces its exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation
9 Months Ended
Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

7. Stock-Based Compensation

In January 2021 and 2020, the number of shares of common stock available for issuance under the 2018 Equity Incentive Plan (the "2018 Plan") was increased by approximately 2.0 million and 1.8 million shares, respectively, as a result of the automatic increase provision in the 2018 Plan.

Stock Options

Stock option activity under the 2018 Plan and 2015 Equity Incentive Plan (the "2015 Plan") is summarized as follows:

 

 

 

Number
of
Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2020

 

 

6,897,276

 

 

$

24.52

 

 

 

8.07

 

 

$

841,704

 

Granted

 

 

1,478,994

 

 

$

94.80

 

 

 

 

 

 

 

Exercised

 

 

(348,420

)

 

$

17.06

 

 

 

 

 

 

 

Forfeited or canceled

 

 

(228,118

)

 

$

41.86

 

 

 

 

 

 

 

Outstanding at September 30, 2021

 

 

7,799,732

 

 

$

37.62

 

 

 

7.74

 

 

$

431,288

 

 

Restricted Shares

Restricted share activity, including restricted stock awards, restricted stock units, and performance-based restricted stock units, under the 2018 Plan and 2015 Plan is summarized as follows:

 

 

 

Number of
Restricted
Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Unvested at December 31, 2020

 

 

359,945

 

 

$

59.54

 

Granted

 

 

170,150

 

 

$

90.75

 

Vested

 

 

(83,775

)

 

$

57.98

 

Canceled

 

 

(34,033

)

 

$

61.24

 

Unvested at September 30, 2021

 

 

412,287

 

 

$

72.59

 

 

Performance-Based Stock Options and Restricted Stock Units

The Company granted 669,581 performance-based stock options during the nine months ended September 30, 2021 (the "2021 PSAs"). The Company did not grant any performance-based equity awards during 2020. The Company granted 170,150 performance-based options and 128,900 performance-based restricted stock units to employees in 2019 (the "2019 PSAs").

The performance-based equity awards granted will vest one-quarter upon the achievement of specific clinical development milestones. The remaining shares will then vest ratably over three years thereafter. Performance-based stock options and performance-based restricted stock units are recorded as expense beginning when vesting events are determined to be probable.

The milestone for the 2019 PSAs was achieved during the second quarter of 2021. As of September 30, 2021, 42,536 performance-based stock options and 28,905 performance-based restricted stock units granted during 2019 have vested. The Company believes that the achievement of the requisite performance condition for 2021 PSAs granted in the first quarter of 2021 continues to be probable.

Stock-based compensation expense recognized was $2.1 million and $8.3 million during the three and nine months ended September 30, 2021, respectively, and $1.8 million and $5.5 million during the three and nine months ended September 30, 2020, respectively.

2018 Employee Share Purchase Plan

 

In August 2018, the Company adopted the 2018 Employee Share Purchase Plan (“ESPP”), which became effective on the business day prior to the effectiveness of the registration statement relating to the Company's initial public offering. A total of 460,000 shares of common stock were initially reserved for issuance under the ESPP. The initial offering period of the ESPP was authorized by the Company’s board of directors and commenced on January 4, 2021. Each offering period is approximately twelve months long, with two purchase periods. ESPP participants will purchase shares of common stock at a price per share equal to 85% of the lesser of (1) the fair market value per share of the common stock on the enrollment date or (2) the fair market value of the common stock on the exercise date.

The Company issued no shares and 4,295 shares under the ESPP during the three and nine months ended September 30, 2021, respectively. The stock-based compensation expense related to the ESPP was less than $0.1 million and $0.2 million during the three and nine months ended September 30, 2021, respectively.

Stock-Based Compensation Expense

Stock-based compensation for options, restricted shares, and ESPP is classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended
  September 30,

 

 

Nine Months Ended
  September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Research and development

 

$

6,429

 

 

$

4,759

 

 

$

17,598

 

 

$

11,983

 

General and administrative

 

 

5,948

 

 

 

3,482

 

 

 

15,791

 

 

 

9,230

 

Total stock-based compensation

 

$

12,377

 

 

$

8,241

 

 

$

33,389

 

 

$

21,213

 

 

As of September 30, 2021, total unrecognized compensation cost related to the unvested share-based awards and ESPP was $122.4 million, which is expected to be recognized over a weighted-average period of 2.8 years.

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Net Loss per Common Share
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Net Loss per Common Share

8. Net Loss per Common Share

The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:

 

 

 

As of September 30,

 

 

 

2021

 

 

2020

 

Outstanding stock options

 

 

7,799,732

 

 

 

7,238,363

 

Unvested restricted shares

 

 

412,287

 

 

 

363,195

 

Total

 

 

8,212,019

 

 

 

7,601,558

 

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events
9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]  
Subsequent Events

9. Subsequent Events

On October 13, 2021, stockholders of the Company approved the Kodiak Sciences Inc. 2021 Long-Term Performance Incentive Plan (the “LTPIP”) as described in the Company's Definitive Proxy Statement on Schedule 14A filed with the SEC on September 13, 2021. Stock options were granted under the LTPIP, contingent on stockholder approval of the LTPIP, to named executive officers and other eligible employees at the vice president level who made a one-time election to participate in the LTPIP and agreed to forgo a portion of their annual long-term incentive awards over the seven-year performance period ending on August 11, 2028. A total of 5,502,334 shares of common stock were reserved for issuance under the LTPIP.

The options can be earned based on the achievement of the performance-based requirement and/or certain operational milestones. The performance-based requirement consists of seven tranches of options that are earned based on meeting or exceeding stock price goals between $200 and $800 per share for 90 consecutive trading days.

Up to 35% of the options may be earned through the attainment of certain operational milestones to the extent that number of options has not yet been earned from stock appreciation. A participant may earn up to 25% upon approval by the U.S. Food and Drug Administration of a Biologics License Application for KSI-301 in the three major anti-VEGF indications and up to 10% from generating sales of at least $2.5 billion in a fiscal year. Once earned, options are subject to a service-based requirement and will vest through the remainder of the seven-year performance period in equal monthly installments.

Performance-based stock options totaling 1,920,625 with the same terms and conditions as the LTPIP were also granted to employees below the vice president level under the 2018 Plan. These stock option awards were also contingent on stockholder approval of the LTPIP. As discussed above, the LTPIP was approved by the stockholders of the Company on October 13, 2021.

The Company is currently evaluating the LTPIP approved in October 2021 and its accounting impact as a modification of the portion of the annual long-term incentive awards granted in 2021 that were foregone.


 

XML 30 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) applicable to interim periods. The condensed consolidated financial statements, in the opinion of management, include all normal and recurring adjustments necessary to present fairly the Company's financial position and results of operations for the reported periods.

These condensed consolidated financial statements have been prepared on a basis substantially consistent with, and should be read in conjunction with the audited financial statements for the year ended December 31, 2020 and notes thereto, the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 1, 2021. Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or omitted from this report. The results of operations for any interim period are not necessarily indicative of the results for the year ending December 31, 2021, or for any future period.

The accompanying condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.

Reclassification

Reclassification

Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no impact on subtotals in the prior year condensed consolidated financial statements.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and expenses during the reporting period. The impact of the ongoing COVID-19 pandemic continues to evolve. As a result, certain estimates and assumptions required increased judgment and carried a higher degree of variability and volatility, including but not limited to, the fair value of marketable securities, performance-based equity awards, and research and development accruals for the three and nine months ended September 30, 2021. As events continue to unfold and additional information becomes available, these estimates may change materially in future periods. Actual results could differ from those estimates.

Risk and Uncertainties

Risks and Uncertainties

In March 2020, the World Health Organization declared a pandemic due to the global COVID-19 outbreak. The significant uncertainties caused by the ongoing COVID-19 pandemic may negatively impact the Company’s operations, liquidity, and capital resources and will depend on certain evolving developments, including the duration and spread of the outbreak, regulatory and private sector responses and the impact on employees and vendors including supply chain and clinical partners, all of which are uncertain and cannot be predicted. During this pandemic, the Company continues to work closely with clinical sites towards maximal patient safety and the lowest number of missed visits and study discontinuations. The Company has taken and continues to take proactive measures to maintain the integrity of its ongoing clinical studies. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact clinical trial enrollment and completion of its clinical studies. During this pandemic, the Company continues to work closely with its manufacturing suppliers, partners and facilities to maintain the supply of its product candidates needed for the expansion of clinical trials and to retain the number, scale and design of manufacturing runs that regulatory authorities may require to obtain marketing approval, including those required to support a BLA submission. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact the timing or likelihood of clinical resupply and of regulatory filings and approvals. The Company will continue to monitor the COVID-19 situation and its impact on the ability to continue the development of, and seek regulatory approvals for, the Company’s product candidates, and begin to commercialize any approved products.

Recent Accounting Pronouncements

Recent accounting pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”), under its Accounting Standards Codification or other standard setting bodies, and adopted by the Company as of the specified effective date, unless otherwise discussed below.

Recently Adopted Accounting Pronouncements

In October 2020, the FASB issued Accounting Standards Update 2020-10, Codification Improvements, which updates various codification topics and disclosure requirements to improve alignment with the SEC's regulations. The Company adopted this new guidance as of January 1, 2021, and this guidance did not have a material impact on its consolidated financial statements and related disclosures.

New Accounting Pronouncements Not Yet Adopted

The Company continues to monitor new accounting pronouncements issued by the FASB. All other newly issued accounting pronouncements issued through the date of this report have been deemed either immaterial or not applicable. 

XML 31 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued and Other Current Liabilities (Tables)
9 Months Ended
Sep. 30, 2021
Accounts Payable And Accrued Liabilities Current [Abstract]  
Schedule of Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following (in thousands):

 

 

 

September 30,
2021

 

 

December 31,
2020

 

Accrued clinical trial and related costs

 

$

21,762

 

 

$

11,119

 

Accrued leasehold improvements

 

 

7,470

 

 

 

19

 

Accrued salaries and benefits

 

 

4,790

 

 

 

5,094

 

Accrued research and development

 

 

3,392

 

 

 

3,082

 

Accrued legal fees

 

 

582

 

 

 

252

 

Accrued professional fees

 

 

223

 

 

 

253

 

Accrued other liabilities

 

 

797

 

 

 

583

 

Total accrued and other current liabilities

 

$

39,016

 

 

$

20,402

 

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis

The following tables present the Company’s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):

 

 

 

Fair Value Measurements at September 30, 2021

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

762,550

 

 

$

 

 

$

 

 

$

762,550

 

Total

 

$

762,550

 

 

$

 

 

$

 

 

$

762,550

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements at December 31, 2020

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

917,485

 

 

$

 

 

$

 

 

$

917,485

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasury securities

 

 

 

 

 

10,006

 

 

 

 

 

 

10,006

 

Corporate notes

 

 

 

 

 

14,572

 

 

 

 

 

 

14,572

 

Total

 

$

917,485

 

 

$

24,578

 

 

$

 

 

$

942,063

 

 

As of September 30, 2021 and December 31, 2020, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (“BBA”), which are considered Level 3 inputs. 

XML 33 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities (Tables)
9 Months Ended
Sep. 30, 2021
Investments Debt And Equity Securities [Abstract]  
Summary of Marketable Securities The following table summarizes the marketable securities (in thousands):

 

As of December 31, 2020

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

U.S. treasury securities

 

$

10,003

 

 

$

3

 

 

$

 

 

$

10,006

 

Corporate notes

 

 

14,522

 

 

 

50

 

 

 

 

 

 

14,572

 

Total marketable securities, current

 

$

24,525

 

 

$

53

 

 

$

 

 

$

24,578

 

XML 34 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock Options Activity under 2018 Plan and 2015 Equity Incentive Plan

Stock option activity under the 2018 Plan and 2015 Equity Incentive Plan (the "2015 Plan") is summarized as follows:

 

 

 

Number
of
Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2020

 

 

6,897,276

 

 

$

24.52

 

 

 

8.07

 

 

$

841,704

 

Granted

 

 

1,478,994

 

 

$

94.80

 

 

 

 

 

 

 

Exercised

 

 

(348,420

)

 

$

17.06

 

 

 

 

 

 

 

Forfeited or canceled

 

 

(228,118

)

 

$

41.86

 

 

 

 

 

 

 

Outstanding at September 30, 2021

 

 

7,799,732

 

 

$

37.62

 

 

 

7.74

 

 

$

431,288

 

Summary of Restricted Shares

Restricted share activity, including restricted stock awards, restricted stock units, and performance-based restricted stock units, under the 2018 Plan and 2015 Plan is summarized as follows:

 

 

 

Number of
Restricted
Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Unvested at December 31, 2020

 

 

359,945

 

 

$

59.54

 

Granted

 

 

170,150

 

 

$

90.75

 

Vested

 

 

(83,775

)

 

$

57.98

 

Canceled

 

 

(34,033

)

 

$

61.24

 

Unvested at September 30, 2021

 

 

412,287

 

 

$

72.59

 

Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss

Stock-based compensation for options, restricted shares, and ESPP is classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended
  September 30,

 

 

Nine Months Ended
  September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Research and development

 

$

6,429

 

 

$

4,759

 

 

$

17,598

 

 

$

11,983

 

General and administrative

 

 

5,948

 

 

 

3,482

 

 

 

15,791

 

 

 

9,230

 

Total stock-based compensation

 

$

12,377

 

 

$

8,241

 

 

$

33,389

 

 

$

21,213

 

XML 35 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Net Loss per Common Share (Tables)
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share

The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:

 

 

 

As of September 30,

 

 

 

2021

 

 

2020

 

Outstanding stock options

 

 

7,799,732

 

 

 

7,238,363

 

Unvested restricted shares

 

 

412,287

 

 

 

363,195

 

Total

 

 

8,212,019

 

 

 

7,601,558

 

XML 36 R22.htm IDEA: XBRL DOCUMENT v3.21.2
The Company - Additional Information (Details)
$ in Millions
Sep. 30, 2021
USD ($)
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Cash and cash equivalents and marketable securities $ 799.2
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Accounts Payable And Accrued Liabilities Current [Abstract]    
Accrued clinical trial and related costs $ 21,762 $ 11,119
Accrued Leasehold Improvements 7,470 19
Accrued salaries and benefits 4,790 5,094
Accrued research and development 3,392 3,082
Accrued legal fees 582 252
Accrued professional fees 223 253
Accrued other liabilities 797 583
Total accrued and other current liabilities $ 39,016 $ 20,402
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Total $ 762,550 $ 942,063
Money Market Funds    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Cash equivalents 762,550 917,485
Corporate Notes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Marketable securities   14,572
U.S. Treasury Securities    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Marketable securities   10,006
Quoted Price in Active Markets (Level 1)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Total 762,550 917,485
Quoted Price in Active Markets (Level 1) | Money Market Funds    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Cash equivalents $ 762,550 917,485
Significant Observable Inputs (Level 2)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Total   24,578
Significant Observable Inputs (Level 2) | Corporate Notes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Marketable securities   14,572
Significant Observable Inputs (Level 2) | U.S. Treasury Securities    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Marketable securities   $ 10,006
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities - Summary of Marketable Securities (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
Marketable Securities [Line Items]  
Amortized Cost, current $ 24,525
Unrealized Gains, current 53
Fair Value, current 24,578
U.S. Treasury Securities  
Marketable Securities [Line Items]  
Amortized Cost, current 10,003
Unrealized Gains, current 3
Fair Value, current 10,006
Corporate Notes  
Marketable Securities [Line Items]  
Amortized Cost, current 14,522
Unrealized Gains, current 50
Fair Value, current $ 14,572
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Marketable Securities [Line Items]        
Availability of Marketable Securities $ 0 $ 0    
Realized gains or losses recognized on sale or maturity of available-for-sale debt securities 0 0    
Allowance for credit losses for available-for-sale debt securities $ 0 0   $ 0
Impairment charges or recoveries related to marketable securities   $ 0 $ 0  
Maximum        
Marketable Securities [Line Items]        
Marketable securities, effective maturities 1 year 1 year   1 year
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Additional Information (Details)
$ in Thousands, SFr in Millions
1 Months Ended 9 Months Ended
Aug. 31, 2020
Sep. 30, 2021
USD ($)
Sep. 30, 2021
CHF (SFr)
Apr. 30, 2021
CHF (SFr)
Dec. 31, 2020
USD ($)
Commitments And Contingencies Disclosure [Line Items]          
Operating lease right-of-use asset   $ 68,450     $ 73,672
Lease Agreement          
Commitments And Contingencies Disclosure [Line Items]          
Operating lease right-of-use asset   0      
Lease liabilities   0      
Clinical and Commercial Supply of Drug Substance | Manufacturing Agreement | Lonza          
Commitments And Contingencies Disclosure [Line Items]          
Annual suite fees payment | SFr       SFr 150.0  
Revised estimated capital contribution | SFr       SFr 75.0  
Manufacturing agreement initial term 8 years        
Clinical and Commercial Supply of Drug Substance | Maximum | Manufacturing Agreement | Lonza          
Commitments And Contingencies Disclosure [Line Items]          
Manufacturing agreement term that can be extended 16 years        
Other Assets [Member] | Manufacturing Agreement          
Commitments And Contingencies Disclosure [Line Items]          
Manufacturing Agreement Expense   $ 38,700 SFr 35.0    
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Additional Information (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 31, 2021
shares
Jan. 31, 2020
shares
Sep. 30, 2021
USD ($)
shares
Jun. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
PurchasePeriod
shares
Sep. 30, 2020
USD ($)
shares
Dec. 31, 2019
shares
Dec. 31, 2020
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Stock-based compensation expense recognized | $     $ 12,377   $ 8,241 $ 33,389 $ 21,213    
Common stock, shares issued     51,698,775     51,698,775     51,112,302
Stock based compensation expense related to ESPP | $       $ 305          
Unrecognized compensation cost related to unvested share based awards | $     $ 122,400     $ 122,400      
Unrecognized compensation weighted-average period expected for recognition           2 years 9 months 18 days      
Performance Based Restricted Stock Units                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Stock options, granted               128,900  
Awards vested           28,905      
Performance-based Stock Options                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Stock options, vested           42,536      
Stock options, granted           669,581 0 170,150  
Performance Based Equity Awards                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Vesting period for achievement of specific milestone           one-quarter      
Stock-based compensation expense recognized | $     $ 2,100   $ 1,800 $ 8,300 $ 5,500    
2018 Equity Incentive Plan                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Number of common stock available for issuance increased 2,000,000.0 1,800,000              
2018 Employee Share Purchase Plan                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Stock Issued During Period, Shares, Employee Stock Purchase Plans     0     4,295      
Common stock, shares reserved for issuance     460,000     460,000      
Term of offering period           12 months      
Number of purchase periods | PurchasePeriod           2      
Common stock purchase price percentage           85.00%      
Stock based compensation expense related to ESPP | $     $ 100     $ 200      
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details) - 2018 Plan and 2015 Equity Incentive Plan
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Number of Options    
Beginning balance | shares 6,897,276  
Granted | shares 1,478,994  
Exercised | shares (348,420)  
Forfeited or canceled | shares (228,118)  
Ending balance | shares 7,799,732 6,897,276
Weighted Average Exercise Price    
Beginning balance | $ / shares $ 24.52  
Granted | $ / shares 94.80  
Exercised | $ / shares 17.06  
Forfeited or canceled | $ / shares 41.86  
Ending balance | $ / shares $ 37.62 $ 24.52
Weighted Average Remaining Contractual Term (in years)    
Weighted Average Remaining Contractual Term (in years) 7 years 8 months 26 days 8 years 25 days
Aggregate Intrinsic Value    
Balance | $ $ 431,288 $ 841,704
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Summary of Restricted Shares (Details) - Restricted Shares
9 Months Ended
Sep. 30, 2021
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Unvested, beginning balance | shares 359,945
Granted | shares 170,150
Vested | shares (83,775)
Canceled | shares (34,033)
Unvested, ending balance | shares 412,287
Weighted Average Grant Date Fair Value  
Unvested, beginning balance | $ / shares $ 59.54
Granted | $ / shares 90.75
Vested | $ / shares 57.98
Canceled | $ / shares 61.24
Unvested, ending balance | $ / shares $ 72.59
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total stock-based compensation $ 12,377 $ 8,241 $ 33,389 $ 21,213
Research and Development        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total stock-based compensation 6,429 4,759 17,598 11,983
General and Administrative        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total stock-based compensation $ 5,948 $ 3,482 $ 15,791 $ 9,230
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details) - shares
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive securities excluded from the computation of diluted net loss per common share 8,212,019 7,601,558
Outstanding Stock Options    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive securities excluded from the computation of diluted net loss per common share 7,799,732 7,238,363
Unvested Restricted Shares    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive securities excluded from the computation of diluted net loss per common share 412,287 363,195
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events - Additional Information (Details)
$ / shares in Units, $ in Billions
9 Months Ended 12 Months Ended
Oct. 13, 2021
USD ($)
Days
$ / shares
shares
Sep. 30, 2021
shares
Sep. 30, 2020
shares
Dec. 31, 2019
shares
Subsequent Event [Line Items]        
Consecutive Trading days | Days 90      
2021 LTPIP        
Subsequent Event [Line Items]        
Performance expiration date   Aug. 11, 2028    
Performance-based Stock Options        
Subsequent Event [Line Items]        
Granted   669,581 0 170,150
Subsequent Event        
Subsequent Event [Line Items]        
Plan description Up to 35% of the options may be earned through the attainment of certain operational milestones to the extent that number of options has not yet been earned from stock appreciation. A participant may earn up to 25% upon approval by the U.S. Food and Drug Administration of a Biologics License Application for KSI-301 in the three major anti-VEGF indications and up to 10% from generating sales of at least $2.5 billion in a fiscal year.      
Subsequent Event | 2021 LTPIP        
Subsequent Event [Line Items]        
Sales | $ $ 2.5      
Performance Periods 7 years      
Common stock, shares reserved for issuance 5,502,334      
Subsequent Event | 2021 LTPIP | Maximum        
Subsequent Event [Line Items]        
Stock Price | $ / shares $ 800      
Subsequent Event | 2021 LTPIP | Minimum        
Subsequent Event [Line Items]        
Stock Price | $ / shares $ 200      
Subsequent Event | 2018 Equity Incentive Plan | Performance-based Stock Options        
Subsequent Event [Line Items]        
Granted 1,920,625      
EXCEL 48 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 50 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 135 258 1 false 32 0 false 7 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets (unaudited) Sheet http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (unaudited) Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (unaudited) Sheet http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited Condensed Consolidated Balance Sheets (Parenthetical) (unaudited) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) Sheet http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 100060 - Disclosure - The Company Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompany The Company Notes 7 false false R8.htm 100070 - Disclosure - Summary of Significant Accounting Policies Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100080 - Disclosure - Accrued and Other Current Liabilities Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities Accrued and Other Current Liabilities Notes 9 false false R10.htm 100090 - Disclosure - Fair Value Measurements Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 100100 - Disclosure - Marketable Securities Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities Marketable Securities Notes 11 false false R12.htm 100110 - Disclosure - Commitments and Contingencies Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 100120 - Disclosure - Stock-Based Compensation Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation Stock-Based Compensation Notes 13 false false R14.htm 100130 - Disclosure - Net Loss per Common Share Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare Net Loss per Common Share Notes 14 false false R15.htm 100140 - Disclosure - Subsequent Events Sheet http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEvents1 Subsequent Events Notes 15 false false R16.htm 100150 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 16 false false R17.htm 100160 - Disclosure - Accrued and Other Current Liabilities (Tables) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables Accrued and Other Current Liabilities (Tables) Tables http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities 17 false false R18.htm 100170 - Disclosure - Fair Value Measurements (Tables) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements 18 false false R19.htm 100180 - Disclosure - Marketable Securities (Tables) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesTables Marketable Securities (Tables) Tables http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities 19 false false R20.htm 100190 - Disclosure - Stock-Based Compensation (Tables) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation 20 false false R21.htm 100200 - Disclosure - Net Loss per Common Share (Tables) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables Net Loss per Common Share (Tables) Tables http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare 21 false false R22.htm 100210 - Disclosure - The Company - Additional Information (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompanyAdditionalInformationDetails The Company - Additional Information (Details) Details 22 false false R23.htm 100220 - Disclosure - Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) Details 23 false false R24.htm 100230 - Disclosure - Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details) Details 24 false false R25.htm 100240 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails Marketable Securities - Summary of Marketable Securities (Details) Details 25 false false R26.htm 100250 - Disclosure - Marketable Securities - Additional Information (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails Marketable Securities - Additional Information (Details) Details 26 false false R27.htm 100260 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 27 false false R28.htm 100270 - Disclosure - Stock-Based Compensation - Additional Information (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional Information (Details) Details 28 false false R29.htm 100280 - Disclosure - Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details) Details 29 false false R30.htm 100290 - Disclosure - Stock-Based Compensation - Summary of Restricted Shares (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails Stock-Based Compensation - Summary of Restricted Shares (Details) Details 30 false false R31.htm 100300 - Disclosure - Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details) Details 31 false false R32.htm 100310 - Disclosure - Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details) Sheet http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details) Details 32 false false R33.htm 100320 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 33 false false All Reports Book All Reports kod-20210930.htm kod-20210930.xsd kod-20210930_cal.xml kod-20210930_def.xml kod-20210930_lab.xml kod-20210930_pre.xml kod-ex10_1.htm kod-ex31_1.htm kod-ex31_2.htm kod-ex32_1.htm kod-ex32_2.htm img6467664_0.jpg img6467664_1.jpg http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true JSON 54 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kod-20210930.htm": { "axisCustom": 0, "axisStandard": 16, "contextCount": 135, "dts": { "calculationLink": { "local": [ "kod-20210930_cal.xml" ] }, "definitionLink": { "local": [ "kod-20210930_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "kod-20210930.htm" ] }, "labelLink": { "local": [ "kod-20210930_lab.xml" ] }, "presentationLink": { "local": [ "kod-20210930_pre.xml" ] }, "schema": { "local": [ "kod-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 308, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 6, "http://xbrl.sec.gov/dei/2020-01-31": 4, "total": 10 }, "keyCustom": 31, "keyStandard": 227, "memberCustom": 10, "memberStandard": 19, "nsprefix": "kod", "nsuri": "http://kodiak.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Fair Value Measurements", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Marketable Securities", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities", "shortName": "Marketable Securities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Commitments and Contingencies", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Stock-Based Compensation", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Net Loss per Common Share", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare", "shortName": "Net Loss per Common Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Subsequent Events", "role": "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEvents1", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Accrued and Other Current Liabilities (Tables)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables", "shortName": "Accrued and Other Current Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Fair Value Measurements (Tables)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Marketable Securities (Tables)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesTables", "shortName": "Marketable Securities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Condensed Consolidated Balance Sheets (unaudited)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited", "shortName": "Condensed Consolidated Balance Sheets (unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_83602e3b-403a-43a4-ae96-ae8d95713283", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Net Loss per Common Share (Tables)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables", "shortName": "Net Loss per Common Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "p", "kod:TheCompanyTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - The Company - Additional Information (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompanyAdditionalInformationDetails", "shortName": "The Company - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "kod:TheCompanyTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock", "div", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29", "decimals": "-3", "first": true, "lang": null, "name": "kod:AccruedClinicalTrialAndRelatedCostsCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails", "shortName": "Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock", "div", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29", "decimals": "-3", "first": true, "lang": null, "name": "kod:AccruedClinicalTrialAndRelatedCostsCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_263b39c0-fc6e-4304-804c-806e5d34aa8e", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails", "shortName": "Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_263b39c0-fc6e-4304-804c-806e5d34aa8e", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_83602e3b-403a-43a4-ae96-ae8d95713283", "decimals": "-3", "first": true, "lang": null, "name": "kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails", "shortName": "Marketable Securities - Summary of Marketable Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_83602e3b-403a-43a4-ae96-ae8d95713283", "decimals": "-3", "first": true, "lang": null, "name": "kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MarketableSecurities", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Marketable Securities - Additional Information (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails", "shortName": "Marketable Securities - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss", "span", "p", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_e5c59142-312f-4066-abfc-c35cb8d948e8", "decimals": "INF", "lang": null, "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "shortName": "Commitments and Contingencies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_b4b42d07-b554-47fb-9b37-295ad99f4b05", "decimals": "-3", "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_e5c59142-312f-4066-abfc-c35cb8d948e8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Stock-Based Compensation - Additional Information (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "shortName": "Stock-Based Compensation - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_6eaad1c4-f84e-49b9-8c0d-bf85eb1191e4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails", "shortName": "Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_975902bf-d85c-41cd-863e-84e008163d3b", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (unaudited)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical) (unaudited)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_c515656c-fd5d-4d4d-bb5a-78a9994f0ad6", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Stock-Based Compensation - Summary of Restricted Shares (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails", "shortName": "Stock-Based Compensation - Summary of Restricted Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_c515656c-fd5d-4d4d-bb5a-78a9994f0ad6", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_e5c59142-312f-4066-abfc-c35cb8d948e8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails", "shortName": "Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_9bdfa9aa-1ba9-4af1-8101-e5969ff5eae8", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails", "shortName": "Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_9e4a81b8-d848-4b6b-9f61-d7f1ba8aa59b", "decimals": "0", "first": true, "lang": null, "name": "kod:ConsecutiveTradingDays", "reportCount": 1, "unique": true, "unitRef": "U_Days", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Subsequent Events - Additional Information (Details)", "role": "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "shortName": "Subsequent Events - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_9e4a81b8-d848-4b6b-9f61-d7f1ba8aa59b", "decimals": "0", "first": true, "lang": null, "name": "kod:ConsecutiveTradingDays", "reportCount": 1, "unique": true, "unitRef": "U_Days", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_e5c59142-312f-4066-abfc-c35cb8d948e8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_e5c59142-312f-4066-abfc-c35cb8d948e8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_5c21659f-1cec-4a85-8710-24968233ef93", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Condensed Consolidated Statements of Stockholders' Equity", "role": "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity", "shortName": "Condensed Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_520836e4-6ccf-4a48-aec5-56fdd89596cc", "decimals": "-3", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": "-3", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "kod:TheCompanyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100060 - Disclosure - The Company", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompany", "shortName": "The Company", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "kod:TheCompanyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100070 - Disclosure - Summary of Significant Accounting Policies", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - Accrued and Other Current Liabilities", "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities", "shortName": "Accrued and Other Current Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "kod-20210930.htm", "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 32, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "verboseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "verboseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "verboseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "verboseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "verboseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "verboseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r287" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "verboseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "kod_AccruedClinicalTrialAndRelatedCostsCurrent": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued clinical trial and related costs current.", "label": "Accrued Clinical Trial And Related Costs Current", "terseLabel": "Accrued clinical trial and related costs" } } }, "localname": "AccruedClinicalTrialAndRelatedCostsCurrent", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kod_AccruedLeaseholdImprovements": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Leasehold Improvements", "label": "Accrued Leasehold Improvements" } } }, "localname": "AccruedLeaseholdImprovements", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kod_AccruedLegalFeesCurrent": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued legal fees current.", "label": "Accrued Legal Fees Current", "terseLabel": "Accrued legal fees" } } }, "localname": "AccruedLegalFeesCurrent", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kod_AccruedResearchAndDevelopmentCurrent": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued research and development current.", "label": "Accrued Research And Development Current", "terseLabel": "Accrued research and development" } } }, "localname": "AccruedResearchAndDevelopmentCurrent", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kod_AmortizationOfIssuanceCosts": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of issuance costs.", "label": "Amortization Of Issuance Costs", "terseLabel": "Amortization of issuance costs" } } }, "localname": "AmortizationOfIssuanceCosts", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails": { "order": 0.0, "parentTag": "kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Available for sale debt securities accumulated gross unrealized gain before tax, current.", "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current", "terseLabel": "Unrealized Gains, current" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Available for sale debt securities accumulated gross unrealized loss before tax current.", "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Current", "negatedLabel": "Unrealized Losses, current" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Available for sale debt securities amortized cost basis current.", "label": "Available For Sale Debt Securities Amortized Cost Basis Current", "totalLabel": "Amortized Cost, current" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "kod_ClinicalAndCommercialSupplyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clinical and commercial supply.", "label": "Clinical And Commercial Supply [Member]", "terseLabel": "Clinical and Commercial Supply of Drug Substance" } } }, "localname": "ClinicalAndCommercialSupplyMember", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "kod_CommitmentsAndContingenciesDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies disclosure.", "label": "Commitments And Contingencies Disclosure [Line Items]", "terseLabel": "Commitments And Contingencies Disclosure [Line Items]" } } }, "localname": "CommitmentsAndContingenciesDisclosureLineItems", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "kod_CommitmentsAndContingenciesDisclosureTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies disclosure.", "label": "Commitments And Contingencies Disclosure [Table]", "terseLabel": "Commitments And Contingencies Disclosure [Table]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTable", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "kod_ConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consecutive Trading Days", "label": "Consecutive Trading Days", "terseLabel": "Consecutive Trading days" } } }, "localname": "ConsecutiveTradingDays", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "kod_ContractualObligationDueInSecondYearAndAfter": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contractual obligation due in second year and after.", "label": "Contractual Obligation Due In Second Year And After", "terseLabel": "Annual suite fees payment each year after 2021" } } }, "localname": "ContractualObligationDueInSecondYearAndAfter", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "kod_DepositsOnPropertyAndEquipment": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deposits on property and equipment.", "label": "Deposits On Property And Equipment", "negatedLabel": "Deposits on property and equipment" } } }, "localname": "DepositsOnPropertyAndEquipment", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "kod_EstimatedCapitalContributions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Estimated capital contributions.", "label": "Estimated Capital Contributions", "terseLabel": "Revised estimated capital contribution" } } }, "localname": "EstimatedCapitalContributions", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "kod_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in operating lease liability.", "label": "Increase Decrease In Operating Lease Liability", "terseLabel": "Operating lease liability" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon exercise of common stock warrants.", "label": "Issuance Of Common Stock Upon Exercise Of Common Stock Warrants", "terseLabel": "Issuance of common stock upon exercise of common stock warrant" } } }, "localname": "IssuanceOfCommonStockUponExerciseOfCommonStockWarrants", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon exercise of common stock warrants, shares.", "label": "Issuance Of Common Stock Upon Exercise Of Common Stock Warrants Shares", "terseLabel": "Issuance of common stock upon exercise of common stock warrant, shares" } } }, "localname": "IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon vesting of restricted stock units,net of taxes withheld.", "label": "Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Net Of Taxes Withheld", "terseLabel": "Issuance of common stock upon vesting of restricted stock units, net of taxes withheld" } } }, "localname": "IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon vesting of restricted stock units,net of taxes withheld, shares.", "label": "Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Net Of Taxes Withheld Shares", "terseLabel": "Issuance of common stock upon vesting of restricted stock units, net of taxes withheld, shares" } } }, "localname": "IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "kod_LiabilityRelatedToSaleOfFutureRoyalties": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability related to sale of future royalties.", "label": "Liability Related To Sale Of Future Royalties", "terseLabel": "Liability related to sale of future royalties" } } }, "localname": "LiabilityRelatedToSaleOfFutureRoyalties", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "kod_LongTermPerformanceIncentivePlanDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-Term Performance Incentive Plan Description", "label": "Long-Term Performance Incentive Plan Description", "terseLabel": "Plan description" } } }, "localname": "LongTermPerformanceIncentivePlanDescription", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "kod_LonzaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lonza.", "label": "Lonza [Member]", "terseLabel": "Lonza" } } }, "localname": "LonzaMember", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "kod_ManufacturingAgreementExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Manufacturing Agreement Expense", "label": "Manufacturing Agreement Expense" } } }, "localname": "ManufacturingAgreementExpense", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "kod_ManufacturingAgreementInitialTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Manufacturing agreement initial term.", "label": "Manufacturing Agreement Initial Term", "terseLabel": "Manufacturing agreement initial term" } } }, "localname": "ManufacturingAgreementInitialTerm", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "kod_ManufacturingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Manufacturing agreement.", "label": "Manufacturing Agreement [Member]", "terseLabel": "Manufacturing Agreement" } } }, "localname": "ManufacturingAgreementMember", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "kod_ManufacturingAgreementTermThatCanBeExtended": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Manufacturing agreement term that can be extended.", "label": "Manufacturing Agreement Term That Can Be Extended", "terseLabel": "Manufacturing agreement term that can be extended" } } }, "localname": "ManufacturingAgreementTermThatCanBeExtended", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "kod_NumberOfPurchasePeriods": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of purchase periods.", "label": "Number Of Purchase Periods", "terseLabel": "Number of purchase periods" } } }, "localname": "NumberOfPurchasePeriods", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "kod_OperatingLeaseRightOfUseAssetAmortization": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating lease right of use asset amortization.", "label": "Operating Lease Right Of Use Asset Amortization", "terseLabel": "Amortization of operating lease right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortization", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "kod_PerformanceBasedEquityAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance based equity awards.", "label": "Performance Based Equity Awards [Member]", "terseLabel": "Performance Based Equity Awards" } } }, "localname": "PerformanceBasedEquityAwardsMember", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "kod_PerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Restricted Stock Units [Member]", "label": "Performance Based Restricted Stock Units [Member]", "terseLabel": "Performance Based Restricted Stock Units" } } }, "localname": "PerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "kod_PerformanceBasedStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance-based stock options.", "label": "Performance Based Stock Options [Member]", "terseLabel": "Performance-based Stock Options" } } }, "localname": "PerformanceBasedStockOptionsMember", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "kod_PrincipalPaymentsOfTenantImprovementAllowancePayable": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Principal payments of tenant improvement allowance payable.", "label": "Principal Payments Of Tenant Improvement Allowance Payable", "negatedLabel": "Principal payments of tenant improvement allowance payable" } } }, "localname": "PrincipalPaymentsOfTenantImprovementAllowancePayable", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sale of future royalties, net of issuance costs.", "label": "Proceeds From Sale Of Future Royalties Net Of Issuance Costs", "terseLabel": "Proceeds from sale of future royalties, net of issuance costs" } } }, "localname": "ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "kod_RiskAndUncertaintiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risk and uncertainties.", "label": "Risk And Uncertainties Policy [Text Block]", "terseLabel": "Risk and Uncertainties" } } }, "localname": "RiskAndUncertaintiesPolicyTextBlock", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "kod_SalesForecasting": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sales Forecasting", "label": "Sales Forecasting", "terseLabel": "Sales" } } }, "localname": "SalesForecasting", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of accrued and other current liabilities.", "label": "Schedule Of Accrued And Other Current Liabilities Table [Text Block]", "terseLabel": "Schedule of Accrued and Other Current Liabilities" } } }, "localname": "ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, options, aggregate intrinsic value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "stringItemType" }, "kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options performance period", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options performance period", "terseLabel": "Performance Periods" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options performance period expiration.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Performance Period Expiration", "terseLabel": "Performance expiration date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, options, weighted average remaining contractual term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]", "terseLabel": "Weighted Average Remaining Contractual Term (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "stringItemType" }, "kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award vesting period for achievement of specific milestone.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Vesting Period For Achievement Of Specific Milestone", "terseLabel": "Vesting period for achievement of specific milestone" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "kod_TermOfOfferingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of offering period.", "label": "Term Of Offering Period", "terseLabel": "Term of offering period" } } }, "localname": "TermOfOfferingPeriod", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "kod_TheCompanyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the company.", "label": "The Company [Text Block]", "terseLabel": "The Company" } } }, "localname": "TheCompanyTextBlock", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompany" ], "xbrltype": "textBlockItemType" }, "kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand eighteen and two thousand fifteen equity incentive plan.", "label": "Two Thousand Eighteen And Two Thousand Fifteen Equity Incentive Plan [Member]", "terseLabel": "2018 Plan and 2015 Equity Incentive Plan" } } }, "localname": "TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "domainItemType" }, "kod_TwoThousandEighteenEmployeeSharePurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand eighteen employee share purchase plan.", "label": "Two Thousand Eighteen Employee Share Purchase Plan [Member]", "terseLabel": "2018 Employee Share Purchase Plan" } } }, "localname": "TwoThousandEighteenEmployeeSharePurchasePlanMember", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "kod_TwoThousandEighteenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand eighteen equity incentive plan.", "label": "Two Thousand Eighteen Equity Incentive Plan [Member]", "terseLabel": "2018 Equity Incentive Plan" } } }, "localname": "TwoThousandEighteenEquityIncentivePlanMember", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Twenty One Long-Term Performance Incentive Plan [Member]", "label": "Two Thousand Twenty One Long-Term Performance Incentive Plan [Member]", "terseLabel": "2021 LTPIP" } } }, "localname": "TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember", "nsuri": "http://kodiak.com/20210930", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r36", "r69" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r146", "r147", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r256", "r257" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum", "verboseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r146", "r147", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r256", "r257" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r137", "r146", "r147", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r256", "r257" ], "lang": { "en-us": { "role": { "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r137", "r146", "r147", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r256", "r257" ], "lang": { "en-us": { "role": { "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Repurchase Agreement Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block]", "terseLabel": "Accrued and Other Current Liabilities" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Payable And Accrued Liabilities Current [Abstract]" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Current", "terseLabel": "Accounts payable", "totalLabel": "Accounts Payable, Current, Total" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": { "auth_ref": [ "r62" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Accretion Amortization Of Discounts And Premiums Investments", "negatedLabel": "Amortization (accretion) of premium (discount) on marketable securities" } } }, "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities Current", "terseLabel": "Accrued and other current liabilities", "totalLabel": "Total accrued and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r7", "r8", "r29" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees Current", "terseLabel": "Accrued professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r17", "r38", "r39", "r40", "r249", "r262", "r263" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive income", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r37", "r40", "r41", "r71", "r72", "r73", "r191", "r258", "r259" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r15" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid In Capital Common Stock", "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance", "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r71", "r72", "r73", "r173", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r148", "r150", "r178", "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value", "terseLabel": "Stock-based compensation expense", "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r150", "r169", "r177" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Stock-based compensation expense recognized", "verboseLabel": "Total stock-based compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount", "terseLabel": "Anti-dilutive securities excluded from the computation of diluted net loss per common share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities Name [Domain]", "terseLabel": "Antidilutive Securities, Name" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Arrangements And Nonarrangement Transactions [Member]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r68", "r99", "r101", "r105", "r116", "r188", "r192", "r206", "r238", "r248" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r5", "r35", "r68", "r116", "r188", "r192", "r206" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r197" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Fair Value Disclosure", "totalLabel": "Total" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r108", "r112", "r118", "r240" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Securities Debt Securities", "terseLabel": "Marketable securities", "totalLabel": "Debt Securities, Available-for-sale, Total" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "auth_ref": [ "r110", "r118" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails": { "order": 1.0, "parentTag": "kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.", "label": "Available For Sale Securities Debt Securities Current", "terseLabel": "Fair Value, current", "totalLabel": "Debt Securities, Available-for-sale, Current, Total" } } }, "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r151", "r171" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r194", "r195" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis Of Accounting Policy Policy [Text Block]", "terseLabel": "Basis of Presentation and Principles of Consolidation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r23", "r63" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance", "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails": { "order": 0.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash And Cash Equivalents Fair Value Disclosure", "terseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "auth_ref": [ "r23" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.", "label": "Cash Cash Equivalents And Short Term Investments", "terseLabel": "Cash and cash equivalents and marketable securities", "totalLabel": "Cash, Cash Equivalents, and Short-term Investments, Total" } } }, "localname": "CashCashEquivalentsAndShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompanyAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]", "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r58", "r63", "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "periodEndLabel": "Cash, cash equivalents and restricted cash, at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash, at beginning of period", "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r58", "r207" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental disclosures of non-cash investing and financing information:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r32", "r133", "r241", "r253" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments And Contingencies", "terseLabel": "Commitments and contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r130", "r131", "r132", "r134" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance", "verboseLabel": "Common stock, shares reserved for issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r71", "r72" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Common stock, shares issued", "totalLabel": "Common Stock, Shares, Issued, Total" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r14", "r135" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r14" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "terseLabel": "Common stock, $0.0001 par value", "totalLabel": "Common Stock, Value, Issued, Total" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r44", "r46", "r47", "r50", "r244", "r255" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.", "label": "Contractual Obligation", "terseLabel": "Annual suite fees payment", "totalLabel": "Contractual Obligation, Total", "verboseLabel": "Contractual obligation under funding agreement" } } }, "localname": "ContractualObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation Due In Next Twelve Months", "terseLabel": "Annual suite fees payment for 2021" } } }, "localname": "ContractualObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNoteSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about short-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest).", "label": "Corporate Note Securities [Member]", "terseLabel": "Corporate Notes" } } }, "localname": "CorporateNoteSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": { "auth_ref": [ "r113", "r118", "r119", "r120" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities Available For Sale Allowance For Credit Loss", "periodEndLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss, Ending Balance", "periodStartLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance", "terseLabel": "Allowance for credit losses for available-for-sale debt securities", "totalLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss, Total" } } }, "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": { "auth_ref": [ "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities Available For Sale Realized Gain Loss", "terseLabel": "Realized gains or losses recognized on sale or maturity of available-for-sale debt securities", "totalLabel": "Debt Securities, Available-for-sale, Realized Gain (Loss), Total" } } }, "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTerm": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Debt Securities Available For Sale Term", "terseLabel": "Marketable securities, effective maturities" } } }, "localname": "DebtSecuritiesAvailableForSaleTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r61", "r126" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation", "totalLabel": "Depreciation, Total" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Basic And Diluted", "terseLabel": "Net loss per common share, basic and diluted", "totalLabel": "Earnings Per Share, Basic and Diluted, Total" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r85", "r86", "r87", "r88" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss per Common Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee Related Liabilities Current", "terseLabel": "Accrued salaries and benefits", "totalLabel": "Employee-related Liabilities, Current, Total" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]", "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Unrecognized compensation weighted-average period expected for recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r170" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Unrecognized compensation cost related to unvested share based awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "verboseLabel": "Outstanding Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r71", "r72", "r73", "r75", "r80", "r82", "r89", "r117", "r135", "r136", "r173", "r174", "r175", "r182", "r183", "r208", "r209", "r210", "r211", "r212", "r213", "r258", "r259", "r260" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r197", "r198", "r199", "r204" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r197", "r198" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value Assets Measured On Recurring Basis [Text Block]", "terseLabel": "Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]", "terseLabel": "Asset Class" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r197", "r204" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Fair Value By Asset Class [Axis]", "terseLabel": "Asset Class" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r198", "r224", "r225", "r226" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]", "terseLabel": "Significant Observable Inputs (Level 2)" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r197", "r198", "r200", "r201", "r205" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Fair Value By Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r138", "r139", "r144", "r145", "r198", "r224" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value Inputs Level1 [Member]", "terseLabel": "Quoted Price in Active Markets (Level 1)" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r138", "r139", "r144", "r145", "r198", "r225" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value Inputs Level2 [Member]", "terseLabel": "Significant Observable Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r198", "r226" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Inputs Level3 [Member]", "terseLabel": "Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Fair Value Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r224", "r225", "r226" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r203", "r205" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value Measurements Recurring [Member]", "terseLabel": "Fair Value, Measurements, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r121", "r122", "r124", "r125", "r235", "r236" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite Lived Intangible Assets By Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r121", "r123" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite Lived Intangible Assets Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r52" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General And Administrative Expense", "terseLabel": "General and administrative", "totalLabel": "General and Administrative Expense, Total" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General And Administrative Expense [Member]", "terseLabel": "General and Administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r60" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase Decrease In Accounts Payable", "terseLabel": "Accounts payable", "totalLabel": "Increase (Decrease) in Accounts Payable, Total" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r60" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase Decrease In Accrued Liabilities And Other Operating Liabilities", "terseLabel": "Accrued and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase Decrease In Operating Capital [Abstract]", "terseLabel": "Changes in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r60" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase Decrease In Other Operating Assets", "negatedLabel": "Other assets", "totalLabel": "Increase (Decrease) in Other Operating Assets, Total" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r60" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets", "negatedLabel": "Prepaid expenses and other current assets", "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r48", "r98", "r215", "r216", "r245" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense", "totalLabel": "Interest Expense, Total" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r53", "r97" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investment Type Categorization [Member]", "terseLabel": "Investments" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments Debt And Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r115", "r237", "r247", "r279" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block]", "terseLabel": "Marketable Securities" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseAgreementsMember": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Contractual agreement that stipulates the lessee pay the lessor for use of an asset.", "label": "Lease Agreements [Member]", "terseLabel": "Lease Agreement" } } }, "localname": "LeaseAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r27", "r68", "r102", "r116", "r189", "r192", "r193", "r206" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r20", "r68", "r116", "r206", "r239", "r251" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "Liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r30", "r68", "r116", "r189", "r192", "r193", "r206" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecurities": { "auth_ref": [ "r242" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security.", "label": "Marketable Securities", "terseLabel": "Availability of Marketable Securities", "totalLabel": "Marketable Securities, Total" } } }, "localname": "MarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [ "r3", "r28" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable Securities Current", "terseLabel": "Marketable securities", "totalLabel": "Marketable Securities, Current, Total" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Marketable Securities [Line Items]", "terseLabel": "Marketable Securities [Line Items]" } } }, "localname": "MarketableSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in marketable security.", "label": "Marketable Securities [Table]", "terseLabel": "Marketable Securities [Table]" } } }, "localname": "MarketableSecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.", "label": "Marketable Securities [Text Block]", "terseLabel": "Summary of Marketable Securities" } } }, "localname": "MarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r58" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r58" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r58", "r59", "r62" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r42", "r45", "r49", "r62", "r68", "r74", "r76", "r77", "r78", "r79", "r81", "r82", "r83", "r99", "r100", "r103", "r104", "r106", "r116", "r206", "r243", "r254" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements Policy Policy [Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": { "auth_ref": [ "r64", "r65", "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash Or Part Noncash Acquisition Fixed Assets Acquired1", "terseLabel": "Purchase of property and equipment under accounts payable and accruals" } } }, "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r99", "r100", "r103", "r104", "r106" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income Loss", "terseLabel": "Loss from operations", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r218" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease Liability", "terseLabel": "Lease liabilities", "totalLabel": "Operating Lease, Liability, Total" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r218" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "terseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r218" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease Liability Noncurrent", "terseLabel": "Operating lease liability, net of current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r217" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease Right Of Use Asset", "terseLabel": "Operating lease right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r7", "r8", "r9", "r29" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities Current", "terseLabel": "Accrued other liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r194", "r196" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r25" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets Noncurrent", "terseLabel": "Other assets", "totalLabel": "Other Assets, Noncurrent, Total" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r186", "r187", "r190" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.", "label": "Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent", "terseLabel": "Change in unrealized gains related to available-for-sale debt securities, net of tax", "totalLabel": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total" } } }, "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r43", "r46", "r186", "r187", "r190" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent", "terseLabel": "Other comprehensive income (loss)", "totalLabel": "Total other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent [Abstract]", "terseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r31" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities Noncurrent", "terseLabel": "Other liabilities", "totalLabel": "Other Liabilities, Noncurrent, Total" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r54" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income Expense", "terseLabel": "Other income (expense), net", "totalLabel": "Other Nonoperating Income (Expense), Total" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).", "label": "Other Than Temporary Impairment Loss Debt Securities Available For Sale", "terseLabel": "Impairment charges or recoveries related to marketable securities", "totalLabel": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Total" } } }, "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r57" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedLabel": "Payments for restricted stock units, net of taxes withheld" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r109" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments To Acquire Marketable Securities", "negatedLabel": "Purchase of marketable securities", "totalLabel": "Payments to Acquire Marketable Securities, Total" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r55" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Purchase of property and equipment", "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r151", "r171" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued", "terseLabel": "Preferred Stock, shares issued", "totalLabel": "Preferred Stock, Shares Issued, Total" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding", "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "terseLabel": "Preferred Stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r13" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value", "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance", "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance", "terseLabel": "Preferred stock, $0.0001 par value", "totalLabel": "Preferred Stock, Value, Issued, Total" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r4", "r21", "r22" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense And Other Assets Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Prior Period Reclassification Adjustment Description", "terseLabel": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": { "auth_ref": [ "r56", "r172" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.", "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised", "terseLabel": "Proceeds from issuance of common stock pursuant to employee stock purchase plans" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds From Sale And Maturity Of Marketable Securities", "terseLabel": "Maturities of marketable securities", "totalLabel": "Proceeds from Sale and Maturity of Marketable Securities, Total" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r56", "r172" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds From Stock Options Exercised", "terseLabel": "Proceeds from issuance of common stock upon options exercise" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r24", "r128" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r10", "r11", "r128", "r252" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance", "terseLabel": "Property and equipment, net", "totalLabel": "Property, Plant and Equipment, Net, Total" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r10", "r127" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": { "auth_ref": [], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.", "label": "Repayments Of Debt And Capital Lease Obligations", "negatedLabel": "Principal payments of capital lease" } } }, "localname": "RepaymentsOfDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r181", "r281" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research And Development Expense", "terseLabel": "Research and development", "totalLabel": "Research and Development Expense, Total" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research And Development Expense [Member]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r6", "r12", "r67", "r280" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash Noncurrent", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Shares", "verboseLabel": "Unvested Restricted Shares" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r16", "r136", "r176", "r250", "r261", "r263" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "terseLabel": "Accumulated deficit", "totalLabel": "Retained Earnings (Accumulated Deficit), Total" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r71", "r72", "r73", "r75", "r80", "r82", "r117", "r173", "r174", "r175", "r182", "r183", "r258", "r260" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r219", "r220" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability", "terseLabel": "Operating lease right-of-use asset obtained in exchange for operating lease liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Stock Price" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]", "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]", "terseLabel": "Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block]", "terseLabel": "Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r150", "r168", "r177" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]", "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r151", "r171" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r154", "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]", "terseLabel": "Summary of Stock Options Activity under 2018 Plan and 2015 Equity Incentive Plan" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block]", "terseLabel": "Summary of Restricted Shares" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r60" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "terseLabel": "Stock-based compensation", "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Unvested, ending balance", "periodStartLabel": "Unvested, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Unvested, ending balance", "periodStartLabel": "Unvested, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period", "negatedLabel": "Vested", "terseLabel": "Awards vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized", "terseLabel": "Number of common stock available for issuance increased" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Issuance of common stock pursuant to employee stock purchase plans" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period", "negatedLabel": "Forfeited or canceled", "totalLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price", "terseLabel": "Forfeited or canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross", "terseLabel": "Granted", "verboseLabel": "Stock options, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r171" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value", "terseLabel": "Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r156", "r171" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward", "terseLabel": "Number of Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r149", "r153" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price", "terseLabel": "Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2", "terseLabel": "Weighted Average Remaining Contractual Term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "terseLabel": "Stock options, vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent", "terseLabel": "Common stock purchase price percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r34", "r71", "r72", "r73", "r75", "r80", "r82", "r89", "r117", "r135", "r136", "r173", "r174", "r175", "r182", "r183", "r208", "r209", "r210", "r211", "r212", "r213", "r258", "r259", "r260" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r71", "r72", "r73", "r89", "r234" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r13", "r14", "r135", "r136" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of common stock pursuant to employee stock purchase plans, shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r13", "r14", "r135", "r136", "r157" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "negatedLabel": "Exercised", "terseLabel": "Issuance of common stock upon exercise of stock options, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r13", "r14", "r135", "r136" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period Value Employee Stock Purchase Plan", "terseLabel": "Stock based compensation expense related to ESPP", "verboseLabel": "Issuance of common stock pursuant to employee stock purchase plans" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r34", "r135", "r136" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period Value Stock Options Exercised", "terseLabel": "Issuance of common stock upon exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r14", "r18", "r19", "r68", "r107", "r116", "r206" ], "calculation": { "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders Equity", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited", "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r214", "r222" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r214", "r222" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r214", "r222" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r214", "r222" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r221", "r223" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEvents1" ], "xbrltype": "textBlockItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Type Of Arrangement [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r138", "r145", "r246" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "U S Treasury Securities [Member]", "terseLabel": "U.S. Treasury Securities" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails", "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r90", "r91", "r92", "r93", "r94", "r95", "r96" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use Of Estimates", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number Of Share Outstanding Basic And Diluted", "terseLabel": "Weighted-average common shares outstanding used in computing net loss per common share, basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "8A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563" }, "r115": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(i)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r134": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r223": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803" }, "r247": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r279": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.2)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r282": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r283": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r284": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r285": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r286": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r287": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r70": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" } }, "version": "2.1" } ZIP 55 0000950170-21-003800-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-21-003800-xbrl.zip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
2>?8M[Q[!K&AEW4HEMNS0\JC9G+GV1_*@/7J#V@L6LDYS"Z3U3S<^GZ M>;9/>HL5(B2OW-K4FEA:XGZ0OAZ,]N-NK!QU64R] Z!2D1I'_7G=B/2]MPA8 MF+2D\XRY17#ZI6'R&,_X2Z,7B2)ZJT]L^ S)VV*I]]<6^%$E\W> 3Q, <"B0 M'/X.&"DMP>K TZ!4[5QG&<\?OM46[-MZSNS966UQG%*!L4'; M;\%/Z)9,.LK7FZ@.?$N?8RKK>ZQ3.FQN2M9[,!4XRS):L6]E^G(ZQ3JH,5ZW MA5#'W;GZM3"L)$(QV.FH@H:\Y\R'W^LWA6!6Y8,*628^E U^D"5 _#H.98&N M1(KU61!?^.EL*09G=%]^57)XF,_%0^2-6TKM%>0*7A1-5,>MLM3]\@EOK:AR MHI(0XW:;?P< M9OTW3/-'A)5.01_H'!405V#F?'S5=4!P&M]NU#K7:=7ZJ*O M5A\JTU3:W$9#'9U\M^3G(]O(MXY%&?@WF8)W!-[$Y^>VD &?I[H) M08VNGY^X!I+XD5@\@7RXS<8^QX[=I[UQ'>(85>4.=F,0M=3'29>ZW^P@G[WD MI-K1>(4N8H!*8&0AC3#.>6?7VA)Y-[!.,=1V#D)7+#(,KQGTMG5G2G'_M&W# M$Y$TG_F:[=XONRN5*B?XT6QQ0=IG?1;/9)@-)ZP+/ETGPVSJ$"OEIQ,B979V M"1^&235?T3UIP@]P#WBML>_T_]B1.-W_4S-(-T'H;Y#R?>"(P916_+]RLHW8 MXCGT=[/W'0!P!_@SU\!R!]#O5!E$AF&BTJ (LEL2D!7P G3^D^#_RK5>_HB#U/4<4 M8?PCI[Y14Y6VJA X8QIW #(^I$R8L_"8^\97 MQ4TVLSAL!F_-59;0MO2'=7NT]]YJQTU.Z1*GZ Y=?-$PYRN5P6ZF:NJN.,I# MX%.,/))_P)C[T[5S/OZ,Z^)RUY^,PN;/O[5%M]]35 T=-EF+LWY)AV(XH B- MRBCCG07$T>H+A'X>L8"Z62)=41!5\%6WH:*@36!9.QP06&Y1H*N#&FOTS*6> MG8K4\@(57^7>PK9@\)LMT9C2%?17)[RN:[!27IJ[\&N3T#5F(Y7*'T+G5V\' M1^(![)TJZZ%2GZQ#60TW8^1>ONK2? B@N.:6F$@?GE.:RP+:>ZW I:U1W0C2 M:B0WR@\I&O,3+O*O.-S9JEXV[;L\U^_AW%9*G6_+Z]Z5J9W6+DMI.H@/J\_1 M$G[KK6%)-RI*;!U&K.0F/+&&)XVG0U=FS59=^ ?B8_ZA6NI"*M+EIMIYRS.; M1_[@_R)_2=E_=BLEB,F@ MCV=YP#Q6![3?MNTG(^YF7:^&K("H! MGN:N!XIN?W[7#'8QDP9G^Y(5 6TLGII@=)$RA>5#"([>5:(IWDEG82?_0>50 M=H6;LD#M2!O69]X# ,"3KY'7!Y'->KLFCK:/24E\E_A93FWK;HDV.@==*!N/ MB38LGH!CG,WM0U4ES($R.OPCDC!!(59;V>YGEA[=6!IA*5ZJ>50#VAL8BJ$K M C/USJ>GA/2'9I1\.-5@-?=:DVBL%3RQM7JHU/7@&6'E'!=7>V,"D][9(?Q" MANV>>Z5@A)!D$76=C\ 92M.%,W6WS*:]$-Y<06D<3(/1(D0_U^0O*V MXYD2QF(H-5UW#?>S0>RC>]=EV]IDN@4/W0'R5=5NVSNW#_P9H/,I<=C4$8L< M"KT;"VCZ -3@=JVV>0/8R(1)7XNY RS7WP&FFD![<4'W#*.B0Q+;[?3S;T5$ M&1PD1AL2D-"0E_2"Y>.;ASO>FAJ >#6_&_D/CN(#(^UC;/+JD(GZN.%*?(A= M+9HDIS+8_R4$!X%M+C46*C-(;X!1EL,K-J'@"1>.=!QQ8H&$6 WC&P*43,L= M(+A791:B6(2AF_1G,.?)%[Y55)^RJA73'Q>J@N2\:R1*NXE+B+:,O-:.="O* M:WB914U05I&6<+5U3T'V[P")2"09MLWF7NO\PO_.X0.W/1 $MSZFT/V^RC\M MG/>3S.ZY[OS7GC5QSS%<)D+O!?9I?+LV0?OW.&G[O<1*+1X[Q;>-42?O&U&X M+? ]PFO0<+P?VFIMJ>>L_]*<"FWDNL')&_JCH+[6$?'AE.^C1M)HW,CM E?> M,\.=ZFGQROI717NF;>6TDAI+[OT+W&>]ZVN8O*B^M8O;$NA^8^6?:TX%T^*K M%&V85%3'*+H3^_C;'8!UOGL-10V]?38[@ITVIT!"(X#6L&!RL#]1Z3'MH$IM MFGY=K;[7X*+UZ8ZM>5&PC!\1'ESDLI]2JW@XL6' +7=T^Z3Y2LK7#P'J6R-T M_BS-@"CM2V.4JIGJ:[P>ZS\*71K+59LV%3"*?'K:@!.!\QN ]\WB'78 >&H+ M>]*Y-@L\C^$^;N'*-_AAW-=+-L('PA+TPA"JT"LJ"/0.8)$*NWZ0LK?6L!=V M4?D-6,=6V:=!_ '%A(@W'A[Y$A3^3SJ7N.OKL^@*X)*5K\%?-HKVRHX=I\$C MH%?QFG/AR#VLN81P=-V;#[Q/+$'0T9\S[=@>W$MDLUP5-\AW!U#&AW1N\8?2 M[AV%('WU9R^8PEJ\^YAP5FBD(T14<=P_O["_S]"'L1]&+MUZ$[())9B*DC5+ MZMG7-%,9Q!4XC_S],$SHYAS,9W1*KL,2T]'8AAYB1'G',>WU7Z]+$F?"S7<" MH>)_^#E Q(UOW2-O<4,I&B->1E"))\B5,'=IB@-(>[+DW^^,GBO4K:_7>\NP M_J^%'O]CRSL)^P2(@_;NA2(JL"NW"87='U&5QYW\8Z>YNFN-1WO.7GLTXA,Z M%CDS>B4).UJ)SQFLP!UD44.CYNGQ%<1RLGG#[ML(>8N<[JZE#V_@1.VTZ"+A"DCI, M<44TWZI1Q]0'M7"59R&R$,0H^+:+R_ "M_T0)8;>L4?"-MC2JQH;YNOD51GD MQE?D7G7=+I<$ $K6R;NZ;"TE#=JTC%IBM782RCX5::1+\@UV0Q':+J'>M.;Y M&]"(:W&0;WC69WZ.L%!EBI/&-.8O8,^A-_%Z=P T^TFO;\8N4J.? >37C_HE M9+ADJC;2S-NQ:9HPOONJF6&VWV]$WJ >DAE\@W_LES_Q\K9(!J_W/O\3@,G% M@H\N,HSP=W]X\GGQ=#VM1XX/:.LF3#.O;Q%L0<. =?/]_(MX*O?HP#UH_K!Y MIJY5P;::.K&^5N'1D.$_7*7$PKK?@AKJ8F:M/.51200,:Z-S 6;MBIZ!Z)[&B1HMZBH-YQWK:GX9#,JC\5N(V0J-<@5Q5X8:N(M!3V>;ZK\_%]6J(1#JQ^ MD_IK'4:-)@7= H\U1(JR[>J)7@R<4?2(*5N+$\3>QRN#OS$4"I#2E-*?Q:KI M*EI>]GMAW3 <\"6J\#:WS)\'7*F8)HM8S9(6^T+S\M-D'^OS%V%>Q$%?B">F M3SQ^&\OPWP&&E:5%[AWVV@(;I7)+EE.Y=.CK40V;O85;F"QSLPPP4DYC7#?, M3'JOR^S,I'0:$N<\=4(7#F2942P2!#./YW.J)"^!0N>^T*BU*OX8$1VJ2"P; M0FT+C_60KCZK)ZZ9_6)B<1>/ZYWG7BB.<M\6U1^6_)U6#(S,CCWWX"78H\%0NLF1O]P M0Z/7J'Y$U9?!2O4'[>G2G Z/ELI'L^&RM[\)@+?^]:4;L(6P+N SH)T?F?:4 M,.QH@M[1F)7:U3$4M9%2H4+0.S"NR0U+W@"3)$QU+.04+M53)*@'VXIQ@MPW MXM !2JJ^"42#>[L\MZ<'6;[,IH+7]O+V3LSQ=!V-8 M;5+SE>H--9A,$SV+G'X+,TIU4E1 9)68BBT]\HQYR7&$($80?(Y:[5[OU=;,JD2;1IFD1E&=HMM[BJ?T7+XAQ'W9.['B MN.V[D=PTRD,K65J1P;J:6O*4;/^C1PJ8Z3ABP^P]FEH%';:Q#UFCP,ATF'G- M&I3-C7SSQF&V!\DGNL[;<:]Q246!*WEW L%SG]BT$Q5?ANIKOY8E*'J9G"98 MK;RX/(]V\,M'3_1(BD4*7UFW35^8&+H<%6B[[[0\-(T=S%:T(JP8[]"^#;F( MD.8@ZV<*4>->W<<"YHW?"&D^:"&2BI_FK78^?0_O)84'')O?5APRN5@3^QJO M& I6/2 ?[)Q!50HH>!86SX_1NOX1R7*M'/^MFM^L2?.<5$EBXK0TG2^ YOT\ MUW]:O7WT^WJFA2IXKHR/#T]14N#QKV\/GD8C+T1:I]-;4B@,V 042#72Y>8% M*D$Q+")M^'\XP3O+#__;3F9OK2B?RO!UJWE[0"2@3B,Q\> MLW:B?'TH72HEFV_=S?44&ANYV=Z'MULN_=WIE-@QH!S2N+&VM+4E M%B?-5G"X1'"$W/O[-0]W=_P,2^[+MD9C)?89'$0:;!D VB>+;IDRQH@@;5[7 MU-T!%KU5#H;!.GAGF-)[-FG5SG#!O]BX 1>L:L"./1XOPR'@\<52)K] %?YR M2U-*]J?%3I)L5H;K9S]"SH>(D(7)"':N\685Y+]<-G:D4]@S\2T:&+045.HZ M#E3N]Y, @2@S_4TYJX4R;;)!.QI+M7VTP&@9-@@%VG>C=<$32&>([IC03R52 M?#;RT=:YS#[QLU^7;BP=74/F8Y=CSZU*1C1T"]8]1M9%VY9*&UO/6.S"JJ.R M.VHG/KC$%ORD]KGNT,M2^UVMP\!\"5TO>JOSPU?_L,TKZ5YO>VL^M-:[^. GXX(& M#EUVUR@*_^<8WEEIN@(0O]\6TU/P^/4%=MK3I]R,A=#"804%GGT;\6AH02AR M[#8,HU@*3D.I(.:*RQS36AH*F6?$5M=,I:<;X,VS;D>J] # 7@ ^R%/6R-G> M7N?/Y0T=89EUWZ>GWTD66+LQ>-^)3\\MB#"CK60];DL M4:^;QQ2C6S<+HZ3Y<]ZAHORDP;Z:G,6.;JP3+;N;R-FU3U96AJ$/6<9]2J96 M,#8(ZOY2_B!C8.0_B!9!Q'''8CZXU4*OJ6.*.;IQZ7TP\LN&W#'_MS2MZ6_) MUF,G$U;+Y?\&W8\H03&.I\(^>"J]G^S6+6U0E+-_OYI^A:AX\<,:02V)LI5) M6 [((^1>%Q '!'QR_Q8UL+3:_*MK*6LU8;-TNWW:Y5<S1;(3JH)SVF,_3"Y8G#:W.'2V_4P*Z4?KK(%^/7"ILXXA,T M>,RQ7(5Z,Y=6=126N:52\)&ZZ@:?;6(MU_AV'W%L_:"YN6JI.5?:, UA^&N\ M3QS16XC*K NR1>B \>6UAP6#/_/(YFU(;E9EKIKP,([T(A?^(FQ]9:K]'5<$&["QBO:/%1WMIES]U=XYW;T?[ERVAN/F7AZ!7A?H&J?T- M/\OB/&KSI9CU6Q +I[1!J/_D=4-]X:<. M:@1U2#W1&,? JN2,@7KLZ8!ED@-*JRKUWU^5>(6%-&?9<9OU( NY7OJOML&N M)PDYC=%\5UEY;A36/(-LU/06F M^[*HPNE#;EIB3)]) V @^70C(%#'?1]WG.V188>U'],X:2XJ.N)9EC M[_U0C=8N.. ]!?P,O =/,_US,BI PT5SJ!V;95H);\YAU-9%":U,\/P=H.V[ MH$E-8D6TH)+XX%F^>GKD7I&$ >HGZO=N'KR;@,:F3I1XA#; M%[XQ5S[C5R"P0&,M\Y$C$?ZV,I^F<,IY^WT\3Z1HJKFB^)M^'XWCE8UOO@BJ MRWZ4=_Q??Q8$VXP,QQ1_@92B2-NWAO M"-!3JX;]OHRL;_MEX8D*)&XEC;1OMIV1)<,/Y:I_=_\^ A5.7Q">Y- 9TE#* M>@("'EW/1.]R!/HQ'OM[/OO6).@^S])4$:<\DZ89]MQ%4$1S)V [ 7Y:*N95 MZN.,:+8LCTXY[!YS:]1/_"L6>?/ZUU!T-<$7@GN'^TE:L3G'W812R9B7& "E M=%:GJ30I+N?R&(DFN@;]XX:JSB9>B^C;4C]G2Y %_+?)75JKP!ZR]3G$D\MU M/N$M30M?.:KO2<=NEFZM !X!#-M4SOE+-7Q)@MI-3,NTH#B_ \8B6$H'":CH M>Z8NA!6IS0>I^IQ^T+.W>Z&GNQX-O=['XS"<2N^/+JV3&PO15%>D[%5$'IB1 M;7DE("XM)I>F)LQK$_WH^I@<2!AF^ZP%C85]'PX^)L)K^K=N+7*4LM%95]AU MB;^,Y*-_2=!6 :$1ACA))837++1)N'K_#/"0R'<:8;/U(9R(;/@M?O+K03S M221='ZW%4=*-Q%:OL?9R0933P[1G_G,S;$@J8R.O,9J#*!- M24%*ZHX5V99,.QK9LF R75E##V[!8CY7Y&4MS4UT73[*-8++)U4_#O&._Q9= M*^K?-&8#(9J1ML[#?$#> 7HF*$%)X.'#7@=[OX+#2QSM35^ID,^*P,L\N9_. M6#[EX[=,&G,*I3E$E=GX[^.K[>TXTM&=\C,=K!"YVT(9'C2Y*G(@?\/B(5P& MYNI7!%>R:ZE7J >8+);N6 I6>SE0NDE7HV^3UBU(*H.E7^1_&BIS3+]>[&&A MS6YT1T6-Q!9":BR=G;^N:Q(D0-ZC?R$YNB2SHF4>HS_> 1YALWC4>$?7$/$F M#AT??G2IU13S#I J,I26WV;*"(L=XR#25)&EGSH1CVG70 M0U%V]T:@=^?7XXMCCN.J(4%GAUG1DFV S^5U^E48]M%>L2CL1G2?A6AGR.\K M?15K -_.W[AR@)]BB0,1I&RRI+R;9<_JJSY^_G*+V:0F6G-=B0*O">\$/6_B MXLHP(Z>4X<88]D!/S43-3(Y^I^WW; ,^,Z[2"2P?8%378C+B\0,/__.ZF#DI M%XFJ6NRUJ)3!.#S$CB-R=SW;C^H8*__L>$FOF7X=)3*[M/H.'++A=T#ZJ)MI M/$""W>$\H_DI*]'+F/RTA'$R5S.]F/.OP>Q*O5RA\#.<["#,IX[J.,U@Q1>V MFO .;:$_=X 8M^'_!6 ^X96T54>BI)6^108ULD;3[MC_+^@"TYAAZ0AWLK31 MPY_!!7 <:J\LE>^T]NP$-@@:5!((XR2X@@K1\-Z6V)AB$[^*@=/9EX_4<* NH%69HXW/2W J ZBP[.VI9/>F/>+)JIB:RU3!:.I.M"U!Q4$ M "[2BV/J_PM*569W"!U$(.9116B1K5N!E!.,@1":VV3J>.8J[;42Y#'=EM*A&TH2<>):6/U9P\ZZ]..N#,!K4_%1UCC\UP==FA$3VY ^B\M)>BKG"-E9K/R2&QLR4K>.-ZDS1)L :E'_FS0000$P-DA"M@Z_YKXT-: MAA&6$<>I(2JCYX+QR)J:^+?[BH7OWC(1^_<\7?:?M*B[[.N,;:DO[25I)5(3 MI"%\R9[BQ;4W)\ZB)WX'R*YWP3XN1]2:-X5UP\C/Z7S8X]ZN@*#"A$;'WQ)L M G6P77[K25T\'?6HPI[.8)FG:(X-*%H10IU;$9'[8W4;7G8Z:JS09 M@I>T8&#@"2*Y*)N;?SWHZB+X?#M4CS@VS[(4K_N!ES#.J=A_G5$*800BG0], M'!E99RHA$IL4P7Z%BDXR/B,JU+NG>3&/*3FD5"EE?AJ, Q_R7T#AJBA4W*9: M=I*KPP89V03EW$U"@@OQ*_D: 2;^'ZQ!_LN9M@@E4UAM?>4"QSIC>YER\3)& MHCIR!^ZJRMV:82B4B236+K/TQ>_W)0N2)MI8"_M*;RP6[U)@M (_ ML3E[D:25PN#-22R8%QU(> 0Z[VE;&[@#U%;VKH7? 9YX\-.AHWKO $LRK_Y@ M8$4BA:\.'9U,M>W7=_2,\;= 1[<"\+Y=?#4W 0B69_X MZ;>MRZEDL['6_?X4?X>'E?;=M9I]I)9U],0%ANL_P9,8_2#).Z5IFP?7ZF RX:<&<^Z35^_XF+ M*9EEG[A+U\RSI0 @$$N T4=,#+H\ O?VWP&8_(4/-2=LOW1+DX/*&03'_RTH MT'C!Y>L+V*+86:1")ULE'M8!UY.OQ]-^_072>9*H::#4ZO-3^OODJ++:0JAM M!U-_UF+: UCG%Y#8/BB>%=(5R861F+H#U(T6..7OB/YJER^&LI(Y?:^HW+@\ MNKCW\PV+J(L3(/F.=*C(502+8[3-MP"EGV3C M$C(/L",P>CKCN382I)U&B Y\]8GP'8!B"%=. 8^@09DU5BYXF_CW*.%-;O2E M1=5)5!L4Z;UQ,D@61IW-VH+TBG@8)9*:4&Q.G:#MH/TIF>6W]%@L;I4"\)4Y M[O;>(?"Y?R\,3]JS7+7D8(V,1P;.RX !EZ MM/6&?9C5GS:V7XO[M!\^FYH8#=8)Q>-XOS$+!U!9*7?M10(P(;XM.+*ADZKSD H M3AO=%J]U'XP0^^+ GW?&OP]%[6706-44RYY"-RK \[1S-1IP!_ (=,T,,N]$ MH*60WGW/0-F![U<7 +8UX(JMC8D>* 'F MY62&"L(E[#/DC34+00+/9J]*EZ5PK-OXVRT>Y9^D-1WT""B& H1]"HU>%4)8 M#&1)3G3KIW^HQ,]:B_C[@7LHY26#CTM_W&+0AO<@ MT;Y+&VC]YHVU9H@<[\$0;WVWUJ2QDAE-LLVZ +-]) -10G-O43_N/$#GPR8 MXU3!5!&L\:9#;E%/8L6414N[O( M>Y*^I1J3N2[%XM-P$@L3) 4>YIOL'\YE M]AQB\@RP="/L!D0;L&V2+1%U,5*C(VS7U53-3R$&8,0@:19#5E]^NDYXMT=T MSI[$3B@!!VX;'O91*Y+VS;MU5.L&_##%2%KBZS17)Z-9W<_.;5:CN"UST U[ MSQV \0[PF9\:HM1J(3CR0<@,_@]+E?0:7O$FA]B_A,LO7=U@WZ+!^?7.O7E_ MN"6IE$3#;MY!@&B18L,%\* %=K"U/7S,A6FA@F/U6T/2]UQ+B8O^K[S^'G> M;@W@=AZ8!=N="-W?TE+G:#DH$OA_]7?7#J*>/VM5.'& M(;*;C7^; MWT%WGZ1Z=- @.N^1H*$^/#@6N;1@^CU%CW" %"^=7= MLX.GCNG>85J>9-2F1D,BX[F-9)X>+%)/P9LBSI1^0]))&@D*8JE'*KF9QR2I M=P $:=PFQ_$+Q/R&VE454C&JK.[P E"?"6+K^YN=D1MAE":SKO4?9T] VR-5 MD#P8D2T2F>NK\6?C9JCIW]#%6#U]ERY:S.KM]R/_IX<=PDA"](:/!_^N*TH+ M*M*G)=W_?71:E8:42?QFFY\W,], ;D$,M+4(G,-*3F*@".R%L_74"J9)^%C7 MPD@XQ.@=E=41C;<-Y/;M9H7N!@G#/UOU>I7T4A/D&_[-L&.2>SW6Q_-M/VXQ M0&\8_Z%8A)_>1F[Z[9-.N5-\)I"IW]?\D/9DD,?>P^V5[6=KYNA(S.$=(! & M'9)'&-P&;M\!)@HTKG 7H/-MT&O"HF1=:QIOT1!%KL2H??;V"B.P_?L9 M$3\5EUJ'.:I3,].Q:MA(!$5MPW^-#,0!Z4A^M//:M\YSJ3O #OO-W;UQ-APN ML:5%U*F]4YKY=:.>!75A*Q^56I3^G:72LJ/$PIP0+UL9W DZ">G$!=JO$?0[ M%:"I)Y!>5;$M;@V%D,FNTH#I#OMN>--'W^PV/'GQ ?7QS7+.;G>%N3.94C3H M1@TB@F[?))B49MO4.';28@:E!AV)O=X4X2)R3A0Q+VNSEYY71I)O#@;+D/^- M@&ZN^$^_;XQ/>)(5I\.E]%L^CX\E%%_B2HQ*_[-EHFDT>8+_N/2$V=.T!ABK<_NNWPIB#16-=D$Z MWY9!N#=;WZA@<'O&IE1]OI/F6Z?H?2=%$U# R/^KJ V#/?0$J8D-R+S #K:W MA!T_Z4=Q1UPJ-E7\]QE'=I;^!N,F]'P"X_ZQ2*;>3CS_::8'PK (1BX$HGV^*\[\7 M3WZSV%M2LNHQ*S?%="$CU9],F=&HY"N"C=SYFRXT0F",TB3(HH-WW>E[J*%I M2&<]-$>#(&W7>1%;3RVQL"(TU7J IL,^LL?6;BI.:]P!X)$WC<8W4-2;2Y16 M(VUA L>BVE3MNSTG*;$0YI25Z/6@Z#,M;2Y!5X4Z1\GDF1]ND5?>*-7;TK9W MR,(!F5?W$U.VE*85\)=[>PAC .X+N# MQ]Q;P&A8HV*$,#!\WA\7[;Z.QFA5_#VE V5$,*>["N\#OU;!^]X=:Q,..0]& M$V<'H7QNBV1>0=ZB?Q $03P1\!M@@;6[)&>;J">Z2Z&D%5FB,5!/OYTCR;KTY)$O M)CL%&J,4X:PLAC%#+W!W 6F-I49KXNBPMFW+VWZ_&9.!R.DU3H%4[U7LK M');)P7?&;G+*IV\^M.>K./F^+[MARM?;70H[ID&K70-\4=<,,]=J]5: M8L^8A$>!30%!_U1BKQ@?W5!A@']DJ/Z^VVSL.WGR-UTL'*+.ZO2B_A"]'@^O M)F%='^YU_VU('QT?3(]%1'[O7=FU'2_5T8P;O3[<-.BW(,(P_[&>:S,I%DTI M4):$\W;5I[ONOF;%?:G \D*#U:I.^NE6#-DF,.0((K\Q+%75Y6MD7!61CI( E/N?"!QTYPF$+E M/04-M,.\C]-"^VYJ$"ZK1IQ'5?L1VMT!4H6(1=\$_>*XO5;A[!XIH2N:U2.H ME0E#=AZS(=8V)J++,=R;_.2*!8?3X9'&&4;; *4O&5DLKYJ!JQ^_#77MMO-U MTLN(KA[ :/U?0E30(87]>_LM?N<@5GBS$DU;E!M!4[2?D 5TU?^/%=-"E@SS M;9E,*7MD0Z#Z+@:[GNFKG'K]>,JC6;LZ15I1* 6E6 #&0P4B"/KYR0]D&!$- M[;?EI0[[IZ8]J=Z$"25-9=(.&&IY!P0:'C'[0?[@ MW$?&PWFZ-E-B^9SJC[4/P/-1P,_\P>8$2/9? M/T'^O#=4Y87#ELV-V+&VI!'7&6ZPF7?9,? N97#;>MP[ GV?-GJTM)%RZE+#6+X/7U_EIE BKV4WT M&8O$EA:JH:*(]I_MKCJ5M6YY$I>' J(#Q9EI6RU8(,ZW>=(:-_P0;418\+3" MI,%&,@*NZ/+%.NO?1H-:]6CVQPP'F^?,*=N">QSL[?-;C?TC+O_=?^G9^9Q% MUEV8:MU0\<4*_5GG4U)"-C=9<8DE4FYJ@L(?,R6*)N?+&5OV UGDZ\ @@[Z6 MVXI?/I;SG X[?ZMS1]I[GWSY%\3$>6)\!R#&OG!8HX00Y8$KE4,/UM1GMAP^ M1EY0VFDRI.T^'L49S@Z>[^UDP'* ![>HCS2<-B>H%_Y^=5\#1[[X2/J#N+K4 M).=W*WPT88BM=XO@.=Y<^PT*C/Z6"^&]C;X/)7[^6T=+YK#"(=80!;.A[+=% M0=*U @ RG:7RZ3K(/UO:Y5G>J7F9J)R.1TFH?^C^+<["66DB!.RX@R96KL/= M83YM[-N\1U6*O/C$<_'+09D[P(V@_^PU\)CR(_2S\-ZDM%HAQP_W N$<>?!0 M5Z+8"S>A %E ,4N%NPZ76V0KG\B&F,V$=TX'+9+CN!D99SQ7KW0_NK_/YSKX M#UX.4+G,B::'AU49?9>65HV$:>;7[/K]M9K*XTP80_T(C @&N=$*WCD9?23XM(;M8ZOZ70,LSZO]7!U-1@H#*B M 4K@3X5.&J#.,/(844A\_GU=3>+**@Z+S\*%%5F:'X/2=FZ>8R?-'Z!-J$_J MF$BW^E=9\5*LPIRR6J%M>^ZQI247M[W6O?"[^T:B'_>JJ8Y"M&I M4.5KKAP>]1[S=?-NMM"N%VO)N[W]&TP'F7KZ_>5.N-8!*&WN8C#]'3';YNER MX/X=P/?^H[[Z+-MV1GISSZH.P[@*QR[CZ)Z\U(LDUXD8WMQS%)CUF1 M"4TV#HZ1IZM,DY!=:B&<^N?%D>_'_TF>7=QR%^!8OP401LH$//9TOT8U41JO MKJ0,D='_2M[VVKHHJ^0ZXU=QI:L$A:C"Y8P,GT 6UIC"*%7EIRPTFX14E)[6 M-#_C@XQFPG:NISY=\RKTW?N MXOUC9TJ&6TJ:K)^*@G**NLJ&J]7WRX3EW\I$^/F M['I@C^$F4)ZRF6'37U!K7J4[31?MM[B4L.$U6 MK(U^43^26[;K -^F=7Y<"[1X"KP/)GCHM#Z9Q]@_<_6\;^Q;6K"S'5&C;J-" M]>R/)4D##);N (M>8P7MP=6\8WGAD\K$!PQF)B]2OCUG#E0@L64U-@CT,!3. MHAJ84*EOB.8M#\EJBB1,>D/Y!%]K_EMDQ-!<2H*62J;S.+ +2H!EQ.!-;]-%0"G.)_QS)F0;C2>%O<249!89<,TVH5G,B;Y MV:!]7Y#RA6\Q [F7A4>&TO.AR_(UM)P'I\@;*9VFJ<\G(FK"OS^[_'.:4HVR M$/ :VE%2V%[.)7"@H:>=,ZVS'FY\*5;T#\6K8<^0&O6_L?=687%V6[IH$4CP M$ @$E^ 2W+4@! O!@UN"N[L5D #! P0(6@&"NQ3N[@0/[FZ%%U!4';)ZGSZ] M5O?3O?8YW?LY%__%O/KJ&S5MC/&^4[[7Y4L$B7Z%A2:@$LN;_]SXD+,P#WQ' M#-.LH+?;5ZP0P!-,IIB=)*O-PDVL#G][$D="RQ-/LI$%[W$2P0NYN!<9<2M% MEYV\R)#@ZN&[%U@6]75#VZKM_<$\0 ]65RC9F[R*3?4E$G:YJUP\Q?O-R.(( MLJ!^W)7,LF-4L/_:XLK!-O]4*[/1\Z@2FOT2DH; SS!U#>D]R92 '"-PH4;1 MJTIDXKRO)^W=HL6%]469U4E,Z9/L"P)1DDR41>*5% NMR2A\>C);?/-U)4IM M8AWM"Q7LRIVQ@!SAC-BLM<* U8U4C;1XU9BN*&]'1FI>+2M2NW9S_YT!!2N@5)1)5Y948Y.#B']DR>!BKC%D $ MA22'N@WIZ[/)']($/PX6571['TJH^BB;-8HU$ !P>FP[6-!G.$?L3I5&_4P& MFG;%"(%^\QE!5.;"JLZLQJ?DUA4'((IU'QZ5SYFF*VQS;S@F<:G0:!<%="@] MR;AC:92QF??CMM&KB!FUN%E75'N/HEX#@=",RL0+R?AQ&LC M;-IH25.'%U]H&W8^W?4H+=[;\JPH3%S 0-5\ADPJ$Q/L :K[H.[:]>"-O.5L: 7RO/+MFH";SH MNMJ>B)F:K]^%IO8.Z3;71=?(KYMH.LR?&CMB>!X"TN$-C&6Y2D1"$=RSJ=(@ M2]!SO8!Q$*F8TFDV/A>T-.=-%D<]T$-_0XE+% M OEBXA2"U4(9%^D HFXX)U0_MJ%Z=5< M1],(7(87^@&S;X8Y+%!MN#4(PS/^2+;?:KCYHY2!O%U*XHAPHDJ$RXH@A6H: M!E]IN5W\)LC^59A][&!^3?WJ5Y(6&K6 8-]:CZC1[*-B_86JAI<;WWC28Q8# M(."V6PZN0$XH4!:[_D MH]<-_R*EZ[(YDK?86"R?98Q6R$K]I'%!O[Z; MQR9:V62,-0[?D0(_AN>J[$)E3:V2HK=5\MSY*[BT44;S'(#V(0X)./CQU&1_V9YC;YJR=Q&/VZ6A M?\1-1+FH;CSQ8V4"ZK9=4K%@K=I*)]W7"H/C&V6VQ'H(6+$A>DY@K8Y17KCC MZL?35AW3%(_^2-H=H0\897U][P^/4W\ C>G]LJR<_H\FZ7Y9?5-%? M)J%6[)?E+= M,QNG.;$>W)4$&L_/SURPY5ID\=395CY"RZ+M2VS(FLF4HELK"]Y4+.US+= N M+M)&T38'.GSX <44.M(5J8V9L1LCJZP#^ UW"?_ BX030[NNR$_#PC:F+&K' MX?P>.>;+<>O4SY=UC.;?2[6'WVYJ\Z/'^_%7&:I:ZX+0S M[D*=C'[ Z.N86+Y'?7-F6*6P")8/'^(KXL6K)/Z,-&8C$(.;$P2/I(VB_: M?B>K0)]FW,GY::J$BACVIJSFC5_,5O+6''+([DDKAWKPV%G@!OL$?>62\7^Y M 0RFPCE]6I+:F[MZA*?;%O5$<#XFPU%LJ(ZDJ_%X _6,J'RMF))8;H;#G7#B MXD[T[LL+3 B&O:8#XQL@K5B@@[E!.FK[D205-C12!>].'S&!]PSKI<@+.LV# M-.WRK)HE/452K(%6S=Y?4=V/2Z.!G;<""24V>BU)"::61?L!Q@OEI4=Q3$V_ ML?JVZ\G!5O2XW:M4K'GE62DD0PXE9[POG'0 S*C6&4;$K!VA>-*9TV=]A[BY MD6US,)7=O\W__EGZI66>B^SU8105146J, W.5 M>9@#3\!K1ZQ],A/?:N)T]V8&'+&2&+X_1'KZ>!6*!$F2QH 9F#C M*\F=^<9BWY#Z<$KYFV\$**.\NJF]L5>EDZ])=TR>++7C:"FG^3,FN_1W:.IV M#L2E [Q[@62 E:F+;U-TY!Y_T_-V42'IN[DH\:*8TESV,U* *4\9D12 # Q]:JKW:/I3"*=2X\;94D-S4R& M5JUIO080$ U0[,#O;;\'>U_XYM^\?_MD@CRS7CS:/:G.V4C6B'CYQVHZ_MB& M)$4*'U^#Y^]%T=#8-'NJM! M^]_'#SZ4&2,]ALU7447ZUEC##0MQ4]J#U%@7XZ=U5]VGVE%+(2LA 23="+)Q M,(Q^FL%@>; Y4TWEF[^4AE'IG1S<*7;UI+T-'Y8]%7XY%61W,:3Y^EWCYY6F M($U0Y%//9\ 0LC+$, @#N"8+?PY=">(!CG)YW\[(&,@V(=K8-6&Y:<@;)^GJ.'0?,GS#'S'[W<*';NR3%XG_G3$ M/\>/!!Q6NHP2X%5ZM[%6&BXT]^Q+'1D=XW'FZ#\]%8I8'F4Y@W-H>[3)>GM% MF;]U3\3BNUDJ;VEN!']0,WJ^BC?G+H:_@2MHD- -FG\T,!R\=_6W1S+%AO,S/JD:/4*]L(([@:MIWBGFP.IFV_O3H[MJM\S_!834FWR7CXN* <" 7WX>%Z==W9 MZ,LVUDW6?"-0*5CJK6Q_'_]DLLE32.P9KJL@-20L^.64Q&AXDN43]E-E9MC M#I03<2)%TG&>-HS11%%\ZN_C/]\Y;*G3.O6,AJL)89$@ 24.G7+>Y& 81G;, M$TWFF5+!H<.CW#K[^>77A1&JA0_JX30?0*FVC2A (&FJ3^?)4.\(-O\R_.,&=HW3SD,J4E'P(_WQ:]*K' M?=VEK?AMB4':E8VXR%#>+4B/1*W/UURI8"'SWH>CB6I+QIL]]DAX=:CTZ8%& M8GE)3J@:EOX8@?=D+8\':Y,3NOIO5+I,VQ\PQ].$KA5"JFUVYL4.3P?!EM+- MC_1SZ0[DND&D0@>IZX7))KN=FJSJUG*>IGDDP^(*S)W6=95+:@;HW9PQ5,0P M6[7!RV^S?^]SD!^/N;-)7^EX) M8^'?'GD6"VULD]!\!6&Q;-4/5D:M*4#8:S WN"XV-UA^SNR4C"M%UV778FU: MHA?D:Z=[_"6-_/^;?7F\..#JSQ6\2[SG<,8),:F/ST;XT M=@GZ^G15JK\7\S9B>YY\R-O^F%9A-?&M F$$J:%\ASH>&OY\JQ1L E VX*" MPNW=#57:KP4E*&8V-1A:,^B#+JX2A!>"^&''5DY1]&>2)I8]1Z'0& MU^27Q_4'+#^0W;X0/]W5[Q+4,#G-NE.BI:TI;>(Z/;=@6Z^-UV][Z37"//SS ML=,?"V]&; 0(Z\+&5@4/?:$+'?NS9'JV\8LCI=_/8G+'TBB+,W-8=URNN?$G M:6Z2NS@)ANZ88/L'B.>QGR-+O5(Q4:TG;01Y)&=&\59BM[RV2 '%19L4:PWE MOZ@_7^N%'7%#E6;7^X)H)Y.NUB5?.>#GZ*ZAYY+.59I[ M5U-2(YSC,ZKMD6#L?)[WH;H<;2SM4\ M:+5/45CGL,1J^U%/+!GSX<]!?7H[\%>3U\BW4)X2LZPZ:[>1#@ MQVB!G3^[\ALKD60_F?!K@A>!+QGJ34/0[[]\*Q\/\;<_'5H%A@&MJ+'GK0+H MDV[GL?6S/'%[,VCI^SMTY8=RHI[UT5&&*$+E5D%AK2A>LL9X7BZ*0Y&Z97K' M^M%2X]MQOUG/U @_/ 8X*\YS6CKD^A(?-30ZG@.%Q$ E-J J<.]8)!751-QZ MU0Z/@>?ES3;#/V)69V=!4.65," T#(XK15M=C3[W?:(8=W%V-=#P5D MO8T,D5U>PK6![R !P3\>K>"+$:)KY/8#S[C+QR-.03$K5;&?VZR4'-].B\D4 M'&AID[GA.A+LN7:1\20M)>$]CW?=E9%A81X\G&^F?.O +<$"*[PCA]5=^3^0 MFO(O/D]+^8\A>8D-TR/)U!\2G*RVPJ*J.)=R MJ9"F8N;B^]6!1Y%3186ZW_08O-JII*N,:RBACO\P?J[+V>(JH;MZ88 T?"-1 MFJV0Y&70:K"H=C ,_8H9RMEE3+[L%2L]Y?X[IUDWJW'<(A/3[>9H:_3 FY9K M*WOSPPNF+8IID0CGFFO>:*:WVOG5B^L0<=L M+^M:?0!%_M#9U=I"JN*?499GGZ?-TST(_3$KK3 M X*&[[^8>#6K33TO*&!D)_OJ\=*C2@=Y(3'-E5CJ*M!GD)6]K>(47.[O!K J M:5$1/7Q ^(*V)69FR>[H8Q F"P':X\95'%?=QL@D%H?H'(7SD2$+OSXH]EI^ M#U[@=0#3*; '_,5VG?.I5&Y3B+W)V85D?\>\4G5VT%DQ3HQWGT_+>MN+@!%@ MC1'8M-@KIYN*NDU@G,_I@0FW9CACQ9,F#_'(SO7OH^QUE/\04UF+9NOU>7P5 M7OJ[I]!:N_)[&;L%J;9QUU?78(S-9QCEJ9 Q&.-)IZ'>33X$W*WWZDT\NYWC M> Y5^PAA] T$2RVA.0/\]2U!Q%:PDC=8*&# 4R"5\RC7.1\NUMC8!#7L,NHT M',)GB.\=CIH#K,K3==")B]N B7H:^Z_@^R A%;+W/6&/)V[BWLC_LXAT42; MNC]28LW--7=^+&.VH\4V(O 08P@,&''^F..:$M/A+/%+F9'[[E#]E--?O)F? M6J=17$=98WO+YW+:P50Y(7"E?/G4;YA;746_Y5\VOAGU..[ :6!"^1:4$&4V M$U.B[SF7\DIL@W!F;Z7_1AJ!17G:UXF0^ 7G7CW!LA4(H*\G;G.L3U-,<:!] M1R='AOY:RH*C#[!I3[K/MJ_R!"9PLG9]6&F_=H#@/!3CIO?$OA]XAS/:]HD MB-4!4[S#A_/ I,NE2W_/&]NF0IK0:QMF=A1:1[MR:&EI'2B_%]*1HI%=X]HJ M1!J-EU\,A;H%GRTK6I/QH#YV9Y7OIQ.22$S/)6?N,[-53F_(%3X>^]RVF@0Z MD*#WYT,"[NO+6VW[6U$0PP$O[C/(]27(VZ9/VB#=M* CW>P$Q\0VAZ6X/.", MP!]A1Y\C)046I1I##!&W*;, 3\2XUM$==\"<$14LTA)5)NM Y6HHCF0MTH*M M!^ NJJ,P=BIN@^B[=7N(U6W68V1^AM,T%I45<=$10^=V25)51#MW7UDHW!B4 M_,U/)U?Q0D%6P*>Z5@B&^-MY45$P1,HUKS]N.+JFT*"1:UYJT[3BHAC\. #; MRW<5^ D]M%EHUF6>OVM)T=EO_WR([@-!CZ8<5E$.P"GG0,]79L"AB:2(YRKY M3A0^EHR@\Q.'.1+WE8*ZC;!A*[;0NCZ/\[JK7,A909UUAK20!IOL3^Z;[Q92 M315T1/IK8-JG'T00O9=T'JVH^J@4C <^Z M/&^J<'V0@.ZQWW)KCMU' 0=ZF2OO?T'8!C+7]^VI#IDS984MS!+-5!5VMK"G M9JX[VN:PU\8Z<-7X_9^K-$[Q]W>]\LDK%4JU^H0CT%Y4\#,J*F04D[2C1\++ MY:"@)4/9MT\F G(.N*_R3AUN3V_,KUOD(NZQ-;-'R_G?/HSFIK1UOI7'Y=1 M8-4+/\X[MH11VXO>^K$(,#JN,/'KL_@7QTLO;;IZ;<[)@^I =@/;.2 & NQL3Y.IT\]B:=>02>MGRN-64 M5:?6"]75XT,,B;==P36RX:>^ZP^YO>C@NNTIY&$@]E*U?LSKKH#-@2 MYIO QVT>[=?MMKWH>&@# 5,&1-+,,&5PKI4_62@ZC#QARD//,1JU)R.32>1 MI3#QM._P8%KJY1U3,R[#K_2:3L'B!B3:F?DZ&\F=GE]]A-8=$=ZR><4C 3I5 M(O+?I.X3^=2.SP4D6G9*L:&W]/Y)%I^54M=MS'!3#Z2<.BU_S? M>=UU@J%1N&+ZTOF@[L;UR2-N0KNZDY2Z^^DM)^'K\L]PR[(_4*$/"0B?-TI M3WB28^V=OU"4[JUU3:. 7=YH#J0S+B'SC[!N](>DRZ2R>24Q< Z\E$25@&N' M^SG=Q_CAG9[W>"!>SI;SEP+5(J;M,2?R0_GC-+\7?CB5D%^4E:(PR2.B_7E< M8Y%H-:CZEO.]U_5ASIUXSSK>[Y/N*\^O12NP.<8DXKB U2BB6J 4;3+UB78O M-;0*LB>!WP?]+BTP!I.76-IRL[\3JWP*7&&H/#"N,B*&;B5_@@OF[NK96; # ME6IC)AX[R+]1+0;[/;7M!*V%M%)11R !4/!]M0%B$C&-^'V'4?]9SWO9,B6Z M5?DHKV4,*:D/7_UP M-*S!%#9K+$,T>#EU\G:P'UYP>OT9SKT!7HCLGF>*@H!AZ301;BQ%J54Q]@@['B/_>M6_+CJJXLCE+G3C=TEOLQ6)$%]+K89 M2$"8&9P#"?AQ'=D&Y9E% N**J^=E< $%2Y,!AHQ8''G MGMXYLV^-:9[2<;;Z];K;Z9@][L#8 +9P50;SON,

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

    %UMQ3?;L?51OIC#)0\I6RS/H4OOTG34WY%K&H#]1^^ST%AZ!I(2-A+H(W M<9Z.A ^?1:-GP]N\O,Y")1)?B_R(I5(S,4Y"V_&;T_FXDK;T1I8Z'A#&YS^[AL0+*IVKN[[":M'"D&YCIZD[DRC6^7\6T1:O<]S3&W SY M(TG[L5E)L@)A-^'O@.+\UU0/$?@HQBM_3=!3AH,';8V0)EP)[=K@@AM+(F&SLUJ=(2?N\M>$+ M.E/;35&[O[>7*ZI!! FSK9.H/YPYA+A O[!?>X_R#)*H=-%G2)!OQ,)7DLO+I4LG-BCG/Y"*A.B*GQ M DBTA!=H]5,[FWR3:;D_YZ9__G$53[FL?:=VZN0]AE5-3L+O?X;@ /+W7*2< M_;&_MB6HXF'8E'I=DC?N\>X\ZD!_]FOJS&!?RXA$S+/;1:)>4N=_9&@SB%4E M0N2"2J@$&$?L,AM2#3K$W(GZF%^;XGZRR74J[*:G2/+O]_A]#AHB0@LJ'$0E MU58X3)O2<%\@.BKD_N/8,S\V3(V5O7\&1Y4(4YE@R?X1@-C2&'_-4@\N'IJ*QD#F:F2#(V!S 9=L31@ARJW"V/RC MI)[X#V@/[KJ*C.4YON"[5!!WIZ0J*_&SBOT@-.6/RK\"C04Y!>P 8Z1\@W(V M5HP49IA/'IPM^^QN9OPJ*31[Z[8F7$8N];S//?.E++EM?QR"=,X0_P+W>XMF M$<:[+J0QA:Q#*)*U>:0_$06;ZU+CN-!R3"ZLZKT76[X=GX7YC:^CXC&68(8/ M'A?']D1L7< EQ*%5/3TZNZ05]^*3E>FJCH"QJTN^]>\604,P'EB;;@N8T+ ; M?+\[)GNFUZ?64OT56P]W9:.(WA$0JD(EV<6D2>HW#AX!O0HH67+ !'B?_\Z? MP#8JMV%-R&)JB7?&O<4Q5WZL2:UQYAA!JOQ*,=5P')Y;TP^H#'3T^$Z8D"IQ'?D?$+5.?)[F8V->/<7L8RI3WV,-;;/;TA^+=) MPI_5M^1>\LL_'_V!CP#KQ&5)K*\1&8ET$;R#DW$BI!5]HGK0V=G9FYD-N;^^P&)=DU7C%CT3_S+@1GV->&S\J$Y6?).// ?.=NR82,H2 M'T-_+O!3."FC6ZU.3L?=E9QLKY1:YG4NL467-^'[]V#Q,CTB ME4>U&:A!/FW,7QZ'R@+&YU*9+]A6L![I:E:RL__!J;)-+7NL>Q1;?+X5BR;QK&*(&(I\H7 MPB6=< J=&[]U8;7:E YSF_!@C7%H9%OA5C6>L@,')1.X&R'X$ M$J5!%=/A'T*@.*<(R_4V+G L$8),V=N MO%4$L>]XGO(Q.1R=61+Z &J*2ARK$,1-4HD)M;^@Z48*XX 76MJM_P:A[M/T M:OABU%AGNBW.$S$7%H M1J3M,QI\R@WVY(6N?HE*1'^&"L-0FE3P'T-K]I0GCGJNY'MFY M(!3TLJNA]*G69_? ,3=N]ID2*3W1>.OB4T[G-96!I*?TBC2KX$K$YFPQ91S. M@<&FPF%"B>[,50MN?+&)?^#.=:8/Q>Z+^'+Y&\E?7_K(2"R $40*WC@7K]9= MTP W-%5'X+G'I78V.:$CG@*\#P7YEQ[7TPK'9N6VNY01_MCQSRGCIG"NR6<>#3W!<39LPHC!6HHC23(X*AEWQX?CKG8.A@0=VC3%WIEU M3>4:EK+#O'[$ZZ-,N2@^G]8!PAHC9N@[E-B^XC#KM;@OTA[%YE;W*FFR>)N^ M+/J2I%B; >BJ,80..D!U4U[,I-L3PL,:XJ[XEM/CR^T=I5;?>NZE]'5/,:>^ M_%$E?] O"VM^F*K%]$G^2Z^=#T,VO3%$@S*WP$$RQCKCW7'TT4V"GX\ ^XW) MNFO>'8'XH,(9Q-,HC$/Q-Y]/\3K/2%21$ID,'5G8-X;M1A90]UEU +IL#,F M<"$7BY."9%$[KQ6]Z#5=T0A!@YP? Z4;==$G,VMF6^/DI8RW6(4?3P/%YS', MX7E=&@#E)X1?XQ)T%,):7?:\A_NL*U]JL_O)P4QWCY--LN=T:6ZRTT@FF+C0 MXF_^?;)L3^>_GO/.9AU=E\11F9$/U:.DD'3K"!6%ACBK'A]($!^_>[V7QZ.1 MS5&]3(^E*[D\.:8_'7=;_X3U+;U('R!T477/<<8NSL0/:V\9=.8V2,Y6S'BI"#IW547@(WK]S//75$[F M$!<)NW-8B \^%IZ0:Y_M\T)L1Z73NV^*>)UUP56JZ50->/4^6K>?N2$@8D2_ M]NOXI WUK<&:4KMDA,L?$^G6NYL*@/*W*B?V8'U>E90XYO]8VU;Q5NZ_= MK0N9N/@.%) M))?[-CB,*M/U9:?3\)"Q$!'4%H<[Y5HJ91LUL+Q45:GSJ +.XVJ.47WP(KZ4 ME4H[Z;6@'(2_^.D1T&6&^)N@UIK,WJD)GU?<:#VOQ#Z$DR.?="?\9]2TB!9/ MB?[S7Z>GU\&U3F6X,QT@0.T6&ASQ;':U162X??V>R>@9>+5E00@!W\__XM7% MNR\^=I]Z:@ \#^4D./^+I/@#\IL6#0/B;:^52N $ ]8&=$W_3W,2=7W!?HT!$ D.ZC"8ZZ!R[91)G4\IPZVSL! MMP.R>"Z)]:H_Y M3#X\F*?P#_M :RO=G/;&1FWNH'7;2PZG)WYU*J08E$)LY MS9.YEC<6>Z/:%;6,$CVD='O%*I\J W@^R3U]_/%[:[5Z!1O=8-X!3K@\YFLV)5$$FU9"+PNN_4@8G_H! MJ@21.!I[0-PMX@18JY $UB.^++!$?ZG@)2I<7%WP-2%I^> M1H>!;_D/G.WH;)"F)!9;:L$*(&UB91.E_?47WXQ3E=-BN X&\K%%^?A4TXPM M(=4]X31)RT/V5OK-?L?/:P5H=T=PNZ@%A][0W>*/_J*[,&W_C<]/JM6UT5S3 MBM=&=>/"GK915?X\D@V)6EJH#B1S0$@Y:TA2P@U0";BR<#,!!9DV;*\+N*ZX MY\XWG_NP1MIM_4J28;5@493"KV[Y3AF]?H'D;O7!EJO4#KA2AC4TR-EJK!CU M6STSO_$'R_"BCI/5ED$:8NLRFSY: M S75:PNY?>=HIK*%LL);/A).4GV*SZ3T@:2@.'HPQOUYH6Z[BIIF7O?C+*KT M41<-QGJL;&.O[L#S?^*W5@ 01W_'O<%9QG1CGXE9HE[I-9H*2; MC/3.0VXWWG,^;Q=/VJ!:UL,>++(?*$6$&'XBC'7@^99?%\VNSVCMWW1W[[>@ M[;DLM)C0_R.<]>J?_O\/44LC^FSHP'$E>*IMD41Q+9GH(1Y"!N4<_]8UK:^5 M8X\JB>J??&4O[W(%N 9\9+N2)^RL+KF]3GKS7SYE!"D?IR[&*>@X=8[+E%"@ MZ(,$^B#Q]EWW%N'1E:31;:+%@H^LA:DP75*8YHH$ZT,I%G6XNYFED'#[155,J/B]NC=F:D^_QQX!A , BAF!A*>"ZQ)ZYC10SC%HS_+M M9KH-)NK@0QK88)]2)P=78<7/WLXXF[IUN"$XK>Y;.[KO[*R;5>M2V6( MOP%N."%DJ%Y$>Q >W8'5B:LVC)H_-TK21PWSSGW,S;Q(.\(.<:#!;PH)4'[^V;T'WW\57)S->O,R\#(&GUETE5,[WF% M:UF57'7-<="]V8H5D<^QN_3"7^@22ER W"9)? $90>(G2A*@IVO*#I%1B'(?+?7V9_);6#K.GBA8_OBH"BRT7X[M*R5CLYPKY=/UA MDKZP-99/[V52Z)W70]EK-T#5XV:+:22E0*H3#LVC< 54+'LNU+$_&2)F7,/, M\B"TL2 2IRH&_FI;A#(U[@?GL2QB?#3AM_2F-D'G9;_*;X_YXWKV+84>;B'^C [0DU3SI!F+SGZ)N%K%BB_ .QE![1LJM\;MX);'Q$&A M<_Y")38RXL F\'ZPR%AUOX67C"U/EIEYWLWMF\)2/0"6YF*8XBJB'T:%$=:, M_'A[?;D'%?G:HYIX]?'GDHT_Z<'[0"N5*I3[G"PPV0M#=-O;W$2=/XZ.+%%@VJL29>-2OMO\5,O^Q9Y MG46MT$RB#!7.#TM)7N7F!'MT;89SMNW<]38OM*!:2I7KZ=9SW9WO*[WW(B23 M>V\HW #EC)OX+YD-+?S7$];AN,9>O!T"51E.0 MP<[%ECT9 M9982JBT,8K?LKG\6*(GGH1V.H)U8I<)P 8/=;!3J_?Z.M+ M ,]+IH&AM+,.#OM]HI>7'*))C81ZJFU!J,Q-, M\P<#^IA8062BRS?\/@*&32!Q\IOB"MN/ /X@$71\AI=8=UFV&Y>IAO H6@ZN MH>^L.QJDK#W$^?#-.8 M^[L8$$&2PNA(O!>B3X9?'0)F";2=R!]LZZE323:(']+E(9/:4>>_C[1CL-,66\'HOM_Z?SA[ M\WBH_O=_^ A9,]EWHVP5TF(IVRC9$RWV,I6RADI$QHS(OH52*$,(689L99OL M)-FW$6.&2+89RQAF<1_O^_[C]WE_?H_[][WO/_SSU^NZGL_7N5[7 MLS4I]>G43N/YLOI9/%TXKA-Y;/3D,E)LTHEJ>,'X7I1UW?.3O@LW9X/X>!_- MH3AMY6C3H= R=;N91NS*"IDYNCFEU#9U-5])YUXL1U(9UH%OR\)N=_JNL3^=D8&D.\_^%YXQY>,9G+O M 26WIFZ.TT^12FO0KB4V&B&HLU9']X"@VQ=%8%1!F'0$8@2#:KX(OCQH M2199'S#K2FP9G)ZR&P=!D]^O#( Q]0'+2?_G"P>('+0"*HW( NL[%WH,"RU6Z84%*C?>1,X3WT(O2(4IURUU8;I1.)?]SPV:^':T<)/8R0C"V6R3D.+ !S/?)^0<+.H_0A$XAEG4478.CPVI7V5E[#VA)V=X#$L?^=M(%9CN=Y:GA M-.V_=6]B$1<^4=]+_]:TVHW&Y]KK*W>GQ%Q Y 2$1E_A9E1 OLF?3*\:[ M/< 7%0VMA(:N(I0(WM!6NUW_=GI&G$4Q[I?9J>1!=5FQA0NU_&H/YK+<6;?- MOZ)CX'Q/H'%(]E%=.:+7Z9 /GN5B;G'G[G2=^!NL76Y[?;Q0@XQ?%J?Y!VY3 M[8XF4>HT26GQ+;&Y@96RHZ^ZE")/B77KAOO(^X1*/>\-,?H?UC]! MN3S1)., U&$8Q;>=GR_RIWE<*?3'UP2_EI3*$U\[R0CLZMBO/:!R;'F;X#N! M(2S+")&J'C>X&CX*0CVYD+7^&#AS'N +!;)O SISZ"[H?U4LC"TN++.0_=K1 MDBBW8)@@==?(^>R8>#8D[]B')A5&,6PFGRE$ ME2[Z%>C67/,P$-_^4L?HR720A22'E/!3Z\N)$':A>+\T-N]L2-4?3"M*=!^P MP-PA(LXWS:#Q0Q>J7_U^4!6BSYER\G1$@/&;#3\;A!KHA**,;(2:'P\FZ=[( M[83/H[C\A(9%V>YSKJ?76-&$V\_\#*!U-^Q:X)_[P#C4BA>N#O;EI9M45)%< ML0][I,ORV1(8[_V.S+KX=C^/6?R:;K7]_!LLH)_%"+%?#J!$)<]B0F'<]-,E M@3PWFV&S".=+F-H'73.([P6R;K'TC4HPHJ0P!RR#@$SBL?6X M0L2?C(>2?GWT>C"?Z0GO)-/,P+=QP*A69_;RS%#0GI2 51=?0<]D<5VZ_RF# MA\)^ WD_34BQ.Z!_4BC4/:#(63(=J>@9H^A7,WWLR)4\1EN\&LH*!,U_/F"E M]/>5,VWUE:EJ-K5)'1^'.I\ISE2JU)!QTT<74J623Q3)!OB?WY+VVO*:V>Z M\-*?D/C>$_< +F=&I5D#F_"C&GMY9YGC=C#EHK]Z^W63LM*E2/#&S8;ZVG1S MDMV*VZPTM!5_N,$F>_&4T=V[Y4,:Q9GN; +HK) MM4 >(]HEH+Q@'.[,(]0(8FFP69;RK&ID0>G-7\U'G,ZG/S5>O4$(E9,+8\&, M?V+Z-QU$N([^TS@J)L,N$:'G=2>HV*/X3#M?@60W*]?=P,S'N;G0US]/M;[S M7X3;[9=V.3-/_W*^(!CH]8UP+_D&L67CG!)T8]L BKEQ%2Z&'$.!N)&/SC*" MT54@*',B;LTZ/;SV.^]5G+2^U:KYC=7DSL#A>#?VYVS6'!.;=H3...Q^+0Z4 M;ANX*('@_[ P\-YA#] \5_;T"J,1"?-X>L =J?BW;%;JI@G; M4G/?5& 7 T28'V/I8?O%X^S>U +"9$^@+CQW44;C\TFV)"G8W0;9K-@!YAII M?0^08/CV;W%M>0M:-7VMR+S\Y6MMHL<#'\XS3I7'%#5ED[^:-3=W& '._S]U M*_[C#W.&D:_/ ^)P0X0P&=H*,OVD94/RV8 ^P:]1R^SZY M':GE]N[VKK<0"_41S0W9#B5UI34)@+1'C6H!J\U:U-P#[C/BNM8OF<"6\J;J M>RD=TSNS\T[VR"%_7IV:G43!@+/Q[URQ5V#_KZ+L /(5^#1OL'\K4+]!;##U MFM+9C _'DK)1;CIJP![@M0?X@)!A?%J)$C71U+<0E&)Q$M&X5BOCJD]>S*)B MG$JP0JBNRGUAFW?X799LR'S-_^8<$?TCYK\T>4+UT8S/^C#H1.>,_E=BIG$4 M[=FU&HE+?L#WL6MN7OR_CD:]3&0ZZXS-9%64P .C;!M'-'2^8JHE)[*(\W\# M5.4_GU?YV;8EG^*UVX^@I$SQZ$:DB^,/ MU;*87WZ$2$Z$-7W'4 ,YU7>%%'@TBF0&C7"D1&@'6ET?;5 K>2%S M:>,F3\_C;Z@>T_&#LGO YUGI1N7?;&#DJD)X)P@+]+5XQIX2?M)MP#K$\%>C MZQ7/HNB[_W2L^?Q//?>.&[$6A'&'$>)D9L7,FB".D6H_I+@^QVUF)A2?%QV< M>YP7DK,4[5\11Q%*(/?4ZQCDS_8FI".V2A]-)U:?>:5)9G^('7DL; M!$@+L>RL[>\RAI*A*T=F376O$XMOG<3;QO:JQ'D$K'!W1?_X;G^VQMY73C^4 M;V013[*<\MB$3\I]NV.VOLJ<\#J*>3B:ZK('R'"CN %&(36!M'V16CJ3X-*" M5/CLQ!"]$=K\B'\F?EW:BE3W4MRI AB;25I1INDO82OA[98F+=I='BMCV[L^ M'P0]G7$5.O(R46$EC>GVCT]9;2K ]9"3^,K$Y[2+=-'AW&$?;_40KXN1MTPN MCY:-FT@7GY@W>MUG>LONT&*$3P Q%'9F#[@#G32'3SQM<\Q*QY2.YLQ87I7P M6%%E>JBNON;KOGO-H&=&CC<^H0"F"(E#(*AX(@0G2@PHGH4=[HY9S>RIJ;15 MU-'Q5^IYKO=*QBI I3/%JT]Y#)QS;'B=26=2DKX$*:"^Q"1WT>ZQ>FJE_L1) M&Z&*,+FA'XC;@OWWXE^R +L%3*XDFB1:PDL$+ZKK^=1>1]T?3#],3]#CJ MX$SXZ+GQPTUE9^EBL.)JPPO]57L SY\:"?U4-Q%T_KA!VFA-^D WIZ*,JV]'?:Q0PXFK0NYK/P'D:]V->F22@&!%#>X"!)P7R?[@ 8&Q@ MFD&7/:9$SU)KP^S2P_< LSN8:6XZ%/2X,%0WD6Z^!V"Z8)MI$@")1U(RX=KN M],]!KI,^J_+V=R(55-9U#@O?X,M+ 62V=LU(;DPN (>.6M& Q#2IU U6'V\* M4O=F=PEX'JQ\A? *6S9\0D=D":X'1O6S""4W(@:WUK(6(G7=)-]IRM-,Z-OA MP;S+%2\A9&7M+YO'()X,;#;D.QS'P^12^T15:]E^MMWJRV]%3'5-4-\]F<_= M^81S(SMMD##\768"(>T$5I-@CSP1*Y2$FC$JWDS M%7_K[ .=F.@;1'+=[P)UG1!7)M4RT9)GXB.G69CSXWXT"S"0F","ZU4EO&&&J ML$USNP6.?ZFR_@&A]!ZPH[C?5;G]T6X(-$K, V']MMH@R@4=":I\L@&>>-\2(BDA:T MFNI+@8\W),E?\F/664XVX!]XKV7IWZ^.6M&R;JWW?4O0&U.F+ M;-\+[-;D#= TWLH;9\&4\_)] 2/ BL%IS;%H13\?S"P693I!&1-P?^9/- >* M8$ 7)^%#4=5[0"VJ8O >LY^F-4%?.Q.DT/>FD3+[HW-:[RQ>>%'(FH/021>Z M/H.B'T?A+!S3ON.[^Q&6[ST[/0G">2X+'3J'/D?)!MB9)S&Y\.1RA!@CO^I( M$"PUAYK$E'\SF2B,&)6Y'%4^>2Q)?M/V&8-WOP 0 =D#(HII.K\"PSKPO6.Z MDG*>R<+BKM6RJH,A!R)>@NE,@NZ8:!QK].1N8L&)[P\O2'.JLS#.V"T\I0LO MS?I2U,(1YTEU+;/>HY6R(_[JMG-.E]HNQNO)6/=NA8(D_K-=)R?R'/+GM!@Y M8NH[REVAJ'ID:OS0&^M#GRL#6,KE*0[L2%7D"%0\G[I-GFW/.K4A7D6+RSV8 MD=#1HA]1[[DI4[SC%"[ORB),!N/HHN )E! M36KX"B)LAKTWA#^\ES1S<_Y<#GDDNWL\@65M_MP*O/#&/UTK2'L 7Y),M@X^M6#Z(,8A:H #".3 MU4CRA)O'D?2F!U)N>D V)'\/F'D%$UVE2](,+&:*3L*(5L0>,\%NE_728<[! MCMG^5P*8IM^;PC11>!BTO&3-EW83<2KPYZAVH>&F^Y35'TOD=C_'1L%_:AY^ M7>,(A-E3GQ/?J[5F02M2KX]6ZT345%7' =UR4BPI!JQ?Y4,!^9?L3V RL+DO MB'WMTKA][=)TY24(55[KA6HU!L?1IOW[!_\/G&:$TD3ZL*#08(^$+]SP=XR= M?J([:R,)1N>OHVP8ALVVX_ESAZH=Y'ZD:=MF+G2R\@_]#!)%ZA XKG MP368 M8]#RM5CL?9'R81^-8[J6!(L=HRJ)]H:#!\TH:>OYT94/Y)4/&YXZ8B5+AM?Y M;\#I0EXFM:,P%U3T@2?LI2F#\TIR"M(^A+EG]T3@N1( 7;VBZ:JF(* M[N^T49KXA[L8R:+OGY/[PUAZ48;P2DQ;D?XI!"_))%[IA*_&K9/B/M]/CM , M)!6_+>NV(X+M-AKA7T'$TBT!'Z\D=+ND)EQ L13^>K[+#9# S&JUPH,B0'C^ MH'FJ=(:\8-%'@J?N=3Q2&A^I:1<)5DG\[+/%[Y)[&'4\-R$_^:I0?47+I_@4 M*P/V$+O]9#&J,+P'/+ 2=C*5='WO=L=+!E7G[?(FJ<.VS(D"D$K1\3"OM2A- M47*[1M53/WB0'_"M063PYSN9/%U/%"\%9.-,-E2SG 94@/IXTH[ZGFB1=.C7 MKT]==3*I GIMQXP?J6!>@_>Y;U.QE,6^WX&*9.I4"FG==BQHA0K=]*I-F_DR MH)&7H)!N,&>B?<=B5_E$.(. WQ*)!9AN/JJ_J[-,E1((&9K'R%WY#O92AR_\ MN; "M]I/RZBY#5TPD-WTAS".9!6BFHT:E-P($!RMTWK<1$ASK-2[,.@J<*!; MH\%7T6!U4-27*@RFKC!7,/;/!T*97_Y"=PWU "1AOPN%71+S/U5YG9N=_TN] M%T#!-' (.:H.<2W1^71XJPSOH/S(EH-H[\,\^8>7. ^I) 9>8H]2^@K<>ZD< MAQFSHLJKA3YXDO0\ZRC9Q5%VI#K!U<*WVF5>L[Q3IHVC?$/&I=/Y;+\UQZO MLTS.#6*F1ZE:-28:9_1^I"%&:V+YR8[/U71[Z?J)7+GG8QZ[=I.H&I/.6=HY M.L>8[G7W?I 9F]NVFB;>%G?\>WGEKLX+ZW5^?$_G,\I?.@CSPGJ]SG3F(TX, MVCV,#*I6+F NWG/RAW<*:"VL&4#3ZSHJ0HC2CMLWAE?GFX9]78/C,HO&JU*Z MYBIU!(=3S# #D D8D\O-;1;-OMBD1BTJ_*O)5=1R4H4.*Q".O!'SU23+^%!8 M3U]:]F'.'K<3,&U55Y$QZQ]W$Q])1ITVYS)I_CG:S,&Q!'GB[ M_HGJP94M]Y+!KIHW/OTET?$_\L-U[D>NG_T#K!A PXVDUDW] =;8Q+: MDOI[BO%YU,B94*K8R=058@KOPOZ-QIZP4!/@_Q:HIXK_>VB89:.3+J+$-$6% M89?O0G^93RGS2@YB9Q^U"(LSR>O7]P&!L5L M\E#%YUWUE[T&CK'NI)=BV*E:]M0(8J]RJS.T(L3"<>2DR.C@Z!F6(+&9QZ; M4_F7 %L*4)8T2TF 1.GK($P&O5^I-D;%:"C;CQ@#-^J2C3GZ[8;Q)%,L=W,) M"7/),/L0?V97.O)J\D3%=*@>M 5*,JXOQD#RIA6I MK](D?E0;W0ZJOT\%[0C2Z=AT7PHT@0AJ!B8?=A8HX>SZ;:)&I2BY2[ M/WJ)?+IZTH:3K^1%2F+]&^44_3MA7MO332"P#6MP[\W$BV=\_$#O;TFA0 MJ97@X(C[]"L@R@29?7=?%//<"%(B$&](M@77Y]8MF76=GJ?+#F+2I7_S[O'_ M$E#>U22M?O4F^D(6,]I3?2J'5>_61S1>N\17L'X4FY'!C(&Y/?6 N>T!D5?: M*K4BU5O,_EI-',V&]&&I*GWT>#P/:JG/&@2/,YC>78;L?P%?.H64&-LD3W:- MR],-$QI6NUUUYO0W@_43"Z1>("2$I@A&1/4MT/.SA&O(2;'^::2D",QU9%9Y MBV)#PZTV7YPI?\?#AYT*=1'-;#1T&Y0JEQ6)4VC+XB!/YXJ4)<]+ACP3FPMS M8\W5-<]G.;_@Y=(_]J6G&O'AMEMK+4! BV MR0"8/DVR5(Y;5*=92Z>6)H4*;YV;@_.G;DY6'(K\)AMV[KYL).\YV7#X+53S M29A[\5H47/PV-:C0&5QIRL1.]]G(Z^N3^!<_KC1%&C0YL!:=W@,"ZC!4%;N( M!YMKL5EL9#;^5NGIHGQ+[X?6P-J<.7?E,[)FO]7]3D\0Z%\I57Q.-FS>?:?3 M,*GJ^O.WYM:OU%Q>Y-%06(YO+'3=4M=IO^D!EB&P19\!(3[9D&E6$(=:YG^Z M!WQPQKX#&?X^3]%!=4/(&$:\"4A3^Z01&/72>X_%XC+JZ,S97 M"J#,]%GW@&3)5BR%;W^WQP*>@24>8Q@*,^;?EAWE[BV?[ZI*EWR1$C=C3;82N>E\;+8KL.5Z)=K!3M&9O2:_ MI+HF(P6E.1SIO8S:!E0A_1*CJ.GHM*>@V='%W:I=HQ(?3OX+#U:X"Z6?C]O3 M*O0LD3MCLW9TH5R*$YFC%1Z'P[?I\(BO-8@3G5*#%3:]OCY8G9/O%OI"R\E4 M*0G4J4BYD,VG13G$2'WBBRON=%Q!1_OW)"B;]*_D?LF8_I9=5W>R_<:1VQ<+ M)S5@AL='[I!_E;;7MF8!9WOQ@U-.OE,Y95*2N M0RE5R3[*CD3!A.1XEB]\;QSR<9Z^UW=3^[ QLGH3%K[?;@$.;3CR.X>H:,2)*?6-&GP H65(/\<03 @UDYC,^"C>)!WX>_1774D-4C'^[*8Y&][W%EBJ$CBD-O[N7-9<* MS\1R@?>J$%T*\?4BRS7;#CJ>GE3,)]3>"V308QS"@XD7EG7L_JRU@IE1!DK- M)TAKM3%%1HZ,JNM=A)V9_GO@8=#_O;%$= MJ;P2W U3'ZKMX^5%U15_OJCSQFHUE@J?Z6N!'J8_H2;D!9YMU23>LK!./>AP MYFAM].,-4Y-+-MUZ?2!>@1C1'+S.+.&K%MHMOM8>E%' AG+\%3D_K<'!/!#V M@9$%IM(^06:OC J6#'VQHEZT9=%S]NZ@9]K**=.XXG*#LB_R'S; 1/H1N;_Y M9T:7[Z^R/TK6S"D+1-M.Q*S:SCE>M$^LZ A]SJ=6LM4:G2UO-@2AR)NQ"EP:##=D'$U5MTJ:+D0H2 M5MH>=7]R*+YE*+YSY^NU:X&=""[A;WT/9+;H))V# ;=S6,YS?_U&F)< M2CN/[)U697RD^^\!G L1N9'RM?$WX7_MO&MXSCUEGQ[__38U-*Y;/U1 ]R,6 M#IMYV20<;L% ZQJ5B;F(9I1AY5WO7_V:$RD6=ESOH?1O6515B#MK[QIHB_AF MA#ZRG6S5.R;L$(53OY4VJ*EO0[S;=7:DR7<[V&ZAH!T2F0%.-O@D7C(0LEYV MY6C5UX:B6=M?\9R\90E3#@[VT(O:=IO!\)=PDMV*A"04)]?Z[(7YI^UIR:C> M;[0?;T1YONP!WP*2J(< T-WH@M>)^0NM:%QF*^[Q+[%-M&!)AM&RRPTBIBZU)A@]#F:]I MZ;1+7F>H3V<@;:77#DV'H".KC\].#)^9-+U _Y8-Z8!,!E->#X,=_MOA4@ MCST7NX*:6H&S,W'8\HYBFO+4Q)*V:XY6- )2>/EVY*Y[6)^')I>]V^1ZR@T! M*4#2"U'\/ OS[]V!AV!>A,WD0 61>@B=880H,1-ZJ"89,:#3F!^?W"MI7(-0*/T14+*_Q%R)\PB:J0QSH?DUK'*DWNESFFODH;>'L0@4+J MKET?DTV,O\#83+R4H9&B:9<0>O_^>3:9%Q),UZ5=<<;;Z@*RZ/(LJ?7JJU3U M:8FA'_%3%G%/>%$"7-F0%D@2=/WF/Q]9V@OW@,7+K_L"=9IW.]L@0HM(*1(C M/B.KNNB7:G5^B?U!,[$9WA1 NEL>8)$/5?NF7N50Q6X?7/B25F^775D_&LJFI?JQAEWCEB'R;^G#N((Y8QA %]?";74:^I@B9) M-Q#,5GV0]N;T>?%C2T\ALAX#@*RSU9T%9PNR,H4@C2C!0)I3!$X98VB M?7$/F !-"W/;:.B>C9-QP\%]='\PAH:D-^#<=JNU="$GYN4^H@GC4>4>,+CT MC'X\&P*&'C*M1PY,+?CURVBVU?U<7DG MB)9;IN/:-,^(1[G J?-&RE?OM2+M[X'F*U07X"W@MQXI:(7, +UY] M/+=A0_?(AS[5Q"AO<<9$M*8$XJF'>63?=D 2 3/1AY-S?-.*!9 *GB]]-I;I M6H5]XE=RTG 7(?/L*)TG+(MP 6B=!&0.>HFM33QUT:477(E_EU?_.Z$N\@) M>M.!1VD P"5/4MZT:L623*!LS?F?EIKTQ];\I<.?9#P!4;)D/.'6/7E_YA&& MLAN3BY4@J:HUHQ;3<*FBQ5_UNG-PD**UULZI5M&T^) ,,R?HRMBT$ OU*0W. M;&XZQDAC]I4ZX5$MUV?JBUYP?3*!O%:M*DVIZ).Y[.'][D573\^[^L#@KE:8DGT'#,GFX2GK\ MR+269PZ_9*M(PWYESWQ2YF=.0U]X[03;?4=5HB-4=?W(VX3IYX7RUQ9W(['W MV7]VIE9\;R-/^0!N<@L=.R M\OG]A@P1R303E8 V3MGGD>=T(];^@!D=-I-(L?ZCI07CHWL%:18+^,19D=D> MO?HB1T7\&0D0G#QF_"A%>VS1L="&.YN=%> +2PN%9?0)!OI>)_E&5ZOR.%:F M6HU43<:HGERY3QLPC[=YQ>#433R$C$$U@SS*(VYK[&33H:7:I@"TB@#>_>#U MM%@CG?E:.,7!PISC;@KJ64,KF. )3C (T"IL((TB17C?(MHIE;5O7 MAZ11'J[R-':QI9A]LV'+"OPF']*/)1E;H)932LG.\)7+!Z3#1T!>U(2PR% M94&3\"RZ5VGGZ)>^DI)B/T2M6(A]J:FON=L_]:T][/N+T(?FYCF' M[+PQT[G"/H,1F+S2[W0R1SA_-S'%T;SE_*O$/4!.1";^4[#=));D4"J#7\9R M5UL_]PG_J_GCV^/%N [5(/79.@=R<:1QHE\XU=$X->/,:Z*_K_L4J >9$Y M@:\PH9]1P+SXN >\Z&$*]*TLU%EB)U!WUW63^?MV%[5\-D(J:IL"&9V87E^J MRAH]7%\ I%G>U_> "U79D!_!_RXO!;]MCU\3U@]3M]=' /F%,"X=PM M<+E<%&: A'E'I*YS'R:+O]YH6>:]FC> M94TF?2V6&:*\>XUL0H_3QC*">O> ; FFESOKEAN3=VF^E81X".;6S\,HQ1JJ_/LB@NCI%P M*$CO:4CL5-EO?RN?$N*UE#0ARN0:(_KB# WCVC-&/^DJS'Q-'\7-&"[<@@O? M+7&Y:'"#5\S79?AA0>$.M\:&O$W7K4YQEU#]C]B\/@ZJ:U\S4G"@ 59@*"6B M?>N=[4,3@0@;T_YCWZ3/";&01..Q,XGZ8F\NI3+YK:">H[BZ#G/4@V:AT?7N M1);U$7$AD&"P"L_E3&12,78<[G8=-\G.WC 3,7CMR[*.O_W'M#T MAW7#[W_Y#&>W^17>*P-"VR,Z5KO+Z-W#F$57!]VW4UVNW#QWC,TZ\P&DYGX; M+9B'UUHL6@RCR_YQ>@]H/T(X3P\7,OG]%Z]J+*7,?[L3X9P[T?MUSQ M_,BA/4#@#JDIZN@XKEW\Z["_1ZZ:\"M@]A&0\,.,NS@YY5DHEXQ+F>?GI;K1 MG*(K9EGK1(L8KO,*[^.@PV,8YD]4=6<"[/ZX_S#).RM./J/GHL_'X149C].' M0V+S3+] &URH_1R+L"@P1J:BV-5[I;VKCR,,2^!B+=TA"M07:[,JT=& ]$.^ M9=;A+4PRRCN)JG03S+G3X4H)#<*%4TO3AQ)M+":=V@\N7>$UL#N9S26GX4$%<\B;^(%MSX VO*Y\=WU?G M0%U$'B*[HF>Q7.[3S4SAL8J*OB!6 +NT#F$H1%:#ILM$'JXA/UT)F1D(8GNJ MB;L[Y6E\_@9_TSGH=Y_@D@1)B+\0RRIZGZ,G31\A/"7M323 M"B9XNH]R9 ]*4=#CFH^C MQ*YZ]HODM8==9C;3DD6_C9 C=IG,01#@-=)TZ9?+OQH,6!(:+R%:=>R=3&VB MOMSFW#X !EP)!@XT/))NUT"MIZE2KUL/+WB5.ET6<-_VTU+ '9R4%)R*-SYJ M]=@,T^+(" ,O->CJHYVE1I_NLA*9.D$R@YRV! #SI:A+.<9L20E43+HC" ML!?$-5@JCT]<+MA.ZV?_L5&0>^R>=;!Z* 73]B8@>6(J3DU([3&G%FW]'.Z;]HN4\AA?UYA(6Y-?%]NX M7QKLO%UXVG IW@PF7/[ RC=+%%&)E(QL(]HG#MC*=>\FX"/J9H,]T9Y M'F:KO&VJZ& V'M?)Z\01+Y@,!V?_,T<+6@)QF"J:%VC1Z;B558LJ2*.=K[*= M=/-Y:/NKZU=W^6KK'0.V8UW67A/$ZDAQQ91S*><5;Z]_+F0?![(K5A\""^7" MS<@!B1]-TE16LO*-\*=H-T*I>2#%G[=F\##JU#%6J8OHKS8Y:1CFVQA=!\#ZF M[*G='/7C2.9JJ\#

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

    SSW:F:O#]OKFDL:3765>:\$B, M9PHE4G [.CK5?-[]3]R6.I!I M*:#>,:M_L?U_9[8R_D^VHN]-LJVZ*P_DC*:41+)LPH6 ;L(FG2NS ^,]@^[@ M$D-/E^*M4\#S=\]A%^QT^8Y32H$+]%.KJ"UUDIM=Y "OR#5<0Y**J9D/S\FZ M.] E/G+"+2!Z\"7^^^#[FP]"S]V/8 NAO$,H$6-(-\BRQ-(2DY*0XO8FO?*2 M 4#J\:>]*E%A=:,86^JUZB]O$Q^O/[1YIT*+*_=>!GF0EXFMI!"("?$0C[H] MWL;PV[M-%!G@("BO?HD?_.R9W-B@Z @?X+&?T2-+8WZ-H[_E@^6,XB)J'_52 MW>2AZ';$,U:_3NUY_4$CZKA&72.',9+[4;":&0#@7ACAA)O#@&B!-WK1%8-F M7(\4S7!CD>^IH!M.,;SKR>8(<_%UT-,@AF+A\5DZ838)![+L%]>K?S0P>9>T MUQK4 :$Z'Z??P+W?XCG^H7!"DI1MN"NZOS2][8I?0-0G#'1&CB33(GUEWR[ M\P\%DNU+?E7UA2V(MID$K'-F/7%R%A_Y X>.[>3(V+ 6G)OOV_P MVSXNOQ"E*\MO33E"FE0./0+.AZM/DS-I,05*G8MDI^3J\"ZR,X:,35DDC^U: M:!564MZKEDVZI6_S##AKM(XG461 _XA3@H9CP,V2Y3G:(LRM3 MS<3M$Z5)M\;17E]LQ:J?_J.(>9.1:+!XJ>K)4#B)E\S^2^=FX$>J@(?!0=M> M*9,1T]%KHT2J[%!@FQR1 ;?4!YU!X]Z'B-Z:Z,U^(2\WN=&IYN!A:+3$UUER M(&3CUS.:!/+ZO'.DZ2Q2D/]]^;..P_]Z3)Q$942? E3#J31<)86#\IL:H@Z$ M@SL1V%Q#H]I6W'Y[_5"1Z46/"R9))0_P=3Y\(ITU9#K[[O$2AO/ <:(- M&:U53K/?K]1/U%&<51,Q0P)]]!\M(^Y])5P^L5E#1Y\"/$=8J./H,U0I+RI/ MS:\M'Y56O;WA.Q.NR9J.V08OV\6^S?4+^W<@3(GY. ;L:F]L/52 :&(^M5)O M^?ZW6KR'\-. ?1)IX"T]WA)2D(P\,3. MW1%&YMJGFLTYG@*^!L*H\=PG@QC0:RA[)-_&N%<>!^[9.^R\@0=K7:9]8):^ MV!T[VWP9O?6G5K!'W R)*/>16/A%9+\J@C-$\/94H.&]2.^![:) M&.895['M>0=/;WZ*L_/@#+IT3?7OG3ST6)H!(S^AF\E?:/BQ-[5%"3UZ\_=1 M>71X>OO=. AKOD?3CUN=(#O; G^IQ_I/7HUH*6;J0<0+_BI:E>H/ M )1F K0V4,'*+^G*%?=IEU5G7?YG7&DIIA3YZ3']+$9<:VJ@DOD(XS_^(,U MXC444RE;2%8:/VBUZE#/0B7+^UB.*ESY]@C9G&+C-; D^"NM+OV!GW&'D.L4 M],7N;/:BXM;X-J#%<(2@O:.7 MQ?UL8061;>>;-D2S%:#BBW12)2@17JM;5$BZ%[E0WZ98,_:GOEJ+O"#9[.ST M'&M\H3KNL5;&WKCN3',0);O"GV'W;F!U$29)200N7\TR MI,0@413Q%L08<$Z0X%]/*6AC\Q(0M^AM$_\ZM//.CRBHP 4MEY\1%[VR=:.2 M?+49R$X=.06PMD@N?B>;?PD1U1_7T1?LE]D(JC=**S>JJ+G^4CF#K?UD1W6- M>]Z!<\12]4IARJ 93$Y(HG)D5=%X?"< SC\SO= A4;E<_^G]$/W HZ64IV?2 M7Z_=HK^T#?H&KP_NT!Z!P6MWWT*4"V7:&OEA#\8MLCU20Y(A+7DW-IS.AYQ[ MK6-C7ADY!&5N,5YDR0U^2 S'SFV[K(#K3"/4X((FXKG!M:X2-5I3!9/_)(*0 M'R2XW3FDL)2L#T]W/A*72-S4Z1'2E0UG<1PLJ8[5TH=Y;\U4M;7EB:(*">D$ M^Z= -K?CP77Q2U]==1+@-&5:0U.F52WJ&!2=AT!!F# 2\RU9L"0=H?"QK!2) MTHUK%$&4*3F1_!#AIG\E89-1< ZW>G7WTV^ 0PO9C)?LGS0J]9"&\-F]WF+R5="[G\QTQ_9G2H>, MT2)*%N@#.S-/YJ*40 )=BU4RU 2:V_+!R\+E$JVS&2E*E)\K=_I(W*0T1_7D MMO-D/2*\[%9I2$-'D^);!.:-0X]_R4S!F/B3=_3TB4MR?2(%DUQ*9KDVEF&_ M)RO90J0,\_'0#L6959(KE2EF45=YJP<)OC0W'Y*JTC?L%M/E4 +N\=#];;[XTLJE:*2G&(JI!*2\W$Z(4F2&.>I)$F2 MG#4L$S^[S[+T_^[7W M;S][[Y\_UNO%;;FO^[K>UWU=[^M>]UIW;]7#ZV&2EW+"T@+> /+6""C".J!# MD+Q+$Q[8'=Y\I]J6O$WCI/M%!(=B.8^8<00T-4GX[7 V$OF"\ZC,^N9M>]=* M*XHU."BMX?TF4"E,\,5!W:!M.9L!SO<;TE/#YJ,6*!K#>$:ZN!D;*&CN9 .Z M]<@B[0-D5M)0*]>E=H\'JL4[Y"X]G,W/NVF=7E 6:R_>%N@4W@6-P25$'1^& MKBMA<;;=99R2K!E0SE *4QRSWQ\J%_%S(X]?;KOTA\\>IJQ=N!5OHB.:U#Q5">OJ5TTFN-; 3]:Y[0LG)!^OP1HNS1H8 M,LNP=EI(UJ[)W=QYX,6JCYY<,V6/>&(>[Z-N,.^Z^_.=B.#!S_&-A*T,B):* MJ%9 M%2Z[LG-KSVUEXOU*V*J-O=_T<^6,('*@KUF:UA]]%NY$B+Y\X%3U%ZF?A?-Z5"EFNKM+ MKTF#K0QYO [-,P Z$"I<<8GR?WFB=2 -M6]GG;+:)D10J^]R'9)V9-/R$^TC MCNIRU2[ 9,)8TKV]O:%ES M)I_47,Z3?)*B,BO)U4KC$U:Z7KJGB'&1FYI"D\M'W6.^\)#C3G22-A*02:I, M$\)LDB/]<,N0T58:7J=KK&TNO[YZ MK[%C350I_L+AZ-!D(=JKM,8,;\SI]Q2>Q'TM]^+* M(K@5G?9O3ZG2JKHIM*QDM,OP(L^N#]Z@*KC$O\@D_4'E0[DZ%>V?O.!""E3&6\U MA L >32]F$EL8"O7PT51:\>/0QVM=]^)VW]\Y!XE'W$T^E2]US$;P6YJ07CY MCU%OWYA0\;C'%)=?]H[-T<1!1O<<'8I3L[/^(5.#W&T>A&W8$ _1@]^6:W$; M^I5?*9YZ(R^KG'*FH;WHZH-M+63>&KE-*&DZR#C VMO!4**R ;E99&]<+F]2 MH6=KOYZ&5R5\4*DI-T/7/2_7X4PZ,]W!+[H)V:\^]!<^FC=@V72@^)_X:#W$ M1Q_$O--ZK!V[JD&"]3G5$(J6JY!/^AJ#G94T-&P4C"H*8[3,#@\_>]DGL'V# M1B16?A^:I#0)[M$&&!JTMA[<,'*K8Q^#.G59Y$G;NZ;T\5O/MCB7SKZ^PN*@ MP8CP8)8(MDU3AN0'U^M0 G1&BPZ;6P=FG'OV,@Y\\>R+)A_"9-?%#-6W:$7] M8*&:^XX3N*\@3<*%\3KT"7S&I'3M4[OJ(R Q$SWOV3?.#'H'+I[#]" W,+AI M#\B-9HE7R/%!BDB>*863SNEEG>\ZA(0/-M=O-5XV./C:-RM+TYZNC5*D!>?K MYWDG5O7M+<\]%RXRB/R>_N%#5DU@G0-@UB($NSO5;V".FYJGVGYC&IW"-/#2 MI'@9R?X0(-8>,*94'-9A&E_-69#2+; M-_ML#%K*/Z\4JWI1!G5N,$-%3=<@987)!C9=IPGD]--:SM$R,BU;/=)L+ \E M97\1_KFW4+>QV:M1Q^/JF\6OWKBOJ<45:Z\^W1)VJ!75.-_%V.7SSGNLKU=F MM[[B&]T)7IB7JA%XD?PP:@G$XQ6T6 M2C0OC#MY-^B'O M7D4?^PX]W!>,E ER408NZ:J_V/]1?3L>Q9>T9:$VH=]\)#;-S/I#\7+IO%SU M2L49#_H=;_7Q^J-*I;*0U..=TY%!]\V4!&P+:< M[P*U],RU; SNTZYEU%Z4H9'Y MLV*# ;$A$5-$<=D5.^G]EP0_!+A]N195O.I \2)Y1E+22-]*B0.^6JN>V1R/ MF]X(A)STTCL*%D7PAW9V?&[^'FUO>\+* DG1+'/_G'%$9\Z-O#"$:S# 1".% MBC""MW=R^UT>DU$?7#S,8>L=HYK4Q?,P[&ZC\_=9Y%L8V50ZO FTCXG[VK*] M;#3!9I,$IUBO(.>4RCL_OTW^]PG^7^ "%0*4 T79VJ(T].7PBUUQXMF.?4I? MJ<]3F^2/W<_A/ZRGAO._YX8LPHIH\TTB]_D+> =5J]<6*?N^$]E4=YN[^NA[ M[Y%+OK$>)E$T\<^:IN=.N[_V1)(WG59X<5NJ7'OM&)-C8-^\ M=W!JZ9T=K//]IZ]S5:IH?E^6,0.)^6:^=] 0\Y#O9&9+?!X.*J;K#+CY/@U M1V-6PTYJX'*E>5L%-U275-NJ=$N1J4$>V8[QYOH_[]Q!7^J8:S]A_'K_@)#0 MG;O?:V6^ORZW(H.SDG0_6K\^N/,6PO+NLYOG==R\KE.%;0+EQ>SRV4""KJIU M@ U-E$MO)KYDM5%]](=6YL_/\=*EB\L,/KN:\2&I&9LA-L ]_2#Q?->2C=[% M\'O?ODL6!\A;KVHT^1?/R\UD4I*7J684O08;3K.GO#G<5)U]JKZ-40?9 MYJ%_B[:R2Y^!!1XE0DP"ZRSAC_>'7W8LLCGZ((OT:7]Z5JOP3L$B_YN\C,5W M$U>";\<>D,G(]KAV]-ZCN D*;#N#$VW+?*[I0+FB.V8H7K?74[Y$=5[Y!*X1 M]<7-"><<.E@6W<=)#8'OQM[$/DSF"B.V>*5:7/0X?.5G;;VXE27GSP.Z<&H; M8B*^&MG;X(3\?@@>TA?[*$Z]IS3%NM5M4[/@:-C\L'O!$_[*Z88+YT^-^'AK M22],4TV9SUC[:4'40/(5[:,T<,B&M_9CR;2?GT_NK>6]/2SK_2VCA64<"Q^. MVFG^S,]"!.L=T6?(3O]4&SU_R3C"OP..P-X$0SB)A"IPD[=^VBZ;[Y,3^+#- M\(X;7PO9P(@>6+5M<>HP)NG%Z\3G4P^.W,\5)^.I$>TR#$.ZJW>A7KFLC!*O M@$QZ@T)(KT1S7M!W8L*J&S41LJ;5I#8?#02'D,%](05@UF1!8G@DWV7WI/SK MMN8U36%GLEJ<-4KL.+F %40]X2%ZMY)]EI8IJ5? M\2!IZ]/S?([6&[PV )" M=%_;C0^]>M*<39&8JSNB;7FT'^'KX25>,X9#X!:&-61->Y*SE56;Q[)325'; M,?M/?LHS.V^(7+]L+)@TY;O!0G=#!#.7K#MMQI\T0"\?@9>YGY@]JA-3W@T*_"O[4IZ$=QJD9KL=;HXHF?#W8=5Y ML8&B0[$9M \N#U=YDG*M6I7*;G^PU;^5'Y%[X#&'9I9KR/,W!\NQ4-D+D0D_ MNK[UK4(:KDJ9SS ]_MV4"PIB3]+%@-]Y>8 M%A"&!>[?WATM4[[$ M^'8+XQ:#P-KULH';3*[ZP2T0X+>]C6H'#Q8ZB3H8^:D8=#O!-7'._'"]A7F"QM2=2.3FTI MU+;/-,=W2%NDE>';QIME&3-Y6KBDG2;\+>7[RD-UW)XOW.>U9)22;9_0S[.J M62=Z&L))TOT#ZB,Y-OIBB;(I&;8Y>^='%L2K30+K4$U$^>T:"'[EW/98Q8[8 MGQZ&ZJ;BROEY=DLF#<]1QPLI-Y-4PM$UQ[U?$>M?)+076W5N*Q@2E\*]5X"5 M-UAUX;^"9-/Q$*->\(R3IVX +:ZMH?WI%4QOOFN$:P2BN0?ONR)3**+E]+5Y/I]/I*4.#HG$;3#N-K/EN9,>,U M%4A&G-Y.EWO8P(>EQ,/$SJ('1V0SPOJD+8:Y;MR^V#Z_?7A?M.7CSDCAHLY8 M O) \]T,M6(1<2G65O'4>@>Z)BW4>+[+FN =9>\H_R5*PWL#IDWA'$C4+883 M<]'S3E0L]7@?.)$][<#:FD3$[J3Q0OFR$V7X9LI?M.MBNP>L&-'KQ0= +Q#)DT0390._2FV8!C$3S#7#.LB*=D,?!:JO\ MW2Y])B?/7FT5"'9^UIA"M^FWF[^VTL,[,T>1IH8SGR^)6M58"M0Z&UVVT755 M3-#.3K4YO_=>BN;W"!VC_?NE),^93O84PAV1OEURQ6/D M^LBR2<\>C&3[L[,:3\]R.-=RB0L)*I$(Y/.P$/_C:]]BY#9@[<9M9I,]!U"X5?3@1+?<5&5[4O\M4)R.5V(:9:>@5%_]0KX:@'6^!3! MVJ;C]BR:]LX=Q^09Q%IK'P>_2%)*F %SV,6DZ?EEZB)-@"*U]C7VO1D4D9-D M:G;VI I^;UE25'9F;W&S%6Z/ZX:835S7>,5TB9P\KZH;\?!";#T\#"L*=T _ MP2-W,A0\WMZ>=?;8'+O1]\+'P+%#1?NW/)OO$%T9<8BK6LR3YTY.4G\R$7,H M?/0UL6>\"4L^1UA1X]T-U2V05AEQ'DULX%_NI+$M7=M22X,/KQT1!BMFZM6+ M;:4(A"RNH.1=741[,.D_+.OF1++$E#7@5C08D-/[5!K\ZCI'@/OI]*#J\;#IR]%X$>R9I'JFC;0' MW-Q]5EU4P:#X?3"_\RS)?)=\E>FE-W:=&[#"(#&QN8#5FPPSY3"]UG62\SU= ML9A^"AF#?B]7#7^HKMEENW3"F=S)-(D!M M7&G\VHW8HR5^\*\S^>BBS+M0;G,ED$VR[]Y@YBO%EG/-3&9^SZLEV_II6 2:^PU8LC'O]TX$;<4I@X:K M/J[G-C1PZ$>?]>3,D#*V^(?-:?D#J+J;*,[(:IS:)=Y6R%\\P'[C"@TG,E:G M Z63.EFPOR#\N+JMSSCJ4(3:C7C9985P M]]O-D^7)+K<4*5 9(1%$/Y92 $7W%Y7(V$CT_$Z1C\.1Y841GO7^> 0)74/@ M^(%29I962)*.8.#%LNXNPGT6+9XY5RZT#^QW &).2O!]P?QHCO GEUQ_GWB> M61-V&'-X[C][5BA<&+3C73GW]AD;N.;LP@;TY:07@ZC-S-=Y:U^R"O):591O M2#[4N>"7^J-R\UK))2RUW^4XO%>@6?.ACV]@X^&^-*/)=S[!5^9M=#+!9-/GBPO#X#'V(=X?C>4Q^G5V78I=GGYAWHH9"IVQPFT. M.5^]^RINIIN<66>[OQ2O! ^M%*WLD;U)/XOO=*04?3!X'7^SP<#A-3[#[+>U M8JG_Q%IQ-_-#]*R7!PF[B0:K74WWE2R>ZQ,/&5-R:CU->=$H:)XF$Y#R Q", M6^#E%,1TR3U!%I;4&H4O2WL,\VZ:5!^8N(1U_LLN!I.CUYI$0^X=P>Z .\B% M@%SY"=._+8Y9]6PRG''UB>#9:_N7PUT)-2%'.G.FC*P2NE-PFP0G M[8;F@L!"'#63L9L-U*D[60;ET@+[INL*\@FOO_"%E@!0!!0M\F8#^:%=^"KD M1A1?%NHNK90(X]17[.RSMFV\R0>GS#F.*>(W^1U_Z[ ZAO5WS^,U:ENT,A0W M^A"(.U_TT-EYAA1QS/AT#K^=Z;Y-VX#&#%=;7F:ROQ *CD_I82@1#;G.=)/, MS#%W[MB%7=F>8;Z94WS_LT6E8DT7*:V>U30UDD_I':H&;7]4SQ92B%*88-B<+>UM0C#:C4]VU.2W7:ZWI;V"R%L]_&\NN)F 9B MB E->&B)MQ='\L\;>J*I_X HLV$:&3-BJYTA$^&L<6'+M0,H!\^3:E2,;G[? M4K?I)OZ_63".9 /;4:9T'O^.O9VW2DS.QB$X36/O^6L$-Y4[ H>?,0EU 5IW9-_MLC5R*L M;!F^S[;Q\)QG3<,E(+> /-O4B4DW?5G\,F;M;7#(Y>98KCX=,5+4D_G1 IBOR]? MF%GON9KP?/7J=[W#U' MNC[A2IJ4I*J&HO]]AB6SO%(*Y4<;39G$'.!V6"HQ+I;V.HU^L3'-,T MTBYM5H_AOU0@+@4["67:2\>61#6H9\BQ^04@,S?W5+ZYG@\X^@Z\]=+2^HE$ MWYNC/^^\!@#7521XE ]H1_NY MY!CNNQHW?^G#N>^B+\Z9KVZ2*O83(*)#6<(TIS3EYR0;GL;:5;OSG8F&VIO" M%,0!;F?1)F/<^[QQG6="HF>DM_-?>ZJ787>4@*5F>Y2F9M(Q-^FPY^![WMEJ MXEPOH:IL+HCAY)0M6=R0VI>1P7QTT#4^3'50RJ8J>NG\*:%O8]^.*T#*?S1J M""?TB0R5T>;HNZ=UR$O=607MFX:NZ\^F>&X^?6K_<_%*SQB.E?OGGR/SXL$" MEZKI6=2TPMI*\:3?;RO%RP&[A%:=\TOJT0!KG_<<78.U&\8YH?ZI,Z\^(V' M7+?%9NP M=Y]R!.\U"W\.F@X1$PQ"__<(7M.'#*DDC#)SZ2>ZKRU\O-M;?FO\[G(CO:'4 MU#WK6VSQG0EW=%'$7,$*%_WJ ZJW!?Q'OW3%F+26K=KS<]552=(GKNQ8G31 M,W8U")G&VLE\6R%/-T)MI"6]H]FVF!04==Z1NY.D9#X/3=87/K44^T_._KQ,)E+\,\CM0KS9U]:?Q:ZE!R!*/A M[WZU7HL-2*$Q(%Y4 ^(80_^!I6*KM15>ROAC23Q*A^C,;=ECOT5LE5HO\2HP M0."8KC? L9@7=^)H>:ZSC!T\MZ7WJ->4[PY_J(11!4<6%F&KPUEL8%*SF ZW M]2/]ME\\@'%J;SF)P'G+4K9PY[WX'K,C^YH%=WZ_JM D >\L6J16+SEN?!IGL8'8 M8*=A]PFGUM_V+7Q@ R'N(O ]@PR53H;4<-,9Q8]EL@]%/FA;)?J\WQ H MWY4M4M!VLYSDTQ:MJ997C#7YYWT+:*XQR@X\1 JFT7O/R&"?_-1T=G3-KC\Q MX_[I0;$/IQPYZ:OW; ?68YJ21D46=:UQO_X.7B$+QQC+[^!=W)!3%<]H8;!- M>J1-0:"!C^-/HU&ZW%]7BP\NWV#\%Y#1HY4I67V3PGZM3.9793/E L6%'S_. MB8<=[MKKX"FU[."8PBA,%K&N3$.G9K MKZ\9][(!2O,?.[%#K"!_B'6(X@Q2*SI9PF[$.29_-"<;(.DYL('&PW^O$ZU( MY"AX[\$Y+RW9L 6C/X[BC[U0EN@,%1J[% C>['"&A^R 7):(1L8?O%')*\XFH67 MA=-?R5X93;LUM^@LUE+;IQ45^[8_(SG);J/GQQX*\WNJSK;'6H$!\&VEMHY_ MJE.C@EP&YB>L*-3=UX9_#/VKL^@Q%,>K":O28EQ0UHV"BITHX[^X3^C_9*O_ MGW&?=476%5E7Y+]P/G69'JK7<^JAR.._/9EK3]4R[KLBZ(NN*_&]59(:!(#)Y&RU%&R*' MM ZV6'?C3<\N+(TP\CE&)I4_,RRC_==).F'] &-C_4Y M2%WT=-!.DSV[W#(I%TMJ!>R':>V@F*9'B-6*P]V1J M4OF#,W9;C.2Q%;/=_0-/E#KQ?R;\7IKHN?M3[J?]D>I;"7]6]R,/A+'-+!+] M_]>P__X@I!F ]Q6U?!% MU0D832&(#82EL?:6!((3KFUPL@-4N? CEB[H,>CQ/[YBBXZ#"ZMPVFXVH)"3 M6HJD60YN90,IC6O+D*]A#%,8N;B"CPVAA DHM[X=R5KZ6<@G>%I;."AW()ZCG3L'V[\@[FF7D:O+,N5AE)# M>%F@'AO8@!S[,V;5ZY:'+?Q$NO'.;HG_/D']C:3V:GO9S#KU1&PN>"7\MJ%=C6_WLJ6NJ&R,*V2U1>>&)W[P0M MIYJ!7XFF@>3&&O0V=_ET[S.U5#&QSA*76W>N;1U364XJ*W]0<*C,]]\#.4=, M8/? @)K?UXR75^/"BOZT4U7^U1O9P+HC_[<[LL%OW4@]'-X!H.E;__61)AQ- MSGQG?NOCM';: Y=KG,K5DEVYPG'[7]L_'@GX.^@L-N^8-OXS@;[V@]G=S)RZ:<3&.\7)#T_=+.DA$(=?\[]769OVO\O]9O^._.]1-)C_DJ]R<-6Q@ M\80CC 83^"W(_"+_GX++R[\ZL()_6-6O]DO[5?X_.\!?)\PKK,[57ZWW1_%_ MXW!_#51_!K^TOW4 ])]X;?[IV<R&*(X<,#:PZY6RI%_B^OE&?LY]\S1.DIB:U)/#OV?UGB&O@I4NOB;/, MD?LMLG6E:KHG$/,.8XTS>O3#*'U*26,N&(']*:5_WW3F/:WOBS.^3O_%>(X&'+8O[F3_293=V, _ MN]5-POK$^1\V<1P(WD$&'8MNN;939IX)EU.;7#*3=@/O3IH-7ORQ+V+?PC/K M.89L="AA48OFP :X]K(!AHWOBXFN/+';KLX^TF') KLL5"XF.GH:)L7R-T#$ M;8+F!]F&$ *275T@-" 8N--(RTQ>?R&(=]9CV8" )1.Q-FK"CU:PD()>&$/2 M(.W$/Z1^(M!L8+S8B0=D'(M'A@W0RN D=Y0V9+*Y6CA-M02":&(U'[(3%F)O M_@HL5 L;X !'/*\@1/XH1.\/HX:90KY7 I%47 .(>P42Y1A1S6'#X!]$0'9L M)]-9H=CMD",,$=A >-K4I^@5*FL,UDO#K2S(,3:Q@6>]QM8N?Q1!+M.&@6W+ M)#1CGQ4;H+C[_:YI+1T.C4S;G@T$8.B??DUE)Y3XA#3L3^^G??'];*;G]IZ#/\K8V\'(?73Z!+:0XZ>C^!UQU\J_8 M-ZY/D?\=4^3M&46OG>D%ZE_XLFZXJYEQ/3WU\\A2\[U_ZV3K?48-]+-=VMPT M5L_I&K4*>)9NO6^ BZ5$?DW&/BV&[;ZMWOUCU&/&DR,9K MRN=*'QJR0AD]1Y^67IH>YF7$P"%\OO/0USZ^B]7 $N/A\P>\":R:>Q#/2K-E M\11-$)TN)A96&*E7B)OLVO+%QB*1#9!G7(()BV(4D+79D@W,*\%^;?#STG%E M XYV\/%AE=4\WE'MLVP@U XERP;>+$-,CGP"#Z&4]7?:GC64R8D3S5*F9 M6^7UAKR94P9<$8[^M:&R/#5Z]I@#@W%MR1+6C'K"!G@::#9LX-0<1(")]AAH M4AG_G38$WMV8F;$V:R.T<\^L&#V#D[X3N+$36A"=9VR'@M+([3^VK/X,@Q<5 MH!G3W?O MT2CC\]ML=7;$71\X; M1V5F3OE:&[*!C=GGN+5QM-/7/GW3]0(^V&5>8,7.R\U$TP5ITL/C-:45AD,[ M3)"%6,/S3O)BB:X;= IVG^ 1$U!K26:]1GSO"V6DML)G3D&ZG,WSR63PV;$, MQ\99M?'P55EA0O^5M. \];NXU]$.PK&.#>>G7^#^O$FDF_]B$\]U;UJ?ZNO@ MK(.S#LXZ./_[P*F\SRS$VL.W^G\K$PAQ0:ED32,^3'DIG#DQ];SV8$YJMHCG MV9>:R:68KC#: ]:VYVS@8'0 =GIUF@WH9/A:W-7@0_!#>3N3I7=(FO?\'OO# MC28SO$_,=GUG-?HJ%=E'>/;I/A?>*R[!L2V"Q3^"WL':-I%\G.P7E^OCD:7C M*O_T1/7!C2(V+Z[ND7JSA+E!@V ^%&W'!JZVRJW46N.K""N'?!'T3G "C[&, M4M@5U#1JPJLBI-YJXSD*AS?8?[_0$LZ_SUY)]9VZIQ\S T-[22"WLH0A#YFU M8D$C9 ,-$VP@Q(6,9["!VX3E53F6BFV>CC?8WYL)M3Q;9 -34=!=)Y^Q*AU> ML(%:%9H3"RQVH3,AIQ-)8PEA:Y$+S%R0,(&E#?@6[P%=;J(76*=862/(Q:VP MZ3$?(X8"&((=IYNQ 6P[2"F#DQ(92A! ?25,%N0:D?A<8STJU1%J&8&M2UJ7 MM"YI7=*ZI'5)_RA)"]%K9,N=P#F=()/W:-E$S^=K"*G[<2U'PQY??& M#Q=Y9Z4%P=#W?-TNP^(LVE/08FZO11I/M2BP<=7>J1OK M*+1J]QX&2)AA=\=NTHL9N"MCE6/H4QLDT\D)%Q)[:8OF+,2,B/K MB!_4W6I;Z\LB'2>NLH&:M'8V,#Y&9[&DV, N/<91+1C+WP4[-P12^/O;D0:L M[!O(16Y(9V\VT+_R6W:O __M?]);S7@&MAT#,2]!ES'(;GJ[V,"V:#V(/23. MT6EHA@Z,G+4(KJQ40L:#S%:'<-&!3<6MP5' JKS&Q": N)5]_Z+3/;](M/F\ M!\RQ$&!N:%Q=":6R?D/4]9=>C7\1ZKEH_$^ZP-8U6==D79-U3=8U^;^@B9NM M.EDG.GAQ^D&XQ5T)'\GYIE*%#9U4MF[A!3'T'IO%_I_47]T]KUI^YWO M=ICFZ^(KB*_P36S 88X7I4L^:_DMPR>[VKWSRRX#"[LK-X"FP0JT'&>R@5"(KT#&VQY*G%O=ZH1>9L%8 M2K8D'3>(BH +3+0TZZ,#>I%?;GK$&V2<@ 5A)R3S00(-I'7#R$W^/&S@35PI M&P!);].<>8^;G5VP 1X5-W_1A Z=L8':!#=Q"M(T(?=3@?W5YK3:W^8F=[<$5D'@.M+KV#FS7EMIU MY+0UWB@OY1!VCQ^>]%T'&[K8]"*FH*\N3>O>SFUM.99RC(?OX-.#<.9&TSZ: M&N,"(^YMX6]'';[Y^J^=8#BB?9P-?!&G8'__M/I".6NK&QLX*!#)!F:D>%EA M2JOBE%"6/FSM=RX_-I ^ATPBD W0*SLK7""SJ8*+QIC;H8SP:=\Z4C9KP:@= M[6RLPS^45/T?../[_[,+>1"LO@B.!$[ J2?ZV<"D3+>?UQ_;?"U&K88> ??6%" ML<1L^/QA&C<+FX]=M$3\4"(O,_BE6#HP#A"_A&>%GU_Z@%[N ^%?7IOCB :K M4W[/*4B6H5@CJSH!N1!2BGF(G;^PB%E^"RF*L9&K!U<4'\#HFQW!;\)CE9LA M%U+HP XFL@'=SP\4($K-R08P!/HU"L248ZK![RJL$8V^PZF5)YD[_[-';OY7 M7-*U\%MR*\(5K'VN\^\N=76Q.I#S1N*0TA/818%\JVKL_-%)<*G:B6(-9\2^ MC%Y=@#$/,_-+&(\=07SCBHBBL8[?ROS#?_3T6+NLI>KG5CAZ(9T:6LDY[@$H4-?"A&>0F"3:'\+%@W3*>6,*^4,KVJ4$QK90.'T-G@=QYH^C@B M7OBWP.?U9]G ]$^7,>ENUK]1A:C(0.Y@"1^.9CV-SLAF Q+?I%@U<&HG_E9J M&!GW;4/8X3?_\*OR-O,#&Q@S8@,E.&8*\CR^%?D1R?C"!J@K;*!(>DK5@:7; M!<[.,0_I#=Z38[Q0=:&#;.#+.! MQ5T(IS%[B@)I"N72!3G@\W\M)G ^I=5"9HEN@,1Q0B5LAQ?FVQQ-$L=X;*O" M!MZ_AJ\>QD]$-\!6)/S7?A==9CW_[.\%5LN"(Z>A$/X(2D_MNI]S8/-R>=-\ M(9GT5KBN7['.'D28U[^UI?J_[5K;$;!)#?(!;F@J?6^!\D=ZB>G2P-]MGK3' MSKU@7KR ($OX#J:P@<.%1O2=UR']I-<^.;KQ.QMX[@-%W?>C.%9XR&>Y2VS@ MA44F\[$\.!&[]I6@P#O@EXH?4'?WQ]F 3JW-$OS'-(BO388W9K+XILJ@6.2] M6/./]K7?_$T,&FPZ&VA*(\JMLLH@!1V1]_"U!/(5],H>%%3T(_'(51GIGF:0 MX B%HT.N=O"'5E8<'9T#H]E@$DXBJ!_G0.FH,KG(LG_W1&B=%6!JM/%;&!(-@>)=QF M0V)NDIF-3*J)C]B;@F.)0_JJ)D(-*L.8VZN#6%$V<#=Z11TK!N*MD$SQP #M M5S"RJ;.4.)QG#H PS $I.;,, <@+Y&AV0]QU'WMFE-#;[[*!^-S'9D.;QDLC MXA=9O);]9-X9-;*!)5DN5$F$L,D''^_K7%S7 =XFR*Z(2=Y4Y0-.Z!.W(UZR MVD#R1=$-\&VVT\CM"=1.LP_!&:RZ3R]^Z'D+Q!04HEH.*43$;22ZOF[CZD_@ M?:R(X[]%+Z/41/H.CY4>1:"YJEWX9!<,$..%$).ZLE\ MZ^VI+\7JKNRP&?9XNG$^1N\"_VG-6OS&*-]M*UCJ!MI"%DJ%5IQ)TYV:3:P5 M._3)"E'R-*; YGW_]L<:>YT+T)=JX>YV,YA^(VH,165F^ WM^G*MF;KA8EG& MU[:O9>].-.5DA>D29,]6CRRU G9@M29#G\)9A]U6K,]P>,A%ND2HHY^S-!S>-N+M)S>/3DI M%K_G68.=^?ZGNT5__/R:1Q#DC$:*,5/@Q%0! G>%7R[MS$DR\M6#C(M7DQQ?7BJ#'DN5E1TH,D@W,A-BJ7"SR@W'F^U,-Q_[$3[P3] M1NX6?3/SV+#S3B MW/ 91S6C1;]C6-&X2>!>[X>DYX@N[>[QXHKKBMHV7>VR>]Q7C)V&>6E''1@O MYB#G_P[YV**;&57I9P]LK9 MJ[CYLA@#.XX(O',POYDR9_] M-[P0\)E1[>)ER!,J'-,89\CYB4,R&Y:4=HA?>FRX<;)![_06S9"-.T^-[#SU M9D>9] BZSX"UC2.% ;OI'# STN>,8__7$[68 \T)-T !>[46"GPF'5 Q(G/BV-Y+JM7.*:S+@' M\E>J>XL3(RN3X)$>V!GSXLWNQ2X?C. O+QVY1D^_8W=_J=%R''1 ]CG4PHI< M0L?*._8::I@7FO]2I3 MRD_D"BXVF/9V*'GV*E.DSN>JKZN@IF\;UY1 +3PL>2^MEM2#KSB0 SI-&FA8 MB407MO#.[3EBWW\P]YZ03X,:1H3Y6?/4,($'M4M >^.#:0>G$<.+(-6 4&1S<:(_R?@\ MR;NQ":Y.)U 3: OY#!$:G]VP\[:6BY^Z\J6*(ZJS&B6>!L=RJVR9N"_?J,@Q MA"0;H@51YRBG*"JPQ;SAF$=Y6@7V #I4.?B ]@,LL /33\D9#P@+K'[G"H7%R#6KN-O M-X4F7X$_X2,4)7B%:LH[W!1\$3@D\@2]CZCP)!X>&(4.?@"53-U04 ,Z_(][ M1W765![M2"/C'[L(ZCFXNAQY8%#*RRA?[@SN@/A &;""?V\9H5A)*%//PU;7'U:=\1RN@ MO'$P/YX-6._%\D/,Y(O%8XC1R$/$)+IO&FP*B6>BP&>%$,$@H _O,=8!_M$7 M?PW*E@T\%45#XYK)LQFXAQ; CG Y0$D41I=&-+J&,AZ[(DE,XT5K+38@;BF& M3=- 1A#F'5?CF0&S6&JLC]Y,(62 9 *K2' E79\@WA E2Q/'1?&=L)KTHU',LOO XX+>I1WW4Y>X"]=HTJ/2J[;'JM)UCN M*CL_N3\3S#:[K+H_D.<6YPMF,J1E*Q_U$64D6:"3H93EJ++57G*N3S93SR:K M*>->Q?@X+-9/"AG+!LB&L!757#2=PP:<:'):=!I:;I#;CMI)?C1XD&(X^;'( M;#XE1)*@]#5]MWCD@X+JZ0#@R_Y+7,XZ_JZT3-:V5T,6Q5Q0)>U2[6N:]/BJ M /VRXUW):\GZW^V 9\EJ#;[)3'PU@78D__F0S'6" 845! LU\]Q2UH"6UK_[ M:'%!_%HI@OG&"K-_>P) #PO+QS^K3+X[.R#UN'ZL8:(_MN'$%O$LI94Y(IQV M='.QQU"N*@-)&CB*JRVW=\HN^C3V(%G\>KB@H_+HZX,+C9K/>@+@9P]COHD^ M8&U+''KB<<(=NEMWF&^?:*W:8=V3(WQ! ;SI$.4"%N3Z^(:3HJ'0J,HP MSG*,%RXN'VRTISY 7''^EE_]X8?="#P)!95GO!?)&.:6U4;6)AV;4,:>2U9J8P,?XPVCON3I]8T'M9P0@G)7CLDU3I/"@%=\"M,RJM7>WVFZWS=*>IPW'$:^"(:481X5JZ%@3CZD MS_<%;:T,2SX8<3;MB=7?>[G145QHXZ[7"QV5&LP0;8G;MAS,%(::H[-&I(KM M2\?XGOZH+V<"Q:]KF38_]5/A&0N ([,P+]G '5Q?9AVLT![_**UM,5+EBG"- MC6+CI=VH9./'L@,1ZBNA:HO\PU P(E\YXHSB3-]9C;ZU1-ZUM;QYZ]]$2T$/C9 S+KW?:K3@L9=TWY;V56[/7MZM_K6T)R: M3_9BP8G:.8,9V _X.6F4(*(,(,DR'6N%4+[P2 M&]A:Y4!!4$];][_;-6=_<]L-]XOWFX._\]R_+DK?Y2NC7[[+E!!\^47R?>>J5'ZU5-R1:I% MJN[P(KU]KM:O'D6*'QI3,VW-(E3P,;9]DPD;/8UA"8-:VHC' M//TO6\KACZ>1&97<74HVB.I5R9_ECOPAA6[VV_%Q3\=O*)S8,*& :];?MXH8 MDYI9IKO"(?!"E<6V%9,EX]XFHSY8$_11=BHRXLD6FH7MVS)-:L*8 (U)U_,V MH7J19Q"KC _64P(/@D.>.P5IM6R_L5#SIJE%[-6P%!#@F\&_4I##!JI--!UE MW^#>TE1.%1?\\*SUD.@T*'DO^RY(2ZT?>9+U#592$E*I[!0W*-RS.$PRXK-& MQ>5T^GPL<8DNBPXPQ=E?PYVL>WJ8<^JV= UX!];':<%,\H9)I/(502 M4K]7(.C4HX(9J,@('C=!1BMJ-GWM,*N,4!*SOB>;%&Z %=2:KG>QNS%_QDGT MT[FF.+WK=3%?B4?9@%M2Q0W.N57I<63O'#6E2UL2Q4F!UT7S3>ZJ*Y,9:/Z< M',RM4;2S>L^C8"^-Q/&[Q*N\%]!)*%.(L1CU9)2]0JD0G;BM[KGN2^D]5=3IS.Q+9*#H=);Q>&#N\Y=),U6 MP##G5_%#C8W2<$[4IB[M0Q.7:H>DM\SF_9PU:95/GSQ6\$;C_7FB_FL[-4%% M#F0]NMBK)GH#+8Q^"H^R<\JR:4-J)G6(G6JO,J-;XL[511U\AN?P7G2R;TT:DM%*DJ MV),>,:&."GCJ5$^,X_NI@\XZ-QPLA"T0D?E<8N;B$?.W"?6XON'&9 X:'WE\ M2#N1-+N7BJ\[_C"K4;WU8Y^G3?NCVNC8P"_X%&.<(L?2 #^1#7R S1Z1FCU M3+I(-RXJ[BR>E9UK*BLJE!E=N5.>^O2N!)'4:)OEE,],K90_0Y8BR18/-81) M)S9MJ+5SDC_@\,FS+^S>J:K1*![/W$M<&<9(&?]&9#%7%-Q1Q@GIASS5H?B9 M4_\AIW7OL?*13YXK.P7N'^>W3E9=\7,2IT+4)#"$]H!TM]2+A-LZ&3[4>K>] M3SHW\V6C@\M^U2-/M\8^W+CS.-?RDXT +^8PIG6 :RV3?_>0=':I3I 90Y>/ M1=4XYHUR1D7,[I?"D!=F>RH)-!BEOX8 JY!DEI(20[]>.%CQ_A/'71D)<0V; M4^(;W:^>4]4 M#HP.:H%<2YVB.5+L&H4=@A4?OK.Z[1NN;E6\E*JWRU[7+^-1Z,;@_:Y?JN:0 M9RYQZ'B[-$3WPR!-J] ">B3L+O"V479QCLV'R9Z6HPWOS ]?M[E'D'6=T,OS MS0Q@V#M0>*O+X$_<)V3S9I0,/,I*HN:/QZPX-\>\>7KBN)[6EC<[IGX[RBI? MP9+635ZH3,Z;'[H=SW2D0C0 M>![!\0,*R;9A*^AJ*-=?B@ZV5:28/7_3%WFW8_IR:52'$.98^P$+T<#\L=W[ M-IP3:O1=O1ZP3?HU+7)X5H$$!GJX[)GFUG!,N'':L:>;\TO1>^2+W1QJXI]] M&JMA?=-5,)CF*9]4[_N&IPDF'TOH1L^R3Q8(V6WQRS5]8* M&L0WX9+9)7*) 65D< ^B>PZ36LGZ1C?,R-$J-\!>ZQL[>3YD6'5<2(A_%KVK MPN\M2HY\,6\HZ9J#L\*%QX;J?6]\E..XYP-/2DEXO>&)"EN!L\1LR-$LOPI] M-A"PBPU0^@KLH%@O2=/R4HTRP[^+9_GB,@/3T%31Z,F^ .VLU$]0C-U7L942 M-I!!#GURI_C)+I4OM]_9?8ITBRBZR)F%$Q+G'_@_^2R. @N'?835X@('C\?7 MVDK%7RGI&@Y1:WQ^O4-W8OA [,.1>WI=P@!U2IJKRE^YPU_"&WZ>HARJ8>UH M^>*@MX1]W_02S-K1Q3 >VMK7?Z[SJ;[FX_+$N&UO M>$8* :[/@/L51!A*G/E>>Q_J#N4>F1 RYV)EZN3UZ=R?->R_,#NN$S M^DQW*K[(!F[R4#*,N]_[IYU^YXVP_)0 ^YE[/J*1@,U?=!R3I&42/WEPO7]> MO[K=Z\N1AWE6)@'G/W 6I=CT#B3+XQ4Y.MMU]@#&.FZ$G9H^:2AY\MWLH>B= MUB(VXAG8 MQVF?F]Z]\'*@C[MXSW$7T^G_DO6=4D]^W+OHB(-*,-)$:% 25)B!@ 8(B M342P 4K)3^D@33J$O$@1Z4U!4 @*B(@0>A,(O8KTCI $4.D))012N''O,^XX M_[W/OON<;_>.^R$?*%EYUURS/,]<<\Z@@QA.>U%+%O%@$,E%5@/YR"F&^.$/ M:9>SBO'*3;_=BK82@W[3.>C#XFSD ]7K.-G]3RCC27?Y#=S%;H'MJE!-Y MFRF"T\<0M.$@Z*V=S9AY@4O0<"UN5#M=*B6@\K-]@HQK0!RZ;L:%FCL7>O5 M=ND0( ?\;D'OT\9AA,?S"^8[&/(Y\Q;-&\:I 6%[QD+-KL7*SV'$#A?@0"_F M-X*/R-<&Y;TTL [A7)U&?G-2:EQS?,1EQSB,)4@%X/KQ_P?W %W@3"[]#KH+ MM3L^P0BK6/1D#-6?5@];7*$&'@+6;N!. @= >T*V9'QT5RN4Q%;!V-MY:[&Q M436SX5FK6TG7.82DTO0X/N?8E\B' <;#RRUBK M5P2N0GEH:F ;IP".B3(G!FW!$\&:KCBZ:D#00EL0\IT'3O,H\;:_I^4MQ]JZ M&^!89;XY1T#W0Z%%WNL=0*!,&X2,0@YF\U^]=8IU(GK]\=@#L(C;)Q\\G=C; M-,J0?"'8C<)"#PZ!?Y.\Q7RI^EIRL5.39#4Y?4%3RUK.4F]^" M8S+DPI'42E'>.QN 2#6(_0+?DB&ST3$;F)W'IFP,',+2> BD,*,/@N(RF_/YM*[> MKKAC,&PZ9DO;]Q"@")7 =M*&F]B'I4U>PJ ?WN'58J6_U)N5VXW[3"6IF$2= M_3&^;R6Z 61]5?K!#83P$+=)4V1?8AON1P%N%15E;KIB?/32NIYY1./[-E8A M"^Z6 " TD"6FE;%?AY41"_I@>O4K;^Z-*"_1V&RM1V<\D1@%&)_-!R*%-$:V MQT,C#M"12/$_$+!H50W]5-TY;$[V=(W%VB]D7$;%T=@;3E#F# M(K'5T[T&V?X&E-N,S6=AYRG,&'J""\F#+(-B<"Y."ZK@"-7#/W]JQ49B_%,M MS*4^VMXU(#?CH\7(E9E4(=L$0_<@KH !JH *_99_.+AV_! XN%+TFI8&@&8ZG<.(H-\F M[!&Z,R#N+&Q=DEJL_UG?WF\\^:N1+_^K1<&[+;YVIS0]NZXT=RE1.*CWQAJ4 M*%<0;B>W5*#_6YB;>-/L4<.?DXHJ6KP*()I8JW!VED^?R\^ MURO0;O_1Z0JGS$OQ480ZB"3/J > #3O'O(W&#L0UJ&+GHS/!5U3GC\;X8K6A M;%PEK1>Q7[8EI$[H/;4A\5L*>,Z.+J6Z,>1Y@NQ!A+3Z9XM,- F[J!_HCNI) MAQGB6KU">[IZ^Z:B)';0F9]&$+8406K 2U>:\K5W65?-MYK&>-0RLXJ.Y!5N M")D\>_UD0#;FX*4)^;S_"TQ91#2A=W%E)K#&6>+$T2[J[DQMW"%0I@V]3&]# M7J@CH-> MZWS@-K;T<]5JP-DE66.]6C+='BCKD4'=MQF@"-&'E>B#XT'?@PHBW7RR_ U3 M^REF*"?=W/8U/^#W-;N[+?>>-[N+-2_"L 79[*.J\Y%(42)K5D/ZR0,Q2FS% MJ8$WHKW\UX(];L*+8@ /*E\-;C.RX2[A*'[[$6$\L<@ZWN67DE?($_YA-YZ. MR-G>.U,&-*2B#]-RT34#MG&J[KJ/KP;"D!"V?(1+92SR)G'YFM[A.W[ MA*8*W.I/"\VU]/&*J5NQVU?/O)U5NZB<,:N,=']O/@BOD8F7:Y)$=DXK1N]L MR.VZ]G'63OC=;,$K4ELUG3$ MI7?T&W76AWP=P*%.6(LL-D7PRKM/OGPC%O7S;(_O@.FD:&$.9&B>B0IAZ#6* M?88&R9?XF\7)\QW/<+947,_TUY7G"F\]14$>$1"KYB MR#D>H8;2NILQZR^/DLR$XK(+1%X& <>9*!K(&>A)I#S5A]X=?KUB;(?[WN(U MBPMO.Y.?710VT5 P .PVV;Q%%7XVF[+]$?L_*04(<%QG_=OZ'WD(0&FGJC9\ M_Z5%;8S018T_O:Q(.XM"$>>IK[X<,$B64?0.]+^^GZC_>_-FN CNT@3I8;M] M >IT76M%>JT\4C:*X8\J&'C7AN&<\J%5XX= ,K?BWW)\20<&*,1HF9[[^#D@ M_'$U83R\T&4O/VW I#IEXWEL7817H4/SAB8FL:=_< MQ%E0]JF_7V6_&,0EH4BA)5_^Q]?QEMC>(^=C^\4/7&4/ 4$G,_6DZAZW#=]S MMBEJ._9RQV"/@>4_'RR4PXY?7^2! _1IL!K2/A")$7(@H"(5/A+H[YYXL,P% M3^E>FQ59[]!$)IN('IMGBAB1JXBF+3.R4W(I;0]&)7P MUO J?/ TI>&I+EN2J(0G;'KG5^.%_^D+@DO,\37Q*!RF#;?\4J_WOAV [P/S'DSYWGI+"$4'<2N]=4* K&OMZ*_K>M:,^IY.N MEI=JA'WE#H:$(ZSSR936>O-7E9:)E+^JA%WC&4QHY]$6N737 M1HAH1/I!MB> G>9(P8G-34S5^CWU[&M&:F]LYSZ\,6*><&83QX=J_HCY3L"\ M*FZPQC4J6E8D.'W=%7':P%J^)1DNU;^T[IO$AL>,,""7[ #HI/CJ,:H5%:YU M@6B3^+3^9<&GZ?TDG3-IVAUCZJ6B;[0[NKMQ)I+%0)" P/XV100Y.<]'ET&X ME1$*8MQQQ*-O"G4]U\],Z3)/[GM=>O$BVOS"K8C]BKVH*ZL'W/\S0T]"/*!] M;1*DBC6FFDQ0C?@S&QQ=E^N#5+\3LR][OC_=\D,T?%E;'*.+*/[$<*^&=,B\ M3: *Z+%,W. DQ69IWK)-\!*-FUPD#;#-P&Z0(7C]2+J,T_QTD\"$W&Z?Z+JS MO-2L[3-'5_2<7I<#,,AF^"_$2X H2-6PO'L(1/8< L=@5 E2DSGI$" ISH"5 MEG[SE8%:#O.*:(0C,0=2X_0O%U88^4T,-F?^U%-RL8J>_,CM1-.+$(ZJ"-#' ML*97V6T;\6.*>P\3)6K*MJ++?[XW3 _R8?W_:Q=R6S Z!Q\#OACB80>[Y8? ML ]Z@N-_=?V&(>]2I$%G^@ 2(.?B.!5W:AL4/_64+!,4#T9/)O]:UJ9+:)'% M]/M'E;1<"7VD#]^&Z$P!,SCX*[NTU=M-(XO"\BU](H_\CUY$'3C,)M/&!QSV MP3L8Q[%',(8H7G[I%;)L$W:ZH'<=:I> T3@$W#VF-)L@Y!=46URP#N/8; K4 M-_^)#AAQ/T4;<)JDC0Q"TQ/3);@8S^G$>,X.*P;0Y%AE 'Z=>PP%NM7@'%*" M"(S23M$3]HLJN%':]F->^>ZO:S2#!$ZE=9GQ'.D\>N.V]\6U_#O#04>*:"O 'FH*2O(BF(Y]*EP>;-'78B4[ MXM"O-%3Q'ES+!"?B*LKIY5;K&(MGM.WDS5?AD;.B80#S$EOAE2$:@Z]@/Y P M7$WBSG0^8EHX^.53*F1JS9=;=?#;#=A8UYDKIFIQY_X)8NK4,TE$CD KS2HH M%@';NN'&0S)5I14_7?.=+_X*7$K1L_[AEV!=G3-]F4G?QA"@, #J(;!P;5,0 M^9V==2=>Q2G=_ZJ5LI:AT@6IS\K!Y]*==CC87*B39$GLY289JA7#KY:(+52- MJ1[[4.M$)T1=216G,#_%6(#VAT!X.HP9R309X']W6C6#UW5=6]+]8?;UE-"$ MXV/'ZD1Y\Q*J]E$48;!G %C*"3#R(9,M*&?'R>NH0FYI@2[)B%QUB&WK^+0 M\XXU%;KU<>O-R8Y=&;\@F[R&FYG4,EJ6NS3!8UT'Z_0QU2>)G,*MF14P6WY; MPJ,Y2I5B"(^%?A9 QM(G455Z11250Z!5DI;Q86H5/@-_ MMJTU(5N0OKA_JG.N;MMD4?:W$9Q\P3S&L2Y&$ALORN991WG0^$-V!](NSCVH M84D"U_LAQN-- ]]ZZ(.5":"BG[K;W'&5*N^$6O$W21@VQ)&OQPBPERVB89?> M@?0SH5I(AK:D@SWU,^"D'X/MZ?;#A>@]T"I5]%J_%S[:':&IAJ&5I_5^%/G M]F9)R/#'W0J4R@ZZ H;-G]]RKYXGB3'8PI"W^0\8P00:QE"DCL"%2F)"^/': M>H2?WJBQ7/12NLIF9Z?0CX[596TQM@X(^7QG 3Z1?7Y97) 0]D<]O;22N]!Z M/N3#!S,6WN17H^XMN&@)\<[:>;+,?'.(;1?LY*5-$:MI0[9(JJ;D'86\>T5> MWI6O%N)0C959W_6-ZG\_)A*PXJ+X M+V\UKP5;KH&+DSX@@W$V,$3R*51CC\YQ_4L;81.+BFP0Q/6)N$%T1W?9E!\M M#\J=>(47=TSC 4RY4M@D1=\,%#\'"<:;H4@!HN-+7XP8.>I6U?CFDU$1X_*: MIC@C?J:G^H%JHH4.V]H]HFX+Q<'SZT,$F"EYA/#L$'C2//&8'NE%^^#JC@K" MJ;U).RLV6<*UU6GXN^>//6REP:Q>N;,1*G)#ML8A(ZQ:+ MK/:L'$\5E M##]VH;&,(/AP-WI6YGI>FLEJ:7_W.XZ*LS)2.N_,C$^TU/O=@ MZ:"+EYBV/-:'&$[>?&'@8-650<<]S9?U.R'[ES GP4G47W[^$J/Z'PH4,;>T M+H(]^>0*>CLED29UB8D H_*YTN_HPM8@OM2%DE0ZQT,LG)L,[K/EGQAUGM2>W1*/?Z''$SE@RP/,HB#W[F2 M>S<[P4I,;/\BFA2BMNCL1US0>G 7*'"2^>;A421,V:2SKQ\"TC6X@8.#1D8T MBT*G@-@/**9=#U;J_0;B>GQ>:H KW"[%\E6+?54]A\#0 &%30CEUM()I.%03 MV@RK 5O EW/'JP@_H@FK%N&W7PK$Z*J1\DL,F!7/;VOY/54V1";C&1( @"[2$J+/8XZO-\@Z MNRZ@7A8JU'@<2S#JAYI4I5S[Q"S2VVWZ0;-9?D"RA$V74$$:(YBW)\:;:0F" MD0=^*%S_W;3ASJ5GMID$*[ZV6S%Y+)H7ZV1'4U1"V6$> [R&"XI3*KBH5](S MOU8FT@0W*_]Q3VLUORR>X;(-)(BK%?CZ*?Y&F8C='A@\>S " & M"!C1V1W_YJPZX:13)C3>2J;=;!1NX!CU(B%KQ^RJ33(N\7AKBM7/+@\/L:I2 MTU"-% " 78@K6V%3)2:\HSQ"?F2.[,PAX.&F;CYZ"#A ^?7S]*6:+&<&_)(6RVH,'[['^IWB"GF=_8: M6;M/5,'!VD">U1'$G>&:O#ZI--SCNG$A0Z3XJ MN/Z0&(P;Z+1V-!C7X,&)H#A6E/*25_0,GL1<^["U;URM)OD*-!=.KP@]+T-Y.SZJ.F078W>ZZS)5P3$(C8]%7"/T:XV:2 M*,Y&[@C.F0I@OFEI+&.H7-7YJ5K6C11]EK/J1NAQ(+Z)Q"Z%_<>.9LY8M>L0 M2 T>@ZT]_9N+/[G#1$A?M__H/"=*^]C@]6E9[62]399'4"%WUFM9+B7%UU$< M,0"SU([8ZFYN,_P8@AWWUB<+KD\PC_+)>GS-_CQHFW^=:[5>0TWJ 9 I\I"\.A6AX,A_(> M[&EU!DD*,^ ?2LQ!W]^L%9;<16$G@ZW/O^Q/S(F]FC:@'MLP]8BLF&1[.% F MV8A@P!96!MY,C1@^!-:LJQF[W1/8BUI#,)6RUAGAOL\H9FMTPW"M(YW(C>E."NQ^IME/,UCYV\ M:-7[#PCN^?!DD_J;UZ&[DQ,,#LMZA'Q?I@V:>"\@W$2O9J3A-F;:LP?:5[YL MP!<:XN^6"ML9+P4=X$==P,JN=4UG$"_HIJ?D<[!1H8+N_1-WZK286L7;$0][ M&;%SS&MP#O*=39(U+=RWZ+.DJPF?E?-S%\%[3%$Q*XMRSN3.8F&::2890@HB M%H1I0:EZ4>WBFH/N#<:?IF\.>!0T)W<7>QI,;\G%,5^([Q*ESH3(DA3QB2_< MZ-+4JT1HI#NJ-]:L+&W4Z!#0F$I?!,F<;AZMF#-4@9* <)(^>4J9G-Y*.HCO M>!MLM"YS-^Y4R3]/M0+>%XJ^X2H'],5:&% C@=Q(\42(D%NPFCIMF36AJFG; M\E-R&PVQ'LH_K,12]%IOEXQ?:5Y1/G[]3$,;G;UO@1,#H0^-/]:XE^R,MIB= M'A!T4.H<*0K1?ZT7$B_(Y0$[B;*K=?4EU7$S(/_V-WK M3PQYLPXK&^A,A%"#"8WCGYL@(U1-?,B9Z]P+DQ8LH9O<51]3A81,K]]XKMER ME/%L_\M,^+^V\@U7;9NOIQ\"RB"M"5SG.$@0.@22JZ"4X$/ ,'GO/>X:>E0GY^/ 2ZA=OHC0N'P*"N];]V\NUG(&Z3@U BNPR&GO?_TD8^N 2# M>1C11<%68X+C'>)M'H]OA)\$Y:8K)T?PZHR]A4';5'=WO3$\#2)N1+YFF].$ MCCD6X:JXIT#F.B#)T'%J8V)UR3;K\9C3YYTM03V<_.:Z!/A?3 M%F!B#B/E+20.EA[9Y/,&@2A\O-U55 -:+DB;=/(U<^7 M3CT=SHG1\I^MFY>&3<^N,HZIQ(=INR8"4+ MY8'/?X?_])<\O]XB0,G'S9]X1$:UU3O4V$H$<]\8O]8MU?WKRHFKJ.X8ZA_: M-YAC+5*(>I[\L-#B9@%%O >A^?E6>%1280:'\U\5HC!-AV2.> M<"W.W(BQ(RS5]%/:?J-FZP^!;Z*)B0=8)^9?(-3%'*S<7#<))LDXPGE#='!47D6F?IJ.X)9D23AF>]LNM?GAPY4@ M)G@FE'#[$(AB:\>$9_@7XB.XJ*2^#-<&6XR:SL #S+'T M5-PJ>^8L.8;<]?Q/^\F::!UEK\D*?=0_^D' /D#PP>I$1(CJYPK&<0T(.AW M!_[DN8.(FC,_IEYM0KO7%K0^>$\N'/V"N,IPJ#D!MC9C3\J)_I'N5!6NR/N4 M&\-_;-HC=AVM7_5B-C:UQK83UQ(73%Y@(/*^\G"\.TJZ"B^(ZBNO>G>'8EW5 M8OAT'YZM&1J=+1)^EQQ28/@AH'[.GE7>!U-N^;/U MSJFKZ+Y:SY:R[&-7%@#H1Q2_EK(SC)M^8IZJ$PVKV7$-D*B+75,N49!,NZEK MY_Z6AKVR@^Y")!@MDU_5-LHQ# MKC/1%HN*:Q(C?QK7=-49491(EE>(MM_Z)"^1*$3Y:"#4]4V8O$G*)_Q(Q\Y/ M,W=F,OYX\EW^HSDY/U)IG)3KTH=FJF$.!(-QG)^IN$%N6\AB;DY#"H[Z4+Z] M%=.=W>X<2KQPU+OY=U($4G77+="QS61J%=<5)CU$U?D0H'-G1+6V^(71)$]$ MC(TF>K[V*4QX]RH@BSA$#G'&?_BRTVC B9GQM5HTRC'UXX, M#*C MP%7XO9_?A'JYG-?4U/EC"1T)@CSQO\=B@P;9SN/1$7,2!%AH@]#"MO>!JRDT>QEB!]INQ/<0*+#J*JBM5)/VYC!9[_VY<\>@_ M;%+'W[V< G:2S%\CQZZ:M,'%D?W^V8*##0]Q9=ZX5:>-2M> *LOGS3.?AGCC MJ6FQ04RSI>@LSQ47\D%#M"'@)[(P!RDTZ !" M#W'0)EWE.A%=N0-'-]-Y1GY[VGA2_[D9QM4/ M_G4YRD'U8/D_O2L#59'8W$9<@8DYGT2XUB-C?,44?S4'#MN)/R+Y.M@$\4)< M -ISLBV1SY",QFJ*= 3)O5M3//BQXB4*5IU& ";\]6,1V11CM"'3U!/$_4*L:"@#;=Z6^:+ MP(5,PAM+D=K1#6Y4O9BY,V/%^Z,30B7SKI@:QW5CT9/9ODUO-)INB]11CF;P MV>=)YCQE?^:C*"'6 02 ;?/[T+]3YIY<\Z )5QT0_]/VTIL4"+3$B$/ 15[_ MYC#VY+1[%K[-V>V8U%J\0O7GGM5FT8D5P;^12KJ-R$QO$#P$]/(!I >]$\Y" MU21NXJLVHS1N[Y4M$Y95; K+WMBF?G_TY&Z/V0*ONL^G"0^#I^@ ]L08]&@-0G_SEDB*IYZ7J5^]@/J6_NL6/BZ(H**M+&[0=-]"@OT/V@F(P'(@X4SJQ M87:NZINS<->#E^+\=T+%5J[)%LG:5AO\%D)#_EZ;AR32!60B:@X!!O D_=X M5U%32]LPN$(9#/L&9(@S HX_N4G>IMBCTNGT'G_ZNW/,&[W_=\[[OWGM\]$Y M&)%42O#Z(5"6Q@C8ANY%J_7_J]\.]X'SYP_>OT5C#78;=>AW'5 DB8Y#X*-9 MPPB=O8PAX&W&.Y[TH6B"W$$V_UU/X[<5L&Z<<8A1&F"B"55FS.>N+H*X'/F_ MU6?YMY7.@.SN.$R57/@64#Z^I94<@+5;?];#KA7*<_&@%MTHRV GSB91,$)5 MTU$RIBT:DA6HFFKBD.-->E4FI1UDGZ0X% \$L%'Y1/#JI+W68N]6OK[ZA;:] M)A\.$Z/@N%+FY3.])A1\!8C]#.4%RQLX<6B6&:/H7==/F/J'&OLGXLXD_QG6 MTF]XN.VQQDP4H9^ 3BL:5F2;*'2U\VBE7K3M)+7=\%K]=4:1RC4*K0*CT5J: MR''AEV_R:J9OP'5PC:K7NWMA:9XA7/V2=GXNP#;\A996.@[::7*,G&U,T'T2 MS#>[>,*X,OQ9[4'[>N)G](R;SL/*X9VBK%LK/C&=TR=KTYXC'\8_*'MV\ \? M_"T#^LV'F8&<5!ULB)%^>-]PR:6 G;33X%+QQR^RZM_TAFA^PKL0$>30O!M# MG?R6_3E]#P&^GW/&OVOBQONOF8XQ+XFMI$-C MD^LO(>G)% M%U[>:],]5V/?[T-<2<:.1=+G PY:W.CN-7FVV[68486>2 M]8Q4Q 'F.O0 C'QVH,TK! \7(/_"RW4].>+L%](.<#N:2/5J;.,JSL%5CV98SM#C]M\D"/*=W[WW_KO]%'G#[:^5A60&2;?6O M24@A BD77Q513BM;LKPL)7GYW*V*I)!;B?FN5-F_?8P(+>)XV=%T]*1-@#(> MUZKOZW_&V#EU4".7]=ISTN7E0/F.L8V MX!)JVI9D#FH\X1Y\YPTH22] M@#[X&/VR>!W1R OA-RK0=_UU9<:]QN'BN^B?>WHJ[RF_0F%WD !RVD:0]J'! MS0N7):(SMC-3^\RN207^JJ'\U9\([I([WA+KDQ.#54L8+M !^A(\2M51J,,> M MR@G4O*3%7N;$C3+T3[]Z_FS\K+=W5_"^$;;X5RD)GI'('$6+HVC/N9S,Y8 ME7;!2JD>2-QC .01%;@_.=:FC%#RHM#U\7O\S)V1];QO=1GU4D[Y;^G:$PN= MD7*8*L7UZV*_,+YBD=F-7]Z]ZU&0/I9&L.68KYB(V=#26(/\N=KJL.F5 M,^LNS5)E9\('@<07TQ<86\:^!4]55S<2QNG(X[[6=]8Z7SDO_]5M$3Y=V#7M9I&H MI-5P%*[W4/6 X3E9>1D^[\DX;)4^P @[,=0]LBY!^C?^=RL8G3GWNMRX),!\ M33#9$JT5\BT6I0EL-.LEP&8EN*H 9#<9M"DEWHDJ6!6V[K5QKB&<[:]J=UQ* M43?M;2.H;@M2^3G_=L=%6A(FZ#R:9W[W$16CR2F"M2M3L"BS:0 MH=V!F5Q2;O;V/=Z6?&/%:0\U<;G*/]V<'-G?]4;9OEUYYIL#T:2E@XOX)M%_ MSX_K<=!.,6PO&NPI787N,H1R".3J(D.H1ZMB^DBEA)"&8Y(OH?P=PA)_OL@T M0]\@P\#_(,E0K=-_Z8%#(X24-*%A9%OBDODR0SS=C6M(+=NV+]V!16U7PVNZ MZ?4$!INF)939T1F[X/9X?-MYVF,=GZT\B3WQ[IC0GFH[XX1DP45/XAXMX/$A M\*<+/<0(PS;C/IA7F#)TYVF.G]5O2J;<,J^L6V>.TV??)^0$)JL=NZ#/(A[A M=3! @.&K4)WHR&G!V+4%2["F%4%Y&#)W<^56CWC(6U'>H]?9&A$,36*U2/AN M2)B^WIFCEU,@AH\B ,:(E;2THA@ZT@5$U1<&X35:G M [5N!KR6FWNXB!N'%ONE_+S;,K- MK:E0+KU.,6TQU_*/H5?@43!.A#PA50>E3TA(%H_]-. Y\=RR0[+6^=%#(_M) M5'W,5=)7CVBP8KX-'<CY-VEPBB"]FY^HYYEX- M$W,E@1TI-M.B'FOD]:(Z/:5R,38=QSC (IO.$#;2/ZQH<8Z45-(4^#SLBAN, M6.QC^1_I!+[MD1'YEKESP'@V!#-%%G&.;/NEJY#LWV*F5A^G[V-NKB@_FWSQ M3_?(M==:J^$VQ;K\3)$+BDQD;_S)US[S?$Y^PNL)ST]C:A[=4%.J>ZY7]K*)31>AT!6*50[/*@;]A@Z!^:/6F/S@*GZF-SB0_4\3^Q!^N));>D!O MY"DEK?JBW-WP69SVXIZFL9/U5,OGQWUNOES^:B/G#4]G,$L6GI((;V$;'*TT M98N:I[>C6'SE;\[U844NO?-;K]XSO]B!.OB5PM)5K60]AR&8-].E"?+H<%4( M]Q0FLMC:AEOAQ*".R'FI$Y*R/QXEUDEENU9]#+T,O@19&G@(_A0C^HF?1\0@ M%/T^BGFJ7.*O_6"28["H[7=D=M6DRV.W3V6VFF]H7]7'[W](< U^VY[<7?"E M/.FZ>.?7N]KBT"_(=@R+;XCVW !6Y/(O18Q;\5A_PZ,?X%C7F4^:93$[F",( M54)-F]BYY3F!P6<^LGHMOA41L@;Z-];WWE/*I.L?_Q^.(?J703N-/_Y#!_-! M$\-;)N=IGCT$\BJVZ=<8/PC +H\CAX"W44,>Y]@17=X'@);9D]AJ]_!G5Q2_?S6 MZ?R_A0>+SX9T!?9^][)Z'0)"L,4D\@*]V7S^X,[NI#F4F$HWA"3 UEC_+4&F M#4UD^&'%5IKL JR3$??)ZI:U#54CJHJ5^R/.&]'*^W[#O=^,BL[MYP)+)BPT MU_7U8#J[!]8H]HJ@+M'CU5=WDE@*?%]0Z>7:K:]>*9KE6E5$Q;5O1!4#LB9Q MI$U+<2)M::?XVKK-\ZE.G"% '59$9J ;=F'D\S6M?99">14C&H;! M/D646NZ\NU'NS66OL<%8&C> $+0M)%>03,C+GM5[6F95N-41EE5.^LJ&7-B# M@[Q7UQ?M[,2/+9"\C8BLV06X/N-GMTJ=]TY&!YW-"/NBUPWU%@\% E7)+F[-5%R:4,$Y7Y:]\+=-,W7*!=*+)U#:$$6%8EA0BAB M0X3]:Z+,[$O3;EY[5"R/-QTB3L7^S0WI: O#^$!LO@T3P0^MEH7KOT#I5&3F M3]D2,IL;>T5?2/J^H$G"[K*,PH[#L)^TF(EFA=Q1T3[6.JU''3AJXL_\M#P- MF[?GZ%69?R+V0W9I8$K&@LR&$X/='=>2Y2E<[?=:>K0\<1518S;8R@^]^*50 MS^%I&_=[EE,K+K_7[4N0 \A+@^M5'I$=/HE\.I.#A-W4>'>^:[[H27&KL0@MEZ%K,/T6Q MD$1HQ7Q,DW# \%15,:=10Z@2<8:[+>CX/%VUP=I@KE M_Q'NCZ>U\RK/VAQ#?%CJM/KMFMI]?[K.8WJ;E$(0;$M\-:XE0O1O+89U^5]\ MI!_,NKZ7G+O79QV-_YP9 VZ)01SK&5%FQ"5'^)4*1EE.BP6VQ@ M*A7RFWVF#P&YE/(M]G7XL;^I6\PBOABSQNK*L$OI' C#W44A+UG_:IP&0U*^0W> MAFJ%FN2,ISRM6TQEMJRQ_,> *V<[@J/6#@$& 2["8B@G&>1F2&!?A)"(HV($ MM*0#/%I-!TCWBVRZW+?79Y_>>+[!]IQ?J:L*"%DJ!EON-RBZ%08&F8>I6E(D M%D5BBVK7YSWVPH#]@Y,"F_., +ENC!V8EA[':W(8KJE^LZ#.%(OOW^@7=G3? ME7CCT\,LP3 $KAB\;R)9IJ!E=>"H29Z%4\U)X0^A7Z].-64:1:2[L\3E4ZL7 MN4H&&]ZSKL)1AT#YG<9 +&K:NT7<"LW9]T4AXVKG[-7>V[<+Q/0LH)_9&."S M&/&4O(2#OM""QIH3W:AI958J^FXL)RK+9R\+70CU>N__E(&)BK^ +0\:8-S- MPAZAOK*UZL_WS(G-D[O3GQ>TIM"?0*1'6+^K)AX M)JE^R_6\.WM"Z(7=G^>BH2HQ^R$(.(4_P+UYVS3Z%!+ M+@XM[*FM&^&9-#AYJ@3*A^RV.3]^ZDD5A+UQ"KH[/ O;S8&\A&$S85M>YC#2 MD;^%\TD3*Y%(!JSZ#S5&8QP 68;.$4R(F+7X ^65^Z=O)CG?Q5Z?P/N8'5+Z M=,6$XB1K2V=/)'I37%NFY]OZIBJ\<^M&Y002I:?U:/A$^Z0-!A(;VRWH,(DB MP02TQ,CAK4&A1V8>5@:P1#CVIGY]SK12(A!5/[&HV*(HZ@*K\%AG_S3OXD1" MY[GP.M#&>E2A8BQZ"5_36D9G7V+RZ\+M-M"G[Y]=7[_$',6YU-[]*: M&, Q["W5SEB]^0 26MF7'^C;*1R_>G/JZ+ *Y<.&N,E;< (:Q#"D,$?JZ4,@ MPA$W5[C0]T=MGAQF4C%5<=QL6%HB>;G)>&J7YT,.I*C!;0%]G*I(J/I1AY>_ M-:\W]'7T:-K]%R-+-^_V*75QY*1.FG=K23%6^Q1@TW4OH!+&LA)4G%+-VO\3 M_[CB^*+$H\L[/>)DM,2_57,982::E!Z3KSCZ#%\2,-#CIRQ>^ M2@$@JVY5&VI Y:35T:'49V/K.\H*""6\;'@UI_QM=+KG_,\84\_^/U_YLYLG MRJCWB+Z84*0(.;W=WPPZG39M'3%Q;^HDA\S#&[?LPJZ(/N=&ZB"'1A!*\%>F M+O/'%$LDAQ4D^?I#,09O:E+I6SK)?(SHO(1.QFQ"FU1U%H4Q8#,AM=O+SH$( %&N#LHK&7= M6EY#]D%?SU%=_>NE$=%WE/<[/96&&P5).;3B8IA#\"9DQHKLXH98(?:?J31_ M"I'M.W?Q>?S[39HL?I,LG4A]_W" %EJ"V;%3_0,E//38/Z4E!DX4;]*CN(&@ MR-]4_F_-9EKL0[[Z0U6<6<&FAN+6)W\\ ,LBWRS U6PKC[0P1W+<.>58=F6. MC7$8*+**U?CI2B+TI2^4^W'O$O*GZ&J@J$[%U2]%MA-.3S4/)M[36^<9NA3> M=#[@Y._.NCS33J"FT RX MQ*R:R+72!*E)-1FNRL\^[_,K8\G"/O;);-QB]2G#P=2P!D]/ ';WTL];$X]& MW'PY15YMK)5\?(2MC0R72B[E^IKGRW("%*Z *X$M5Q'&WGC%J?+>N5_F;Y>O MQO='N)V6BA"Q?RC>;/3BSU'9Y6E@7Y%$I^6K0L+I J6$@I?NF0/MF3ON6S;M M2_;E56S.=CO^5TQ_AM6=NBRYZ#'E2E(?QSA#JLCA]T<7!ZF*7+_4FY3V:P13 M/1_9LBPP:]3]8&_F_J$*8O/0S^@^6 _'AW9:_KN?=Y/>6?SEV .A)LH0^6=;U%9YE5X@?^)['LPLV54&"AX M@N_/7XZ:H)-WYC]FO*SM;U\TRVMJ9ZYT*2 MUQL-0EOBU#25P<_#\G6>8O@:Q.2>'/UXH!--C.]44@D,I-Y&%0/(,.H5XCB* MJ-)<+QCC4_%.S&Q(X:YWJI#DKSC4IJS[_8U/#2(+ZE1^-MQ\:Y;-;]V1A7HB MLLR]0]I8-=GMH]>8\%-/"_%O.K9)!I("."U!/=87> M.,(M@<29RS+BNR1H6(/'!ZHN82P-@^N_)69NT& ]9*4=L',PB1IJU73!$3S!K(93,15T$C>8>JXNEWRRC?C^A(ZCZ(+$SUK" MT0P*'_V[EFH=H7%W=W='K=^;5+3OS^R'>V)X\J):#E>WYU$#4_;+_8 +U8]6 MU01%<([F#6W8US((<"ZT8<2GL7A1O-69G2,*VM;GT]URM,'<\&_[E1.?"T=F M>JBOR#7>YDND^@CO;L&XK+A7*A/Q8UM[:ZF$.XK31@L/TL1/-]2EWJX)L[9\ M\-H L8K*,G=\^]S_6C>[IJ<(F\;$/.H$YA],!%V.$/(C/3<@2)'+)5:((E[H M*!6)3Q7UX.KZ;K7+_4,E#'*):17%05<(@"_ (I].4,\7*GRPZ[(K2ZYV#53Z M_OSTDN6.9)*!Q,1B%/7G;]H G)*$'H%.I9,>#L$<&I4I:X^K2&5?70R%YZUO M=UX6<3!@/W;9RFZKXUUJ-YO ?M8AH!YX"'A/T!?/,>\ZDD+)_9!F^,L:I&+M M\.*X;4WV*>.OWL=B ^,$K\5DHVXQA&\_/]TZ0LJH)8J:S8F\TZ9W6OK9JDZB M^K=OA]H>J^U*WQPOQ6 _PK>>7>VB@5.'P)\A&^@AP%)P""1%M6,.E@K :YD M166AH,.IZ1A5;ISJJO7^H/*Q8_*[RTL\E[+MB!U[KRYW961G%?7#'!1GC@R0 MWDQ4%2O/M/']D?]D>;8GQ;+E"XXKVUKQT$"B P%!OG@^PHREUR*YQW MVL1+=#JI/E[J.<#&WE"1]IJ5>[Q (+'5B7H%-[3'P<->Z4"Y\CAPT<[?\G8E2_E(55011 M[3ESHSZE>,]$)SN#677;$CD)/?Z.%"$<2%8O@/)S^U,D EY5BH,9O_>UD(BL MF6^_KW0)H3\= HYP+NHEPD!H%E)@P-4;U]=7IY!IZ9IZ9=OBW(7O[:47/NB- M+P*R6VUT]VWZ;S2MVY1M;;VCW:S4\-*PW,7._#G#4Q>^O$@QU 0$MDS:-\GG M86V;K"LCSDUB(QX-]G+'[QE]4/?.D7-:#O[QKIFM "$RE^!M_F 9<"$ M(/VH2\MS8PV&?D1K0Q$WA^KHZP'TN 'Q$&W)#ZIX3"EL+1<'C\T\7KP %YJN M+K)U"_*AR"OE.>$=+<;F'JDE62")-^(63I=#3@&[J"-_V[6H B4N)V8"WK5= M37_Y-"G4'9?A\30N.Y_PF:+_I0CJ0N'4F?#9Y',B99:D!A_-__2S\VS8RK@V ML;O@@YFH,-F6-$=+0/#@H)'I35<)-F\O# M;!^I#@R+CUP^!-B:I%>;CK]K47^X0 * MO>G#(3 <4+2.>G$(E$+;1$Q>!EVB*PY)$05?^7)>WE#8D&[(%HC,,YVS(%R_U:>FN >T'/;QU=!^FP;^MU>;_,FK7W_=? M6B7@8IW0K=,=8-2N_I#G'C7>*8@>MX[\KV?K[H+_==L$QK@/7$Q+)#-,.D]R MV07L48EFB">15KD[?>YC@\IVZ']*TTB2(RDRB OD(OP[% ^YH'5^.K._]:.1 M-RW7_S@V1D!O X:] 2/Q,*]_-H6VL3=.22\05(^7*FVUNP8N_3*Z]]JBLRIJWIK;W?CBGC78,)U M(([G\0-3MC=4%5HZ\A15G,CG.G>",$#2^S*H6E9+"1D]!+X]S4]_QB"L#P,[ M ]#W4BYEJB?VOKJ,/-Z3V M/>/)0BO=;]&\CG;X&,I!M%8DJ9"O?227#[17VT"V?+\9C8X^J:>/-+BELTLD MPYW?%K8!GGJ:939C_]X;\QSDTQ(@6RY HLRO$Y'I-'2^W.IS>?J0'+3!M,72 MYUEQL\/"Y5_E2'XJ0!!L$5)5)YB%TV*FD^+=$V<49+99@JO!XN2R^/41L4#T MC7]/E&OLX6N:(4P(]]3;H/ ?V(SQI^B3H[1R/$3.L 8\*!2\,MGH/1(S2_8G MS+2AV*F*D"B$; %H[T3HWLJO04E-.EZQK==S6*1,&.L" DLH7HS](1!Y")Q$ M9Q\"[4T\%?6CJ/2F:L>JK!\7.1MNYW=#YP>NVQ0P1%\3!MK"PYN T8^CE^99 MIP=">&935^X;!5:&)]VX]3TTH?V@_ M;CHW(0B?-O?RN! 3NY7W)9?CRV7F_""S,IR8#)SP9OZEQ[H&[?A&_U?IJFTQ M?^V>TD]8'4AZ7#@J:)*QX0)^?L)]?E$_?]N:%&YLQH M99^FJTEMV:B\!*:L5D=T?$+IZ[]E5DLE$FW-G'(@1R8P3Q3#;"2:@FL(+E-& MDB>?/ GV8G%<%FX:$^]E]8=S,>(,)@K.]LN9>A9G)']A/=VYX=KOVNF@%W)Q M/Y@VF#J"Q/B9.JEWR3 <-%Y8K#IY05Z28GNGNE;02X>4D3-SSLQTYJ.OS)+? M*1G149!3BY.LCBU)#RX(4-&G=U8TO+4R@4Y_0B%>W/BM_(VG690Y9OUSSM$> M86,1_3-%N4>^?E4^IGE= "WN.&]ZU(1LA?W M)W=+NG")K2 '582P4P\-WT&OQ2M8OOP6#%8::=G;/Y2O-W?X$]OIU>$[:LHF M0Q3!P2*0"DZK^63,]:H)N<&-N#LIC MCPB>74[GF^.;@8&:K:W-2P;ZS_/"F%C"]*Y.U-[5%KKAZ_-+(MK+-F5TL.T@Q=KVK+6K2 0N;XR2/?9IRIE\:$GQ<5?%VP/T3WD)8 M7;8R:>AJ];$5E? 774<*J>=I*"H30<]:#\Y*#KSD[,NJ6Y>Z?G]6)6+V@8/Y MT]Q?&ER.<;^/-'+$ +))Y&A"5 OJI-R]D8XYT;()R3B!!*-71#GMW:D+N!'8 M6K)U"#_3]AAZC9.@-4Y9EVSEO<74VZ)0X#.4$*(QBVK/)!T"G&0378)>[-%D M'.W"B-[(:4I:M>E7 XAWZ!69.HWLW>+_8A[FOY:@FOV'44EWVV!;:KF'@ >X MK*RU_0)<_- &SAP"!S<3OU7"]YDMP(D&\.!84961+B,PJ4;1@KL.@9R8;W 5 MQ6@4Y/X"\H,N_X.,_ZHB133JOYEZA+F)_.]*5M=-#X'D$ ^+]ZJP.><#E?4O MC'AUO_9_=\P_-8F&:1(%6YDHNBX32?I+D^274F,XR4][O=]55G])UE"Y[H-/ MX2P_J?_0"BI_WC<+5&4=L4MO%]SCH_9+?6G.5=*T^/YGCJQZH$*<(3D0/-8A MM(2Y\X+$OOS CW-N6K[1O3TUS\LN3$$E)$=0CSV:45-1+6#%]^GVN9."6P-? MY PUZB-695D3O3AJ'S:?[=&J%7_-!%O7)6FRIUX MZ)P>VS>!F1U;>.S0RE[ILKKP8ZON^I!VXFS?,TCWEE[)YT6&:P@%&USWAIL> MC8'8=X< NZKUO:U=E$VU:T:V+7?CFJMH\-NL+USZ'"JA*L.ABF"+)EWD$&CE MI&@L'\01US!$L;:5%,?/KW"GH<:O1,$)'89T6ZYK'5^!\].Y.L"/,X:!7\C/ M%^=CG5[:6#Z/=."X5BIBR?SY!B 5K!KW$B+)V> MQUJZKV W%F8U?"GZ]+X@L5=:PN3[!>1L;=BV,D)!#V_=N?;B/5 @Y6""]U_3(;S#IQ6K%05_Z,M=2:U+"2X^Z>WQ6VGET47;'HT4?MX[AJI] 7 Z M>QL!;*M)MK+6*0Z(ZG-K%;M'#K0+3T[FT$]>"]#\PSRNQ31)O?R-8(R)I@O_ MJ?=+SELMRTL1$7GX8BJI?.TU!*^G4+OF'1>>2>VE?6M0]<4-3(,=_1KWY(2C MPPZF]:W8)0-,>9MRKM;3'DRLEJ3F3?ZY:E^2]6FJY4G!=.>9L/%I)5$OB5., MP 4$<>"02L@!^C'R^J<65_Q/"6MC-U0%7/N7[%N54=F$+DJ!9).*MK@KP9\T M2W8EB;FKO\ C M?P_S9 !GAY^X1$VJS:B'G,*]C?%K,[L\'6IL#2<=@ M/\!.@3@K!&_Z]8K_B[OW#&HRBMI%@ZA(C?1.4*HB(""]!$2Z@**"4HR"= &1 M#H%0I#_Z<._?<'^\, MDTG8;_9>^RG9ZUT+WC^N\7#GV2QY5[OH.I,J-2AR%+ =NH"*G5.K'J< M]""D//3S^(1U*_/[80,V8?N.:+D\(X>,O/;A7W08KW9!X,)QQ.$>0Z#_-8?A M[=IW"C^"['+[J]0!\D8.TU_HW $=XK@@V_4_:]7]:]VXK\R5"?P);JV,\!E M2A^*5[IZ?H=5J^ +LKFTQ.UMA\,3?5W1"".5J?4^?7-)=_SGIL2EDNW&!?@4 MWY91 ^[V?*??%]&T=J5KM\)^#;Z!R MV ;@K-'T/;!L0L!VUD+J9/''=RG M@S%B8T6-OY!$T<)[]4\>.!V% ?36KDO2+NT1))6W^T,*")NR0H%6QG6-(WXG MET:EOQ>X,G%_$.U%&C *7Z@B+TP2VYICR9$PYT)L+ 9.$K4>*(CJ?"JJE_WP M_2M\S2_[1+KW$NH3KUX_%+)H_OPY',Q+D83U8@)3*=U/8(?5Z(W4_Y*ZZ6.] MMBV(17> +N]I./MI-2B&E!LAGW"I=[ &=9G?#&]^ZK^[DY>[-14F$LAXEU"P MD&O3-M5NUN!4RR 5]@K=@F6)LC,8#'Q^2W(RN M!X.0^H^//3M3-3#,%/C2&6!MK0-. ('. 'QEEF#J9HP:]_'*U/0_>0W,TOI\ M#C>]K*=!=J%=&$R"\VIX$>V@1B.XXMY;"_QV$CHCCXI9KZF^#'!2N9 3T982 MH0TJ ?]$M%1B:3&",1&OADS+9PS1#3E#H>.Y+?PTNU\+'@H1C994*CYAX"WS MYZ""M2Y-5S!ETD(&INEVUS_*B-JN,4NE;RO\H>\,> BX_Q^%KOZ?+ZL>./8! M_$2X 4A.HEJP4Q,_B!WZOWGM::8-Y<1\=+D3=LZ@?!.TGWCK#%!Y49;,AER% M8TU33Y0_P8DLMF> ]3KWX2/@B5XV;"**FQ)O?6!.$.\F?1H8),?*P YM%>&L7F JIW(L$NZ2RNIZNQ2$4D\'WJI!$OMZB029[P_8L&E(/7.7&1)<6 MKGPO'%P5&PUSE@8]^H']?9J\AL_9TNS\4WKCM;%_Q9BVQ2U^_<6P9C62'I^^Y3;QHN-,>A+02O M,WZ4%4$.]HBGL0I2BNUU""'9Y/71ZJU0![.&'XUQIJY^[*VW/(:&(BSI-ND1 M&=+_D;#&D%^78CG>9"-?&"-G%.2!;%&=\O9D 59>#-=4QLL1O,\ #(-X/VQY M3F60U6D2> H=Q"-NA-V\=,1ZXGX&H$%0=U-D-E1LM.G^ @I(0)O4IF] M89; MOQKPK:3/V149PR8M[X+,%31I%/%%WD5RW[V_?99D^%8(H/E+8W1+;J9=5$'_ M9^?5=X$SY[X7/8L$WM<&O0/_G.\8C+"VC)")QKFWC@_/&2@8>2#([]>8^7U^ M/M*MXU1M?:1*1\ ///0.$ M(#^&KQ<$M9Y$A\ Z@ 0)KS8(OYO\_!.=TD"+14N9H74TPP\N"436597[E#X/ MH3&35AAUOT4+<8^*-(T6C4/-AFHP'E]G/FM[CTBQB8 *[('%@)"2-A ]@;M= MBS5F#;,3G9P5>^11NWX:!JT_EJ0YT7P%P'=)[3]80N:< 8!@-PBW21!3[':S M>-;]A\^1>1+PP;O.8SP^>Y"J3"6E*<<<+G]_G/64S>=.ILOY=Y(!+8_NMP"\ M(YX:X/KQ]PDPHK;IA;6X[=URQ;A[=[)KLB1C%KKHK_"__OFCER(FZB^2#?!J M!TUM86([SP#LCP-#VM66T=9C,VQF-1E/3.E-PQ6N.=\KKLR(EF[+&R_&EQ>8'!'8B,+!_"1UA MD' X:V4\?&M#YD5MM!^MS$G-,X6*#A'/Q7ZTZ@-( -2%' ?EQDUW/R"4=62? M >*7FM-Y=H;G^C9GA6-N\3!$Y-M?-)'K%WI,EIIL!A&X30C."^7\;5/7U5RS M[1JFVU??VE6.S833.(E6"C.E!W+0G,R? 5AJ<6< ,G,>/VD73)@-5+ F9.!- MR 72XUL.[EJ\J!3]F^DB#6^^2K@*"Z;?60[&_'+'?VD"+=5N.R^83S%V6LY= M1>\>Y2H_B!GSX#V,QR0[Z3DYR@A)]#-WO'!(8FD+5YF?;NQ0TI(FOW4:S[=CL[=L MZ8X5S3)E_9UWFKVMYVW,9G%'K8A]XW8Q%882+ZFKG)V%MJ"HOJF7YF2/^#)L( !RJ?FZ"2S?=<0( MXP']-9L]?>>)1_'@WK.%5S3J6>1,VMPOS>OD1)@S#BN%T:"[7\M**+&=#"G- M!-VR#=N=IP#H!XEWR940;>H&2P:=ARWO-DF= 1RL81MZH?]R#OY+BJDY U5V M@"E"@0:+2O E$TWGCN'-3.OPT<*8D#(?FK=:I,O"S+6:4;1[3UMQ\ 5*,FZP M)4N+'5WA57YK*][A8_%(T9T/\DJ8R/4EWJU.0-C+,*IRJ:9[$T83&-49D'Y?'C__QU:CMFE7[)W;Q/70IEQ#?-(RHMR%/L"F>[)FRA".V D+H4VXA#46D M)Q0:5PSJ++>&R\X [8@PSC/ 7U@7B,!+Q9^>,7>J38M\01*ORH).925X90F? M!'#_I>GV2K_PCR4QD'@(*Y4E(5!(;;:FZBY2_6=-L&>J0WUA39Q0>-ZD6.X? M.HM7@'\'$$$$76#+_)MLT)NAI;S=63Z;Z0\1C(KMN<,W!T7/^2<=("T1T)N$ M*PNP*/_7-@1P>TV#ZOO; Z\:B_+NJ;;W+3.C21,F<=.#?P98.Q@VZT,XE^I;6X!A-!K,U+V2TH53WVT.11W0LRQS8FA M99MH[PG7S)O(SH'?W?0";O*_80R+80*4(1 +1<;=9T.(%:?9C"S5\?R7NI&KM\Y'B[+6_ZBGRY-JVP4OE( 8GJ,NB[]?C%]8]TSO _S29V'"5*)K M== M:+>RI?YHL5#^YET@;#F(SK&/6ZQN2]BDR7$LU+02A?:_7^,="%:_ M^4@TAZ97/)Q!:@T8#ZH];C./#2YJ<-ODGI-HBDZXV\#<,"#P4CTH93WY# "0 M?J1%C:-6W3"VP*V'4>;U#:--TCX*UT6V_-??*@C-O?3<+ 1W$ V&P[6R/]?# MXLX K-7P: KM*,FN[&1X@P_J>N/+P)V4OC_?&"*U-7[L#3<=+,!VO!=@4[0= MZ ;NF*MCA;^JJ]PGF;=&* ($Y<#=\XGP;N::A?@.]$+YJEA,O#V/-Y8J]1[,0-[C^>GBKQ/ MW-9+SJO[?.2N+0O+Q@ODQ\O"+%9T 6%2 MPV'TI(=( AK;K8\K?I\TY5%1LO826??L3Y[M\)W7!@(?>DGNF/_:X^A?N8 ? MYJ1LKPC4#O$,8+(K2;M.G<]44-C;,'Z7%J6-@M+ MI3- >"7G[T ?"H,5-LNF.65J?[Z#CTWC4]A(J"/_G?R,&*V'*1-="ONX/"JR M;&Y*@=LIPB,:CPJMW:84RF_/#0DWRF08' K=L$+\PGQ.7 C'NF4@9(2?&&--[WC'5Z&!V-*IJ17T'. M)"5T*^@4]/T,@.6B1GCR.)C$04LQ?4"5#T?C5,=K<@4QB)@$X[UJR,4:C\HW MN-6V&Q@VQDW\Q1(FS&RS&&LO9 GZ:(,*4=AIR'G8>AC5F[;8I%*4[5#MX)1_ MA0_$\_-8<.?5EEP7%7RO)-S9;]^=S-U4R$T>&6XV/ /$/MR '-[W E,!CN3_ M"XVW(V?L@)UL4EG[/1:-D&> G?>UENS6ES00DCWZ-W=R3O)F)6GGUBMH%]>Z M4\^36(87?^'\D8)19L#)[:4'TIVM@O[Z34LU2]&\O%>;9/^=CW^$BH_ZZ7AX M.RZ:RL]^H GRQ MW?RZY/O''>E,M(,T+22I34&)>W8VQE7-=^2*?U^[:;E)*ZE"=L=UX[MQ7!\7 M!Z=TN_BZDF$72XKG^(T\=G=R-%Y?JXY]:]!L4'G>:ILN"K9L_A>UU08D]'0M:JJJE9Q2J;@0)HOWU5<_5#_X[ M@]2CL 6V6\1TX3VLVH:-;W^?ZOP9I\P>SMBQ5PVK;M7>U0.$ZN@9N/LQ[S19 M<>T788T+EC+%F2J*7EPV.,\ZUQR$"]B9Q4ZWPB[+D@2_MI>? =PFGY)CK!*& MF+2<%N1Y>K2>!B^&:R5\;G8BQ%*9EH%@OB#HMF82$VK2<:RTM](K'G_^M39_ MLV@0JXU065KV#A6MT"!FBI+-G"#(RD,>_X>KOF[DZ+V-:V&TOO7=7;?OR\HQMC;+<^3>/>)WM:4X>LK#AQ^WO;X\:1[R MI)D384@(^'H2OB;,FI3V%(--Q;-@Z5I3XZS-DZI-(1U9UGF?5D]N;G(K[3$& MO6TRK1-EZ%YYFQ8C$'&(*)*D/="ET-?CRNY@84D($GO9Y*3US-8??O-QC>(G MV<_H3A5ZD]Z]=*118;JT7-?]%XR]G_JF(:L#'%5C/9?F);:R%N-IO>LB8O?; MPTY.BF9TYWH2;)(IY!&<'=:J2N$)3.Q$SUV)LL#)1'G[O?8[2N6?V>-DA M;:=9C=!)O$+P' !I8SE1B176>@\XRY/&>[X:SG1^8>SA;0$LAZO0BU M@.DIHFY9?#G^RG/07G5NM1C+#66UJV3'_XAJCDI%"^TLII M*0(]"]0=(2D43KE:F[[C\__DS!,S-SYYSH"/)4)[XZD/%>V M14W3\^XEMD_Z>1/TDJJD#*WZP;X1R!0C(23._%\[)K/KTY062]2IO-MI"09- M8J_"S+C"K)^!^]::C]$K7]U?:ZRU""^@'5#]\ M VO0O<5*A,.V-KW($IDH&PW0@B:X%0P\1%UZ/. C\ZEDH@+.4FSRM80V[PBTA\?K1ZGH^0_OFAMK QS_E M!5N?600Z_$WQU@:96"VB6N9/U,S/4Y4'FNI(BDT@2,X#NFC80AZ*A6HW9V4[ MQX/1"6*CU3NW-8TE2QIJ;E;'"[_B87QEO.Q[7B @'\A!W6Y?W?D:-O/.#]?> MS6;4]7[-P2:2N2!?*NI[XZN^YOG8\5)*7S!PNU>YC9^*+?PSZ^6+*_*YQIK! MN$(_,N;2U:0?EG:?6!ZR]_9N:ZT02K&I;?-\&C*G=(FW.D=?!@2EW;1/;Q4^ M3Y?D^T\W%8TO.5&7+LTZHX 0ZB_JA9;>REHI8[]U#; M>JEG ,/Q^CTJ#K:JA7$0:O;[7(K1MR[=V&'[HVXJOLJ9Z):I/M'+6*7.)5KI MZ3[C!XL^M41B/T-B1V:>BB>+I]_RT?",7.IEO73L>=TJC,ZN;M -0)K_;VLW M0KYQ+H!I8?:#YZ$TN$("O'VJ)$Y6=F[81$&HQ/M\VDM_"S,V#M4^%DJ3%>H> M#>0#!&N1^@:,C2-95.+*WZG[[K%UUBQ\Q<@LTMAH?-NO9[1?=6:*'@OOJ[K6H_&OJ<]2=^PVR01WL*@< M30)++V=-Y4Y4#Y47OWVAX\47-_H6',UJ(K1V_DB1^!QCSC01*-NN9AE5W+GL M.N7QW3\3=WPI@<-Y=.%U2 XZGL1&CB/18$%=_8NY; 7:6*+U(B^; M((%IDTU4O6;EM1&/TV)S1#YP $2X%MMF9V) >.^PM$X=5V]LI["ZKNY17[L? MSW7.5(^A:!%-_]IBB19PPGR5V%K$X2QX$1QUH]J+=?+V#UL(,@E]>,]45QN=0&ZU<]]_KFFN7BD#>\>1/7T_P&M,\,K5V$ M$\1CV\I?G^SZ]@^$M/=U@QVK&XV>WQ\T5^0] RAK2M+V/R<@B:)/2=K#OHSF ML7A$T5-V@3GANII Z9UEE0D&N;F'.3'V@*= $;$P.&$#8\K?"OH)3SDT!T[H M?G'!-S OU")KB7&\3_YH?>^@*/Z&2I,CFCFAL$,5]PW9"%2E)8 [UPWIA9-*PNBU*3UG_5GA5'$X;B:6)C0H*V;]XO9,>5U@FX#U_H7/L]7-1=0":4A(%5#W0F=71'-J /S8,C,=#>=?O^.Y8N2C.'A:UA,LS\Y M#>SQ48MFXV>@34=#:!<"H_RQ)&*[[U.BA%-1%0[P[ZA!^>Y M4,\1T7 N)/V1ZF%_*LOF066Z^RS+H]@!A]DE1Y=>B?3;,9H#@-="_[+UWT.O M#5?'U@U_'O?K)Z,:JTS,A3W7:&;_<+Q2I6E( 5YM9D$C80)ADR"!CDIKQEPO MR[3GD5,")UQ*_2,2! =M(R=-(XG2SM#2?Y6!9<) TW-!6 +)*[AHA_8F.B+[S*>#6I9&ZV)% 3Q9&IB%2(RJ-S? M15$/^_W%:P(O&YO''8^0)6F>5_9/Z_K@7K\D]D48%FQZ<).6\(&!4(*7)W^1 MACG-\[K?=,=;L0?"GA@N-BEM?-PICJOI9C#LX9^1/UIF':$[ZFL"+1YOFU.U MHPQ""5'J6FNM5*4ZJU7P^:YP4&I9H93^XV./QE0?;2%''-5YFBZ$TK:C<-HW M\B30Q8X3LM*.M!MB='=AD'<9Y:[4)@Q(@-W%5B2Z%KG@E4Z=/KKR)##://Y7SK.% 4""DG/" M;D+"J('-+S:J6'YUN2NMOVB+S]NNEK7 3[J:[>)1X.@"5EM$1!7D12!2&'2Q M@P;8Z$YT='$3FJ0C:K ]SC9IQ.3=8R#D\X/69=.?S5QG4_/!DL$V'+NVA.R> M;M(KZO7Z_F:_J_R+R;+MSC;/0ME2S=%+?X3P\'\<3C#=.*+1G*M=]+@]"7D] MU>MS3HJ)C':,DZ,Z]??Y0&UR!LPMBFCLTI ZI:'L4^@6?"_);I!WWE%$Z96( M?<#%$R-)G9;NWSZ03_,' ?!C3=CN;=0S*.,"" A5P,[61&&2K\\;#'M05G[5 M:62,?8R_\3NDBLV\/)";I+Z%F2?=\"*8PFJ@YN125K9.WFR.^R09CQL*H^^";>VC5YB9%:;W47L+"6<2CKP.NT[&H%HZ_?;L:J( MP=0)!#Z5^GV[X8W87OLYOK=YBW_;2>5D3]8FOE65_+Z2@;HI\ 6[] M@G;B1"CT2]BR[M.QKC)WH6*,3>F?M5B]S%LUTGGF[]9;?=:C#6IMPZ%'1.>P M:2U>PB\L(5"J]?Y36^O9&0--2D$ ,+U8Q*.?[YIZO QGO$J+K4^>(#4**JF> MA-@-PC-1K9\^>D@-1&)?PNA'8S2=]0S]3,IR+<2BCQ)+%]/W9W7+PI8_D.IZ MI2)OOXC4#ZI + "WWV. DX./Q_QDF3>M9P]/WS%ZR6]6M5_]5N9YP?_.&X'3 M#&TA!UP9/H< _ XU'FL&D8RP^YNO7':O\(UFVJ]*%E]G2BN3V'.X;C;R0^"] MIAQ$ ^J/[=[^/'=N3%&6)C#A=+HC4G@J#.Z,+Q7)O!WXY/RZ<85"^A/OE+6H MH^X.*O?+8@PZ=JP/'H5J$=NGRF>2;QVK20]FBJ:EF/#,VETTEW!+6CY>K9-6 MIM##L'/C^ZJ>)-U%DPGN#+K<\\]_Q;,Z@^Z&NM#VP!8R7V^!L94D1P%]"(%J MRG[>KS#0@DQ!5_9]IM4US@ M?%CP2>,@,0]U? 52,<\%'5MPRPFXUWL@O_'*V2]E9D/CWHA>)PP$C4XP#+NQDUA;9] 8%83YE-F9?0OOP M6]TU;O%3-RX$X76%Q@ZLMC6)$!?8.=]9F[8\V8256U+3B%J;^:D.1Z4#CH>O M-EF,W\8GY[_565@3.6(*;XF4EUI%Q<.QYO/1(%:DT9&*ARQ).E2=5TQ-H%] MIKL^?FC,X.<%BB_- =47Y!(]"0\6 ]H_P6D#.2N0/(J\]NX[9H%\ESKNU[T5 M=2.\[ARB%P4 1')PP[#6F\ULFVIF\$5P'%]T4^9XPSOW$M=&M)"O&_'+6UA5 M_7V=W4>_I(9([-3XFB/^QSZ)SC>T*^'8'R/@T MI:MK^FY5Y/"?.2D3P\L&')>%#9>T;W(^? 40C :$J5&F(?N^>5IG ,17V&'> M=7(X=H^4>.I,#NX\ ^0SG*PM9FW38XF+\ZE(&+<[7W=\.5+:0B_=Y;MG^3#G M]80H%Q>>% X_B1ST,)=_J8/SA6K'!%V^KN*&!28FRD.:$ZDSP 5Z*DT6X4#D MX$G8!E6X=K>@3JZ"@;!MNY$SP&&VVOY\$OQ'=SA%F7!ZW#FU6[XH96J\JU(8 M6$W\Y/OFTM^K"QI,P9*#FNZS4 E,OQ==H(W^WQMY3UX>EDF^?![4(R]_)X*C M$G!NXGX.0&'BWL7R?]E=_[F*>X"M1.?>"%W4_K&<#//SP!7!:P(L(>A MW$!8SW@L8OT/^G]:N-V*,' &$(>7PB98IL\ KE;OPOK!^T8[9X"M7:]5J<.9 M6HH152RG@$]O:V66D#)4X,1+9X!I<[O/"5+M8)7_J!"QUN2#8VR',_L^&B/= M+YM>;W W_L'XZ?/MDR1ZQI;-V_"^!KX3,(7!CCK.EL<9X/DTA,RM" B.)2D> MMR).):W!9)(71;SZ%GPJ$2..%$Z97I2-UA1M2 J<6%IL!O3,DF^>8^ M7>'X45-?FXX.HMV-Z4^"0UF"$P#D*\B&F-,Y]437PKK:-%W1RIN.?IJ71"*O MQR8TZ="](BLN%W9(;]=6?":(_AM"><)'1:]1->1.DFW>.?4 MKFWV27EQVY<(TD>15!#+,O'Q=!;GY)! M#ZNX)7]*SE:G?N3QG6%YF'K/A781' W&6GBQ!_8OCB<6N MQ#A?\54R^+74I M.CYKQW_5ZE+2G]^6=[EX:;A%5!!___VB9IZ"_BH>KJ4FMY-I0&(RP(69UK-.]%9OQC4)^7W(XO;>(W;JI[8H;\$LH MM]28>7Z9J>[VX-,S@#M3VA?(E=JZ5Q>-]#P%'$1W)'C6.&CF" >=XW, K-FO M1?<>Q[KJH6VGYDP>N54U_>@>V[?RVKON'5KGPZ;S. G$I4J,!^CV^*VM=G>BE-E9!)4$$LI MPF<>!SK!Z6I49U@V7U((KS*O-,$%HL2@%Y;!+%MHM-<_!5ZCF4_BK=]L#/H MD3?_W8X,0T"%R/D:G+@Y34MS.C<%-\;B#YE;?Y#IS#&F1+DFIC4'WT.J"D=Z M$:X#XZBFQE:/[DUU-_:-LBEWQI5WD":=N%E46*?]1?]M%8T71XBA2X[LM],E MK]CI,K?3I6[/V[L/@3,=Y8*(E^;H MB1]4>VW1<[< ]Y]RXG3QXX3[V))'GXQ'%2<5[2SI)A7S4NGK7#X(7!Y\&YZR MU2@BD-"*-2!Q\%-G*EE1\KOCZ!Y)]5;1=2VDV]6X2DVFN#]E1_9TOP"A$H^0 MFL;3!B.>1XR3F5-_QB7R@N"[W7RE3@[; /&2A!=YHID23T1>\=J9Z=+V"!]S M]I!>G '2=9=2B300V(;Z7SK0&8 Y%.M.2>!*/0/ ^,\ \:7;U!@&1:&'.5(7 MQ=\4,5%.E_7!2BV(7O,(&",,XTNR_ OE)I>0D\E?AQ'3S8-K)S97@K165_[X M.^RQU".^'PT2Q)XBO)Q%UL\ E[?W=B/3TYYNF+],FHUPS+Q-USQ"G>F_IORV M(U"]DFY8T2970VX2_/7J'\=LI5/Y=&8[1)=7#(I=PYMX%?JL'NF?/7M('*QR M5Y,RO,OMPL*?M)#;5)AZ+Y@-N!V356JSQ>=13"X\R:R]5X33DJOGU;U&BLMG M_-?@SYQ;/6*XFVM?N<$_@#SNR;/MV_VR6^N-"N6TOE$J*6=K@Q ML*@C$$=@S,J.KSL@66.H8_@]TV9B]#VCD]S@8/32X XO[K8L"/H2YQRGH5KV MU.0SQ(Y>VL8WS1&*!+U:2-'9T08A.7%>.\^)_H38A=1..FQ ]"&S_,YV08Q- M_Z\GCJ]VKM(Q\A5^ 5A"/F3TB@CX;,U?@KD/QL#8D>7<;6H7JWP"$+8V;]_V M.MQRN^O-#FW>>A4E8?5- R!F NL*X%]!7!)-\0C]18^.U&_W5?O?&UT5I/4/- MX]W7C=DT4X#"Z (K?FR6)7:\ (MH;TA]\^_Y A1CKWW5X\F3VPH"*J+G\O." M,WI[50<"SP 15*.0#V)H"EATM^.:,K4Q3??-U THG>YF;C(1,)>J0GWP3_X: M$GR/;OBAU6^^-1*'^\)JZE=R)N. @Y7I"M]FM[G6O6[8G+P<2-M]@L)&>HVU MZMJY:G(&N+1UWTW([$)G891@9W.P5W+S,Z"*9RS=^;]T07JBZ3?N5S6>U^-U M<@@';!HA)U+_YV7-+W4N5EJ7-X(7^:1GKGC9(?^@I ME9KPBP03G+IEK'$U6GP(>6U&E.MT].+\@$,+P\FU=._PQ^QY- AH_KF$DV'( M=#>F",PZWRIO4&Y0)O[=URFM7.3RC38OT72*\\SLO*!JIR6NA,0A0MVI4WS*7DOM+C0 M7';&MPY$1V1%;MI^.[["OT?39.,\16*:/M4ST_NX^E5N15CR=U.\7 M))FB>,BK:;1-)X$$N U!;@9&41@4L5YZ'Y=J?HTK_BI//@W+N0WW7OU J$!A MG'=RL66+<^5<&<7N R5N(Y>O_!Q;5!I4 &'T10N5 J?X)7[2)\ISS;B ,K)RU?1(&DT6>OQB&XB./ZJ;,K?P.0C]\%M M,=S532;B\AD@U=MOU=D94D]2P><#I]5.HA:/=X[_30*<%9E*YQ8FB);UJNY* M?I'W5W=%B9"N4^L3-=2R[,>Y :+J(3?96+B (O$7?YM:]?%I='EE4Z;JRY4W ME]J_L6?= \HTA:!7 _Y+(X1[=%OXK*_BY<63\_K?TV;:,J[7WN/5 1 /+,M6 MRT/P"U1 +3,A M44P4Q4WXI#773WQV/U-WB5M::)YK7>_^OG&] .F;T4*.0S8 'RS5IZ5&&0[C M)N=9&69T*@57OW6+T8L,U9ITU.ZMO=[1L(")$*K3BJFA,)+CNU$NHN"99 ML=:?*2L[8@F[<@*5/05&3/DY+^33!G6U!5< M>+NY, :V[&% F3L##+\(73M'U;&Z,6< JI0]C <%_.<6TFZ9_[G#=+,3A%U+ MJ*2+?#M!LE3A?U3M3!68!-XW)'G]$\M[9(E@TBY5 =B> 7JBEV!$^O8SP.?D ML#@2562G&U!?H)FG<@YZ+8#$MD:Y(TLEFPDS$)G#?:J *L)/YRI5W&!-(X?. MTP_OZP66O/I?373]WWG]'Y1$^[_SDL+L$:Z;DQ*TJ!&$V$*0N=X?,T,UJ7:. M:B'2#%H@1V0_ZDH/_WI90L;#!_>=N10(;)0&^(O_6=4Z$QR$8BK436G-AAS$ MU",B4/MW#Q''7\X 0XBGO\\ R]I41W5,F8#>@2W_@."9SP#U+/@$2<1;\)W_ M;BR2CJF!]QW6HXLI(;\>A>4BP]Y8K:%(G Z4VR!F\%9F(6GG*^V*:<@"I12S M%Z7%2,@M:1HL<0O@YLJ2-W@['G#_[J)"VE]Y6;HJD> $,@TA@.BY$0#YB3Q. M\?MH_ZG3FD_FDY_]XVL-S8Y7+P)@3.'<*@(OLT#^'XD@$G@X['I8AU(>Y_CB M@>^.*:+@-6"6/[2XS[">(O;LNV8+8E"6G<2+,X^FR-A"%4-49: Z^,.?,3RM MC*\?4S;U!K$_?SPSU^Y660U7@UV *J*U5#;@[!31K5IV$_?")[9N5E;)XZNG M=]\EA3!EJ:QS&O!'!\^3V(XI)GC4&J_L]2XX?_Z6,K:/^B^?NT;ZT %^&T/J73-/P.+3+$*_Q?&Y')S$&,UOM%#UB'_VFZB8-@Y\!15_TRY=AI32]% MR8)'(%7V0AUMQBCMLE>XUO4Z@A71D.!$5;Q$O>_6R\&^:/\FL=G"WU??1LP^ M85D 0H7R^8@9_\KNAUA@0>W2H+8IT_8IV\#/3](W73XQXQ^_A_:0]?'O:8[N MM1"%2DV\RM*:QD0?UBK>1C? M/"&J)8P'%YK$K&'-W#%^_%E1M$CAS?25,X#C4V'4DPN P+7M^T3>=3A_DWK( M$I!GQDZ02SVSJFID>WD_:3N?.P#Z0O(&@#'24%6%1ZL<%T"ASRATY_N2!6X? ML*&P;EEF]8]*(XV$,"*IH*TKX, :?0:%9VOJ63P:6=NLQ,>!NIC!2(0&\Y*I MGJ^.X/3LA!N[%(^=+3.N$K!]Y=U;U('4SYVTWBX.@6<"/Y:$N9K!4'5SJNWZ@8K7D! J#RGO+-[ MMF5EK4#;4&Y)T3RT#/5M*:_RF7*L?L]C31 GTG-B5"SS-R=?JT7\T+KAGAVP MPTF\2D \Q%8'9%EFYZ4I=A993#<]4&^;QI\7R6B^BI+1V38-"PGK0/'[>D7 M>%%(Z)U]G<]NEFRNM=QR!;"JW<#9%]=5A6\]$_")D M3/&JA/RU B&%46B0FG#C\EW<<@K;+$'.!5OB+/\8/":1ILK+1N)?T4E> D># M]-=NZ'L.FJ[ $;P>&=[$B:.U&V\*69(*U=*T7*G8T0 K%0BF3Y=!?Y^+6E7; MG8U4"K]DRQ[UE)EH 54CYVU#>ZF:P&^B]: MZ! G6C0"$-*$"Y@S !#J3-AP]<#)=O@\F=CT4NP<(QU+\<_,//M9:'S"8->8 M]^LB/><>!#E/G:_),P &V.[Z#)M3"D[Q=$Q0-RP_>1) ]3 MB@D3"PM '480@Z?((GSA_($6JZM&+U\^G3OMXU)]G)1G_YLN7\Q!92,G;[5) M@L) 77,)S>\P=#23 )U16 M*] 6*B3*_SMU\S6/FV?Q17 3YA^/+E#&4W>4LCTSA[I_LH7IITU"U&,'HFD! M*3YOP;K5TSR'O[3&^P2[^ ,S.69>^W\%.,^?JX--+M-@Z3!?+H(7/XZ #S/5 M#AD )_,4!AKJ@I4N4KEVZU];U+?HU:R6^03X92V.K>#DO7;,-51#[>69$\MS MVR?/(T#7++N%?2#%*.P]X(FB.?<9 &T#(M^(:;Y)W21A4%ML:AM(B)!W!N@\ M';46*Y[[\$/W1F4/9L:X/#7-_)G+.1CAI=<4A%@+)YB6G 'X$$TP1[!@8-DB M=ZN@Q%-!R]?[/3.%=9W<]"<*"Z!6=U12(.= M2Y =WD;#4Y4CK\D,_)LWT1MBT M=.A^]H*$3V\JGOJY$[VA/ W8NO'!I.<1T%\[)?WG(W=L>"=7+HC6!/;T$9>R M :1B0CUV]0 #ZH!?#KQ]ZEA?-UQQ]ZHO#UL!32'4?R:I1+ J@:Q$+M>2<0-? M@CEZ:*WIY^XH)MM+F8I/;2K$1D'%EKW7H76S.@*1+7C$ "QEGAV,\8;:XI23 M+C1:MY?.[$;RLCRYS,DMW(RJ\;M&X MEO$X6/S!?F<6R _E,EV;4M &<8?U:9TGZ"V:/G@P%B9-R)XW&]EAZ'8M['V% M_=0EG!G@>Q(IVL6> JBJ"N)T7QCG>ERA[>;*!>VBG8B5; M?6(RLF;HBIB=SFPK(%J$5QC],:Q_ /N4^'C4%Y&(#V#5\ZZL)ENKQR\EB/,R M"WP6:5&UX.?A415).)7J#J,*OB;FPMX0?"9ZC6=_VU?3.N1CD>@AS]OKY">Q M^QPTH]0]($>1VM02P<+BFEA+S8[EUDTY_^3M"[R+L6A=I,)*!75KVUU:OP!U M)CZ&]?:0]*A(W#'_!V6&4@RT5/]=LA'RM)!-Z;?*OF_]U?G MM1%.N200P;@ M'HYOCLQ9WTUD;NI\_4CD>L#UC!0S&\\P6QQ.MMUFY\$"9$>ZJ*/627V6K@,R MB7ZM^_9G5]4'9UN87U;@*1_Y&Z(S-0&R[]*##7UZ)=1'$_-*LE=9*Q52G6' UU M=$"X26J4>KY /_Z14<_HV6HE>-,G)58<>098^*JE,EX-HB&8M(^S#W@5;P4H M,X?9J[#%W=%7F3BV>"&=LD)7'"2[[4/4A/(0YG1J+(DF**M%4K8P,S30\&$XNM099RZ>S.(D7/E_:'%JHUS M[V_'%EY'QQX5N@LA!Q#$_'D-.^^EP:AF1MR%Y1B;65W#FKS5VX!9N61H>\0F ML6S? /]YF,*_#N'TO#48/; 6Z/]G\DHVQM-Z\5J%KEQ:8=J'75L.VZC(ATLB M&:O-_SH0\5L,.3C%2]!&,%/"IG/LFP8&B M__8PBY(^.$C8H]QY%$HU9,4=IT!\.M68!8'(,&H "D8[ M\_]Q]VH4)]77]3Z)HWH!.2J#IDYMP7IBLLA06%J5'H?5/%SRO_=T___;U__G MFOE*+9\!"-<"2)_*:\FQ'E2[-W84#:7Z] LR5(_D1S62/W80E,3L< TXA=[\ M#' %& \[ZC>C!"B>LD(^@K%FL,0\%L*CH"4TSBONQB%GR;N"RQ-^Z"V( S0,,(@(FP,PBV])^T[^5[T6HG+E :X*>UA+6W$ M@7JE*%E[_4)8 640?&FP%12A9A"]>GWJG>6PK1M+-2CT#4%$H6_)\_N DF7)?M8/8RK<'"WI3+."&'D.?S]G$BZGK] M(E<_R^URW_ _%(O0O B02,0[DS.:%!WPS%:+@N\I!> MAMP$CS?+$6)+)D@"A%Z?,\ E[H0,F\KABL^-P\A^U4>]F!>V[T],KJF;\XB9 M\Z@@OJ)>#$YR8Y0[O=[XSUW'*?WR"2HS/&#LYY%=JDUIN1'-H=*U_9YA.IZ6 MY:8Z/ OE(BC1JD;7F>QSEQ#B([86O3TI'+-H!!T230@W?G0&B _8;5W7[NEI MS0>.(1)/"3C(]OO%7Q[>M198W^,H+_,Y:ZJ8F2S;3UR0:.-'I< XJKTN6<\D M %SC8X9S400#^ :'5&0M> M&Z&4R_Z1'1F70%._AF%7T5EPG_?C.IFB\,+O'1 M3\'AS3ZN7CZD#A" H-K]2#6A$EP[/N=OG@JC>:D[:@K=J..8<$49KL"^$:[] M1]Y0<)UV'42X!N^2-C[H"O9J_Z3^\Y?PQR^-\KWMQ-+1?("H+ M?%XMLI&0*EL(R^'T&2 N3W'HR)QMDVO+6[-PRVGR1@!37&37ILE7$?]%_87 M[J)23KQQZKM^!GC5<"KX_7M0:^L?>K!_(!R#BD5Y MR$ZNM6K=PFG.E3X/?5YL:W=]XW4GGV;7WPQ/(#^I^84 3=(Y]QY@&WSRG+F0 MJQ [$KV'V$.*RW7[N9969WJC^%E7N_[:YC YY]7U#$X]92=8%9'4"%;_^JC' MI#_V[0^Q^>"1N?I A%9*/:=RZ\ 0Q@ @A9!S*0(;*"Z*0J!#FUK'L>649^FM MM 'IQ&]W"^P#^$VD:/I2\G'99#LR'.4$9J0,8+?2"$YG *MFN^<%KF< Y)>$ MV\WW0ALUZD9 6_RJ@SK#*&F4(YS3%06$N:1>W!(2KK=3-OO9Y%N?]S(ZUM=< MR.;ON7:M]T1:##"^F940X1T$C-$P*0Z,,;F5O O^N2=2QTHW6^5]6UO"P1N= M ""]P7&3I*MSA-^KTE>(I/14M 82!4J@D09DS,]9'+!.Q*)5A7WM?0./F M>6F%:]L='K8I^OOZESA/CA=E3]0'S"G='V&'"^Z[0,*UV/;I/0X2:%A#]SFC M+:Q-$_JBX8Z%\71?@;69^L7'!]M&.]H@!4HG=9$OI.XPLY0O@MCF9ZT#W+1^:%G#.=] A]3LZ^]FJXIOF"05L]A9$D-PP5T4+Y+2H\XY&>'77[]##GQ*505%BU MQ;[#F;<%X +]3\=](\V$9!G[F#F;T0P?3FYG)4 ME[Y!P:WY)/B^(=2;RG52_W[2!9"2R>E0Y\\D37)!TY5%X.7Y+Q\+)XU>>

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

    M%GT#_,I1>>@L [.FU.SMW:FSCJBSEX"&7M?'CT;T2 MX-4MG_313W]( (?.;UT?.>9Y,WY2-PMYVFQ^@9O_+LS9%8LV'XDJ@,3H93R= M*A7WUE-QNU3W,;%T3#OXRD+L%?E;W)H&(O!P/ >9OE!V2JOP_*I9I&/[I%3U MNRYIOJ22]7+PA90$\[FEVQ-V$[5@ M:LMG^E\NB.>OB4H;O0J6X[M(=X4J:?): ;+],LZOLTJ?)8*\8U3C?6A%'.O< MYZ.NK#!?R>6W.2;OIT5$UR'#!ZG45U?X+G$?#YF3R[]R?)UWABLE)c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ƾNKCG)F";NV_O/-MYO?*?PWL'E MQ2AO%&1V2YFUQ 8RSS0FPU4[[>,'X:X&2%Z[_8;FVR9Q:DY*:(Q]3'[4/@%@ MJL%.2_.(ID"U]=&W:^,%5TW2I9.UD3LSI.&4$J&A_ )6AYGQAH^&&JR-'__+ M(R%!6MTP-)\&40LK&@8T&O?:%%SV?0EZ^,YM^;]WN MG+6MU*$*HZ'V?O9!*HD_Q0>>J]<,&LCRW=WYTPMXL7A8TGJ-+.I* ;!)!;%UC,,? F"P8$,I#",P_G8OH+.IILI_8 O?],OS+$LY^?>9=K[M3\SZ90]TF0:,6Q![Z M\M87ZH7JL()AWNRG-(5X5(.9 E3*L[IH*VNRN[L.VESFN^=J<5KZY$WH4%ZW MR-#[@M*OV*64S3[<>+6K-21KH1;6RP4"$#UQG:?*%Y*'4%\*=Z@>W]8_^2X5 MBH1<&HDG?=T;C*=W2(P["B*^N'#BT%OKP0*_#8M^6^T0O_W>7^#@V*U[7!ZR M/6A.-#^3)RIA5$8GI,]B6=G]RD7] M>F6@[J_YO931/P?CWVU5])_Y*]'I7JV>1>ZPK62C:[)T^OJM-6RG96<\MTY: MC^PI@.1APBJYTY "6-M$G#[^Q1@-N^I.YB$V]" .D=]4EN:%FJP;OZ4"+*X& M6=-J&9Z-HT;,899.@;&!V<8EVG-6HCNQ!@0MU9"XO,1>G1::P%_M_E.2\6!L MQC[L+6R)J"H ^WMK@0+0F#:%H3F=B!#")F:XJ^GGW(&\?=B]4P>C)Y?>?WUH M?YXQ]W9W&>YVF,."8<>^R@W&*IHK3+]O,PT&2SPHH-=3_."C/MW# M;!V6:VE]H%+D;!$F[[FM3C6R8*,4TU>8JE5A^ MU+XY\LO7C^_.Y\2KJM^K*Y2]O[J2A:KQRT-E$.JF$"X]KU=[E_AC6YX">V,7\+]WOY]\##3 :L4V/RCX/9,(IQJ7AN1^\Z\F.PMNVL([6J<7.F%T M?L)U7U9:4,U:BMLIYI,.^TZ ^!O9H8T\)_(X^7*1SY(W<<(]3>D.><[0="\# M:YN]#8Q4K,FJ$7NAG',_*W7.J8_<=]VR"FCT!Y(-'A;E"T97+Q@2=G)X5B.5 MC1T^:?@I*6I0C8EHRDE5]BC7#07^\]S@L59U[YD82? 3ZWC'K<1X*0[/>[>3 M#/=1WK@*P!J861ET/P'+HZITQG%]D2LZ ?_(]V5?Y9^EX$\CG^PD6ZLU=E+8 M_M8RQN:*CQYX(:0/&YU,]54-ZSY?IP Z%_8/^;Z(:7!Z_]=.]&S9?^M$SQ=F M]W)$Y>E;3&-6]46NS^XPZSHUVDZ4Y8T-H1HG78!7R(QK\S)1"SICTG^;#7X$ M!:Q[\2PE*+._,'H<.OL*L&VH?B;IL@ERD9-N;9 MWXP"ZB\\;(YX O_(LZY-8G E(6X(T]0GB'Y"??GO$YMQEL-8\G;09+SIY\*0 MDVG9K8KZAIW0R3-W(G@[6"*"9"SS;E*ZY?+%3/^0\)5FI>%S;Y,\'^!+^"JH M1[0(/[QU@K?NL6+-K1!('K%&T$T$7;]8?8>Q98& MSD%7 LQ2\C3$6&X[?'K:;D83?G7;CB'H[,Y?U^"$P85P96>LQ.6R3J]DE$&C M4X3"UF51>P[,%PI Y["R,3SM%KNK>:H@W73)](]=I[0& ^>B PMNK(SD3?S# M;@-&$8^]/N79,NVY(J&F.:7:K0-_F3JOZ=W%W B?EUY%+HJV"=VD#KJGY1*. MFKGJ)"'Z;'CAS\,*N_&#+!4)[?JQ[;(I%=5YJOK8A5V1GN*;$BJ: &[4IT#& M(^N14 FL4+-ZQ08:GG"X]OHE8FIYG_D6]ZZ)PDG-2)7\8CPO! T9ZD4=)4HF M!)GHEE9 3N[-G VSR7:?.=.^[M9'6#?:H<@;'BV(IH?+29&J G7G.:IW0Q_C M[]<]B.@D7-0UWRC[J1N-@2@5:Y?+O%5R97[P:EATA0P/GQTQJ4PK =*-2GJ= MU;J<6EQU-4+Y7?:YJ1&",1%4DQM'Z-O41B"1O\9VMEAQ^]N&E@4),4I<*N^N M)!TG!">F%LRX9-KFYC@RMSN[TJK1ZXXRF8B\.P"8Y\4/"$UU^AB3Q75]*("9 M5E)*#32Z+L.9W4;SVE "N0J<:CI^H@3:;=(^R5L>1G=V*IIE$7S:[!X05'/. M"Q>/X]>M,C%'W?M*?+)CC*0Z)W8*(-=YW2['_NP!Z]!_;V5/W2D'_=ES+?=^^3>7(?TNDI<.34M!6-(NNM=E, AT,79*OSJ@C) M1A[BY2)ZE/PIU_4.P8*904 TNBOO]])O7LQU;Y7-F^ M,]V :Z]TQV3N/;^BL<_6GW?'M/M39>=*T[.JS!=;29\6_H']I;X0L-IC"+V0 M)S6$^Q]@^1M,05-R(RJU! H@B$?GTPEG1(:HK[PC)*:V7\@]V1GP ML-2[F/IVP!T?J]B-[K=K3Q0:R%5N/PN>\' MGGLG>3OR<6PZ\BXA OW&+/UFW[<+D@\^-Q;NQ]0E8"D =E?>*_CS^89RN]Z7 MA5;EJZEGN7UY)0^4 0HR-79ZA.$C6#UQ"6VT #E&V]:]?5,_U5?&U62_>OL8 M\ +X&+(J^?&;4:W]AW0QQ=KRX;C^=8P;]AN]AQ:MK96Y_YY=2)!G4&^4\L,R MZ,7_T4!PCA-?&5?EMNAO?3IB\]$K!C>8SJ/52J(*_ /2[Z3W'^G]+V:'6?HY MJPD] + &J/@G^L@:Y?$MD1WZ@(@6RGO^@1/\]-^.00&L*JU;P]BK]^]^)#D0 M:K^Q/]!L36&(&"&=B\[W*-\3+N!^',^7_RI/5.#8;<%\XG1VR-)?U3#^0>S- M;_FWOREIA*'_G!>I6)\P$B?/I#? ;,W>A<0H(+?>-P95?FM=T\K]]\RBMZ1$ M@TJB!+W<27FY5(X7U466])0"^+Y;#EODH@#V],)8-5ZKR_<8_UNC1E&TY_I" MJ %O.K.3KTLG(T=O,NT?1=^Y])(XYX[3W@X@FS5TG!,8E4_,*#(HMW$5]V:+ MR9Q[/])S90%!M^J0E-HXJWJ"0VT,OV]E)*E=3!C]U@84R34(IUTN8'DW=X^/ M(_)1NV$&\'9N<*S3-WS4\'-B_X]0=8_'OBU5E;)T#C>"W L'3CYLPN>!?4VG MZP,UECAAX_Q,2*I/2)7=GI;OHR\BWQU)Z;S1T9V./4SRF?_Y( M0VL4$"-#]PD19''8]J5%,+#WK.RA!040"S-[V4&:[=J"\1V\-Q^9["59$)T+ M2=9XO=5H&0Z'^ECGQ*<[KP#-]^.O.@[S2*G&0X;Z"36W+ MG-:UI+:N3S9*>!X=4P!=0:".40J 3OTHAE"1L'",,(_^&!BBXUELX_.PZ'2' M),":_C]5R*=564*EQLE,1!%4)\)WS%;K9K*NP$ ;3<;-2GKMA=B)7:UX3(T4;MA:1IGQW$.5Z4+[']<,R4-8[!8<#TV_,"7 MJ921=,699A43_9CQ-MX5W;!UC#=0:ZQLF*CEN=^#);^DRC=GJ\XSN$.^2:UO M,#X1/*6WNA7]LF!#3@YZE0"/:;[>P(#4M55=SJ1?K:0OBW>.LC\7!;?!JNU3(\S9:B0,5. MLXH8VVNT)AW3E:>C-Y1R?B[M3^N9$VWQ7HL5W1+4KJ<[&1B(L/(::OM&V<#, MUW2@LKOR0/CUX$-VO@BP6G64T=7?RC<@'LA.IA\@-;:4#1/"A@M0L1IEQ O+* M^;%ARF=G7H@JQ%9;HQ"!")ZQE;D?&'$40A3&6#.%E*YQVJ6[V-JSV,[W](7YZC'-4?%;_7JUM'?:=!THN6(XV;67JI2"4$E!L*.=,?, M;1LF28Y86^=>E-DV4LCO0YQUU*&0+DNB_%S#!.>Q@T:"J>GCXG@JP[Z:F[IL%-\_-F>@M(!*^31]Q1920[3M .C?3TM#Y8-O)8"*E/.P4R0/N M_V"(WQBFZK"BO4UX9$IQG_B!2F]_YJZ#X])'WYF&?G:RV N\Y-SPA]K^X6D@ MUI"@^NE*"NDA:H5IP^Q&?-PU;7E'GK=+%?7/+^Q?A1=1XH)U%ENCO&HAXH_# M=$1+3B30UN]I^P9BLA[QM/J#%#>;U3'GH&XK@9U/Q>B"G9P@IE@7?FXI^)+6 M%+:2D_ 'YPDV. G.Y;E#HWGRXTXL@RQ.W=9-Z#4TIZFYH_?MK]5[OY)80VF(W@3) M'%U#_&'D$DI]X"PLY8N=S1XP](G7:?8D&$"BJ<1[O3T$4RVX-4#OX@' M#JZX,"5:LHY$A+\.>;&4^./7&@7@X$)2M A4P@)CF\6OO>J8$FV58OWSYY+F M0%+1O68T'8-F_IR8;H2!9LIDT(S)V;I]9T?I+A>G12#N>3X4MQJWTG* M3BG*Z37L1C.+W%85UNOJ1BX5@3KO2-S:2%0[.?/MK< M@&QN$(:IH ,(P>A00R^L;8#5E#*D8H9[QA:23FWZ-C'2Y)BG6O_Z54#LD:+E M#Y%< 6/#=.7O.:L0'TAA5D- D<+12RWNGST/CVK"0R>Y@VS*#VP71,9VS6X: M:@1J]?U?-_7-XTB/SXND&:-5)2>4E4+R-\SES*!V)QY=(5RAD-L]%KR)(!' M4:S0][>T_PZ46X\R+XPX%S;I^#8%,!:SV4L!O(033PGI9VGP(;M<1G1 CV=_$P6!J#)0#"7/]7/A_R/PD:-D(<1C6) MT(29+UN<"X9LACTT,F76+9QE=](TNU[*J![U_'5;4>]=I&\-!1 >, .Q2LL! M)I'% Q>P@I&UTV;6X.L;J+*C-^9?/Z9Y=/X\>!2S\/$Z,1S3?VK?X9% M,:W3>V.]76F9JS$DC6)BQVE7A)., IW6-1XN5T'^%[R_?@\]M*O3");>IS?E MM.O(WN8)\9L?]H/="ZS;V_^[K_V_ MX0['%:/11[Q@N;;S!.5;O*)3M>?W_9W2N@7%"@/F :NMOQ1V,W=")3 >2NUH M92O/#,84SVAO_N6<)#/[6?BZU8%Y0L0?/#MM8CUO/J>\>SL ;GV$CHTD )(,2;"R"M9%$"^ERW-E@$%P#]C>?&U MBTQ9^U("Q$V(M%;WAIM>M=/^GP>I-&.814./_ M]9Y L<36(X\PY^Y,>(PR"-?*'*BS:>(M<" K]\P^M:KAMN<5[[:E2!S@4NQ1 ML6@%8VQ99$HJAV6+(JA]+9A=&2HHD97+:>9AN98)"3/6@])_>]_)1Z&+W?D/8&UZ[)\R[M:0LV?8_MJW/[$IM89FEG4!0ER&+- M869*8'Z3W> N]#VV:^7?X\W_$"0*X+P(M-04F$6>@QVDB9P#*H8I +3YN2 . M%3/9R"!>[4T!V!%H >> [[%"_QXN#\-__Q'_B?Q;_VC.!]]$"VT=&S/A+&O*ISSED1X1H?-2<-4@< M]&W='QJ:@Q'&8&6 8 I@FXI.8JO[JS#?@Q]P^-EATN9S]5O VGOU)>T0X@UGE,.KUD>BB\ /<(+D>8',5?+1^1LA1+"B MQ,%7QM:?_T$P5\@"UN%(+=D3(%4#[F]"Q, MX$-K05A6^04/N[@@(LL?KL[\N?4 ]>;3.>2BRM[?WVKE//B]GU0[,ZMQV.5( M 1SI ,[Z_D?;]_\G_A/_'I"7SW\NR\%YZHBHG'"T 70%CB\?P])JGBK*@+< M'D:K&\?M!B$&S!92^&%C;U7+S_-+(TC7"&)752TP;Y.^&W"04Y> E8,],Q7L M[?#FM$2:D0'0T4L[ J%C>'OA:J@M[\,&O4P[^*PM!7 F'HHY8YH/@LH3J'X$ MI>LSX\ZG36!;!Y>.5/YWZ[O_$Z'_>C,["QC],;&8+$Y' 5QB"R0_1I(O@L$& M_U.ZBI__T7C**@T@2E-Y$J59$N$ 7I(D6E"E'IAEZC!$+O'4$% M(=*D-^F]5P6D0Z@)56HB$ *D;#[?>^_.[WOOS-ZY.[NSO]WUC\QD)C/GO,[S M?C_/\WJ]GG-.R,&8K >F/" !R%E'_)]%MQW8=J,>?[N]QB[595DHJ527G*[^ M+#$\N.. P)G-DSXM&S3/WM42J]NI#C):Q_(#7+Y,&7P8(7V;:) '0 M[6W^"^>OWC^XOF+YR^>OWC^OX''[0S6=W#Q+2*L-@X>M>LB ML6]K^CJ,=7TQ\EIN?%ZB:,-_:.](%46(:\_279PF*I.ELRG%@2C<6GW/\61L M4;E:3>(1C8#^9WFJ)% ZD$6%*F :=+F-:X=;&D/5N_?ZR%_T]-;MUSD*)2CTGPU,?>0^[7U?$*+DB3R(3*=A7PZ7*1'WT\X( M;:[,M'T27ZRE='>_(&G!1*QH1.2/L9Q1;,V3Q9R6U?[E&OMN_;"VVPFJ&%"L MUR*]2;) IM-^9LB'-ZKU +0.?*AL$#.//(-JU*.O8UPRY&+MDW(LN:]"YZ:F M99-2NT(J0XT"G )RXK7-L70.>YXM.8T)D3PW6H30%1K$*0PLTHL$H#=E1B0O MCU2=QA$FKQQC[AQL^-?K[@?V'7 M%?ST%X0R[*K,S[2@X9N[9@QD@C%N+<#!])[5[RF&=?64SHY,#9Y^6@UC$QK_ M*):R#C;8,&X="8[&)%PASH$N*[F7]N8[\C!XO7/=>%6E[C$*WKBW(E)3G/TI M*Y S_7>; M1T3(4!JC+E;6D"JOPE:5/38'GO8/WY#4NQ)P/1'.%.07].BK&> M>NIEIHVKX&_O:9E.6\^92(#.ATJ/5B6Y=]+:6?&>N8Z(F^;VG^T%UF2Q.C/< M;VDH7[S,#,-5C(E36TZTZ.>:O47H[2K&?_9C''7V=4*NILNR&1MS/>+:WC', M9/,82/?F,[02.!/MQ[N>@Z#L..\RW3SP\G6O&$L=1F,+!ZY]1K9B-^/FUX4>FJSNHCTK^Q42 M8)YZ931!Z1%E5 Y4==RE5GN-0[6- M!/BU6C&KN,R@.:N??"*5^PS1G]XC]S'1$?M]85&?J[9&QTK[FUMDM&*R/N"% M.$V;>JKRR/^V[BCUO$D"P':-)[-T9)=P$ MHT9Q?!_QH6VB),",N"0)H-J4(_VN<*@,>_7Y>A&KA>=15_2A?B2\IJ#K(/1D MV!K5SKEUIO$UQ'.VM?^SV].RA[PI MNX8#UE\*1[3BNJHH.%?<^PM+_;_L#=M;6T&69B:/:/6-J\:@4T1JYLKK4YD " M!'\B 0:S(;G$MEW@4;$BAAXGF-"[3 F]14C'ZQ7B1GO281'.@I@G@]16NN&? MP_*K>*_;?@F:<9 O6XW8R-TS/JF-M35)*^#;#8@>LP*C1[').&M,].DNE&=5 M3]*\WJ603:Q*B^D3W=K%R^_5FOIB]SM?:.C>ZZ"8;LQG87$4Y?B6 M7\RE#DEK/0?CZ=!+58(?_3!"&NE4(\3:MFO(K:IY8<3ZBEGV@:-FJSJP4U.BO''";L>5AK5+D[.EJ&;0GP47+U.,ZOP?OU3[3405L&A?62ZW5KT M_:1_=$SK?KGMTX(:#^.YL)LFZ=#'A'P5%JA0&YB'";>I.2YSB2.K=U_I1QA5 M]CW!3;83SAFE-VM[3)YVD][V^6-6CN@9; KN-2;$0);[.J;\8]G;"S3P-_%J MG.L:'H]=F")9-RGBE=4]X'7T_3OZ0>U7O'=6'-6"+NKC\S-#( M4B.A$?Q%OQ?%GIX&=7F-O9KI9]Q[ZE#Z&IZM,Y<3E ME>">)J:4GQT&S96J_O@M-8,AH8\KO#=BO9VU(EMM!$AY[7G M8]OU-7;_TGJY9_W.SHP?DQV_W+X=GY?2P:2K@=&(0_$)CWN#N0RZ$^Z:+>3- MW_]B[R@_0@]2LP*?6\(&*_"&)$#5^T,20)T=5TV\LDX"\$I&DP#'/W3):55> MHC6VD2M2/QOU?^]V;Q+-PFSV\-#A[Z%WFTZB:_W\;VA&CQ;\<$YI6XBI'X$*>!"/+^!NK^7-^%I<;K-&I-O'@KA>M^VS4A32U MQA=''R:04=IW@T+/UM[+Q>"MOVVQYR6*CYLO-E/=NR\5L<)]58,G# Q]B.M< M&0U[+Q!?A5IF,-LRM]T-%@5G?.,5\,CO8*7*_ KO@O/73+A[:C;.CED9E@=, MP:[@Y9!QHCV*"0DU?LY"+S23^UREJQ=R'O!):7QMO)#Z\8%[4O0".5\F.H!L MV8TIG58B$_B'SI7VX0A5@4CNL-Q7K!3;&O=[Z;Z,-YM32;N",Q=OQG8^K[X. M8./'5MS ".V5H1]TI94-G+U>0C'"@##7G)^ M\+6OFY:IB%,"^A61 ';S.TU.9_$;^M_5WW'H-GHV.%$IL"JPKE)FH_43\'(8 M(;4$,W1Y\VL4K?C(F'?!@E@A!R#5B2. ML_,3HM)YFR37(PYY!D;OWC^XOF+YR^>___B83HE(.M(@- 2[*>ZS "; M!LQ]2_H3]M_&MN@[_FC607&^,('G--Y"%]LL M"7\;LVZLR :NO%_[F(5!7@7=""9846IG.XK#[4_L:+<%;#>,O9 MP&+Y;>V+@0^BA9X?Y<$_/24FO7NYZ? MI@2^NXDJ'[\Q]G)_JV+0-09.T0Z6#%ZF.TY@AX2@L)5G*FE5-3OVJ[2JVEKO MC&00!0#\2.N972-P;K,;5#.S=__;CMS2=5PCBG5E_%L\=<*>)#.H1U,%VFJ5U_1E+I/?)DN+SAWA5X;]Z:O&L5(:KRK=UYT&M?G]DPX M3BJ14#Z,7O6"WX]5WO%1?*%NLYZ]+VU,'XQ_AUR.1- HSH0=EXC[Z62$-E5^ M_L<^C&JJ5*:"@Z M1;K1I9,VB\F3Y3:I^^_%F;JT,?-(/(S!N>62DMFW'ZL<$0X3FN$@*;SJG> LD!#\S85W&)ZT%U'XY/7%-;5OR%G67CU1]T#8<%X M,TM1%\X??IDR3&M+EPFE*@Q0G38_23K(B79[Z_-W*D,COX:&BLVB\Z)+9PVT M$?2 Z?;N! 0UY&:XJ\ILQ0IVJH>)KJ/&M4? MR/HI,W7B[7%E7_$":'5B01DD1!]-Z*D[_)8IF"WR-6WM\<_([ ;K1/F*\/8W M[3AAJD@EV]5%CYE5GG@OYP>J,4\.Q=9:PI<&S5>''P4.E:14MC.5WCTLHI+? MC5TWOILPH$Z3/ZEU=XD[KZ8-0_/(BEE3@,EG M]%5.8P( _Q3]L5>/=.=;DO_E\]([$>FJQ ;Z%\?='6LL+],D^KJIIV=@C,O.5<,+/\ M]\<3B-! ;4N\9L>V3\F-WG<5H4 GR1 5)XH#+5VTY10HCIM2QCR\.7F MM;C_W5@"I;>CG[2?*EUIW^4JA/%:>J'W#;[D%]P9%1G4$5%<(,05NI2O5-:F M;6PX[.TAC?[HB5Y^;""E+10(V'_[]L\HHH"H!T<5$&+8$X@IK1Z]GMI\.4\' MJW])N]YT6+HM%2=D7#5%(W]X.7-(KUJASR %V\ \S)!5S;'CRP;#MOQ$VZZ07Y]2).[O*Y3M&'IM M-[E/]TEO%W7J;;U_\6*R5E><>7C_F'I S)FO[W3?UG3UY1>:ZNN4VA28"F4< M^%P7*HEK+1Z>K^" S9C M"20!=%\5QLEN"^OJ?KR33R50EI!;X^_W!'.Y>31_6S;]PY5Y=@N%Z1?&'?(" MVFR=G'Y39_@=LD)TP+]$NW;QS)7T(."Q>,W7R!V%EF?2[C)K#8ZFYA:,#)1F M SR+E&V#./MS'>A=7&^A)%YA\G88 M^I*N\]M;,/.%_+<3^_PQK9\,NO>N%4MIKUS#*/MA9W!A(GJ*=QV(9Y M:T)J%DI&H8\FJ42(ZW2UU9I5!W:M,3+Z&O ?(S8/=;?'3Q>E*75?=^/ M59!8-:N7E2WO\DQ)"HKW$$;#8VMXN!T2=[@YIIV\%T5<& _U&\QRA!H6\@(U MWG%IOL>G$K)AZ\*)L-FYK[ M9N_6:]R(I^*(H8T7;\^ETZ4%-VO$YZT_;3B19'R\MM&*E,O7@8WO)(0*WMR")'L MJ5.Y'=^;))$^//@G)MC$[9;U PL>-4.\#FYQ13^D0)];&J,>$6%A<$A;O*1 MZ9SANP)X[PKZ^>+/$+YN,LL6O*S6D%/HH+@!1_DS=IN.EZ/:)R17=$LL"I\: MF6:JB18=W0IY:9=Q_A"J.!W .[ABP5D[+.;)]\>EXW7/KQ^E!BPRKB_#E>&"/44P2]\ V"Z#KH31I"^XGE> \D M/OL*7]R#AJ!:S=N5VVX0?RX#I'D0XUQJZKAB1$6DD[=?U"Z>I^8J;W-LL[2S MI(GI4&/?A5-*[V1O#?; M^R'U%D5_K4^+XI?).R"7 JG25181>- 9K^D,MQ2:D%5$^*S2_*VSR-64V"^P M );=Z)N:?>KAB/J[Y0XX@J^SG:E% 5G" 6+;0LS$VH_?:FJOK&Z,_?G] M5,M.4.:\P4>!%=4N"W.P3L")<%Y" Y%BOX!'U(K1\KY&'J$UWQM?B JK:X,] ML731&$L_["\<'[+5P_(V"8#2B/WXJS%:/6S)1H/K4=+-K[##B[52IWPVA\\!T:(/>E3X MQEL$QL46G#3*4JU\.QIO2OAR QM%*%12+W%88L(-HVA5=O1J M65)4JE"9&M(V$C>N61]>55#NJ-#"U:,+L$V$]!91SU5+-51=?KD#EI;#4L\: MI5LR%7@_S-BA_(6OQ(:!6T&%DEUS?HCA1[[TQJ$J\?Z,U%D"**?-C)S],.*D M^'?2R,;>P*:AGB:I@S#'"M[(]B8@NTL6-$=$T29PFZ MWHY$+:/C8%WO4*XX32!2\9P'"\3V]L\I)=18#_WQW9V+EUUE+;4.^Y O+&=_ M0]LD.M:F"5[J9:CNGLFK#J4F 2X_)N37MD?XM+&@Z4.\%]549PXLSHV)A]I- MR4NH!^Y-\F_H0CD?'/!3P!:X&E90BVGB2!2W:]@>C8'SSLBGY>+]__8 MC)KA^7?"&ZA\,?J0!/AWV@O[=P+^E6[&9))%9]S5%11:%[3A=":20A!%ZL\] M[:VECV=7ZM\X5S*Y44\XLR6ZB&[!8N#<+1SNZ-&>-(1F9)ED+4>&7%WX%6V) MOD>52?VO>HA,Z\ JP? 9%:F98X]&75VF>JJQ?#?8!\W#K_15#O^SFSM[590" M1APQGL^JIW9E6(]:C5C;1N^D2_V6?I5<$)+8D;*3Z%^"V/I*GT "("-E1L_8 M:LBB 2/ @^YAWR30(& $7');1TZ@"KE_A-^: 6[9_7/%/1]@W=?!\*/[_]!B ME,[YQ6@ C@0@LH:\)(N%#+)8:&O"5.LDJ/VAM:3 M&.X,).*U-?'W*!O)(9,EARR OZ)2^"^&OQC^8OB+X2^&OQC^K\%@@G;=]2V% MV/>><5=)1CK9Q^BW!>_E:KUD81@H?W@B7U'\'Q_K.9T@7F,C 02],2S$1C+W M^>W 5WM_?)"/DF\%' 1F! MNWSD:\O)JZB .>J'M['C:M$F/4L<&+LBUZ];AQT"SF_64XVZ'K\:O"4 M\M'K1*V!86@8"7#I/0F0)(32)(0Z X^>IVZ!T"]HJ7K.9G:7G M8F+>8]R1@G7G#++LV&$?,,CJV'-%#NR6<3O9IM05;GP[=3NI'?TBJ7*3V&TN MD2#XT1.C_[)AJN4['%&'6=2O>]2WSH#X-# PP+G&75#F 4<_&>6Q@LAABT%7 M?C>5+.%@/0:+\]JU;'R-=]7Y?XU6-3Z+7&9;NWI%!K@[(GVMDU?0ICWKE,KJ/3Z-EV'=UU?]\'VB8Y] %47L5ENG=2ON']K7%EU3?H% MZS3^5+&GYC"DQ=>-#668/ZF>F8)]U\??F-#!/2N!Z*) D4J:)6^Y%<+YWF.3 M6,='%(3"IE;]AT9Y#>^B%S[BIDR.>*C M.OCQ(/"(X:7W]A#K>_>812[I;#;C#'_ZO@1FB>9SCX %1AS88&JIJVOU65-E MC?AA65Q89=) G**K351".].8LEE=>$>"8H[ $X;]C_TB BL(R[C7)KX*P5OCG,L6-IFEVX* M3:^MW9?A0.KHF^PR ML>G0O3*PL6QU7Q6B^+[>^1S(1N?9K;4T99:4Z"WHG[74JP),A+=O&OE^%I<, MI!"O4I N!^$)9"GR"L\R7/3""Z\>;ODF& M?3?K,@W8E]94L?D9(EY;:7-IW>#:,1S'3^.RS-3B>\O(T,MTLO[5DYV@,YZA M!B#"RY(G)C ;6QVR:I(H 6SBWX4(GI+S,I&X(H_30<=[]K:FK%X7AX8 MO;8J?\MQG_ 67%;#!WK-/3,)VZ- N<87R[B,E0Q M!IT7DGY67M;@X[\KTLC*1Y6@@V/)0Q#G>*K:&K-QAR93:^TX>[&3]]Y37S 1 M:9+?'SSB[%WU&,JWL;KK$\:&JH3JGGM"K[G2P'&:,#O8M02&06XF;W'N#H2Z M4+F1^!]Z)UZ5G+83'! )I\/]6.&L9V?I_@$*JX94ZR9)2G_R:BBUT>:62_ L MOKW/F5RJH5,IS];K.?VE:.+EX-*9[(1L >N(R[#S]\;3U^=7B<,JK(2"MMO@ M,_IHUV,PM3)01VY,)4':< T$G>W3VO!N3LKD',U_3P"NX:I'=W-/A? N78L M76MK#;88E>S&GGT83ZA5=^1\/#"?^OQ=+-,S$4JYY+L/*R+:;=OC6>!5]/WT M#' 6W)L_*-!WW3S0;TQE/(2?,3?"(:F9O%'%#C02(""3V*VK& MM-#;8';2Y/0+YW]+:;$;84Z3])VS*%$JMK^_".E-0>)=7=GT5R9^I>HK[>91W@ M1^$H4/810+M1Q,R3R39&7--.3P"@L;D^V+,>UPI'V")].;AV\Z M@L+Z+[;%$]("9*!2A!P5F44'=MCN'-)?M!MC48I%M)8'@:73G@E:>/^(#,YI M ^BUA(-0BZG3N1\4%E+.2-!\1O1A*7LF0P+/T'".(,,BSN=\*3 MB8,]:679N85(]4FB:;(]1=NI;,H(\[T#D"8DAGA5$GU"9,)CT[E;R_I7K^S] M>%1L^3-\R:P+S7T++F:3@'P0_KY. 5V!$X[H;&?&''#7RUT!>/\?!T+ M>PLU>3ZE*89> )AIW*60?KN31;?!5=(TV;Y2EAX1V4+.,SJH4D-"_\P8-?@= MX^H>\V^W96'(ZM4VM2],L2>W&-U')!%#F<"25L6STW3BWM. ><_^]I6T)&VJ M/7/K5)VA=/'M[_4&:AI7*F;3\1!R#7O9*5.Q9\TO=V5L03-W*2_JUFEJB,85 ME=.*V?>K/X%Q?Q3OPKJ58K!-)$ *")=+ KPYWB1&RV#L\0P_B*H@)A)@)^TC MN:5:FB!@M3/X=!*@E^>6Q&9";G)\V M=N3.. G@5;3=_K"(B*&P1YWL'IX+0H10!S'>DI$@1J'ZULD*JQ,BP^*]N; 0 MH!1?)%_2'\O/P9F?C"C'*?7[EWE>XT#H$Y1Q3!GT,N9;;K'I8V:,34,PQ'ZB M?!5:WI\F_(..*>)2,)TVJH9X&1?2!:($.NB];E/!J1SVZ%YIJ&^N:0U\J7WY M4*MLF' MH?4Y8(P_[\E6V^:\E0#T#]_OY%VM%P<)$CO@5<81YSJ.9R=1T-?^_BP17LWY M5<$_]!,U3E@XF!::$]VRS>0YDQ_?S]^Q"\/$AU(]#',60M=H(^(CTJ+A4QM% MKI[OXU40$M^F)8CSH.^3H*K1."@?"G1A)SW6W"6;;]">_T]"K:FEJF$\OT&C M$2?3*A^8(HOVO>]>V;DE)*1WN9JGRU^E"UES#N=PC/,O'WX[K]1YE4%)-#[R M3Q1KPF/J 2$5M7.-@%\JXH1V%2$(J#N+$9W9PURGH76T*"%[^,T^L2!#:01P M[2N9S7P/9-07;(LC5 /?6+H2V>J1WR%/E_1\S=%T64X'>\[76SZZ:S'E)PM0 MB!D;_+Q)L^:WC@E:'C0[[ M?--*Q(_2L.FQCJ_OTWS*N>IB6&=SQVZ)M8@O)+KH_#K^1[I))D;[77W8_2CK2RI4/T_?]/,'ZOD#SZ]#GZ*%]BA6):]; MF1%'B1SHMPZ'XB-)%;_3N=IFJVK>Z;O=MJQG>]#W$YH72]OXIN0#GXH7PA]1 M/^ U:2O\IP:>JV*,^TT"W%&*(?:+LYPB9G9M Q3P7B3 ARQU$L Z+0:_!\9* M-;C#:2752N@Q^I.BAR'_B\FRU?:UGOZU1UU\U>*G3ZKC-(50KKQS>R:<-UJR MAYL1=^]<%4R+.>D\R;IMJM[;NIB_>Q&E)9FN[JJBM?9*X!+5]E/??0!&EXI* MPB[#>*O^=63RRZ**EI^X<_HNI6*L]_W4.?Z02^!T=7J.).SX6W0&S'?L,ZM# ==&U=KJ,KF-_1F>]E M)!=^\EX:T"^NM!8CM!>%$>T$,BD]R@8#:8F92(L3^2AU,\ZMZ9; M0@F?/TBJU,Z;/[WV82F>X*M0)" D7Y800@*\@L\>=,)K!5-612N8MM_OPP7C ME$N-5S4;PF]UJ2?6D0!2;%(!CV*M6P,Z9^>^P:U=P6QV\5>F!<0GPP TYQA0 M['(5;"^(:C=",LYK&-8U@RB<8F?D#7]T:?JP>^..)IT\%4QYLD(M"P@B^?N4PUK03KFVW31#*V]=FB,+_4,]W9 T0!]4FT_I@BPA8 M++7##M=<[42H^*VA"!) %Z%?YZ[S\3Q?_\497<%Y#RT\9KEZ=/?S"CRF37RR MC1>JE;5T8M3JMXS3].JW8Z;!#\3?BM<<]+&[YO-:BT.+#<@#]8] PKJ7H\PE M:M$L?>GQ1:^O6_0FHZXBX4^;X_XT41"*GL"QH.BO0ED)V3+A MN/.5\U$&L=NHI?UQ[ 5W?I;AV_5P?H^[C,$4QT(/3@"0(IB3?I3555P1BI;: M#.>*WN"YB)-BW:@.WA<7H;Y1]))7XU-JQ/H#BA[ X"V5IW*OWM>L"NNIUTVU ME+H]U3%TYH>C_)'GGI!R?2X2H%/%J_U?Q=8U9_N?8GLW7JW?Q3R'W-PT2(#! M>EP*L>\'G,!779[;![M6RQ.[C-9;IL79:P2^W#&"W%=O_A[1DMQYN:69A5#P MW(9[5]&D&_B=9:^^,&"@R35*2;04HN/\MFO[< ]D)\=CTU#3=(TO\:Z-4W!A M8/"%R\H[HZ%<3Y1^=WN--&JKEMJ+IRORX$0U\5_ZDLB]LK>"^,'2I)D,\3D) ML#9/Y""OF#D/@2^MC9%0V'8/E[!ZTM.]6@93]Z=<-JI1'R^[\B9X1-;+*%DJ MX:XKHVU'IW/'A5CZ9MA*,>R/,PE 2P+LBM,3DWY8*I73A5IM;W .Z91^3%H' M5I&URT$WO(:J:Q3W5,FU;!MMOC@J4Y=AFS>4Q!0O*SS^8" !#@^X":!<2/8, M6F? N9 6!E"4\TPO=;4M\80[>E=% L_X(19[K:LPP+=U7M/GF/BNODX3;;@ M^!OVQ"<[G<#C&7+S'I_;^><.>S#1B,V7!'C-Q4("/+8PRC?V%ITL$/J6__3+ M:YT;T3-J6V21*G+2S^7:V<:$7@Z4UFUTNHVYIN=9K$>]]T[\5W&I N>>G9WX M]G6Z1[>KVNUY<((\05![-.@AAB?N6,_.TK.'F>'ME2;++C6N+T:%D.#PN'IY M53GF@4$^3IL3./I9Q5R]%:Y])9.ZE\A4E?%\"B^S*3"2Z12VD36MEU?S5L%. MX\D>9^*NWYL6H14A/--M4!CLFE?[%4AN9\I._1G3=],Y*W,KL8NFUI95><4# M/M\+7RS<3U1@&W$OV!,(C^X^\-<3&BJ1LW")&&^O.MB5+ [XJ:(XA;'* W:5H_))KV R,O=W)$MPIZZMK+5&% M&E:E;+(57^L32EWSSRVZ4OIP8)!U8 >4#:]LW[/&F& 3,2:1[A5T%IT_U8J-_^7^G-3;-TXU<2WTC M<%$C@U4Z^GU2#<-,.O8 )T#?0ZO9"P0<^U,;-"2O*RF72#/;/84VO^,SN_3J MC.I0ZXB&ZJ'H!&PE&_[''L0 VTF%$]/F9T)AG3RPM0S\(Q*@LH;GC'_FP9=B MI,"=YAH28&!._5F/ )=$PB\1X9R6E%__LC=6B1(0;E@4#[VW*]W\RWY[F'A+@/[HXP/_HO?@' MJ0.@L'_S<(3_S0%*Q5Z^>0%# OR;BY/[;Q:0R>Q?#'\Q_,7P%\-?#'\Q_&?% M4.& HT??I@^I^WBH_[XIKHXF>[*JL)!2EO;9>\^=FP870"I0.T(J M"8"TAC2!KCNRURC:G.BTOPV&Q(@J!F9/AO0]9&/=OK_4%O)_8E1BW!\"LVZU M[E:1_'4< K3CFE2(!W M"06G<"OB.)P6*HG^(Y(=&=N9^2K-E-::X53G M;V/7KES>QA30;7W\MI.6O%B.Z#-N*2DJ)>Z",G\A M,N0GOY3TRXG#;ID7.6(RJ)6M.,JL. QZVWY6#5%4Y[YLOBA=.R;>?Z?3Q[>4?\O\PES9*ZD M]3#SR1R#N2'V2YEXO:TK3O!C_#Z>Y=Q4*-2KS.P KX"Z>P5@KBI2PC:P:S3Q5[,KG?DZ^@AXLN^9 VDWEUE@.<#@YG($0M\6M M'>1.=2&8TOFV_!/1-V2UT;P(4*7LB!"MYW3N]5I&&R><*L3Q$7MC0 3AIO)Y MR7*A)2$9$F!NN>B8:C>*'.W3<2++=A8##H[B87S;%!'/%[HLDR?.CM X[!H: M.$_-4KU4L$'3^/J+=31NIU_(BM =-&&BON7M,;%(LJF,VPL-BU$.5[SU?6L MN-I$S2_.9XEB+?1(@$3G H*'/N&2R;KFGN&Y%/X)X0L)X*!-%,=+3QS4=D.6**;R;Q V:A3!SPQ"GQM_ MG#P^B .B==LO0%R15E6E$"'3&3$EO9PY;7^:DQEM,5]!?HD773F[;R@I) #R M*S-DU=7)"UNK@_P@]JZ2 /EW)]O$"#7M#OH((>12%=+R1L?=W\P3LWJ$JM+? MV)2<_.*^/MH\]4_%5;!?S/8"N):7_D^D#L/Z]_2GEX973V_LO'#_$^ M]>N6M"_BN7.*]W^FA)11Z9G^(0$20$PURXC[V.:6&)1D]+Z2#'I';W)S(B>+ MU0:^F^963=//Z;#Y\W.B;5T==>RZP;6M "!.'ZN:@2Q;(P&HH?]M0%'F(NY- M%6-P*W!@P_1B+D,R*]/+8U8E.6P>[D$9<0A8LT94SNCR49% 2^07_2BRT"R9 M*YL*[7K39Z$=%M]BYQ]4.#;9;0=.0%.P6CG&)7:B;!*B6"].,M+Q;4N3( M3#DN=#RDWO90^>[G8Z;OS09>%:Z"98=28PHB:>V9) !%-B$+#[0_MPL84&R/ M@/J5;._YHA$;X$S%C3[(M#:O;.GK^&?\+F;/2V/ZZ'[E*IF$!'3!JO7#@8X' MD>G$$%0&P;QK5'\\[D@_=_BF!\MA[I-[R7(<;IM?J>0WVI\1KVQQ>['[OXXHOKGG&SU[\4*91_TT?3+T MS>_&[2:X*W$^0!*.U28D09577"^]E?NE!QG;DD7$CE<@.*\*Y/5MS5=R M-QH*:2BEK@)?X:%C_?B;+%CY":47*QER(995S?ZJ\]II!N-LMZ749:J<7E7? M66B5\O$:AOJ=*Y$K%7T ]=9]G!RJO6/X1L],$_1/\=MG6W4%1K%I MD-9JL_ MF-X\% BBH X)T@D.Z.T%I9\A!N/+6G-<%NK&SUF)5+@49,5<.[9NO%8_-$"B M"<,2Z"*QM_)Y_W4:5=JX\8OTJ\9:$YZ"VB;SL:'*'J(M_RH*JST@+B X1C\, M:^*4[I+I9Y_SNRY^3=5E_Y+?QJL'^Q\$WW5][7]F-78NB7?"@<[5H4Z-Z/6( MW2FDOUSWCO/FH^)Y!]F407N1M?W&U]>?:_:Q<(8#H/-M($GRT6.@+!C[+E?$ M-9[8)9ZZST=^.QD6QY.\">]G01W7+]SJ'V+MB\]#:[]&U,1^K-?1&:\W$F#9 MS8AI:E=;.#[ \;=WKZ*Q8&4.J^F4OGOS*71%WE(<[UPNQG-?AXO91E@W4$Q5 MC?X H9^PVM02RLIX/^OH\\U%(2/NGX3$"C%",6QMCB@"FZTJ)'>A!S-%,VD!4\ _3B0 M$W#7=!)VE+G34X#IGSS:1%>C)/_[A_3+>/[EIF6NP&.6)":)O'CM]'^Y:6/( MQ7MSX5FC/Z-N!2OP",Q]?K[;E2B;>-\,B-:<^ERN(A'C\[Q!%N$0]\56S>[@ MTKE=VUL<3P5.?Z5B[VJ9W-Z%E?D#AD^A:$MSJX?UC&K0\1+_G'^YL:YK*9G( M0"631N&A%]OR=67.S =J/XQT/MRP/"%W2 =J6!BD:9\AZ[LA2M0K.UX--=%GXH+4%$4+=^+R M!T*=;]\=>V53R6BSZL9T0K5'[N?"1>@30@PW.]''ZP6HT]7O>.$."?"CIZ[J MD&67ZIS9 513%M^*TF<%@=21>Q+K3E^_3ZPQM/:LJS7ZBKAEZ[BU)"]J*!2< MNQ"'T '];7?1"5$M5&5O[SFFAY9C$Z2[]XQ9##XXE4:SW J__%1*ME(!51C0 M!ZJCK#@7=CBKP,+#7(X/+H'KS>(A^LEO6J)8(/&J^2]W(2>\"A2O64?8@(Z2 M")Y>6/UH#XP:Y]JE'I@(#W@(\?IX2!_&'0PW^UB<6#)S+K!5:$4BP 2 M8(>V?C^ $M:$E04Q[,#K(O:\43PL 3]@5TO%RC/T6S!UZ2?I1],%/Z1*!=Y MPA7YDZ-8@^8N_KE*%8:36SF8G5Y&QG]IO][RKF@),O)GSK;5#ZRG(5V9&O[$ M\%*]\/S]X.&6>Y?BKS#MP>M8=M7*8-U2>-EZ]!YJHL!A+^;1+WBN:/6-_DN"_9A3)%X:M]=.>PSS]EX8%'1\4PUOJ%K7(- $4;0!E)U2^05>$ M0K4E(]NX<=&$FMHLK;Q02SX*K&.L2[&QNG/QT[%.-_G;^?]^P_K1YJXF1JT# M6",4U_+(W?Y<%LL+IE3AL$2S]$/VO_HIF0#G-.8,2+3VW8U$SQ-XS%#'8-2C\> M!,OA:2DNDP#EJ(;V^=5>1/T>Q?DS2(PF^HCQK8\5_<1&C2ER3<2\[W!)Q^]B M*3\()J[Y\MK1 4Y$**B"R(IW0VOV[E'(UK.T&?B%O8P\V&,S%W+U27A%0?R4 M3F:R*Q_:K\SW,!-5<)DHUH!EP<+1G(X3T>81VBB7V,=9UEYRU+[B#:RLV%.P_TKL5;G3,K5AYD+DS-N^G=28SD(K4+Q9]YNZ M"[C U /K%"9R6T&J^[*4<6JP]Z@%$PFEO-Z;3 . M>6& Y(4A4_V@=Z9D36.H/[?3#;_0)O3; Q=P\KS%E;'?NW@)YJC+$;GN."C* M/3!!?_&QU>RFHS3WKLX%B4E:\+^<3IB,P_N>[=X7:\_9$S;J ?F"5?A"1 M01T)BFI2*4%19_H]_\7K6'90?LOOA1R#)M_>BS#35T<_N!4WVBX3&FL>M-\, M6.26'*O!^[<;3DKOZ/KW4_Q,GIYCR5I( KTA]H/0!LX4_;X\=&TWER'O=YY, M ZM3GBAF/ U':+\*N5KKWGP2?+]S2XMS4^907L<=#;)/%9-F=\D;7M MA]>8AN4JPR6:H.#$=H5;6=I,%L2K%*N+.JO$&P>4HY[\B!=-%ML^B?>&NOF8 MXXW:,@(3$K">"S.+[9PDP%K4/RYJE=\_EKJCZ&$%\0J!!!#@0]$3@E^1 &-3 ML6^?UK$7U/C6QME>F2BC4[<^EFI7 *Y42D%2SD61:VXQ04@^@8F7K(?K'#^% M/F[X[4HYCY:LM@;$S0S!ZD[V; L"1CTA%FI34%KZ>&E_+YVSS+(_;RY<2V1Z M\9E=SL.7*X_[QA<7R@9TNN$LG9BIXEJG'I@YL+D(QN M*V&PZ6KKI,22A\I$#97-O:M\U,W\+H_ZR"+R #W:77$9+T&(P>OEX*B>);Q$ M(]'[19[<99Q%=UH<;Z6F:WB=ZGI9*5ZFJ V X-_CELE"X#&:,J_M.NY1,<2Z M_W[8N?AZ8_ST^&+]16W3#9%5-@YH]DSA#D@CH'OI$D8_A%RH>&)\TPFUO>$9 MI;/;+.\MRWZ)]-VS&9JXK,PTP*J,M<^^=":SLG!S'FP)WW(?2]Y8UU:6T^P' M?:?OT8\!T4$MRA?Q?.A^//]9;6]T[SLJ+/1CP$N55[QUN1=57E'JO4_8NX-) MP1;C@M ($N I9C-$!D@'D8F6.:W^95L?U56W?FCCW/M<*F22)BC]<'FV )LS M3@+8PMD@(>937KK#'N+Z^A;2T2//XQ*CF$X8%QLJ\MONP#I-:T#,4&4,95@. M%-BJ2S : C-]-&J)[68=)7XI,$5QY(8#N"R,KOLP4;A5) MP$VAY1.#=NQV:R[QZGVT=2^[7!1>%T/_;*+<:_'BCB[QQW=PWCU"%<(TW_$Z M0YHZ0U!SML3#$3H5)US%ZA:1F;B4)8B!UCD7]N= 1L#8&NU+=H:&4\Y2RM+'!I-2O#55%:'[4M(",AKY:J+ M_=1_!1!"5XR"<-"G"23 XZYS$H"*W//[P ^P>8069Z)P0#]&-N[;#^2B29]B M[)FN6>VOS^,CM'$/]J^U*$!6.SDC8#J'S'3U4D;&C0B,]"["/@[/-E4& [O. M-[ER0+[]F=='[Y6M@@65-;RBF!$+Q0@+?,\=A>OA%(6,G-YE//-=X\LK_7N6 M.5 CM&#):P\9[=M3OV87\DJXCFAR;%_E(5\Z6<-;-^3+4["V9 IK-XNWP\GE M0"9ZLH0G:ZC+0#^SEH:F$7(7E]U-%V-\7U'38\W V;A!\FH43"C1H^M[EFZC MEV..+>W-QDOS6L.[4--WJR/[-D$?-MT?SO8_"[(JJ,UE'_1TJ*F-Y[$WG&B7 M.%L@T./ JWOW41\#O>B9MP[:GTZ+K;9$VC!F?!3@X.DI2U4)T_.J/4623Y&& M6R44(!=A2+M\]\]'TXKER>4+G[@"LV2P9M?:%.$*K:)'*BTZ1YGL\50%.@'C MUS1Y,)X=AW@MG%\)Q >Q\4"A0JFL6B<_U>=),F?0[B<\>./?[EX%O3(T98?_ M+[I1HEOTP23 5?& ZQ"SFMG]@$4_=R&XMW>U@T_?Q<+!KJ");7VHR=?_!._5 M_<_P,9KVTGO08^Z$\"E[#2YV/ P4J&D)LXM^XEVFA("_#K[_2;GI6.S_2JXQ>T- &5ZFQ\0F5.4N%&I189W13ZN*((6:/#$MJAB. M&'E;1H$O#/M_5A=:6 06JBXE-%&IZD]]3/,YBRNMFW'3]'86^9#,EJBHF/4U MI)-)ANF'45ZQWHA%->21JHCPZA$H). ">BG'FU:H@\@Q?C ;[%):$P.QY;>F M\OBJ'+%N&7;SN>S2.G]:_WU41;@*'6:JYSXNI>L]3Z10Z 7.]/(,VA^"=!KC MV^ZC2L8;G_/GMIJ@S(K^> Z@J2YX;^H(OIVW^)=\-OMT1WY/M\O9EI,0LQU[W7;]P8U MSNF9>U%\2?J7S;1NA6R!);NM*- SP0AD"Q"Y**0J=^%QO][WZ.7A^>92M$L43 M)JUU9/]QU%G!:TN]64MC?$.Y6='D-1"G 0Z(%G9N-76N&H2$(.F#E,R*:#5?HDTBO#/5>-NF M"AT-]"4TU5I_?2'*C#LBG+.2'-+JF!/-S/M/>.MC-6*.#.Z*#-_TE,NEYOO< MC+->V2'XG;OL=+WG&JG=*%U&/'.LK.W_U( @OK:<#Z>D\[@K^BTG6F)IA6D$ MEXL<#<4[8=HC6R1SP0=LESF>3R ;14.2XK;=0X:]GAMD6%">?QG)1W=W-O7& MQ:62 *$U#W9$KZ/&ES;UPK7V3A)!Y"TNB*)TCUTQ)L3%U7VT=K6U=67*SVP! MT\BB;VFAU $BQ?$7 P$ -T#15L[>/K.F$(H^-(L28U+4?$9 MMDSM&?4/?)T,O]BL*DN!?:(E]EX=*BS?A"J@X7%9?5=X+$G.FVDQ)Z<*O$#VLIEI!'/:B:*3E*9K2S#1/)57[OK]6/N+ M36_O'*H@;1Y96SOGS\[/F5GT.MJ[LG?3MEQAE$]Z>*TX-_ K , )$,V<"6"" MB/:R?W^;/AIR1 MZIGIM:=DQ45\J\>X5'R,-*BYP44XJ8NIRTL\=& V4"^4H MGC>M))2]_=U"M0XM@\V@Z1,.=V=/>U:K\12PFMZ,HJ?$P7K3[IJ!TYDS2N+5P+=M%:KRM+_!JQ/VEVQ M>X+:0E>^7DC65O*622F&2J%]&DLS04;HK(C"M[VI<83I#)KJ]8?7H'U&

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਄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